MTC

eHealth DSI

[eHDSI v3.0.0-RC1] eHealth DSI – Master Value Set Catalogue

Responsible : Terminologist CEF eHDSI Service Provider PublishDate : Tue Apr 30 16:24:21 CEST 2019

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 1 of 624 Service Provider MTC

Table of Contents

eHDSI-AbsentOrUnknownAllergies 4 eHDSI-AbsentOrUnknownDevices 5 eHDSI-AbsentOrUnknownMedication 6 eHDSI-AbsentOrUnknownProblems 7 eHDSI-AbsentOrUnknownProcedures 8 epSOSActiveIngredient 9 epSOSAdministrativeGender 166 epSOSAdverseEventType 167 epSOSAllergenNoDrugs 168 epSOSBloodGroup 173 epSOSBloodPressure 174 epSOSCodeProb 175 epSOSConfidentiality 176 epSOSCountry 177 epSOSDisplayLabel 184 epSOSDocumentCode 187 epSOSDoseForm 188 epSOSHealthcareProfessionalRoles 204 epSOSIllnessesandDisorders 206 © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 2 of 624 Service Provider MTC

epSOSLanguage 557 epSOSMedicalDevices 573 epSOSNullFavor 576 epSOSPackage 577 epSOSPersonalRelationship 580 epSOSPregnancyInformation 582 epSOSProcedures 583 epSOSReactionAllergy 587 epSOSResolutionOutcome 589 epSOSRoleClass 590 epSOSRouteofAdministration 591 epSOSSections 594 epSOSSeverity 595 epSOSSocialHistory 596 epSOSStatusCode 597 epSOSSubstitutionCode 598 epSOSTelecomAddress 599 epSOSTimingEvent 600 epSOSUnits 601 epSOSVaccine 622

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 3 of 624 Service Provider MTC eHDSI-AbsentOrUnknownAllergies

eHDSI-AbsentOrUnknownAllergies

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.47

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-allergy-info No information about allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-allergies No known allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-environmental-allergies No known environmental allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-food-allergies No known food allergies 2.16.840.1.113883.5.1150.1 0.2.0 no-known-medication-allergies No known medication allergies

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 4 of 624 Service Provider MTC eHDSI-AbsentOrUnknownDevices

eHDSI-AbsentOrUnknownDevices

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.48

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-device-info No information about devices 2.16.840.1.113883.5.1150.1 0.2.0 no-known-devices No known devices in use

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 5 of 624 Service Provider MTC eHDSI-AbsentOrUnknownMedication

eHDSI-AbsentOrUnknownMedication

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.49

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known-medications No known medications 2.16.840.1.113883.5.1150.1 0.2.0 no-medication-info No information about medications

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 6 of 624 Service Provider MTC eHDSI-AbsentOrUnknownProblems

eHDSI-AbsentOrUnknownProblems

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.50

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known-problems No known problems 2.16.840.1.113883.5.1150.1 0.2.0 no-problem-info No information about problems

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 7 of 624 Service Provider MTC eHDSI-AbsentOrUnknownProcedures

eHDSI-AbsentOrUnknownProcedures

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.51

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1150.1 0.2.0 no-known-procedures No known procedures 2.16.840.1.113883.5.1150.1 0.2.0 no-procedure-info No information about past history of procedures

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 8 of 624 Service Provider MTC epSOSActiveIngredient

epSOSActiveIngredient

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND Matsmältningsorgan och METABOLISM ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A01 STOMATOLOGICAL Medel vid mun- och tandsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01A STOMATOLOGICAL Medel vid mun- och tandsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01AA Caries prophylactic agents Medel mot karies 2.16.840.1.113883.6.73 2017-01 A01AA01 sodium fluoride Natriumfluorid 2.16.840.1.113883.6.73 2017-01 A01AA02 sodium monofluorophosphate Natriummonofluorofosfat 2.16.840.1.113883.6.73 2017-01 A01AA03 olaflur Olaflur 2.16.840.1.113883.6.73 2017-01 A01AA04 stannous fluoride Tennfluorid 2.16.840.1.113883.6.73 2017-01 A01AA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A01AA51 sodium fluoride, combinations Natriumfluorid, kombinationer 2.16.840.1.113883.6.73 2017-01 A01AB Antiinfectives and antiseptics for Antiinfektiva och antiseptiska medel local oral treatment för lokal behandling i munhålan 2.16.840.1.113883.6.73 2017-01 A01AB02 hydrogen peroxide Väteperoxid 2.16.840.1.113883.6.73 2017-01 A01AB03 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 A01AB04 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 A01AB05 polynoxylin Polynoxylin 2.16.840.1.113883.6.73 2017-01 A01AB06 domiphen Domifen 2.16.840.1.113883.6.73 2017-01 A01AB07 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 A01AB08 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 A01AB09 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 A01AB10 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 A01AB11 various Övrigt 2.16.840.1.113883.6.73 2017-01 A01AB12 hexetidine Hexetidin 2.16.840.1.113883.6.73 2017-01 A01AB13 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 A01AB14 benzoxonium chloride Bensoxoniumklorid 2.16.840.1.113883.6.73 2017-01 A01AB15 tibezonium iodide Tibezoniumjodid 2.16.840.1.113883.6.73 2017-01 A01AB16 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 A01AB17 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 A01AB18 clotrimazole Klotrimazol 2.16.840.1.113883.6.73 2017-01 A01AB19 sodium perborate Natriumperborat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 9 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A01AB21 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 A01AB22 doxycycline Doxycyklin 2.16.840.1.113883.6.73 2017-01 A01AB23 minocycline Minocyklin 2.16.840.1.113883.6.73 2017-01 A01AC Corticosteroids for local oral Kortikosteroider för lokal behandling treatment i munhålan 2.16.840.1.113883.6.73 2017-01 A01AC01 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 A01AC02 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 A01AC03 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 A01AC54 prednisolone, combinations Prednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 A01AD Other agents for local oral treatment Övriga medel för lokal behandling i munhålan 2.16.840.1.113883.6.73 2017-01 A01AD01 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 A01AD02 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 A01AD05 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 A01AD06 adrenalone Adrenon 2.16.840.1.113883.6.73 2017-01 A01AD07 amlexanox Amlexanox 2.16.840.1.113883.6.73 2017-01 A01AD08 becaplermin Bekaplermin 2.16.840.1.113883.6.73 2017-01 A01AD11 various Övrigt 2.16.840.1.113883.6.73 2017-01 A02 DRUGS FOR ACID RELATED Medel vid syrarelaterade symtom DISORDERS 2.16.840.1.113883.6.73 2017-01 A02A ANTACIDS Antacida 2.16.840.1.113883.6.73 2017-01 A02AA Magnesium compounds Magnesiumföreningar 2.16.840.1.113883.6.73 2017-01 A02AA01 magnesium carbonate Magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AA02 magnesium oxide Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A02AA03 magnesium peroxide Magnesiumperoxid 2.16.840.1.113883.6.73 2017-01 A02AA04 magnesium hydroxide Magnesiumhydroxid 2.16.840.1.113883.6.73 2017-01 A02AA05 magnesium silicate Magnesiumsilikat 2.16.840.1.113883.6.73 2017-01 A02AA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AB Aluminium compounds Aluminiumföreningar 2.16.840.1.113883.6.73 2017-01 A02AB01 aluminium hydroxide Aluminiumhydroxid 2.16.840.1.113883.6.73 2017-01 A02AB02 algeldrate Algeldrat 2.16.840.1.113883.6.73 2017-01 A02AB03 aluminium phosphate Aluminiumfosfat 2.16.840.1.113883.6.73 2017-01 A02AB04 dihydroxialumini sodium carbonate Dihydroxialuminiumnatriumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AB05 aluminium acetoacetate Aluminiumacetoacetat 2.16.840.1.113883.6.73 2017-01 A02AB06 aloglutamol Aloglutamol 2.16.840.1.113883.6.73 2017-01 A02AB07 aluminium glycinate Aluminium glycinat 2.16.840.1.113883.6.73 2017-01 A02AB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AC Calcium compounds Kalciumföreningar 2.16.840.1.113883.6.73 2017-01 A02AC01 calcium carbonate Kalciumkarbonat 2.16.840.1.113883.6.73 2017-01 A02AC02 calcium silicate Kalciumsilikat 2.16.840.1.113883.6.73 2017-01 A02AC10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A02AD Combinations and complexes of Kombinationer och komplex av aluminium, calcium and magnesium aluminium-, kalcium- och compounds magnesiumföreningar

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 10 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02AD01 ordinary salt combinations Aluminium-, kalcium- och magnesiumsalter 2.16.840.1.113883.6.73 2017-01 A02AD02 magaldrate Magaldrat 2.16.840.1.113883.6.73 2017-01 A02AD03 almagate Almagat 2.16.840.1.113883.6.73 2017-01 A02AD04 hydrotalcite Hydrotalcit 2.16.840.1.113883.6.73 2017-01 A02AD05 almasilate Almasilat 2.16.840.1.113883.6.73 2017-01 A02AF Antacids with antiflatulents Antacida och medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AF01 magaldrate and antiflatulents Magaldrat och medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AF02 ordinary salt combinations and Aluminium-, kalcium- och antiflatulents magnesiumsalter samt medel mot meteorism 2.16.840.1.113883.6.73 2017-01 A02AG Antacids with antispasmodics Antacida och spasmolytika 2.16.840.1.113883.6.73 2017-01 A02AH Antacids with sodium bicarbonate Antacida med natriumvätekarbonat 2.16.840.1.113883.6.73 2017-01 A02AX Antacids, other combinations Antacida, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A02B DRUGS FOR PEPTIC ULCER AND Medel vid magsår och GASTRO-OESOPHAGEAL gastroesofageal refluxsjukdom REFLUX DISEASE (GORD) 2.16.840.1.113883.6.73 2017-01 A02BA H2-receptor antagonists Histamin-2-receptorantagonister 2.16.840.1.113883.6.73 2017-01 A02BA01 cimetidine Cimetidin 2.16.840.1.113883.6.73 2017-01 A02BA02 ranitidine Ranitidin 2.16.840.1.113883.6.73 2017-01 A02BA03 famotidine Famotidin 2.16.840.1.113883.6.73 2017-01 A02BA04 nizatidine Nizatidin 2.16.840.1.113883.6.73 2017-01 A02BA05 niperotidine Niperotidin 2.16.840.1.113883.6.73 2017-01 A02BA06 roxatidine Roxatidin 2.16.840.1.113883.6.73 2017-01 A02BA07 ranitidine bismuth citrate Ranitidinvismutcitrat 2.16.840.1.113883.6.73 2017-01 A02BA08 lafutidine Lafutidin 2.16.840.1.113883.6.73 2017-01 A02BA51 cimetidine, combinations Cimetidin, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BA53 famotidine, combinations Famotidin, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BB Prostaglandins Prostaglandiner 2.16.840.1.113883.6.73 2017-01 A02BB01 misoprostol Misoprostol 2.16.840.1.113883.6.73 2017-01 A02BB02 enprostil Enprostil 2.16.840.1.113883.6.73 2017-01 A02BC Proton pump inhibitors Protonpumpshämmare 2.16.840.1.113883.6.73 2017-01 A02BC01 omeprazole Omeprazol 2.16.840.1.113883.6.73 2017-01 A02BC02 pantoprazole Pantoprazol 2.16.840.1.113883.6.73 2017-01 A02BC03 lansoprazole Lansoprazol 2.16.840.1.113883.6.73 2017-01 A02BC04 rabeprazole Rabeprazol 2.16.840.1.113883.6.73 2017-01 A02BC05 esomeprazole Esomeprazol 2.16.840.1.113883.6.73 2017-01 A02BC06 dexlansoprazole Dexlansoprazol 2.16.840.1.113883.6.73 2017-01 A02BC07 dexrabeprazole Dexrabeprazol 2.16.840.1.113883.6.73 2017-01 A02BC53 lansoprazole, combinations Lansoprazol, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BC54 rabeprazole, combinations Rabeprazol, kombinationer 2.16.840.1.113883.6.73 2017-01 A02BD Combinations for eradication of Kombinationer för eradikering av Helicobacter pylori Helicobacter pylori 2.16.840.1.113883.6.73 2017-01 A02BD01 omeprazole, amoxicillin and Omeprazol, amoxicillin och metronidazole metronidazol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 11 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02BD02 lansoprazole, tetracycline and Lansoprazol, tetracyklin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD03 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD04 pantoprazole, amoxicillin and Pantoprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD05 omeprazole, amoxicillin and Omeprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD06 esomeprazole, amoxicillin and Esomeprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD07 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och clarithromycin klaritromycin 2.16.840.1.113883.6.73 2017-01 A02BD08 bismuth subcitrate, tetracycline and Vismutsubcitrat, tetracyklin och metronidazole metronidazol 2.16.840.1.113883.6.73 2017-01 A02BD09 lansoprazole, clarithromycin and Lansoprazol, klaritromycin och tinidazole tinidazol 2.16.840.1.113883.6.73 2017-01 A02BD10 lansoprazole, amoxicillin and Lansoprazol, amoxicillin och levofloxacin levofloxacin 2.16.840.1.113883.6.73 2017-01 A02BD11 pantoprazole, amoxicillin, Pantoprazol, amoxicillin, clarithromycin and metronidazole klaritromycin och metronidazol 2.16.840.1.113883.6.73 2017-01 A02BX Other drugs for peptic ulcer and Övriga medel vid magsår och gastro-oesophageal reflux disease gastroesofageal refluxsjukdom (GORD) 2.16.840.1.113883.6.73 2017-01 A02BX01 carbenoxolone Karbenoxolon 2.16.840.1.113883.6.73 2017-01 A02BX02 sucralfate Sukralfat 2.16.840.1.113883.6.73 2017-01 A02BX03 pirenzepine Pirenzepin 2.16.840.1.113883.6.73 2017-01 A02BX04 methiosulfonium chloride Metiosulfonklorid 2.16.840.1.113883.6.73 2017-01 A02BX05 bismuth subcitrate Vismutsubcitrat 2.16.840.1.113883.6.73 2017-01 A02BX06 proglumide Proglumid 2.16.840.1.113883.6.73 2017-01 A02BX07 gefarnate Gefarnat 2.16.840.1.113883.6.73 2017-01 A02BX08 sulglicotide Sulglikotid 2.16.840.1.113883.6.73 2017-01 A02BX09 acetoxolone Acetoxolon 2.16.840.1.113883.6.73 2017-01 A02BX10 zolimidine Zolimidin 2.16.840.1.113883.6.73 2017-01 A02BX11 troxipide Troxipid 2.16.840.1.113883.6.73 2017-01 A02BX12 bismuth subnitrate Vismutsubnitrat 2.16.840.1.113883.6.73 2017-01 A02BX13 alginic acid Alginsyra 2.16.840.1.113883.6.73 2017-01 A02BX51 carbenoxolone, combinations excl. Karbenoxolon, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 A02BX71 carbenoxolone, combinations with Karbenoxolon, kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 A02BX77 gefarnate, combinations with Gefarnat, kombination med psycholeptics lugnande medel 2.16.840.1.113883.6.73 2017-01 A02X OTHER DRUGS FOR ACID Övriga medel vid syrarelaterade RELATED DISORDERS sjukdomar 2.16.840.1.113883.6.73 2017-01 A03 DRUGS FOR FUNCTIONAL Medel vid funktionella mag- GASTROINTESTINAL tarmsymtom DISORDERS 2.16.840.1.113883.6.73 2017-01 A03A DRUGS FOR FUNCTIONAL Medel vid funktionella mag- GASTROINTESTINAL tarmsymtom DISORDERS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 12 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03AA Synthetic anticholinergics, esters Syntetiska antikolinergika, estrar with tertiary amino group med tertiär aminogrupp 2.16.840.1.113883.6.73 2017-01 A03AA01 oxyphencyclimine Oxifencyklimin 2.16.840.1.113883.6.73 2017-01 A03AA03 camylofin Kamylofin 2.16.840.1.113883.6.73 2017-01 A03AA04 mebeverine Mebeverin 2.16.840.1.113883.6.73 2017-01 A03AA05 trimebutine Trimebutin 2.16.840.1.113883.6.73 2017-01 A03AA06 rociverine Rociverin 2.16.840.1.113883.6.73 2017-01 A03AA07 dicycloverine Dicycloverin 2.16.840.1.113883.6.73 2017-01 A03AA08 dihexyverine Dihexiverin 2.16.840.1.113883.6.73 2017-01 A03AA09 difemerine Difemerin 2.16.840.1.113883.6.73 2017-01 A03AA30 piperidolate Piperidolat 2.16.840.1.113883.6.73 2017-01 A03AB Synthetic anticholinergics, Syntetiska antikolinergika, kvartära quaternary ammonium compounds ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 A03AB01 benzilone Bensilon 2.16.840.1.113883.6.73 2017-01 A03AB02 glycopyrronium bromide Glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB03 oxyphenonium Oxyfenon 2.16.840.1.113883.6.73 2017-01 A03AB04 penthienate Pentienat 2.16.840.1.113883.6.73 2017-01 A03AB05 propantheline Propantelin 2.16.840.1.113883.6.73 2017-01 A03AB06 otilonium bromide Otiloniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB07 methantheline Metantelin 2.16.840.1.113883.6.73 2017-01 A03AB08 tridihexethyl Tridihexetyl 2.16.840.1.113883.6.73 2017-01 A03AB09 isopropamide Isopropon 2.16.840.1.113883.6.73 2017-01 A03AB10 hexocyclium Hexocyklium 2.16.840.1.113883.6.73 2017-01 A03AB11 poldine Poldin 2.16.840.1.113883.6.73 2017-01 A03AB12 mepenzolate Mepensolat 2.16.840.1.113883.6.73 2017-01 A03AB13 bevonium Bevonium 2.16.840.1.113883.6.73 2017-01 A03AB14 pipenzolate Pipenzolat 2.16.840.1.113883.6.73 2017-01 A03AB15 diphemanil Difemanil 2.16.840.1.113883.6.73 2017-01 A03AB16 (2-benzhydryloxyethyl)diethyl- (2-Benshydryloxietyl) methylammonium iodide dietylmetylammoniumjodid 2.16.840.1.113883.6.73 2017-01 A03AB17 tiemonium iodide Tiemoniumjodid 2.16.840.1.113883.6.73 2017-01 A03AB18 prifinium bromide Prifiniumbromid 2.16.840.1.113883.6.73 2017-01 A03AB19 timepidium bromide Timepidiumbromid 2.16.840.1.113883.6.73 2017-01 A03AB21 fenpiverinium Fenpiverinium 2.16.840.1.113883.6.73 2017-01 A03AB53 oxyphenonium, combinations Oxifenon, kombinationer 2.16.840.1.113883.6.73 2017-01 A03AC Synthetic antispasmodics, amides Syntetiska spasmolytika, amider with tertiary amines med tertiär aminogrupp 2.16.840.1.113883.6.73 2017-01 A03AC02 dimethylaminopropionylphenothiazin Dimetylaminopropionylfenotiazin e 2.16.840.1.113883.6.73 2017-01 A03AC04 nicofetamide Nikofetamid 2.16.840.1.113883.6.73 2017-01 A03AC05 tiropramide Tiropramid 2.16.840.1.113883.6.73 2017-01 A03AD Papaverine and derivatives Papaverin och derivat 2.16.840.1.113883.6.73 2017-01 A03AD01 papaverine Papaverin 2.16.840.1.113883.6.73 2017-01 A03AD02 drotaverine Drotaverin 2.16.840.1.113883.6.73 2017-01 A03AD30 moxaverine Moxaverin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 13 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03AE Serotonin receptor antagonists Serotoninreceptorantagonister 2.16.840.1.113883.6.73 2017-01 A03AE01 alosetron Alosetron 2.16.840.1.113883.6.73 2017-01 A03AE03 cilansetron Cilansetron 2.16.840.1.113883.6.73 2017-01 A03AX Other drugs for functional Övriga medel vid funktionella mag- gastrointestinal disorders tarmsymtom 2.16.840.1.113883.6.73 2017-01 A03AX01 fenpiprane Fenpipran 2.16.840.1.113883.6.73 2017-01 A03AX02 diisopromine Diisopromin 2.16.840.1.113883.6.73 2017-01 A03AX03 chlorbenzoxamine Klorbensoxamin 2.16.840.1.113883.6.73 2017-01 A03AX04 pinaverium Pinaverin 2.16.840.1.113883.6.73 2017-01 A03AX05 fenoverine Fenoverin 2.16.840.1.113883.6.73 2017-01 A03AX06 idanpramine Idanpramin 2.16.840.1.113883.6.73 2017-01 A03AX07 proxazole Proxazol 2.16.840.1.113883.6.73 2017-01 A03AX08 alverine Alverin 2.16.840.1.113883.6.73 2017-01 A03AX09 trepibutone Trepibuton 2.16.840.1.113883.6.73 2017-01 A03AX10 isometheptene Isomethepten 2.16.840.1.113883.6.73 2017-01 A03AX11 caroverine Karoverin 2.16.840.1.113883.6.73 2017-01 A03AX12 phloroglucinol Floroglucinol 2.16.840.1.113883.6.73 2017-01 A03AX13 silicones Silikoner 2.16.840.1.113883.6.73 2017-01 A03AX14 valethamate Valetamat 2.16.840.1.113883.6.73 2017-01 A03AX30 trimethyldiphenylpropylamine Trimetyldifenylpropylamin 2.16.840.1.113883.6.73 2017-01 A03AX58 alverine, combinations Alverin, kombinationer 2.16.840.1.113883.6.73 2017-01 A03B BELLADONNA AND Belladonnaalkaloider och derivat DERIVATIVES, PLAIN 2.16.840.1.113883.6.73 2017-01 A03BA Belladonna alkaloids, tertiary Belladonnaalkaloider med tertiär amines aminogrupp 2.16.840.1.113883.6.73 2017-01 A03BA01 atropine Atropin 2.16.840.1.113883.6.73 2017-01 A03BA03 hyoscyamine Hyoscyamin 2.16.840.1.113883.6.73 2017-01 A03BA04 belladonna total alkaloids Belladonnaalkaloider 2.16.840.1.113883.6.73 2017-01 A03BB Belladonna alkaloids, semisynthetic, Semisyntetiska belladonnalkaloider, quaternary ammonium compounds kvartära ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 A03BB01 butylscopolamine Butylskopolamin 2.16.840.1.113883.6.73 2017-01 A03BB02 methylatropine Metylatropin 2.16.840.1.113883.6.73 2017-01 A03BB03 methylscopolamine Metylskopolamin 2.16.840.1.113883.6.73 2017-01 A03BB04 fentonium Fentonin 2.16.840.1.113883.6.73 2017-01 A03BB05 cimetropium bromide Cimetropiumbromid 2.16.840.1.113883.6.73 2017-01 A03C ANTISPASMODICS IN Spasmolytika i kombination med COMBINATION WITH lugnande medel PSYCHOLEPTICS 2.16.840.1.113883.6.73 2017-01 A03CA Synthetic anticholinergic agents in Syntetiska antikolinergika i combination with psycholeptics kombination med lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA01 isopropamide and psycholeptics Isopropon och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA02 clidinium and psycholeptics Klidinium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA03 oxyphencyclimine and psycholeptics Oxifencyklimin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA04 otilonium bromide and psycholeptics Otiloniumbromid och lugnande medel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 14 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03CA05 glycopyrronium bromide and Glykopyrroniumbromid och psycholeptics lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA06 bevonium and psycholeptics Bevonium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA07 ambutonium and psycholeptics Ambutonium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA08 diphemanil and psycholeptics Difemanil och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA09 pipenzolate and psycholeptics Pipenzolat och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA30 emepronium and psycholeptics Emepronium och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CA34 propantheline and psycholeptics Propantelin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB Belladonna and derivatives in Belladonnaalkaloider och derivat i combination with psycholeptics kombination med lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB01 methylscopolamine and Metylskopolamin och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB02 belladonna total alkaloids and Belladonnaalkaloider och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB03 atropine and psycholeptics Atropin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CB04 methylhomatropine and Metylhomatropin och lugnande psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03CB31 hyoscyamine and psycholeptics Hyoscyamin och lugnande medel 2.16.840.1.113883.6.73 2017-01 A03CC Other antispasmodics in Övriga kombinationer med lugnande combination with psycholeptics medel 2.16.840.1.113883.6.73 2017-01 A03D ANTISPASMODICS IN Spasmolytika i kombination med COMBINATION WITH analgetika ANALGESICS 2.16.840.1.113883.6.73 2017-01 A03DA Synthetic anticholinergic agents in Syntetiska antikolinergika i combination with analgesics kombination med analgetika 2.16.840.1.113883.6.73 2017-01 A03DA01 tropenzilone and analgesics Tropenzilon och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA02 pitofenone and analgesics Pitofenon och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA03 bevonium and analgesics Bevonium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA04 ciclonium and analgesics Ciklonium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA05 camylofin and analgesics Kamylofin och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA06 trospium and analgesics Trospium och analgetika 2.16.840.1.113883.6.73 2017-01 A03DA07 tiemonium iodide and analgesics Tiemoniumjodid och analgetika 2.16.840.1.113883.6.73 2017-01 A03DB Belladonna and derivatives in Belladonnaalkaloider och derivat i combination with analgesics kombination med analgetika 2.16.840.1.113883.6.73 2017-01 A03DB04 butylscopolamine and analgesics Butylskopolamin och analgetika 2.16.840.1.113883.6.73 2017-01 A03DC Other antispasmodics in Övriga kombinationer med combination with analgesics analgetika 2.16.840.1.113883.6.73 2017-01 A03E ANTISPASMODICS AND Övriga kombinationer ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS 2.16.840.1.113883.6.73 2017-01 A03EA Antispasmodics, psycholeptics and Spasmolytika, lugnande medel och analgesics in combination analgetika i kombination 2.16.840.1.113883.6.73 2017-01 A03ED Antispasmodics in combination with Spasmolytika i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 A03F PROPULSIVES Motilitetsstimulerande medel 2.16.840.1.113883.6.73 2017-01 A03FA Propulsives Motilitetsstimulerande medel 2.16.840.1.113883.6.73 2017-01 A03FA01 metoclopramide Metoklopramid 2.16.840.1.113883.6.73 2017-01 A03FA02 cisapride Cisaprid © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 15 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03FA03 domperidone Domperidon 2.16.840.1.113883.6.73 2017-01 A03FA04 bromopride Bromoprid 2.16.840.1.113883.6.73 2017-01 A03FA05 alizapride Alizaprid 2.16.840.1.113883.6.73 2017-01 A03FA06 clebopride Kleboprid 2.16.840.1.113883.6.73 2017-01 A03FA07 itopride Itroprid 2.16.840.1.113883.6.73 2017-01 A03FA08 cinitapride Cinitaprid 2.16.840.1.113883.6.73 2017-01 A04 ANTIEMETICS AND Antiemetika ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04A ANTIEMETICS AND Antiemetika ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04AA Serotonin (5HT3) antagonists Serotonin (5HT3) receptorantagonister 2.16.840.1.113883.6.73 2017-01 A04AA01 ondansetron Ondansetron 2.16.840.1.113883.6.73 2017-01 A04AA02 granisetron Granisetron 2.16.840.1.113883.6.73 2017-01 A04AA03 tropisetron Tropisetron 2.16.840.1.113883.6.73 2017-01 A04AA04 dolasetron Dolasetron 2.16.840.1.113883.6.73 2017-01 A04AA05 palonosetron Palonosetron 2.16.840.1.113883.6.73 2017-01 A04AA55 palonosetron, combinations Palonosetron, kombinationer 2.16.840.1.113883.6.73 2017-01 A04AD Other antiemetics Övriga antiemetika 2.16.840.1.113883.6.73 2017-01 A04AD01 scopolamine Skopolamin 2.16.840.1.113883.6.73 2017-01 A04AD02 cerium oxalate Ceriumoxalat 2.16.840.1.113883.6.73 2017-01 A04AD04 chlorobutanol Klorbutanol 2.16.840.1.113883.6.73 2017-01 A04AD05 metopimazine Metopimazin 2.16.840.1.113883.6.73 2017-01 A04AD10 dronabinol Dronabinol 2.16.840.1.113883.6.73 2017-01 A04AD11 nabilone Nabilon 2.16.840.1.113883.6.73 2017-01 A04AD12 aprepitant Aprepitant 2.16.840.1.113883.6.73 2017-01 A04AD13 casopitant Kasopitant 2.16.840.1.113883.6.73 2017-01 A04AD14 rolapitant Rolapitant 2.16.840.1.113883.6.73 2017-01 A04AD51 scopolamine, combinations Skopolamin, kombinationer 2.16.840.1.113883.6.73 2017-01 A04AD54 chlorobutanol, combinations Klorbutanol, kombinationer 2.16.840.1.113883.6.73 2017-01 A05 BILE AND LIVER THERAPY Gall- och leverterapi 2.16.840.1.113883.6.73 2017-01 A05A BILE THERAPY Gallterapi 2.16.840.1.113883.6.73 2017-01 A05AA Bile acid preparations Gallsyror och derivat 2.16.840.1.113883.6.73 2017-01 A05AA01 chenodeoxycholic acid Kenodeoxicholsyra 2.16.840.1.113883.6.73 2017-01 A05AA02 ursodeoxycholic acid Ursodeoxicholsyra 2.16.840.1.113883.6.73 2017-01 A05AA03 cholic acid Cholsyra 2.16.840.1.113883.6.73 2017-01 A05AA04 obeticholic acid Obeticholsyra 2.16.840.1.113883.6.73 2017-01 A05AB Preparations for biliary tract therapy Medel för behandling av sjukdomar i gallvägarna 2.16.840.1.113883.6.73 2017-01 A05AB01 nicotinyl methylamide Nikotinylmetylamid 2.16.840.1.113883.6.73 2017-01 A05AX Other drugs for bile therapy Övriga medel vid gallterapi 2.16.840.1.113883.6.73 2017-01 A05AX01 piprozolin Piprozolin 2.16.840.1.113883.6.73 2017-01 A05AX02 hymecromone Hymekromon 2.16.840.1.113883.6.73 2017-01 A05AX03 cyclobutyrol Cyklobutyrol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 16 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A05B LIVER THERAPY, LIPOTROPICS Leverterapi, lipotroper 2.16.840.1.113883.6.73 2017-01 A05BA Liver therapy Leverterapi 2.16.840.1.113883.6.73 2017-01 A05BA01 arginine glutamate Argininglutamat 2.16.840.1.113883.6.73 2017-01 A05BA03 silymarin Silymarin 2.16.840.1.113883.6.73 2017-01 A05BA04 citiolone Citiolon 2.16.840.1.113883.6.73 2017-01 A05BA05 epomediol Epomediol 2.16.840.1.113883.6.73 2017-01 A05BA06 ornithine oxoglurate Ornitinoxoglurat 2.16.840.1.113883.6.73 2017-01 A05BA07 tidiacic arginine Tidiacikarginin 2.16.840.1.113883.6.73 2017-01 A05BA08 glycyrrhizic acid Glycyrrhizinsyra 2.16.840.1.113883.6.73 2017-01 A05C DRUGS FOR BILE THERAPY AND Medel för gallterapi och lipotropa LIPOTROPICS IN COMBINATION medel, kombinationer 2.16.840.1.113883.6.73 2017-01 A06 DRUGS FOR CONSTIPATION Medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06A DRUGS FOR CONSTIPATION Medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06AA Softeners, emollients Mjukgörare, emulgeringsmedel 2.16.840.1.113883.6.73 2017-01 A06AA01 liquid paraffin Flytande paraffin 2.16.840.1.113883.6.73 2017-01 A06AA02 docusate sodium Dokusatnatrium 2.16.840.1.113883.6.73 2017-01 A06AA51 liquid paraffin, combinations Flytande paraffin, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB Contact laxatives Tarmirriterande medel 2.16.840.1.113883.6.73 2017-01 A06AB01 oxyphenisatine Oxifenisatin 2.16.840.1.113883.6.73 2017-01 A06AB02 bisacodyl Bisakodyl 2.16.840.1.113883.6.73 2017-01 A06AB03 dantron Dantron 2.16.840.1.113883.6.73 2017-01 A06AB04 phenolphthalein Fenolftalein 2.16.840.1.113883.6.73 2017-01 A06AB05 castor oil Ricinolja 2.16.840.1.113883.6.73 2017-01 A06AB06 senna glycosides Sennaglykosider 2.16.840.1.113883.6.73 2017-01 A06AB07 cascara Sagrada, bark 2.16.840.1.113883.6.73 2017-01 A06AB08 sodium picosulfate Natriumpikosulfat 2.16.840.1.113883.6.73 2017-01 A06AB09 bisoxatin Bisoxatin 2.16.840.1.113883.6.73 2017-01 A06AB20 contact laxatives in combination Kombinationer av tarmirriterande medel 2.16.840.1.113883.6.73 2017-01 A06AB30 contact laxatives in combination with Tarmirriterande medel i kombination belladonna alkaloids med belladonnaalkaloider 2.16.840.1.113883.6.73 2017-01 A06AB52 bisacodyl, combinations Bisakodyl, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB53 dantron, combinations Dantron, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB56 senna glycosides, combinations Sennaglykosider, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB57 cascara, combinations Sagrada, bark med kombinationer 2.16.840.1.113883.6.73 2017-01 A06AB58 sodium picosulfate, combinations Natriumpikosulfat, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC Bulk-forming laxatives Bulkbildande laxermedel 2.16.840.1.113883.6.73 2017-01 A06AC01 ispaghula (psylla seeds) Loppfrö och vitt loppfrö 2.16.840.1.113883.6.73 2017-01 A06AC02 ethulose Etulos 2.16.840.1.113883.6.73 2017-01 A06AC03 sterculia Sterkuliagummi 2.16.840.1.113883.6.73 2017-01 A06AC05 linseed Linfrö 2.16.840.1.113883.6.73 2017-01 A06AC06 methylcellulose Metylcellulosa 2.16.840.1.113883.6.73 2017-01 A06AC07 triticum (wheat fibre) Kostfiber av vetefröskal 2.16.840.1.113883.6.73 2017-01 A06AC08 polycarbophil calcium Polykarbofilkalcium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 17 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AC51 ispaghula, combinations Loppfrö och vitt loppfrö, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC53 sterculia, combinations Sterkuliagummi, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AC55 linseed, combinations Linfrö, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AD Osmotically acting laxatives Osmotiskt aktiva laxermedel 2.16.840.1.113883.6.73 2017-01 A06AD01 magnesium carbonate Magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 A06AD02 magnesium oxide Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A06AD03 magnesium peroxide Magnesiumperoxid 2.16.840.1.113883.6.73 2017-01 A06AD04 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 A06AD10 mineral salts in combination Mineralsalter i kombination 2.16.840.1.113883.6.73 2017-01 A06AD11 lactulose Laktulos 2.16.840.1.113883.6.73 2017-01 A06AD12 lactitol Laktitol 2.16.840.1.113883.6.73 2017-01 A06AD13 sodium sulfate Natriumsulfat 2.16.840.1.113883.6.73 2017-01 A06AD14 pentaerithrityl Pentaeritrityl 2.16.840.1.113883.6.73 2017-01 A06AD15 macrogol Makrogol 2.16.840.1.113883.6.73 2017-01 A06AD16 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 A06AD17 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 A06AD18 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 A06AD19 magnesium citrate Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 A06AD21 sodium tartrate Natriumtartrat 2.16.840.1.113883.6.73 2017-01 A06AD61 lactulose, combinations Laktulos, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AD65 macrogol, combinations Makrogol, kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG Enemas Klysma 2.16.840.1.113883.6.73 2017-01 A06AG01 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 A06AG02 bisacodyl Bisakodyl 2.16.840.1.113883.6.73 2017-01 A06AG03 dantron, incl. combinations Dantron, inkl. kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG04 glycerol Glycerol 2.16.840.1.113883.6.73 2017-01 A06AG06 oil Olja 2.16.840.1.113883.6.73 2017-01 A06AG07 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 A06AG10 docusate sodium, incl. combinations Dokusatnatrium, inkl. kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG11 sodium lauryl sulfoacetate, incl. Natriumlaurylsulfoacetat, inkl. combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A06AG20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A06AH Peripheral opioid receptor Perifera opioidreceptorantagonister antagonists 2.16.840.1.113883.6.73 2017-01 A06AH01 methylnaltrexone bromide Metylnaltrexonbromid 2.16.840.1.113883.6.73 2017-01 A06AH02 alvimopan Alvimopan 2.16.840.1.113883.6.73 2017-01 A06AH03 naloxegol Naloxegol 2.16.840.1.113883.6.73 2017-01 A06AH04 naloxone Naloxon 2.16.840.1.113883.6.73 2017-01 A06AX Other drugs for constipation Övriga medel vid förstoppning 2.16.840.1.113883.6.73 2017-01 A06AX01 glycerol Glycerol 2.16.840.1.113883.6.73 2017-01 A06AX02 carbon dioxide producing drugs Koldioxidutvecklande medel 2.16.840.1.113883.6.73 2017-01 A06AX03 lubiprostone Lubiproston 2.16.840.1.113883.6.73 2017-01 A06AX04 linaclotide Linaklotid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 18 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AX05 prucalopride Prukaloprid 2.16.840.1.113883.6.73 2017-01 A06AX06 tegaserod Tegaserod 2.16.840.1.113883.6.73 2017-01 A07 ANTIDIARRHEALS, INTESTINAL Antidiarroika, intestinala ANTIINFLAMMATORY/ANTIINFEC antiinflammatoriska och antiinfektiva TIVE AGENTS medel 2.16.840.1.113883.6.73 2017-01 A07A INTESTINAL ANTIINFECTIVES Medel vid tarminfektioner 2.16.840.1.113883.6.73 2017-01 A07AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 A07AA01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 A07AA02 nystatin Nystatin 2.16.840.1.113883.6.73 2017-01 A07AA03 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 A07AA04 streptomycin Streptomycin 2.16.840.1.113883.6.73 2017-01 A07AA05 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 A07AA06 paromomycin Paromomycin 2.16.840.1.113883.6.73 2017-01 A07AA07 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 A07AA08 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 A07AA09 vancomycin Vankomycin 2.16.840.1.113883.6.73 2017-01 A07AA10 colistin Kolistin 2.16.840.1.113883.6.73 2017-01 A07AA11 rifaximin Rifaximin 2.16.840.1.113883.6.73 2017-01 A07AA12 fidaxomicin Fidaxomicin 2.16.840.1.113883.6.73 2017-01 A07AA51 neomycin, combinations Neomycin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07AA54 streptomycin, combinations Streptomycin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07AB Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 A07AB02 phthalylsulfathiazole Ftalylsulfatiazol 2.16.840.1.113883.6.73 2017-01 A07AB03 sulfaguanidine Sulfaguanidin 2.16.840.1.113883.6.73 2017-01 A07AB04 succinylsulfathiazole Succinylsulfatiazol 2.16.840.1.113883.6.73 2017-01 A07AC Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 A07AC01 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 A07AX Other intestinal antiinfectives Övriga medel vid intestinala infektioner 2.16.840.1.113883.6.73 2017-01 A07AX01 broxyquinoline Broxykinoliner 2.16.840.1.113883.6.73 2017-01 A07AX02 acetarsol Acetarsol 2.16.840.1.113883.6.73 2017-01 A07AX03 nifuroxazide Nifuroxazid 2.16.840.1.113883.6.73 2017-01 A07AX04 nifurzide Nifurzid 2.16.840.1.113883.6.73 2017-01 A07B INTESTINAL ADSORBENTS Antidiarroika 2.16.840.1.113883.6.73 2017-01 A07BA Charcoal preparations Adsorberande medel 2.16.840.1.113883.6.73 2017-01 A07BA01 medicinal charcoal Medicinskt kol 2.16.840.1.113883.6.73 2017-01 A07BA51 medicinal charcoal, combinations Medicinskt kol, kombinationer 2.16.840.1.113883.6.73 2017-01 A07BB Bismuth preparations Vismutpreparat 2.16.840.1.113883.6.73 2017-01 A07BC Other intestinal adsorbents Övriga antidiarroika 2.16.840.1.113883.6.73 2017-01 A07BC01 pectin Pektin 2.16.840.1.113883.6.73 2017-01 A07BC02 kaolin Kaolin 2.16.840.1.113883.6.73 2017-01 A07BC03 crospovidone Krospovidon 2.16.840.1.113883.6.73 2017-01 A07BC04 attapulgite Attapulgit 2.16.840.1.113883.6.73 2017-01 A07BC05 diosmectite Diosmektit

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 19 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A07BC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A07BC54 attapulgite, combinations Attapulgit, kombinationer 2.16.840.1.113883.6.73 2017-01 A07C ELECTROLYTES WITH Elektrolyter med kolhydrater CARBOHYDRATES 2.16.840.1.113883.6.73 2017-01 A07CA Oral rehydration salt formulations Elektrolyter med kolhydrater 2.16.840.1.113883.6.73 2017-01 A07D ANTIPROPULSIVES Propulsionsdämpande medel 2.16.840.1.113883.6.73 2017-01 A07DA Antipropulsives Propulsionsdämpande medel 2.16.840.1.113883.6.73 2017-01 A07DA01 diphenoxylate Difenoxylat 2.16.840.1.113883.6.73 2017-01 A07DA02 opium Opium 2.16.840.1.113883.6.73 2017-01 A07DA03 loperamide Loperamid 2.16.840.1.113883.6.73 2017-01 A07DA04 difenoxin Difenoxin 2.16.840.1.113883.6.73 2017-01 A07DA05 loperamide oxide Loperamidoxid 2.16.840.1.113883.6.73 2017-01 A07DA06 eluxadoline Eluxadolin 2.16.840.1.113883.6.73 2017-01 A07DA52 morphine, combinations Morfin, kombinationer 2.16.840.1.113883.6.73 2017-01 A07DA53 loperamide, combinations Loperamid, kombinationer 2.16.840.1.113883.6.73 2017-01 A07E INTESTINAL Medel vid intestinala inflammationer ANTIINFLAMMATORY AGENTS 2.16.840.1.113883.6.73 2017-01 A07EA Corticosteroids acting locally Kortikosteroider för lokal behandling 2.16.840.1.113883.6.73 2017-01 A07EA01 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 A07EA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 A07EA03 prednisone Prednison 2.16.840.1.113883.6.73 2017-01 A07EA04 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 A07EA05 tixocortol Tixokortol 2.16.840.1.113883.6.73 2017-01 A07EA06 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 A07EA07 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 A07EB Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 A07EB01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 A07EC Aminosalicylic acid and similar Aminosalicylsyra och liknande agents medel 2.16.840.1.113883.6.73 2017-01 A07EC01 sulfasalazine Sulfasalazin 2.16.840.1.113883.6.73 2017-01 A07EC02 mesalazine Mesalazin 2.16.840.1.113883.6.73 2017-01 A07EC03 olsalazine Olsalazin 2.16.840.1.113883.6.73 2017-01 A07EC04 balsalazide Balsalazid 2.16.840.1.113883.6.73 2017-01 A07F ANTIDIARRHEAL Antidiarroika, mikroorganismer MICROORGANISMS 2.16.840.1.113883.6.73 2017-01 A07FA Antidiarrheal microorganisms Antidiarroika, mikroorganismer 2.16.840.1.113883.6.73 2017-01 A07FA01 lactic acid producing organisms Mjölksyreproducerande organismer 2.16.840.1.113883.6.73 2017-01 A07FA02 saccharomyces boulardii Saccharomyces boulardii 2.16.840.1.113883.6.73 2017-01 A07FA51 lactic acid producing organisms, Mjölksyreproducerande organismer, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A07X OTHER ANTIDIARRHEALS Övriga medel mot diarre 2.16.840.1.113883.6.73 2017-01 A07XA Other antidiarrheals Övriga medel mot diarre 2.16.840.1.113883.6.73 2017-01 A07XA01 albumin tannate Albumintannat 2.16.840.1.113883.6.73 2017-01 A07XA02 ceratonia Ceratonia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 20 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A07XA03 calcium compounds Kalciumföreningar 2.16.840.1.113883.6.73 2017-01 A07XA04 racecadotril Racekadotril 2.16.840.1.113883.6.73 2017-01 A07XA51 albumin tannate, combinations Albumin tannat, kombinationer 2.16.840.1.113883.6.73 2017-01 A08 ANTIOBESITY PREPARATIONS, Antiobesitasmedel, exkl. EXCL. DIET PRODUCTS dietprodukter 2.16.840.1.113883.6.73 2017-01 A08A ANTIOBESITY PREPARATIONS, Antiobesitasmedel, exkl. EXCL. DIET PRODUCTS dietprodukter 2.16.840.1.113883.6.73 2017-01 A08AA Centrally acting antiobesity products Antiobesitasmedel, centralt verkande 2.16.840.1.113883.6.73 2017-01 A08AA01 phentermine Fentermin 2.16.840.1.113883.6.73 2017-01 A08AA02 fenfluramine Fenfluramin 2.16.840.1.113883.6.73 2017-01 A08AA03 amfepramone Amfepramon 2.16.840.1.113883.6.73 2017-01 A08AA04 dexfenfluramine Dexfenfluramin 2.16.840.1.113883.6.73 2017-01 A08AA05 mazindol Mazindol 2.16.840.1.113883.6.73 2017-01 A08AA06 etilamfetamine Etilamfetamin 2.16.840.1.113883.6.73 2017-01 A08AA07 cathine Katin 2.16.840.1.113883.6.73 2017-01 A08AA08 clobenzorex Klobenzorex 2.16.840.1.113883.6.73 2017-01 A08AA09 mefenorex Mefenorex 2.16.840.1.113883.6.73 2017-01 A08AA10 sibutramine Sibutramin 2.16.840.1.113883.6.73 2017-01 A08AA11 lorcaserin Lorkaserin 2.16.840.1.113883.6.73 2017-01 A08AA56 ephedrine, combinations Efedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 A08AA62 bupropion and naltrexone Bupropion och naltrexon 2.16.840.1.113883.6.73 2017-01 A08AB Peripherally acting antiobesity Antiobesitasmedel, perifert products verkande 2.16.840.1.113883.6.73 2017-01 A08AB01 orlistat Orlistat 2.16.840.1.113883.6.73 2017-01 A08AX Other antiobesity drugs Övriga antiobesitasmedel 2.16.840.1.113883.6.73 2017-01 A08AX01 rimonabant Rimonabant 2.16.840.1.113883.6.73 2017-01 A09 DIGESTIVES, INCL. ENZYMES Digestionsmedel, inkl. enzymer 2.16.840.1.113883.6.73 2017-01 A09A DIGESTIVES, INCL. ENZYMES Digestionsmedel, inkl. enzymer 2.16.840.1.113883.6.73 2017-01 A09AA Enzyme preparations Digestionsenzymer 2.16.840.1.113883.6.73 2017-01 A09AA01 diastase Diastas 2.16.840.1.113883.6.73 2017-01 A09AA02 multienzymes (lipase, protease etc.) Multienzymer (lipas, proteas m.fl.) 2.16.840.1.113883.6.73 2017-01 A09AA03 pepsin Pepsin 2.16.840.1.113883.6.73 2017-01 A09AA04 tilactase Tilaktas 2.16.840.1.113883.6.73 2017-01 A09AB Acid preparations Saltsyraersättningsmedel 2.16.840.1.113883.6.73 2017-01 A09AB01 glutamic acid hydrochloride Aciglumin 2.16.840.1.113883.6.73 2017-01 A09AB02 betaine hydrochloride Betainhydroklorid 2.16.840.1.113883.6.73 2017-01 A09AB03 hydrochloric acid Saltsyra 2.16.840.1.113883.6.73 2017-01 A09AB04 citric acid Citronsyra 2.16.840.1.113883.6.73 2017-01 A09AC Enzyme and acid preparations, Enzym och syra, kombinationer combinations 2.16.840.1.113883.6.73 2017-01 A09AC01 pepsin and acid preparations Pepsin och syra 2.16.840.1.113883.6.73 2017-01 A09AC02 multienzymes and acid preparations Multienzymer och syra 2.16.840.1.113883.6.73 2017-01 A10 DRUGS USED IN DIABETES Diabetesmedel 2.16.840.1.113883.6.73 2017-01 A10A INSULINS AND ANALOGUES Insuliner och analoger © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 21 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10AB Insulins and analogues for injection, Insuliner och analoger för injektion, fast-acting snabbverkande 2.16.840.1.113883.6.73 2017-01 A10AB01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AB02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AB03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AB04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AB05 insulin aspart Insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AB06 insulin glulisine Insulin, glulisin 2.16.840.1.113883.6.73 2017-01 A10AB30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AC Insulins and analogues for injection, Insuliner och analoger för injektion, intermediate-acting medellångverkande 2.16.840.1.113883.6.73 2017-01 A10AC01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AC02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AC03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AC04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AD Insulins and analogues for injection, Insuliner och analoger för injektion, intermediate- or long-acting medellång- eller långverkande i combined with fast-acting kombination med snabbverkande 2.16.840.1.113883.6.73 2017-01 A10AD01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AD02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AD03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AD04 insulin lispro Insulin, lispro 2.16.840.1.113883.6.73 2017-01 A10AD05 insulin aspart Insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AD06 insulin degludec and insulin aspart Insulin, degludek och insulin, aspart 2.16.840.1.113883.6.73 2017-01 A10AD30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AE Insulins and analogues for injection, Insuliner och analoger för injektion, long-acting långverkande 2.16.840.1.113883.6.73 2017-01 A10AE01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10AE02 insulin (beef) Insulin (bovint) 2.16.840.1.113883.6.73 2017-01 A10AE03 insulin (pork) Insulin (svin) 2.16.840.1.113883.6.73 2017-01 A10AE04 insulin glargine Insulin, glargin 2.16.840.1.113883.6.73 2017-01 A10AE05 insulin detemir Insulin, detemir 2.16.840.1.113883.6.73 2017-01 A10AE06 insulin degludec Insulin, degludek 2.16.840.1.113883.6.73 2017-01 A10AE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A10AE56 insulin degludec and liraglutide Insulin, degludek och liraglutid 2.16.840.1.113883.6.73 2017-01 A10AF Insulins and analogues for Insuliner och analoger för inhalation inhalation 2.16.840.1.113883.6.73 2017-01 A10AF01 insulin (human) Insulin (humant) 2.16.840.1.113883.6.73 2017-01 A10B BLOOD GLUCOSE LOWERING Blodglukossänkande medel, exkl. DRUGS, EXCL. INSULINS insuliner 2.16.840.1.113883.6.73 2017-01 A10BA Biguanides Biguanidderivat 2.16.840.1.113883.6.73 2017-01 A10BA01 phenformin Fenformin 2.16.840.1.113883.6.73 2017-01 A10BA02 metformin Metformin 2.16.840.1.113883.6.73 2017-01 A10BA03 buformin Buformin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 22 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BB Sulfonylureas Sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BB01 glibenclamide Glibenklamid 2.16.840.1.113883.6.73 2017-01 A10BB02 chlorpropamide Klorpropamid 2.16.840.1.113883.6.73 2017-01 A10BB03 tolbutamide Tolbutamid 2.16.840.1.113883.6.73 2017-01 A10BB04 glibornuride Glibornurid 2.16.840.1.113883.6.73 2017-01 A10BB05 tolazamide Tolazamid 2.16.840.1.113883.6.73 2017-01 A10BB06 carbutamide Karbutamid 2.16.840.1.113883.6.73 2017-01 A10BB07 glipizide Glipizid 2.16.840.1.113883.6.73 2017-01 A10BB08 gliquidone Glikidon 2.16.840.1.113883.6.73 2017-01 A10BB09 gliclazide Gliklazid 2.16.840.1.113883.6.73 2017-01 A10BB10 metahexamide Metahexamid 2.16.840.1.113883.6.73 2017-01 A10BB11 glisoxepide Glisoxepid 2.16.840.1.113883.6.73 2017-01 A10BB12 glimepiride Glimepirid 2.16.840.1.113883.6.73 2017-01 A10BB31 acetohexamide Acetohexamid 2.16.840.1.113883.6.73 2017-01 A10BC Sulfonamides (heterocyclic) Bensensulfonamidderivat 2.16.840.1.113883.6.73 2017-01 A10BC01 glymidine Glymidin 2.16.840.1.113883.6.73 2017-01 A10BD Combinations of oral blood glucose Perorala blodglukossänkande lowering drugs medel, kombinationer 2.16.840.1.113883.6.73 2017-01 A10BD01 phenformin and sulfonylureas Fenformin och sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BD02 metformin and sulfonylureas Metformin och sulfonylureaföreningar 2.16.840.1.113883.6.73 2017-01 A10BD03 metformin and rosiglitazone Metformin och rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BD04 glimepiride and rosiglitazone Glimepirid och rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BD05 metformin and pioglitazone Metformin och pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BD06 glimepiride and pioglitazone Glimepirid och pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BD07 metformin and sitagliptin Metformin och sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD08 metformin and vildagliptin Metformin och vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BD09 pioglitazone and alogliptin Pioglitazon och alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD10 metformin and saxagliptin Metformin och saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BD11 metformin and linagliptin Metformin och linagliptin 2.16.840.1.113883.6.73 2017-01 A10BD12 pioglitazone and sitagliptin Pioglitazon och sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD13 metformin and alogliptin Metformin och alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD14 metformin and repaglinide Metformin och repaglinid 2.16.840.1.113883.6.73 2017-01 A10BD15 metformin and dapagliflozin Metformin och dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD16 metformin and canagliflozin Metformin och kanagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD17 metformin and acarbose Metformin och akarbos 2.16.840.1.113883.6.73 2017-01 A10BD18 metformin and gemigliptin Metformin och gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BD19 linagliptin and empagliflozin Linagliptin och empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD20 metformin and empagliflozin Metformin och empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD21 saxagliptin and dapagliflozin Saxagliptin och dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BF Alpha glucosidase inhibitors Alfa-glukosidashämmare 2.16.840.1.113883.6.73 2017-01 A10BF01 acarbose Akarbos 2.16.840.1.113883.6.73 2017-01 A10BF02 miglitol Miglitol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 23 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BF03 voglibose Voglibos 2.16.840.1.113883.6.73 2017-01 A10BG Thiazolidinediones Tiazolidindioner 2.16.840.1.113883.6.73 2017-01 A10BG01 troglitazone Troglitazon 2.16.840.1.113883.6.73 2017-01 A10BG02 rosiglitazone Rosiglitazon 2.16.840.1.113883.6.73 2017-01 A10BG03 pioglitazone Pioglitazon 2.16.840.1.113883.6.73 2017-01 A10BH Dipeptidyl peptidase 4 (DPP-4) Dipeptidylpeptidas 4 (DPP-4) inhibitors hämmare 2.16.840.1.113883.6.73 2017-01 A10BH01 sitagliptin Sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BH02 vildagliptin Vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BH03 saxagliptin Saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BH04 alogliptin Alogliptin 2.16.840.1.113883.6.73 2017-01 A10BH05 linagliptin Linagliptin 2.16.840.1.113883.6.73 2017-01 A10BH06 gemigliptin Gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BH51 sitagliptin and simvastatin Sitagliptin och simvastatin 2.16.840.1.113883.6.73 2017-01 A10BJ Glucagon-like peptide-1 (GLP-1) Glukagonlikpeptid-1-receptor(Glp- analogues 1)analoger 2.16.840.1.113883.6.73 2017-01 A10BJ01 exenatide Exenatid 2.16.840.1.113883.6.73 2017-01 A10BJ02 liraglutide Liraglutid 2.16.840.1.113883.6.73 2017-01 A10BJ03 lixisenatide Lixisenatid 2.16.840.1.113883.6.73 2017-01 A10BJ04 albiglutide Albiglutid 2.16.840.1.113883.6.73 2017-01 A10BJ05 dulaglutide Dulaglutid 2.16.840.1.113883.6.73 2017-01 A10BK Sodium-glucose co-transporter 2 Natriumglukossamtransportör (SGLT2) inhibitors 2(Sglt2)hämmare 2.16.840.1.113883.6.73 2017-01 A10BK01 dapagliflozin Dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK02 canagliflozin Kanagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK03 empagliflozin Empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BX Other blood glucose lowering drugs, Övriga blodglukossänkande medel, excl. insulins exkl insuliner 2.16.840.1.113883.6.73 2017-01 A10BX01 guar gum Guargummi 2.16.840.1.113883.6.73 2017-01 A10BX02 repaglinide Repaglinid 2.16.840.1.113883.6.73 2017-01 A10BX03 nateglinide Nateglinid 2.16.840.1.113883.6.73 2017-01 A10BX05 pramlintide Pramlintid 2.16.840.1.113883.6.73 2017-01 A10BX06 benfluorex Benfluorex 2.16.840.1.113883.6.73 2017-01 A10BX08 mitiglinide Mitiglinid 2.16.840.1.113883.6.73 2017-01 A10X OTHER DRUGS USED IN Övriga diabetesmedel DIABETES 2.16.840.1.113883.6.73 2017-01 A10XA Aldose reductase inhibitors Aldos reduktashämmare 2.16.840.1.113883.6.73 2017-01 A10XA01 tolrestat Tolrestat 2.16.840.1.113883.6.73 2017-01 A11 VITAMINS Vitaminer 2.16.840.1.113883.6.73 2017-01 A11A MULTIVITAMINS, COMBINATIONS Multivitaminer, kombinationer 2.16.840.1.113883.6.73 2017-01 A11AA Multivitamins with minerals Multivitaminer och mineralämnen 2.16.840.1.113883.6.73 2017-01 A11AA01 multivitamins and iron Multivitaminer och järn 2.16.840.1.113883.6.73 2017-01 A11AA02 multivitamins and calcium Multivitaminer och kalcium 2.16.840.1.113883.6.73 2017-01 A11AA03 multivitamins and other minerals, Multivitaminer och andra incl. combinations mineralämnen inkl. kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 24 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A11AA04 multivitamins and trace elements Multivitaminer och spårelement 2.16.840.1.113883.6.73 2017-01 A11AB Multivitamins, other combinations Multivitaminer, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A11B MULTIVITAMINS, PLAIN Multivitaminer 2.16.840.1.113883.6.73 2017-01 A11BA Multivitamins, plain Multivitaminer 2.16.840.1.113883.6.73 2017-01 A11C VITAMIN A AND D, INCL. Vitamin A och D, inkl. kombinationer COMBINATIONS OF THE TWO av de två 2.16.840.1.113883.6.73 2017-01 A11CA Vitamin A, plain Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 A11CA01 retinol (vit A) Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 A11CA02 betacarotene Betakaroten 2.16.840.1.113883.6.73 2017-01 A11CB Vitamin A and D in combination Vitamin A och D i kombination 2.16.840.1.113883.6.73 2017-01 A11CC Vitamin D and analogues Vitamin D och analoger 2.16.840.1.113883.6.73 2017-01 A11CC01 ergocalciferol Ergokalciferol 2.16.840.1.113883.6.73 2017-01 A11CC02 dihydrotachysterol Dihydrotakysterol 2.16.840.1.113883.6.73 2017-01 A11CC03 alfacalcidol Alfakalcidol 2.16.840.1.113883.6.73 2017-01 A11CC04 calcitriol Kalcitriol 2.16.840.1.113883.6.73 2017-01 A11CC05 colecalciferol Kolekalciferol 2.16.840.1.113883.6.73 2017-01 A11CC06 calcifediol Kalcifediol 2.16.840.1.113883.6.73 2017-01 A11CC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 A11D VITAMIN B1, PLAIN AND IN Vitamin B1, inkl. kombinationer med COMBINATION WITH VITAMIN B6 vitamin B6 och B12 AND B12 2.16.840.1.113883.6.73 2017-01 A11DA Vitamin B1, plain Tiamin (vitamin B1) 2.16.840.1.113883.6.73 2017-01 A11DA01 thiamine (vit B1) Tiamin (vitamin B1) 2.16.840.1.113883.6.73 2017-01 A11DA02 sulbutiamine Sulbutiamin 2.16.840.1.113883.6.73 2017-01 A11DA03 benfotiamine Benfotiamin 2.16.840.1.113883.6.73 2017-01 A11DB Vitamin B1 in combination with Vitamin B1 i kombination med vitamin B6 and/or vitamin B12 vitamin B6 och/eller vitamin B12 2.16.840.1.113883.6.73 2017-01 A11E VITAMIN B-COMPLEX, INCL. Vitamin B-komplex, inkl. COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 A11EA Vitamin B-complex, plain Vitamin B-komplex 2.16.840.1.113883.6.73 2017-01 A11EB Vitamin B-complex with vitamin C Vitamin B-komplex med vitamin C 2.16.840.1.113883.6.73 2017-01 A11EC Vitamin B-complex with minerals Vitamin B-komplex med mineraler 2.16.840.1.113883.6.73 2017-01 A11ED Vitamin B-complex with anabolic Vitamin B-komplex med anabola steroids steroider 2.16.840.1.113883.6.73 2017-01 A11EX Vitamin B-complex, other Vitamin B-komplex, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A11G ASCORBIC ACID (VITAMIN C), Askorbinsyra (vitamin C) inkl. INCL. COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 A11GA Ascorbic acid (vitamin C), plain Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 A11GA01 ascorbic acid (vit C) Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 A11GB Ascorbic acid (vitamin C), Askorbinsyra (vitamin C), combinations kombinationer 2.16.840.1.113883.6.73 2017-01 A11GB01 ascorbic acid (vit C) and calcium Askorbinsyra (vitamin C) och kalcium 2.16.840.1.113883.6.73 2017-01 A11H OTHER PLAIN VITAMIN Övriga vitaminberedningar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A11HA Other plain vitamin preparations Övriga vitaminberedningar © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 25 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A11HA01 nicotinamide Nikotinamid 2.16.840.1.113883.6.73 2017-01 A11HA02 pyridoxine (vit B6) Pyridoxin (vitamin B6) 2.16.840.1.113883.6.73 2017-01 A11HA03 tocopherol (vit E) Tokoferol (vitamin E) 2.16.840.1.113883.6.73 2017-01 A11HA04 riboflavin (vit B2) Riboflavin (vitamin B2) 2.16.840.1.113883.6.73 2017-01 A11HA05 biotin Biotin 2.16.840.1.113883.6.73 2017-01 A11HA06 pyridoxal phosphate Pyridoxalfosfat 2.16.840.1.113883.6.73 2017-01 A11HA07 inositol Inositol 2.16.840.1.113883.6.73 2017-01 A11HA08 tocofersolan Tokofersolan 2.16.840.1.113883.6.73 2017-01 A11HA30 dexpanthenol Dexapantenol 2.16.840.1.113883.6.73 2017-01 A11HA31 calcium pantothenate Kalciumpantotenat 2.16.840.1.113883.6.73 2017-01 A11HA32 pantethine Pantetin 2.16.840.1.113883.6.73 2017-01 A11J OTHER VITAMIN PRODUCTS, Övriga kombinationer med vitaminer COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11JA Combinations of vitamins Vitaminer, kombinationer 2.16.840.1.113883.6.73 2017-01 A11JB Vitamins with minerals Vitaminer med mineralämnen 2.16.840.1.113883.6.73 2017-01 A11JC Vitamins, other combinations Vitaminer, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 A12 MINERAL SUPPLEMENTS Mineralämnen 2.16.840.1.113883.6.73 2017-01 A12A CALCIUM Kalcium 2.16.840.1.113883.6.73 2017-01 A12AA Calcium Kalcium 2.16.840.1.113883.6.73 2017-01 A12AA01 calcium phosphate Kalciumfosfat 2.16.840.1.113883.6.73 2017-01 A12AA02 calcium glubionate Kalciumglubionat 2.16.840.1.113883.6.73 2017-01 A12AA03 calcium gluconate Kalciumglukonat 2.16.840.1.113883.6.73 2017-01 A12AA04 calcium carbonate Kalciumkarbonat 2.16.840.1.113883.6.73 2017-01 A12AA05 calcium lactate Kalciumlaktat 2.16.840.1.113883.6.73 2017-01 A12AA06 calcium lactate gluconate Kalciumlaktoglukonat 2.16.840.1.113883.6.73 2017-01 A12AA07 calcium chloride Kalciumklorid 2.16.840.1.113883.6.73 2017-01 A12AA08 calcium glycerylphosphate Kalciumglycerylfosfat 2.16.840.1.113883.6.73 2017-01 A12AA09 calcium citrate lysine complex Kalciumcitratlysinkomplex 2.16.840.1.113883.6.73 2017-01 A12AA10 calcium glucoheptonate Kalciumglukoheptonat 2.16.840.1.113883.6.73 2017-01 A12AA11 calcium pangamate Kalcium pangamat 2.16.840.1.113883.6.73 2017-01 A12AA13 calcium citrate Kalciumcitrat 2.16.840.1.113883.6.73 2017-01 A12AA20 calcium (different salts in Kalcium (olika salter i kombination) combination) 2.16.840.1.113883.6.73 2017-01 A12AA30 calcium laevulate Kalciumlevulinat 2.16.840.1.113883.6.73 2017-01 A12AX Calcium, combinations with vitamin Kalcium, kombinationer med vitamin D and/or other drugs D och/eller övriga läkemedel 2.16.840.1.113883.6.73 2017-01 A12B POTASSIUM Kalium 2.16.840.1.113883.6.73 2017-01 A12BA Potassium Kalium 2.16.840.1.113883.6.73 2017-01 A12BA01 potassium chloride Kaliumklorid 2.16.840.1.113883.6.73 2017-01 A12BA02 potassium citrate Kaliumcitrat 2.16.840.1.113883.6.73 2017-01 A12BA03 potassium hydrogentartrate Kaliumvätetartrat 2.16.840.1.113883.6.73 2017-01 A12BA04 potassium hydrogencarbonate Kaliumvätekarbonat 2.16.840.1.113883.6.73 2017-01 A12BA05 potassium gluconate Kaliumglukonat 2.16.840.1.113883.6.73 2017-01 A12BA30 combinations Kalium (olika salter i kombination)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 26 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A12BA51 potassium chloride, combinations Kaliumklorid, kombinationer 2.16.840.1.113883.6.73 2017-01 A12C OTHER MINERAL SUPPLEMENTS Övriga mineralämnen 2.16.840.1.113883.6.73 2017-01 A12CA Sodium Natrium 2.16.840.1.113883.6.73 2017-01 A12CA01 sodium chloride Natriumklorid 2.16.840.1.113883.6.73 2017-01 A12CA02 sodium sulfate Natriumsulfat 2.16.840.1.113883.6.73 2017-01 A12CB Zinc Zink 2.16.840.1.113883.6.73 2017-01 A12CB01 zinc sulfate Zinksulfat 2.16.840.1.113883.6.73 2017-01 A12CB02 zinc gluconate Zinkglukonat 2.16.840.1.113883.6.73 2017-01 A12CB03 zinc protein complex Zinkproteinkomplex 2.16.840.1.113883.6.73 2017-01 A12CC Magnesium Magnesium 2.16.840.1.113883.6.73 2017-01 A12CC01 magnesium chloride Magnesiumklorid 2.16.840.1.113883.6.73 2017-01 A12CC02 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 A12CC03 magnesium gluconate Magnesiumglukonat 2.16.840.1.113883.6.73 2017-01 A12CC04 magnesium citrate Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 A12CC05 magnesium aspartate Magnesiumaspartat 2.16.840.1.113883.6.73 2017-01 A12CC06 magnesium lactate Magnesiumlaktat 2.16.840.1.113883.6.73 2017-01 A12CC07 magnesium levulinate Magnesiumlevulinat 2.16.840.1.113883.6.73 2017-01 A12CC08 magnesium pidolate Magnesiumpidolat 2.16.840.1.113883.6.73 2017-01 A12CC09 magnesium orotate Magnesiumorotat 2.16.840.1.113883.6.73 2017-01 A12CC10 magnesium oxide Magnesiumoxid 2.16.840.1.113883.6.73 2017-01 A12CC30 magnesium (different salts in Magnesium (olika salter i combination) kombination) 2.16.840.1.113883.6.73 2017-01 A12CD Fluoride Fluor 2.16.840.1.113883.6.73 2017-01 A12CD01 sodium fluoride Natriumfluorid 2.16.840.1.113883.6.73 2017-01 A12CD02 sodium monofluorophosphate Natriummonofluorofosfat 2.16.840.1.113883.6.73 2017-01 A12CD51 fluoride, combinations Fluor kombinationer 2.16.840.1.113883.6.73 2017-01 A12CE Selenium Selen 2.16.840.1.113883.6.73 2017-01 A12CE01 sodium selenate Natriumselenat 2.16.840.1.113883.6.73 2017-01 A12CE02 sodium selenite Natriumselenit 2.16.840.1.113883.6.73 2017-01 A12CX Other mineral products Övriga mineralämnen 2.16.840.1.113883.6.73 2017-01 A13 TONICS Tonika 2.16.840.1.113883.6.73 2017-01 A13A TONICS Tonika 2.16.840.1.113883.6.73 2017-01 A14 ANABOLIC AGENTS FOR Anabola steroider för systemiskt SYSTEMIC USE bruk 2.16.840.1.113883.6.73 2017-01 A14A ANABOLIC STEROIDS Anabola steroider 2.16.840.1.113883.6.73 2017-01 A14AA Androstan derivatives Androstanderivat 2.16.840.1.113883.6.73 2017-01 A14AA01 androstanolone Androstanolon 2.16.840.1.113883.6.73 2017-01 A14AA02 stanozolol Stanozolol 2.16.840.1.113883.6.73 2017-01 A14AA03 metandienone Metandienon 2.16.840.1.113883.6.73 2017-01 A14AA04 metenolone Metenolon 2.16.840.1.113883.6.73 2017-01 A14AA05 oxymetholone Oximetolon 2.16.840.1.113883.6.73 2017-01 A14AA06 quinbolone Kinbolon 2.16.840.1.113883.6.73 2017-01 A14AA07 prasterone Prasteron 2.16.840.1.113883.6.73 2017-01 A14AA08 oxandrolone Oxandrolon © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 27 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A14AA09 norethandrolone Noretandrolon 2.16.840.1.113883.6.73 2017-01 A14AB Estren derivatives Östrenderivat 2.16.840.1.113883.6.73 2017-01 A14AB01 nandrolone Nandrolon 2.16.840.1.113883.6.73 2017-01 A14AB02 ethylestrenol Etylöstrenol 2.16.840.1.113883.6.73 2017-01 A14AB03 oxabolone cipionate Oxaboloncipionat 2.16.840.1.113883.6.73 2017-01 A14B OTHER ANABOLIC AGENTS Övriga anabola steroider 2.16.840.1.113883.6.73 2017-01 A15 APPETITE STIMULANTS Aptitstimulerande medel 2.16.840.1.113883.6.73 2017-01 A16 OTHER ALIMENTARY TRACT AND Övriga medel för matsmältning och METABOLISM PRODUCTS ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16A OTHER ALIMENTARY TRACT AND Övriga medel för matsmältning och METABOLISM PRODUCTS ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16AA Amino acids and derivatives Aminosyror och derivat 2.16.840.1.113883.6.73 2017-01 A16AA01 levocarnitine Levokarnitin 2.16.840.1.113883.6.73 2017-01 A16AA02 ademetionine Ademetionin 2.16.840.1.113883.6.73 2017-01 A16AA03 glutamine Glutamin 2.16.840.1.113883.6.73 2017-01 A16AA04 mercaptamine Merkaptamin 2.16.840.1.113883.6.73 2017-01 A16AA05 carglumic acid Kargluminsyra 2.16.840.1.113883.6.73 2017-01 A16AA06 betaine Betain 2.16.840.1.113883.6.73 2017-01 A16AA07 metreleptin Metreleptin 2.16.840.1.113883.6.73 2017-01 A16AB Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 A16AB01 alglucerase Algluceras 2.16.840.1.113883.6.73 2017-01 A16AB02 imiglucerase Imiglukeras 2.16.840.1.113883.6.73 2017-01 A16AB03 agalsidase alfa Agalsidas alfa 2.16.840.1.113883.6.73 2017-01 A16AB04 agalsidase beta Agalsidas beta 2.16.840.1.113883.6.73 2017-01 A16AB05 laronidase Laronidas 2.16.840.1.113883.6.73 2017-01 A16AB06 sacrosidase Sakrosidas 2.16.840.1.113883.6.73 2017-01 A16AB07 alglucosidase alfa Alglukosidas alfa 2.16.840.1.113883.6.73 2017-01 A16AB08 galsulfase Galsulfas 2.16.840.1.113883.6.73 2017-01 A16AB09 idursulfase Idursulfas 2.16.840.1.113883.6.73 2017-01 A16AB10 velaglucerase alfa Velagluceras alfa 2.16.840.1.113883.6.73 2017-01 A16AB11 taliglucerase alfa Taligluceras alfa 2.16.840.1.113883.6.73 2017-01 A16AB12 elosulfase alfa Elosulfas alfa 2.16.840.1.113883.6.73 2017-01 A16AB13 asfotase alfa Asfotas alfa 2.16.840.1.113883.6.73 2017-01 A16AB14 sebelipase alfa Sebelipas alfa 2.16.840.1.113883.6.73 2017-01 A16AX Various alimentary tract and Övriga medel för matsmältning och metabolism products ämnesomsättning 2.16.840.1.113883.6.73 2017-01 A16AX01 thioctic acid Tioktinsyra 2.16.840.1.113883.6.73 2017-01 A16AX02 anethole trithione Anetoltrition 2.16.840.1.113883.6.73 2017-01 A16AX03 sodium phenylbutyrate Natriumfenylbutyrat 2.16.840.1.113883.6.73 2017-01 A16AX04 nitisinone Nitisinon 2.16.840.1.113883.6.73 2017-01 A16AX05 zinc acetate Zinkacetat 2.16.840.1.113883.6.73 2017-01 A16AX06 miglustat Miglustat 2.16.840.1.113883.6.73 2017-01 A16AX07 sapropterin Sapropterin 2.16.840.1.113883.6.73 2017-01 A16AX08 teduglutide Teduglutid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 28 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A16AX09 glycerol phenylbutyrate Glycerolfenylbutyrat 2.16.840.1.113883.6.73 2017-01 A16AX10 eliglustat Eliglustat 2.16.840.1.113883.6.73 2017-01 A16AX11 sodium benzoate Natriumbensoat 2.16.840.1.113883.6.73 2017-01 A16AX12 trientine Trientin 2.16.840.1.113883.6.73 2017-01 A16AX13 uridine triacetate Uridintriacetat 2.16.840.1.113883.6.73 2017-01 B BLOOD AND BLOOD FORMING Blod och blodbildande organ ORGANS 2.16.840.1.113883.6.73 2017-01 B01 ANTITHROMBOTIC AGENTS Antikoagulantia 2.16.840.1.113883.6.73 2017-01 B01A ANTITHROMBOTIC AGENTS Antikoagulantia 2.16.840.1.113883.6.73 2017-01 B01AA Vitamin K antagonists Vitamin K-antagonister 2.16.840.1.113883.6.73 2017-01 B01AA01 dicoumarol Dikumarol 2.16.840.1.113883.6.73 2017-01 B01AA02 phenindione Fenindion 2.16.840.1.113883.6.73 2017-01 B01AA03 warfarin Warfarin 2.16.840.1.113883.6.73 2017-01 B01AA04 phenprocoumon Fenprokumon 2.16.840.1.113883.6.73 2017-01 B01AA07 acenocoumarol Acenokumarol 2.16.840.1.113883.6.73 2017-01 B01AA08 ethyl biscoumacetate Etylbiskumacetat 2.16.840.1.113883.6.73 2017-01 B01AA09 clorindione Klorindion 2.16.840.1.113883.6.73 2017-01 B01AA10 diphenadione Difenadion 2.16.840.1.113883.6.73 2017-01 B01AA11 tioclomarol Tioklomarol 2.16.840.1.113883.6.73 2017-01 B01AA12 fluindione Fluindion 2.16.840.1.113883.6.73 2017-01 B01AB Heparin group Heparingruppen 2.16.840.1.113883.6.73 2017-01 B01AB01 heparin Heparin 2.16.840.1.113883.6.73 2017-01 B01AB02 antithrombin III Antitrombin III 2.16.840.1.113883.6.73 2017-01 B01AB04 dalteparin Dalteparin 2.16.840.1.113883.6.73 2017-01 B01AB05 enoxaparin Enoxaparin 2.16.840.1.113883.6.73 2017-01 B01AB06 nadroparin Nadroparin 2.16.840.1.113883.6.73 2017-01 B01AB07 parnaparin Parnaparin 2.16.840.1.113883.6.73 2017-01 B01AB08 reviparin Reviparin 2.16.840.1.113883.6.73 2017-01 B01AB09 danaparoid Danaparoid 2.16.840.1.113883.6.73 2017-01 B01AB10 tinzaparin Tinzaparin 2.16.840.1.113883.6.73 2017-01 B01AB11 sulodexide Sulodexid 2.16.840.1.113883.6.73 2017-01 B01AB12 bemiparin Bemiparin 2.16.840.1.113883.6.73 2017-01 B01AB51 heparin, combinations Heparin, kombinationer 2.16.840.1.113883.6.73 2017-01 B01AC Platelet aggregation inhibitors excl. Trombocytaggregationshämmande heparin medel, exkl. heparin 2.16.840.1.113883.6.73 2017-01 B01AC01 ditazole Ditazol 2.16.840.1.113883.6.73 2017-01 B01AC02 cloricromen Klorikromen 2.16.840.1.113883.6.73 2017-01 B01AC03 picotamide Picotamid 2.16.840.1.113883.6.73 2017-01 B01AC04 clopidogrel Klopidogrel 2.16.840.1.113883.6.73 2017-01 B01AC05 ticlopidine Tiklopidin 2.16.840.1.113883.6.73 2017-01 B01AC06 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 B01AC07 dipyridamole Dipyridamol 2.16.840.1.113883.6.73 2017-01 B01AC08 carbasalate calcium Karbasalatkalcium 2.16.840.1.113883.6.73 2017-01 B01AC09 epoprostenol Epoprostenol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 29 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AC10 indobufen Indobufen 2.16.840.1.113883.6.73 2017-01 B01AC11 iloprost Iloprost 2.16.840.1.113883.6.73 2017-01 B01AC13 abciximab Abciximab 2.16.840.1.113883.6.73 2017-01 B01AC15 aloxiprin Aloxiprin 2.16.840.1.113883.6.73 2017-01 B01AC16 eptifibatide Eptifibatid 2.16.840.1.113883.6.73 2017-01 B01AC17 tirofiban Tirofiban 2.16.840.1.113883.6.73 2017-01 B01AC18 triflusal Triflusal 2.16.840.1.113883.6.73 2017-01 B01AC19 beraprost Beraprost 2.16.840.1.113883.6.73 2017-01 B01AC21 treprostinil Treprostinil 2.16.840.1.113883.6.73 2017-01 B01AC22 prasugrel Prasugrel 2.16.840.1.113883.6.73 2017-01 B01AC23 cilostazol Cilostazol 2.16.840.1.113883.6.73 2017-01 B01AC24 ticagrelor Tikagrelor 2.16.840.1.113883.6.73 2017-01 B01AC25 cangrelor Kangrelor 2.16.840.1.113883.6.73 2017-01 B01AC26 vorapaxar Vorapaxar 2.16.840.1.113883.6.73 2017-01 B01AC27 selexipag Selexipag 2.16.840.1.113883.6.73 2017-01 B01AC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B01AC56 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer with proton pump inhibitors med protonpumpshämmare 2.16.840.1.113883.6.73 2017-01 B01AD Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 B01AD01 streptokinase Streptokinas 2.16.840.1.113883.6.73 2017-01 B01AD02 alteplase Alteplas 2.16.840.1.113883.6.73 2017-01 B01AD03 anistreplase Anistreplas 2.16.840.1.113883.6.73 2017-01 B01AD04 urokinase Urokinas 2.16.840.1.113883.6.73 2017-01 B01AD05 fibrinolysin Fibrinolysin 2.16.840.1.113883.6.73 2017-01 B01AD06 brinase Brinas 2.16.840.1.113883.6.73 2017-01 B01AD07 reteplase Reteplas 2.16.840.1.113883.6.73 2017-01 B01AD08 saruplase Saruplas 2.16.840.1.113883.6.73 2017-01 B01AD09 ancrod Ankrod 2.16.840.1.113883.6.73 2017-01 B01AD10 drotrecogin alfa (activated) Drotrekogin alfa (aktiverat) 2.16.840.1.113883.6.73 2017-01 B01AD11 tenecteplase Tenekteplas 2.16.840.1.113883.6.73 2017-01 B01AD12 protein C Protein C 2.16.840.1.113883.6.73 2017-01 B01AE Direct thrombin inhibitors Direkt trombinhämmande medel 2.16.840.1.113883.6.73 2017-01 B01AE01 desirudin Desirudin 2.16.840.1.113883.6.73 2017-01 B01AE02 lepirudin Lepirudin 2.16.840.1.113883.6.73 2017-01 B01AE03 argatroban Argatroban 2.16.840.1.113883.6.73 2017-01 B01AE04 melagatran Melagatran 2.16.840.1.113883.6.73 2017-01 B01AE05 ximelagatran Ximelagatran 2.16.840.1.113883.6.73 2017-01 B01AE06 bivalirudin Bivalirudin 2.16.840.1.113883.6.73 2017-01 B01AE07 dabigatran etexilate Dabigatranetexilat 2.16.840.1.113883.6.73 2017-01 B01AF Direct factor Xa inhibitors Direktverkande faktor Xa-hämmare 2.16.840.1.113883.6.73 2017-01 B01AF01 rivaroxaban Rivaroxaban 2.16.840.1.113883.6.73 2017-01 B01AF02 apixaban Apixaban 2.16.840.1.113883.6.73 2017-01 B01AF03 edoxaban Edoxaban

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 30 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AX Other antithrombotic agents Övriga antitrombotiska medel 2.16.840.1.113883.6.73 2017-01 B01AX01 defibrotide Defibrotid 2.16.840.1.113883.6.73 2017-01 B01AX04 dermatan sulfate Dermatansulfat 2.16.840.1.113883.6.73 2017-01 B01AX05 fondaparinux Fondaparinux 2.16.840.1.113883.6.73 2017-01 B02 ANTIHEMORRHAGICS Hemostatika 2.16.840.1.113883.6.73 2017-01 B02A ANTIFIBRINOLYTICS Fibrinolyshämmande medel 2.16.840.1.113883.6.73 2017-01 B02AA Amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B02AA01 aminocaproic acid Aminokapronsyra 2.16.840.1.113883.6.73 2017-01 B02AA02 tranexamic acid Tranexamsyra 2.16.840.1.113883.6.73 2017-01 B02AA03 aminomethylbenzoic acid Aminometylbensoesyra 2.16.840.1.113883.6.73 2017-01 B02AB Proteinase inhibitors Proteinashämmande medel 2.16.840.1.113883.6.73 2017-01 B02AB01 aprotinin Aprotinin 2.16.840.1.113883.6.73 2017-01 B02AB02 alfa1 antitrypsin Alfa-1-antitrypsin 2.16.840.1.113883.6.73 2017-01 B02AB04 camostat Kamostat 2.16.840.1.113883.6.73 2017-01 B02B VITAMIN K AND OTHER Vitamin K och andra HEMOSTATICS koagulationsfaktorer 2.16.840.1.113883.6.73 2017-01 B02BA Vitamin K Vitamin K 2.16.840.1.113883.6.73 2017-01 B02BA01 phytomenadione Fytomenadion 2.16.840.1.113883.6.73 2017-01 B02BA02 menadione Menadion 2.16.840.1.113883.6.73 2017-01 B02BB Fibrinogen Fibrinogen 2.16.840.1.113883.6.73 2017-01 B02BB01 fibrinogen, human Fibrinogen, humant 2.16.840.1.113883.6.73 2017-01 B02BC Local hemostatics Lokala hemostatika 2.16.840.1.113883.6.73 2017-01 B02BC01 absorbable gelatin sponge Gelatin, härdat 2.16.840.1.113883.6.73 2017-01 B02BC02 oxidized cellulose Cellulosa, oxiderat 2.16.840.1.113883.6.73 2017-01 B02BC03 tetragalacturonic acid Tetragalakturonsyra hydroxymethylester hydroximetylester 2.16.840.1.113883.6.73 2017-01 B02BC05 adrenalone Adrenalon 2.16.840.1.113883.6.73 2017-01 B02BC06 thrombin Trombin 2.16.840.1.113883.6.73 2017-01 B02BC07 collagen Kollagen 2.16.840.1.113883.6.73 2017-01 B02BC08 calcium alginate Kalciumalginat 2.16.840.1.113883.6.73 2017-01 B02BC09 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 B02BC30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B02BD Blood coagulation factors Koagulationsfaktorer 2.16.840.1.113883.6.73 2017-01 B02BD01 coagulation factor IX, II, VII and X in Koagulationsfaktor IX, II, VII och X i combination kombination 2.16.840.1.113883.6.73 2017-01 B02BD02 coagulation factor VIII Koagulationsfaktor VIII 2.16.840.1.113883.6.73 2017-01 B02BD03 factor VIII inhibitor bypassing activity Aktiverat protrombinkomplex mot faktor VIII-antikroppar 2.16.840.1.113883.6.73 2017-01 B02BD04 coagulation factor IX Koagulationsfaktor IX 2.16.840.1.113883.6.73 2017-01 B02BD05 coagulation factor VII Koagulationsfaktor VII 2.16.840.1.113883.6.73 2017-01 B02BD06 von Willebrand factor and von Willebrandfaktor och coagulation factor VIII in koagulationsfaktor VIII i kombination combination 2.16.840.1.113883.6.73 2017-01 B02BD07 coagulation factor XIII Koagulationsfaktor XIII 2.16.840.1.113883.6.73 2017-01 B02BD08 eptacog alfa (activated) Koagulationsfaktor VIIa

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 31 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B02BD10 von Willebrand factor von Willebrandfaktor 2.16.840.1.113883.6.73 2017-01 B02BD11 catridecacog Katridekacog 2.16.840.1.113883.6.73 2017-01 B02BD13 coagulation factor X Koagulationsfaktor X 2.16.840.1.113883.6.73 2017-01 B02BD14 susoctocog alfa Susoktokog alfa 2.16.840.1.113883.6.73 2017-01 B02BD30 thrombin Trombin 2.16.840.1.113883.6.73 2017-01 B02BX Other systemic hemostatics Övriga hemostatika för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 B02BX01 etamsylate Etamsylat 2.16.840.1.113883.6.73 2017-01 B02BX02 carbazochrome Karbazokrom 2.16.840.1.113883.6.73 2017-01 B02BX03 batroxobin Batroxobin 2.16.840.1.113883.6.73 2017-01 B02BX04 romiplostim Romiplostim 2.16.840.1.113883.6.73 2017-01 B02BX05 eltrombopag Eltrombopag 2.16.840.1.113883.6.73 2017-01 B03 ANTIANEMIC PREPARATIONS Medel vid anemier 2.16.840.1.113883.6.73 2017-01 B03A IRON PREPARATIONS Medel vid järnbristanemier 2.16.840.1.113883.6.73 2017-01 B03AA Iron bivalent, oral preparations Tvåvärt järn, perorala preparat 2.16.840.1.113883.6.73 2017-01 B03AA01 ferrous glycine sulfate Järn(II)glycinsulfat 2.16.840.1.113883.6.73 2017-01 B03AA02 ferrous fumarate Järn(II)fumarat 2.16.840.1.113883.6.73 2017-01 B03AA03 ferrous gluconate Järn(II)glukonat 2.16.840.1.113883.6.73 2017-01 B03AA04 ferrous carbonate Järn(II)karbonat 2.16.840.1.113883.6.73 2017-01 B03AA05 ferrous chloride Ferroklorid 2.16.840.1.113883.6.73 2017-01 B03AA06 ferrous succinate Ferrosuccinat 2.16.840.1.113883.6.73 2017-01 B03AA07 ferrous sulfate Ferrosulfat 2.16.840.1.113883.6.73 2017-01 B03AA08 ferrous tartrate Järn(II)tartrat 2.16.840.1.113883.6.73 2017-01 B03AA09 ferrous aspartate Järn(II)aspartat 2.16.840.1.113883.6.73 2017-01 B03AA10 ferrous ascorbate Järn(II)askorbat 2.16.840.1.113883.6.73 2017-01 B03AA11 ferrous iodine Järn(II)jodid 2.16.840.1.113883.6.73 2017-01 B03AB Iron trivalent, oral preparations Trevärt järn, perorala preparat 2.16.840.1.113883.6.73 2017-01 B03AB01 ferric sodium citrate Järn(III)natriumcitrat 2.16.840.1.113883.6.73 2017-01 B03AB02 saccharated iron oxide Järnsackaros 2.16.840.1.113883.6.73 2017-01 B03AB03 sodium feredetate Natriumferedetat 2.16.840.1.113883.6.73 2017-01 B03AB04 ferric hydroxide Järn(III)hydroxid 2.16.840.1.113883.6.73 2017-01 B03AB05 ferric oxide polymaltose complexes Järnoxid polymaltoskomplexer 2.16.840.1.113883.6.73 2017-01 B03AB07 chondroitin sulfate-iron complex Kondroitinsulfat-järnkomplex 2.16.840.1.113883.6.73 2017-01 B03AB08 ferric acetyl transferrin Järn(III)acetyltransferrin 2.16.840.1.113883.6.73 2017-01 B03AB09 ferric proteinsuccinylate Järn(III)proteinsuccinylat 2.16.840.1.113883.6.73 2017-01 B03AB10 ferric maltol Järn(III)maltol 2.16.840.1.113883.6.73 2017-01 B03AC Iron, parenteral preparations Järn, parenterala preparat 2.16.840.1.113883.6.73 2017-01 B03AD Iron in combination with folic acid Järn i kombination med folsyra 2.16.840.1.113883.6.73 2017-01 B03AD01 ferrous amino acid complex Järn(II)aminosyrakomplex 2.16.840.1.113883.6.73 2017-01 B03AD02 ferrous fumarate Järn(II)fumarat 2.16.840.1.113883.6.73 2017-01 B03AD03 ferrous sulfate Järn(II)sulfat 2.16.840.1.113883.6.73 2017-01 B03AD04 ferric oxide polymaltose complexes Järnoxid polymaltoskomplexer 2.16.840.1.113883.6.73 2017-01 B03AE Iron in other combinations Järn, övriga kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 32 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B03AE01 iron, vitamin B12 and folic acid Järn, vitamin B12 och folsyra 2.16.840.1.113883.6.73 2017-01 B03AE02 iron, multivitamins and folic acid Järn, multivitaminer och folsyra 2.16.840.1.113883.6.73 2017-01 B03AE03 iron and multivitamins Järn och multivitaminer 2.16.840.1.113883.6.73 2017-01 B03AE04 iron, multivitamins and minerals Järn, multivitaminer och mineraler 2.16.840.1.113883.6.73 2017-01 B03AE10 various combinations Övriga kombinationer 2.16.840.1.113883.6.73 2017-01 B03B VITAMIN B12 AND FOLIC ACID Vitamin B12 och folsyra 2.16.840.1.113883.6.73 2017-01 B03BA Vitamin B12 (cyanocobalamin and Vitamin B12 (cyanokobalamin och analogues) analoger) 2.16.840.1.113883.6.73 2017-01 B03BA01 cyanocobalamin Cyanokobalamin 2.16.840.1.113883.6.73 2017-01 B03BA02 cyanocobalamin tannin complex Cyanokobalamin-tanninkomplex 2.16.840.1.113883.6.73 2017-01 B03BA03 hydroxocobalamin Hydroxokobalamin 2.16.840.1.113883.6.73 2017-01 B03BA04 cobamamide Kobamamid 2.16.840.1.113883.6.73 2017-01 B03BA05 mecobalamin Mekobalamin 2.16.840.1.113883.6.73 2017-01 B03BA51 cyanocobalamin, combinations Cyanokobalamin, kombinationer 2.16.840.1.113883.6.73 2017-01 B03BA53 hydroxocobalamin, combinations Hydroxokobalamin, kombinationer 2.16.840.1.113883.6.73 2017-01 B03BB Folic acid and derivatives Folsyra och derivat 2.16.840.1.113883.6.73 2017-01 B03BB01 folic acid Folsyra 2.16.840.1.113883.6.73 2017-01 B03BB51 folic acid, combinations Folsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 B03X OTHER ANTIANEMIC Övriga medel vid anemier PREPARATIONS 2.16.840.1.113883.6.73 2017-01 B03XA Other antianemic preparations Övriga medel vid anemier 2.16.840.1.113883.6.73 2017-01 B03XA01 erythropoietin Erytropoietin 2.16.840.1.113883.6.73 2017-01 B03XA02 darbepoetin alfa Darbepoetin alfa 2.16.840.1.113883.6.73 2017-01 B03XA03 methoxy polyethylene glycol-epoetin Metoxi-polyetylenglykol-epoetin beta beta 2.16.840.1.113883.6.73 2017-01 B03XA04 peginesatide Peginesatid 2.16.840.1.113883.6.73 2017-01 B05 BLOOD SUBSTITUTES AND Blodersättning och infusionsvätskor PERFUSION SOLUTIONS 2.16.840.1.113883.6.73 2017-01 B05A BLOOD AND RELATED Blod och relaterade produkter PRODUCTS 2.16.840.1.113883.6.73 2017-01 B05AA Blood substitutes and plasma Blodersättning och plasmaproteiner protein fractions 2.16.840.1.113883.6.73 2017-01 B05AA01 albumin Albumin 2.16.840.1.113883.6.73 2017-01 B05AA02 other plasma protein fractions Övriga plasmaproteiner 2.16.840.1.113883.6.73 2017-01 B05AA03 fluorocarbon blood substitutes Fluorkarbonblodersättning 2.16.840.1.113883.6.73 2017-01 B05AA05 dextran Dextran 2.16.840.1.113883.6.73 2017-01 B05AA06 gelatin agents Gelatinpreparat 2.16.840.1.113883.6.73 2017-01 B05AA07 hydroxyethylstarch Polyhydroxietylstärkelse 2.16.840.1.113883.6.73 2017-01 B05AA08 hemoglobin crosfumaril Hemoglobin, krosfumaril 2.16.840.1.113883.6.73 2017-01 B05AA09 hemoglobin raffimer Hemoglobin raffimer 2.16.840.1.113883.6.73 2017-01 B05AA10 hemoglobin glutamer (bovine) Hemoglobin, glutamer (bovin) 2.16.840.1.113883.6.73 2017-01 B05AX Other blood products Övriga blodprodukter 2.16.840.1.113883.6.73 2017-01 B05AX01 erythrocytes Erytrocyter 2.16.840.1.113883.6.73 2017-01 B05AX02 thrombocytes Trombocyter 2.16.840.1.113883.6.73 2017-01 B05AX03 blood plasma Blodplasma

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 33 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05AX04 stem cells from umbilical cord blood Stamceller från navelsträngsblod 2.16.840.1.113883.6.73 2017-01 B05B I.V. SOLUTIONS Infusionsvätskor 2.16.840.1.113883.6.73 2017-01 B05BA Solutions for parenteral nutrition Lösningar för parenteral nutrition 2.16.840.1.113883.6.73 2017-01 B05BA01 amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B05BA02 fat emulsions Fettemulsioner 2.16.840.1.113883.6.73 2017-01 B05BA03 carbohydrates Kolhydrater 2.16.840.1.113883.6.73 2017-01 B05BA04 protein hydrolysates Proteinhydrolysat 2.16.840.1.113883.6.73 2017-01 B05BA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05BB Solutions affecting the electrolyte Lösningar som påverkar balance elektrolytbalansen 2.16.840.1.113883.6.73 2017-01 B05BB01 electrolytes Elektrolyter 2.16.840.1.113883.6.73 2017-01 B05BB02 electrolytes with carbohydrates Elektrolyter och kolhydrater 2.16.840.1.113883.6.73 2017-01 B05BB03 trometamol Trometamol 2.16.840.1.113883.6.73 2017-01 B05BB04 electrolytes in combination with Elektrolyter i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 B05BC Solutions producing osmotic Lösningar som framkallar osmotisk diuresis diures 2.16.840.1.113883.6.73 2017-01 B05BC01 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 B05BC02 carbamide Karbamid 2.16.840.1.113883.6.73 2017-01 B05C IRRIGATING SOLUTIONS Spolvätskor 2.16.840.1.113883.6.73 2017-01 B05CA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 B05CA01 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 B05CA02 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 B05CA03 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 B05CA04 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 B05CA05 taurolidine Taurolidin 2.16.840.1.113883.6.73 2017-01 B05CA06 mandelic acid Mandelinsyra 2.16.840.1.113883.6.73 2017-01 B05CA07 noxytiolin Noxytiolin 2.16.840.1.113883.6.73 2017-01 B05CA08 ethacridine lactate Etakridinlaktat 2.16.840.1.113883.6.73 2017-01 B05CA09 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 B05CA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05CB Salt solutions Saltlösningar 2.16.840.1.113883.6.73 2017-01 B05CB01 sodium chloride Natriumklorid 2.16.840.1.113883.6.73 2017-01 B05CB02 sodium citrate Natriumcitrat 2.16.840.1.113883.6.73 2017-01 B05CB03 magnesium citrate Magnesiumcitrat 2.16.840.1.113883.6.73 2017-01 B05CB04 sodium bicarbonate Natriumbikarbonat 2.16.840.1.113883.6.73 2017-01 B05CB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05CX Other irrigating solutions Övriga spolvätskor 2.16.840.1.113883.6.73 2017-01 B05CX01 glucose Glukos 2.16.840.1.113883.6.73 2017-01 B05CX02 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 B05CX03 glycine Glycin 2.16.840.1.113883.6.73 2017-01 B05CX04 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 B05CX10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 B05D PERITONEAL DIALYTICS Peritonealdialysvätskor

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 34 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05DA Isotonic solutions Isotona lösningar 2.16.840.1.113883.6.73 2017-01 B05DB Hypertonic solutions Hypertona lösningar 2.16.840.1.113883.6.73 2017-01 B05X I.V. SOLUTION ADDITIVES Infusionskoncentrat 2.16.840.1.113883.6.73 2017-01 B05XA Electrolyte solutions Elektrolytlösningar 2.16.840.1.113883.6.73 2017-01 B05XA01 potassium chloride Kaliumklorid 2.16.840.1.113883.6.73 2017-01 B05XA02 sodium bicarbonate Natriumbikarbonat 2.16.840.1.113883.6.73 2017-01 B05XA03 sodium chloride Natriumklorid 2.16.840.1.113883.6.73 2017-01 B05XA04 ammonium chloride Ammoniumklorid 2.16.840.1.113883.6.73 2017-01 B05XA05 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 B05XA06 potassium phosphate, incl. Kaliumfosfat, inkl. kombinationer combinations with other potassium med andra kaliumsalt salts 2.16.840.1.113883.6.73 2017-01 B05XA07 calcium chloride Kalciumklorid 2.16.840.1.113883.6.73 2017-01 B05XA08 sodium acetate Natriumacetat 2.16.840.1.113883.6.73 2017-01 B05XA09 sodium phosphate Natriumfosfat 2.16.840.1.113883.6.73 2017-01 B05XA10 magnesium phosphate Magnesiumfosfat 2.16.840.1.113883.6.73 2017-01 B05XA11 magnesium chloride Magnesiumklorid 2.16.840.1.113883.6.73 2017-01 B05XA12 zinc chloride Zinkklorid 2.16.840.1.113883.6.73 2017-01 B05XA13 hydrochloric acid Saltsyra 2.16.840.1.113883.6.73 2017-01 B05XA14 sodium glycerophosphate Natriumglycerofosfat 2.16.840.1.113883.6.73 2017-01 B05XA15 potassium lactate Kaliumlaktat 2.16.840.1.113883.6.73 2017-01 B05XA16 cardioplegia solutions Kardioplegilösningar 2.16.840.1.113883.6.73 2017-01 B05XA17 potassium acetate Kaliumacetat 2.16.840.1.113883.6.73 2017-01 B05XA30 combinations of electrolytes Kombinationer av elektrolyter 2.16.840.1.113883.6.73 2017-01 B05XA31 electrolytes in combination with Elektrolyter i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 B05XB Amino acids Aminosyror 2.16.840.1.113883.6.73 2017-01 B05XB01 arginine hydrochloride Argininhydroklorid 2.16.840.1.113883.6.73 2017-01 B05XB02 alanyl glutamine Alanylglutamin 2.16.840.1.113883.6.73 2017-01 B05XB03 lysine Lysin 2.16.840.1.113883.6.73 2017-01 B05XC Vitamins Vitaminer 2.16.840.1.113883.6.73 2017-01 B05XX Other i.v. solution additives Övriga infusionskoncentrat 2.16.840.1.113883.6.73 2017-01 B05XX02 trometamol Trometamol 2.16.840.1.113883.6.73 2017-01 B05Z HEMODIALYTICS AND Hemodialysvätskor och HEMOFILTRATES hemofiltrationsvätskor 2.16.840.1.113883.6.73 2017-01 B05ZA Hemodialytics, concentrates Hypertona elektrolytlösningar 2.16.840.1.113883.6.73 2017-01 B05ZB Hemofiltrates Hemofiltrationsvätskor 2.16.840.1.113883.6.73 2017-01 B06 OTHER HEMATOLOGICAL Övriga hematologiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 B06A OTHER HEMATOLOGICAL Övriga hematologiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 B06AA Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 B06AA02 fibrinolysin and desoxyribonuclease Fibrinolysin och deoxiribonukleas 2.16.840.1.113883.6.73 2017-01 B06AA03 hyaluronidase Hyaluronidas 2.16.840.1.113883.6.73 2017-01 B06AA04 chymotrypsin Kymotrypsin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 35 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B06AA07 trypsin Trypsin 2.16.840.1.113883.6.73 2017-01 B06AA10 desoxyribonuclease Deoxiribonukleas 2.16.840.1.113883.6.73 2017-01 B06AA55 streptokinase, combinations Streptokinas, kombinationer 2.16.840.1.113883.6.73 2017-01 B06AB Other hem products Övriga hematologiska medel 2.16.840.1.113883.6.73 2017-01 B06AB01 hematin Hematin 2.16.840.1.113883.6.73 2017-01 B06AC Drugs used in hereditary Medel använda vid ärftligt angioedema angioödem 2.16.840.1.113883.6.73 2017-01 B06AC01 c1-inhibitor, plasma derived c1-hämmare, plasmaderiverad 2.16.840.1.113883.6.73 2017-01 B06AC02 icatibant Ikatibant 2.16.840.1.113883.6.73 2017-01 B06AC03 ecallantide Ekallantid 2.16.840.1.113883.6.73 2017-01 B06AC04 conestat alfa Konestat alfa 2.16.840.1.113883.6.73 2017-01 C CARDIOVASCULAR SYSTEM Hjärta och kretslopp 2.16.840.1.113883.6.73 2017-01 C01 CARDIAC THERAPY Medel vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01A CARDIAC GLYCOSIDES Hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01AA Digitalis glycosides Digitalisglykosider 2.16.840.1.113883.6.73 2017-01 C01AA01 acetyldigitoxin Acetyldigitoxin 2.16.840.1.113883.6.73 2017-01 C01AA02 acetyldigoxin Acetyldigoxin 2.16.840.1.113883.6.73 2017-01 C01AA03 digitalis leaves Digitalisblad 2.16.840.1.113883.6.73 2017-01 C01AA04 digitoxin Digitoxin 2.16.840.1.113883.6.73 2017-01 C01AA05 digoxin Digoxin 2.16.840.1.113883.6.73 2017-01 C01AA06 lanatoside C Lanatosid C 2.16.840.1.113883.6.73 2017-01 C01AA07 deslanoside Deslanosid 2.16.840.1.113883.6.73 2017-01 C01AA08 metildigoxin Metyldigoxin 2.16.840.1.113883.6.73 2017-01 C01AA09 gitoformate Gitoformat 2.16.840.1.113883.6.73 2017-01 C01AA52 acetyldigoxin, combinations Acetyldigoxin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01AB Scilla glycosides Sjölöksglykosider 2.16.840.1.113883.6.73 2017-01 C01AB01 proscillaridin Proscillaridin 2.16.840.1.113883.6.73 2017-01 C01AB51 proscillaridin, combinations Proscillaridin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01AC Strophanthus glycosides Strofantusglykosider 2.16.840.1.113883.6.73 2017-01 C01AC01 g-strophanthin G-Strofantin 2.16.840.1.113883.6.73 2017-01 C01AC03 cymarin Cymarin 2.16.840.1.113883.6.73 2017-01 C01AX Other cardiac glycosides Övriga hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01AX02 peruvoside Peruvosid 2.16.840.1.113883.6.73 2017-01 C01B ANTIARRHYTHMICS, CLASS I Antiarytmika, klass I och III AND III 2.16.840.1.113883.6.73 2017-01 C01BA Antiarrhythmics, class Ia Antiarytmika klass IA 2.16.840.1.113883.6.73 2017-01 C01BA01 quinidine Kinidin 2.16.840.1.113883.6.73 2017-01 C01BA02 procainamide Prokainamid 2.16.840.1.113883.6.73 2017-01 C01BA03 disopyramide Disopyramid 2.16.840.1.113883.6.73 2017-01 C01BA04 sparteine Spartein 2.16.840.1.113883.6.73 2017-01 C01BA05 ajmaline Ajmalin 2.16.840.1.113883.6.73 2017-01 C01BA08 prajmaline Prajmalin 2.16.840.1.113883.6.73 2017-01 C01BA12 lorajmine Lorajmin 2.16.840.1.113883.6.73 2017-01 C01BA13 hydroquinidine Hydrokinidin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 36 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01BA51 quinidine, combinations excl. Kinidin, kombinationer exkl psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C01BA71 quinidine, combinations with Kinidin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C01BB Antiarrhythmics, class Ib Antiarytmika klass IB 2.16.840.1.113883.6.73 2017-01 C01BB01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 C01BB02 mexiletine Mexiletin 2.16.840.1.113883.6.73 2017-01 C01BB03 tocainide Tokainid 2.16.840.1.113883.6.73 2017-01 C01BB04 aprindine Aprindin 2.16.840.1.113883.6.73 2017-01 C01BC Antiarrhythmics, class Ic Antiarytmika klass IC 2.16.840.1.113883.6.73 2017-01 C01BC03 propafenone Propafenon 2.16.840.1.113883.6.73 2017-01 C01BC04 flecainide Flekainid 2.16.840.1.113883.6.73 2017-01 C01BC07 lorcainide Lorkainid 2.16.840.1.113883.6.73 2017-01 C01BC08 encainide Enkainid 2.16.840.1.113883.6.73 2017-01 C01BC09 ethacizine Etacizin 2.16.840.1.113883.6.73 2017-01 C01BD Antiarrhythmics, class III Antiarytmika klass III 2.16.840.1.113883.6.73 2017-01 C01BD01 amiodarone Amiodaron 2.16.840.1.113883.6.73 2017-01 C01BD02 bretylium tosilate Bretyltosilat 2.16.840.1.113883.6.73 2017-01 C01BD03 bunaftine Bunaftin 2.16.840.1.113883.6.73 2017-01 C01BD04 dofetilide Dofetilid 2.16.840.1.113883.6.73 2017-01 C01BD05 ibutilide Ibutilid 2.16.840.1.113883.6.73 2017-01 C01BD06 tedisamil Tedisamil 2.16.840.1.113883.6.73 2017-01 C01BD07 dronedarone Dronedaron 2.16.840.1.113883.6.73 2017-01 C01BG Other antiarrhythmics, class I and III Övriga antiarytmika, klass I och III 2.16.840.1.113883.6.73 2017-01 C01BG01 moracizine Moracizin 2.16.840.1.113883.6.73 2017-01 C01BG07 cibenzoline Cibenzolin 2.16.840.1.113883.6.73 2017-01 C01BG11 vernakalant Vernakalant 2.16.840.1.113883.6.73 2017-01 C01C CARDIAC STIMULANTS EXCL. Hjärtstimulerande medel exkl. CARDIAC GLYCOSIDES hjärtglykosider 2.16.840.1.113883.6.73 2017-01 C01CA Adrenergic and dopaminergic Adrenerga och dopaminerga medel agents 2.16.840.1.113883.6.73 2017-01 C01CA01 etilefrine Etilefrin 2.16.840.1.113883.6.73 2017-01 C01CA02 isoprenaline Isoprenalin 2.16.840.1.113883.6.73 2017-01 C01CA03 norepinephrine Noradrenalin 2.16.840.1.113883.6.73 2017-01 C01CA04 dopamine Dopamin 2.16.840.1.113883.6.73 2017-01 C01CA05 norfenefrine Norfenefrin 2.16.840.1.113883.6.73 2017-01 C01CA06 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 C01CA07 dobutamine Dobutamin 2.16.840.1.113883.6.73 2017-01 C01CA08 oxedrine Oxedrin 2.16.840.1.113883.6.73 2017-01 C01CA09 metaraminol Metaraminol 2.16.840.1.113883.6.73 2017-01 C01CA10 methoxamine Metoxamin 2.16.840.1.113883.6.73 2017-01 C01CA11 mephentermine Mefentermin 2.16.840.1.113883.6.73 2017-01 C01CA12 dimetofrine Dimetofrin 2.16.840.1.113883.6.73 2017-01 C01CA13 prenalterol Prenalterol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 37 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01CA14 dopexamine Dopexamin 2.16.840.1.113883.6.73 2017-01 C01CA15 gepefrine Gepefrin 2.16.840.1.113883.6.73 2017-01 C01CA16 ibopamine Ibopamin 2.16.840.1.113883.6.73 2017-01 C01CA17 midodrine Midodrin 2.16.840.1.113883.6.73 2017-01 C01CA18 octopamine Oktopamin 2.16.840.1.113883.6.73 2017-01 C01CA19 fenoldopam Fenoldopam 2.16.840.1.113883.6.73 2017-01 C01CA21 cafedrine Kafedrin 2.16.840.1.113883.6.73 2017-01 C01CA22 arbutamine Arbutamin 2.16.840.1.113883.6.73 2017-01 C01CA23 theodrenaline Teodrenalin 2.16.840.1.113883.6.73 2017-01 C01CA24 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 C01CA25 amezinium metilsulfate Amezinium metylsulfat 2.16.840.1.113883.6.73 2017-01 C01CA26 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 C01CA27 droxidopa Droxidopa 2.16.840.1.113883.6.73 2017-01 C01CA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 C01CA51 etilefrine, combinations Etilefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01CE Phosphodiesterase inhibitors Fosfodiesterashämmare 2.16.840.1.113883.6.73 2017-01 C01CE01 amrinone Amrinon 2.16.840.1.113883.6.73 2017-01 C01CE02 milrinone Milrinon 2.16.840.1.113883.6.73 2017-01 C01CE03 enoximone Enoximon 2.16.840.1.113883.6.73 2017-01 C01CE04 bucladesine Bukladesin 2.16.840.1.113883.6.73 2017-01 C01CX Other cardiac stimulants Övriga hjärtstimulerande medel 2.16.840.1.113883.6.73 2017-01 C01CX06 angiotensinamide Angiotensinamid 2.16.840.1.113883.6.73 2017-01 C01CX07 xamoterol Xamoterol 2.16.840.1.113883.6.73 2017-01 C01CX08 levosimendan Levosimendan 2.16.840.1.113883.6.73 2017-01 C01D VASODILATORS USED IN Kärlvidgande medel vid CARDIAC DISEASES hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01DA Organic nitrates Organiska nitrater 2.16.840.1.113883.6.73 2017-01 C01DA02 glyceryl trinitrate Glyceryltrinitrat 2.16.840.1.113883.6.73 2017-01 C01DA04 methylpropylpropanediol dinitrate Metylpropylpropandioldinitrat 2.16.840.1.113883.6.73 2017-01 C01DA05 pentaerithrityl tetranitrate Pentaeritrityltetranitrat 2.16.840.1.113883.6.73 2017-01 C01DA07 propatylnitrate Propatylnitrat 2.16.840.1.113883.6.73 2017-01 C01DA08 isosorbide dinitrate Isosorbiddinitrat 2.16.840.1.113883.6.73 2017-01 C01DA09 trolnitrate Trolnitrat 2.16.840.1.113883.6.73 2017-01 C01DA13 eritrityl tetranitrate Eritrityltetranitrat 2.16.840.1.113883.6.73 2017-01 C01DA14 isosorbide mononitrate Isosorbidmononitrat 2.16.840.1.113883.6.73 2017-01 C01DA20 organic nitrates in combination Organiska nitrater, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA38 tenitramine Tenitramin 2.16.840.1.113883.6.73 2017-01 C01DA52 glyceryl trinitrate, combinations Glyceryltrinitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA54 methylpropylpropanediol dinitrate, Metylpropylpropandioldinitrat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA55 pentaerithrityl tetranitrate, Pentaeritrityltetranitrat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA57 propatylnitrate, combinations Propatylnitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA58 isosorbide dinitrate, combinations Isosorbiddinitrat, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 38 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01DA59 trolnitrate, combinations Trolnitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA63 eritrityl tetranitrate, combinations Eritrityltetranitrat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DA70 organic nitrates in combination with Organiska nitrater i kombination psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 C01DB Quinolone vasodilators Kärlvidgande kinoloner 2.16.840.1.113883.6.73 2017-01 C01DB01 flosequinan Flosekinan 2.16.840.1.113883.6.73 2017-01 C01DX Other vasodilators used in cardiac Övriga kärlvidgande medel vid diseases hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01DX01 itramin tosilate Itramintosilat 2.16.840.1.113883.6.73 2017-01 C01DX02 prenylamine Prenylamin 2.16.840.1.113883.6.73 2017-01 C01DX03 oxyfedrine Oxyfedrin 2.16.840.1.113883.6.73 2017-01 C01DX04 benziodarone Bensiodaron 2.16.840.1.113883.6.73 2017-01 C01DX05 carbocromen Karbokromen 2.16.840.1.113883.6.73 2017-01 C01DX06 hexobendine Hexobendin 2.16.840.1.113883.6.73 2017-01 C01DX07 etafenone Etafenon 2.16.840.1.113883.6.73 2017-01 C01DX08 heptaminol Heptaminol 2.16.840.1.113883.6.73 2017-01 C01DX09 imolamine Imolamin 2.16.840.1.113883.6.73 2017-01 C01DX10 dilazep Dilazep 2.16.840.1.113883.6.73 2017-01 C01DX11 trapidil Trapidil 2.16.840.1.113883.6.73 2017-01 C01DX12 molsidomine Molsidomin 2.16.840.1.113883.6.73 2017-01 C01DX13 efloxate Efloxat 2.16.840.1.113883.6.73 2017-01 C01DX14 cinepazet Cinepazet 2.16.840.1.113883.6.73 2017-01 C01DX15 cloridarol Kloridarol 2.16.840.1.113883.6.73 2017-01 C01DX16 nicorandil Nikorandil 2.16.840.1.113883.6.73 2017-01 C01DX18 linsidomine Linsidomin 2.16.840.1.113883.6.73 2017-01 C01DX19 nesiritide Nesiritid 2.16.840.1.113883.6.73 2017-01 C01DX21 serelaxin Serelaxin 2.16.840.1.113883.6.73 2017-01 C01DX51 itramin tosilate, combinations Itramintosilat, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX52 prenylamine, combinations Prenylamin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX53 oxyfedrine, combinations Oxyfedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 C01DX54 benziodarone, combinations Bensiodaron, kombinationer 2.16.840.1.113883.6.73 2017-01 C01E OTHER CARDIAC Övriga medel vid hjärtsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 C01EA Prostaglandins Prostaglandiner 2.16.840.1.113883.6.73 2017-01 C01EA01 alprostadil Alprostadil 2.16.840.1.113883.6.73 2017-01 C01EB Other cardiac preparations Övriga medel vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C01EB02 camphora Kamfer 2.16.840.1.113883.6.73 2017-01 C01EB03 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 C01EB04 crataegus glycosides Crataegusglykosider 2.16.840.1.113883.6.73 2017-01 C01EB05 creatinolfosfate Kreatinolfosfat 2.16.840.1.113883.6.73 2017-01 C01EB06 fosfocreatine Fosfokreatin 2.16.840.1.113883.6.73 2017-01 C01EB07 fructose 1,6-diphosphate Fruktos 1,6-difosfat 2.16.840.1.113883.6.73 2017-01 C01EB09 ubidecarenone Ubidekarenon 2.16.840.1.113883.6.73 2017-01 C01EB10 adenosine Adenosin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 39 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01EB11 tiracizine Tiracizin 2.16.840.1.113883.6.73 2017-01 C01EB13 acadesine Akadesin 2.16.840.1.113883.6.73 2017-01 C01EB15 trimetazidine Trimetazidin 2.16.840.1.113883.6.73 2017-01 C01EB16 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 C01EB17 ivabradine Ivabradin 2.16.840.1.113883.6.73 2017-01 C01EB18 ranolazine Ranolazin 2.16.840.1.113883.6.73 2017-01 C01EB21 regadenoson Regadenoson 2.16.840.1.113883.6.73 2017-01 C01EB22 meldonium Meldonium 2.16.840.1.113883.6.73 2017-01 C01EB23 tiazotic acid Tiazotinsyra 2.16.840.1.113883.6.73 2017-01 C01EX Other cardiac combination products Övriga kombinationspreparat vid hjärtsjukdomar 2.16.840.1.113883.6.73 2017-01 C02 ANTIHYPERTENSIVES Antihypertensiva medel 2.16.840.1.113883.6.73 2017-01 C02A ANTIADRENERGIC AGENTS, Antiadrenerga preparat med central CENTRALLY ACTING verkan 2.16.840.1.113883.6.73 2017-01 C02AA Rauwolfia alkaloids Rauwolfiaalkaloider 2.16.840.1.113883.6.73 2017-01 C02AA01 rescinnamine Rescinnamin 2.16.840.1.113883.6.73 2017-01 C02AA02 reserpine Reserpin 2.16.840.1.113883.6.73 2017-01 C02AA03 combinations of rauwolfia alkaloids Kombinationer av rauwolfiaalkaloider 2.16.840.1.113883.6.73 2017-01 C02AA04 rauwolfia alkaloids, whole root Rauwolfiaalkaloider, hela roten 2.16.840.1.113883.6.73 2017-01 C02AA05 deserpidine Deserpidin 2.16.840.1.113883.6.73 2017-01 C02AA06 methoserpidine Metoserpidin 2.16.840.1.113883.6.73 2017-01 C02AA07 bietaserpine Bietaserpin 2.16.840.1.113883.6.73 2017-01 C02AA52 reserpine, combinations Reserpin, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AA53 combinations of rauwolfia alkoloids, Kombinationer av combinations rauwolfiaalkaloider, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AA57 bietaserpine, combinations Bietaserpin, kombinationer 2.16.840.1.113883.6.73 2017-01 C02AB Methyldopa Metyldopa 2.16.840.1.113883.6.73 2017-01 C02AB01 methyldopa (levorotatory) Metyldopa (L-form) 2.16.840.1.113883.6.73 2017-01 C02AB02 methyldopa (racemic) Metyldopa (racemat) 2.16.840.1.113883.6.73 2017-01 C02AC Imidazoline receptor agonists Imidazolinreceptoragonister 2.16.840.1.113883.6.73 2017-01 C02AC01 clonidine Klonidin 2.16.840.1.113883.6.73 2017-01 C02AC02 guanfacine Guanfacin 2.16.840.1.113883.6.73 2017-01 C02AC04 tolonidine Tolonidin 2.16.840.1.113883.6.73 2017-01 C02AC05 moxonidine Moxonidin 2.16.840.1.113883.6.73 2017-01 C02AC06 rilmenidine Rilmenidin 2.16.840.1.113883.6.73 2017-01 C02B ANTIADRENERGIC AGENTS, Antiadrenerga preparat, GANGLION-BLOCKING ganglieblockerande 2.16.840.1.113883.6.73 2017-01 C02BA Sulfonium derivatives Sulfoniumderivat 2.16.840.1.113883.6.73 2017-01 C02BA01 trimetaphan Trimetafan 2.16.840.1.113883.6.73 2017-01 C02BB Secondary and tertiary amines Sekundära och tertiära aminer 2.16.840.1.113883.6.73 2017-01 C02BB01 mecamylamine Mekamylamin 2.16.840.1.113883.6.73 2017-01 C02BC Bisquaternary ammonium Biskvartära ammoniumföreningar compounds

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 40 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02C ANTIADRENERGIC AGENTS, Antiadrenerga preparat med perifer PERIPHERALLY ACTING verkan 2.16.840.1.113883.6.73 2017-01 C02CA Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister 2.16.840.1.113883.6.73 2017-01 C02CA01 prazosin Prazosin 2.16.840.1.113883.6.73 2017-01 C02CA02 indoramin Indoramin 2.16.840.1.113883.6.73 2017-01 C02CA03 trimazosin Trimazosin 2.16.840.1.113883.6.73 2017-01 C02CA04 doxazosin Doxazosin 2.16.840.1.113883.6.73 2017-01 C02CA06 urapidil Urapidil 2.16.840.1.113883.6.73 2017-01 C02CC Guanidine derivatives Guanidinderivat 2.16.840.1.113883.6.73 2017-01 C02CC01 betanidine Betanidin 2.16.840.1.113883.6.73 2017-01 C02CC02 guanethidine Guanetidin 2.16.840.1.113883.6.73 2017-01 C02CC03 guanoxan Guanoxan 2.16.840.1.113883.6.73 2017-01 C02CC04 debrisoquine Debrisokin 2.16.840.1.113883.6.73 2017-01 C02CC05 guanoclor Guanoklor 2.16.840.1.113883.6.73 2017-01 C02CC06 guanazodine Guanazodin 2.16.840.1.113883.6.73 2017-01 C02CC07 guanoxabenz Guanoxabens 2.16.840.1.113883.6.73 2017-01 C02D ARTERIOLAR SMOOTH MUSCLE, Medel som påverkar glatt AGENTS ACTING ON muskulatur i perifera kärl 2.16.840.1.113883.6.73 2017-01 C02DA Thiazide derivatives Tiazidderivat 2.16.840.1.113883.6.73 2017-01 C02DA01 diazoxide Diazoxid 2.16.840.1.113883.6.73 2017-01 C02DB Hydrazinophthalazine derivatives Hydrazinoftalazinderivat 2.16.840.1.113883.6.73 2017-01 C02DB01 dihydralazine Dihydralazin 2.16.840.1.113883.6.73 2017-01 C02DB02 hydralazine Hydralazin 2.16.840.1.113883.6.73 2017-01 C02DB03 endralazine Endralazin 2.16.840.1.113883.6.73 2017-01 C02DB04 cadralazine Kadralazin 2.16.840.1.113883.6.73 2017-01 C02DC Pyrimidine derivatives Pyrimidinderivat 2.16.840.1.113883.6.73 2017-01 C02DC01 minoxidil Minoxidil 2.16.840.1.113883.6.73 2017-01 C02DD Nitroferricyanide derivatives Nitrojärn(III)cyanidderivat 2.16.840.1.113883.6.73 2017-01 C02DD01 nitroprusside Nitroprussid 2.16.840.1.113883.6.73 2017-01 C02DG Guanidine derivatives Guanidinderivat 2.16.840.1.113883.6.73 2017-01 C02DG01 pinacidil Pinacidil 2.16.840.1.113883.6.73 2017-01 C02K OTHER ANTIHYPERTENSIVES Övriga antihypertensiva medel 2.16.840.1.113883.6.73 2017-01 C02KA Alkaloids, excl. rauwolfia Alkaloider, exkl rauwolfia 2.16.840.1.113883.6.73 2017-01 C02KA01 veratrum Veratrum 2.16.840.1.113883.6.73 2017-01 C02KB Tyrosine hydroxylase inhibitors Tyrosinhydroxilashämmare 2.16.840.1.113883.6.73 2017-01 C02KB01 metirosine Metirosin 2.16.840.1.113883.6.73 2017-01 C02KC MAO inhibitors MAO-hämmare 2.16.840.1.113883.6.73 2017-01 C02KC01 pargyline Pargylin 2.16.840.1.113883.6.73 2017-01 C02KD Serotonin antagonists Serotoninantagonister 2.16.840.1.113883.6.73 2017-01 C02KD01 ketanserin Ketanserin 2.16.840.1.113883.6.73 2017-01 C02KX Antihypertensives for pulmonary Antihypertensiva medel för arterial hypertension pulmonell arteriell hypertension 2.16.840.1.113883.6.73 2017-01 C02KX01 bosentan Bosentan 2.16.840.1.113883.6.73 2017-01 C02KX02 ambrisentan Ambrisentan

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 41 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02KX03 sitaxentan Sitaxentan 2.16.840.1.113883.6.73 2017-01 C02KX04 macitentan Macitentan 2.16.840.1.113883.6.73 2017-01 C02KX05 riociguat Riociguat 2.16.840.1.113883.6.73 2017-01 C02L ANTIHYPERTENSIVES AND Antihypertensiva medel i DIURETICS IN COMBINATION kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LA Rauwolfia alkaloids and diuretics in Rauwolfiaalkaloider i kombination combination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LA01 reserpine and diuretics Reserpin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA02 rescinnamine and diuretics Rescinnamin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA03 deserpidine and diuretics Deserpidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA04 methoserpidine and diuretics Metoserpidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA07 bietaserpine and diuretics Bietaserpin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA08 rauwolfia alkaloids, whole root and Rauwolfiaalkaloider, hela roten och diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LA09 syrosingopine and diuretics Syrosingopin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LA50 combination of rauwolfia alkaloids Kombination av rauwolfiaalkaloider and diuretics incl. other och diuretika inkl. övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C02LA51 reserpine and diuretics, Reserpin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LA52 rescinnamine and diuretics, Rescinnamin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LA71 reserpine and diuretics, Reserpin och diuretika, combinations with psycholeptics kombinationer med neuroleptika 2.16.840.1.113883.6.73 2017-01 C02LB Methyldopa and diuretics in Metyldopa i kombination med combination diuretika 2.16.840.1.113883.6.73 2017-01 C02LB01 methyldopa (levorotatory) and Metyldopa (L-form) och diuretika diuretics 2.16.840.1.113883.6.73 2017-01 C02LC Imidazoline receptor agonists in Imidazolinreceptoragonister i combination with diuretics kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LC01 clonidine and diuretics Klonidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LC05 moxonidine and diuretics Moxonidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LC51 clonidine and diuretics, Klonidin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LE Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister and diuretics och diuretika 2.16.840.1.113883.6.73 2017-01 C02LE01 prazosin and diuretics Prazosin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LF Guanidine derivatives and diuretics Guanidinderivat och diuretika 2.16.840.1.113883.6.73 2017-01 C02LF01 guanethidine and diuretics Guanetidin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG Hydrazinophthalazine derivatives Hydrazinoftalazinderivat och and diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LG01 dihydralazine and diuretics Dihydralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG02 hydralazine and diuretics Hydralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG03 picodralazine and diuretics Pikodralazin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LG51 dihydralazine and diuretics, Dihydralazin och diuretika, combinations with other drugs kombinationer med andra medel 2.16.840.1.113883.6.73 2017-01 C02LG73 picodralazine and diuretics, Pikodralazin och diuretika, combinations with psycholeptics kombinationer med neuroleptika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 42 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02LK Alkaloids, excl. rauwolfia, in Alkaloider, exkl rauwolfia, i combination with diuretics kombination med diuretika 2.16.840.1.113883.6.73 2017-01 C02LK01 veratrum and diuretics Veratrum och diuretika 2.16.840.1.113883.6.73 2017-01 C02LL MAO inhibitors and diuretics MAO-hämmare och diuretika 2.16.840.1.113883.6.73 2017-01 C02LL01 pargyline and diuretics Pargylin och diuretika 2.16.840.1.113883.6.73 2017-01 C02LN Serotonin antagonists and diuretics Serotoninantagonister och diuretika 2.16.840.1.113883.6.73 2017-01 C02LX Other antihypertensives and Övriga antihypertensiva medel och diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C02LX01 pinacidil and diuretics Pinacidil och diuretika 2.16.840.1.113883.6.73 2017-01 C02N COMBINATIONS OF Kombination av antihypertensiva ANTIHYPERTENSIVES IN ATC- medel i ATC-grupp C02 GR. C02 2.16.840.1.113883.6.73 2017-01 C03 DIURETICS Diuretika 2.16.840.1.113883.6.73 2017-01 C03A LOW-CEILING DIURETICS, Tiazider THIAZIDES 2.16.840.1.113883.6.73 2017-01 C03AA Thiazides, plain Tiazider 2.16.840.1.113883.6.73 2017-01 C03AA01 bendroflumethiazide Bendroflumetiazid 2.16.840.1.113883.6.73 2017-01 C03AA02 hydroflumethiazide Hydroflumetiazid 2.16.840.1.113883.6.73 2017-01 C03AA03 hydrochlorothiazide Hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C03AA04 chlorothiazide Klortiazid 2.16.840.1.113883.6.73 2017-01 C03AA05 polythiazide Polytiazid 2.16.840.1.113883.6.73 2017-01 C03AA06 trichlormethiazide Triklormetiazid 2.16.840.1.113883.6.73 2017-01 C03AA07 cyclopenthiazide Cyklopentiazid 2.16.840.1.113883.6.73 2017-01 C03AA08 methyclothiazide Metyklotiazid 2.16.840.1.113883.6.73 2017-01 C03AA09 cyclothiazide Cyklotiazid 2.16.840.1.113883.6.73 2017-01 C03AA13 mebutizide Mebutizid 2.16.840.1.113883.6.73 2017-01 C03AB Thiazides and potassium in Tiazider i kombination med kalium combination 2.16.840.1.113883.6.73 2017-01 C03AB01 bendroflumethiazide and potassium Bendroflumetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB02 hydroflumethiazide and potassium Hydroflumetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB03 hydrochlorothiazide and potassium Hydroklortiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB04 chlorothiazide and potassium Klortiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB05 polythiazide and potassium Polytiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB06 trichlormethiazide and potassium Triklormetiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB07 cyclopenthiazide and potassium Cyklopentiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB08 methyclothiazide and potassium Metylklotiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AB09 cyclothiazide and potassium Cyklotiazid och kalium 2.16.840.1.113883.6.73 2017-01 C03AH Thiazides, combinations with Tiazider i komb med neuroleptika psycholeptics and/or analgesics och/eller analgetika 2.16.840.1.113883.6.73 2017-01 C03AH01 chlorothiazide, combinations Klortiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03AH02 hydroflumethiazide, combinations Hydroflumetiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03AX Thiazides, combinations with other Tiazider i kombination med andra drugs medel 2.16.840.1.113883.6.73 2017-01 C03AX01 hydrochlorothiazide, combinations Hydroklortiazid, kombinationer 2.16.840.1.113883.6.73 2017-01 C03B LOW-CEILING DIURETICS, EXCL. Tiazidbesläktade diuretika THIAZIDES

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 43 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03BA Sulfonamides, plain Sulfonamidderivat 2.16.840.1.113883.6.73 2017-01 C03BA02 quinethazone Kinetazon 2.16.840.1.113883.6.73 2017-01 C03BA03 clopamide Klopamid 2.16.840.1.113883.6.73 2017-01 C03BA04 chlortalidone Klortalidon 2.16.840.1.113883.6.73 2017-01 C03BA05 mefruside Mefrusid 2.16.840.1.113883.6.73 2017-01 C03BA07 clofenamide Klofenamid 2.16.840.1.113883.6.73 2017-01 C03BA08 metolazone Metolazon 2.16.840.1.113883.6.73 2017-01 C03BA09 meticrane Metikran 2.16.840.1.113883.6.73 2017-01 C03BA10 xipamide Xipamid 2.16.840.1.113883.6.73 2017-01 C03BA11 indapamide Indapamid 2.16.840.1.113883.6.73 2017-01 C03BA12 clorexolone Klorexolon 2.16.840.1.113883.6.73 2017-01 C03BA13 fenquizone Fenkizon 2.16.840.1.113883.6.73 2017-01 C03BA82 clorexolone, combinations with Klorexolon, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 C03BB Sulfonamides and potassium in Sulfonamider i kombination med combination kalium 2.16.840.1.113883.6.73 2017-01 C03BB02 quinethazone and potassium Kinetazon och kalium 2.16.840.1.113883.6.73 2017-01 C03BB03 clopamide and potassium Klopamid och kalium 2.16.840.1.113883.6.73 2017-01 C03BB04 chlortalidone and potassium Klortalidon och kalium 2.16.840.1.113883.6.73 2017-01 C03BB05 mefruside and potassium Mefrusid och kalium 2.16.840.1.113883.6.73 2017-01 C03BB07 clofenamide and potassium Klofenamid och kalium 2.16.840.1.113883.6.73 2017-01 C03BC Mercurial diuretics Kvicksilverdiuretika 2.16.840.1.113883.6.73 2017-01 C03BC01 mersalyl Mersalyl 2.16.840.1.113883.6.73 2017-01 C03BD Xanthine derivatives Xantinderivat 2.16.840.1.113883.6.73 2017-01 C03BD01 theobromine Teobromin 2.16.840.1.113883.6.73 2017-01 C03BK Sulfonamides, combinations with Sulfonamider i kombination med other drugs andra medel 2.16.840.1.113883.6.73 2017-01 C03BX Other low-ceiling diuretics Övriga tiazidbesläktade diuretika 2.16.840.1.113883.6.73 2017-01 C03BX03 cicletanine Cikletanin 2.16.840.1.113883.6.73 2017-01 C03C HIGH-CEILING DIURETICS Loop-diuretika 2.16.840.1.113883.6.73 2017-01 C03CA Sulfonamides, plain Sulfonamider 2.16.840.1.113883.6.73 2017-01 C03CA01 furosemide Furosemid 2.16.840.1.113883.6.73 2017-01 C03CA02 bumetanide Bumetanid 2.16.840.1.113883.6.73 2017-01 C03CA03 piretanide Piretanid 2.16.840.1.113883.6.73 2017-01 C03CA04 torasemide Torasemid 2.16.840.1.113883.6.73 2017-01 C03CB Sulfonamides and potassium in Sulfonamider i kombination med combination kalium 2.16.840.1.113883.6.73 2017-01 C03CB01 furosemide and potassium Furosemid och kalium 2.16.840.1.113883.6.73 2017-01 C03CB02 bumetanide and potassium Bumetanid och kalium 2.16.840.1.113883.6.73 2017-01 C03CC Aryloxyacetic acid derivatives Fenoxiättiksyraderivat 2.16.840.1.113883.6.73 2017-01 C03CC01 etacrynic acid Etakrynsyra 2.16.840.1.113883.6.73 2017-01 C03CC02 tienilic acid Tienilsyra 2.16.840.1.113883.6.73 2017-01 C03CD Pyrazolone derivatives Pyrazolonderivat 2.16.840.1.113883.6.73 2017-01 C03CD01 muzolimine Muzolimin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 44 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03CX Other high-ceiling diuretics Övriga loop-diuretika 2.16.840.1.113883.6.73 2017-01 C03CX01 etozolin Etozolin 2.16.840.1.113883.6.73 2017-01 C03D POTASSIUM-SPARING AGENTS Kaliumsparande diuretika 2.16.840.1.113883.6.73 2017-01 C03DA Aldosterone antagonists Aldosteronantagonister 2.16.840.1.113883.6.73 2017-01 C03DA01 spironolactone Spironolakton 2.16.840.1.113883.6.73 2017-01 C03DA02 potassium canrenoate Kaliumkanrenoat 2.16.840.1.113883.6.73 2017-01 C03DA03 canrenone Kanrenon 2.16.840.1.113883.6.73 2017-01 C03DA04 eplerenone Eplerenon 2.16.840.1.113883.6.73 2017-01 C03DB Other potassium-sparing agents Övriga kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03DB01 amiloride Amilorid 2.16.840.1.113883.6.73 2017-01 C03DB02 triamterene Triamteren 2.16.840.1.113883.6.73 2017-01 C03E DIURETICS AND POTASSIUM- Diuretika i kombination med SPARING AGENTS IN kaliumsparande medel COMBINATION 2.16.840.1.113883.6.73 2017-01 C03EA Low-ceiling diuretics and potassium- Tiazidbesläktad diuretika och sparing agents kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03EA01 hydrochlorothiazide and potassium- Hydroklortiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA02 trichlormethiazide and potassium- Triklormetiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA03 epitizide and potassium-sparing Epitizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EA04 altizide and potassium-sparing Altizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EA05 mebutizide and potassium-sparing Mebutizid och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA06 chlortalidone and potassium-sparing Klortalidon och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA07 cyclopenthiazide and potassium- Cyklopentiazid och kaliumsparande sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EA12 metolazone and potassium-sparing Metolazon och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03EA13 bendroflumethiazide and potassium- Bendroflumetiazid och sparing agents kaliumsparande medel 2.16.840.1.113883.6.73 2017-01 C03EA14 butizide and potassium-sparing Butizid och kaliumsparande medel agents 2.16.840.1.113883.6.73 2017-01 C03EB High-ceiling diuretics and Loop-diuretika och kaliumsparande potassium-sparing agents medel 2.16.840.1.113883.6.73 2017-01 C03EB01 furosemide and potassium-sparing Furosemid och kaliumsparande agents diuretika 2.16.840.1.113883.6.73 2017-01 C03EB02 bumetanide and potassium-sparing Bumetanid och kaliumsparande agents medel 2.16.840.1.113883.6.73 2017-01 C03X OTHER DIURETICS Övriga diuretika 2.16.840.1.113883.6.73 2017-01 C03XA Vasopressin antagonists Vasopressinantagonister 2.16.840.1.113883.6.73 2017-01 C03XA01 tolvaptan Tolvaptan 2.16.840.1.113883.6.73 2017-01 C03XA02 conivaptan Konivaptan 2.16.840.1.113883.6.73 2017-01 C04 PERIPHERAL VASODILATORS Perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04A PERIPHERAL VASODILATORS Perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04AA 2-amino-1-phenylethanol derivatives 2-Amino-1-fenyletanolderivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 45 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C04AA01 isoxsuprine Isoxsuprin 2.16.840.1.113883.6.73 2017-01 C04AA02 buphenine Bufenin 2.16.840.1.113883.6.73 2017-01 C04AA31 bamethan Bametan 2.16.840.1.113883.6.73 2017-01 C04AB Imidazoline derivatives Imidazolinderivat 2.16.840.1.113883.6.73 2017-01 C04AB01 phentolamine Fentolamin 2.16.840.1.113883.6.73 2017-01 C04AB02 tolazoline Tolazolin 2.16.840.1.113883.6.73 2017-01 C04AC Nicotinic acid and derivatives Nikotinsyra och derivat 2.16.840.1.113883.6.73 2017-01 C04AC01 nicotinic acid Nikotinsyra 2.16.840.1.113883.6.73 2017-01 C04AC02 nicotinyl alcohol (pyridylcarbinol) Nikotinylalkohol 2.16.840.1.113883.6.73 2017-01 C04AC03 inositol nicotinate Inositolnikotinat 2.16.840.1.113883.6.73 2017-01 C04AC07 ciclonicate Ciklonikat 2.16.840.1.113883.6.73 2017-01 C04AD Purine derivatives Purinderivat 2.16.840.1.113883.6.73 2017-01 C04AD01 pentifylline Pentifyllin 2.16.840.1.113883.6.73 2017-01 C04AD02 xantinol nicotinate Xantinolnikotinat 2.16.840.1.113883.6.73 2017-01 C04AD03 pentoxifylline Pentoxifyllin 2.16.840.1.113883.6.73 2017-01 C04AD04 etofylline nicotinate Etofyllinnikotinat 2.16.840.1.113883.6.73 2017-01 C04AE Ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 C04AE01 ergoloid mesylates Ergoloidmesylat 2.16.840.1.113883.6.73 2017-01 C04AE02 nicergoline Nicergolin 2.16.840.1.113883.6.73 2017-01 C04AE04 dihydroergocristine Dihydroergokristin 2.16.840.1.113883.6.73 2017-01 C04AE51 ergoloid mesylates, combinations Ergoloidmesylat, kombinationer 2.16.840.1.113883.6.73 2017-01 C04AE54 dihydroergocristine, combinations Dihydroergokristin, kombinationer 2.16.840.1.113883.6.73 2017-01 C04AF Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 C04AF01 kallidinogenase Kallidinogenas 2.16.840.1.113883.6.73 2017-01 C04AX Other peripheral vasodilators Övriga perifera vasodilatorer 2.16.840.1.113883.6.73 2017-01 C04AX01 cyclandelate Cyklandelat 2.16.840.1.113883.6.73 2017-01 C04AX02 phenoxybenzamine Fenoxybensamin 2.16.840.1.113883.6.73 2017-01 C04AX07 vincamine Vinkamin 2.16.840.1.113883.6.73 2017-01 C04AX10 moxisylyte Moxisylyt 2.16.840.1.113883.6.73 2017-01 C04AX11 bencyclane Bencyklan 2.16.840.1.113883.6.73 2017-01 C04AX17 vinburnine Vinburnin 2.16.840.1.113883.6.73 2017-01 C04AX19 suloctidil Suloktidil 2.16.840.1.113883.6.73 2017-01 C04AX20 buflomedil Buflomedil 2.16.840.1.113883.6.73 2017-01 C04AX21 naftidrofuryl Naftidrofuryl 2.16.840.1.113883.6.73 2017-01 C04AX23 butalamine Butalmin 2.16.840.1.113883.6.73 2017-01 C04AX24 visnadine Visnadin 2.16.840.1.113883.6.73 2017-01 C04AX26 cetiedil Cetiedil 2.16.840.1.113883.6.73 2017-01 C04AX27 cinepazide Cinepazid 2.16.840.1.113883.6.73 2017-01 C04AX28 ifenprodil Ifenprodil 2.16.840.1.113883.6.73 2017-01 C04AX30 azapetine Azapetin 2.16.840.1.113883.6.73 2017-01 C04AX32 fasudil Fasudil 2.16.840.1.113883.6.73 2017-01 C05 VASOPROTECTIVES Kärlskyddande medel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 46 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05A AGENTS FOR TREATMENT OF Utvärtes medel vid hemorrojder och HEMORRHOIDS AND ANAL analfissurer FISSURES FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 C05AA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 C05AA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 C05AA04 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 C05AA05 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 C05AA06 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 C05AA08 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 C05AA09 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 C05AA10 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 C05AA11 fluocinonide Fluocinonid 2.16.840.1.113883.6.73 2017-01 C05AA12 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 C05AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 C05AD Local anesthetics Lokalanestetika 2.16.840.1.113883.6.73 2017-01 C05AD01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 C05AD02 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 C05AD03 benzocaine Bensokain 2.16.840.1.113883.6.73 2017-01 C05AD04 cinchocaine Cinkokain 2.16.840.1.113883.6.73 2017-01 C05AD05 procaine Prokain 2.16.840.1.113883.6.73 2017-01 C05AD06 oxetacaine Oxetakain 2.16.840.1.113883.6.73 2017-01 C05AD07 pramocaine Pramokain 2.16.840.1.113883.6.73 2017-01 C05AE Muscle relaxants Muskelavslappande medel 2.16.840.1.113883.6.73 2017-01 C05AE01 glyceryl trinitrate Glyceryltrinitrat 2.16.840.1.113883.6.73 2017-01 C05AE02 isosorbide dinitrate Isosorbiddinitrat 2.16.840.1.113883.6.73 2017-01 C05AE03 diltiazem Diltiazem 2.16.840.1.113883.6.73 2017-01 C05AX Other agents for treatment of Övriga utvärtes medel vid hemorrhoids and anal fissures for hemorrojder och analfissurer topical use 2.16.840.1.113883.6.73 2017-01 C05AX01 aluminium preparations Aluminiumpreparat 2.16.840.1.113883.6.73 2017-01 C05AX02 bismuth preparations, combinations Vismutpreparat, kombinationer 2.16.840.1.113883.6.73 2017-01 C05AX03 other preparations, combinations Övriga medel, kombinationer 2.16.840.1.113883.6.73 2017-01 C05AX04 zinc preparations Zinkpreparat 2.16.840.1.113883.6.73 2017-01 C05AX05 tribenoside Tribenosid 2.16.840.1.113883.6.73 2017-01 C05B ANTIVARICOSE THERAPY Medel för varixbehandling 2.16.840.1.113883.6.73 2017-01 C05BA Heparins or heparinoids for topical Heparin eller heparinoida use substanser för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 C05BA01 organo-heparinoid Organiska heparinföreningar 2.16.840.1.113883.6.73 2017-01 C05BA02 sodium apolate Natriumapolat 2.16.840.1.113883.6.73 2017-01 C05BA03 heparin Heparin 2.16.840.1.113883.6.73 2017-01 C05BA04 pentosan polysulfate sodium Pentosanpolysulfatnatrium 2.16.840.1.113883.6.73 2017-01 C05BA51 heparinoid, combinations Heparinoid, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BA53 heparin, combinations Heparin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BB Sclerosing agents for local injection Medel för sklerosering för lokal injektion

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 47 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05BB01 monoethanolamine oleate Monoetanolaminoleat 2.16.840.1.113883.6.73 2017-01 C05BB02 polidocanol Polidokanol 2.16.840.1.113883.6.73 2017-01 C05BB03 invert sugar Inverterat socker 2.16.840.1.113883.6.73 2017-01 C05BB04 sodium tetradecyl sulfate Natriumtetradecylsulfat 2.16.840.1.113883.6.73 2017-01 C05BB05 phenol Fenol 2.16.840.1.113883.6.73 2017-01 C05BB56 glucose, combinations Glukos, kombinationer 2.16.840.1.113883.6.73 2017-01 C05BX Other sclerosing agents Övriga medel för sklerosering 2.16.840.1.113883.6.73 2017-01 C05BX01 calcium dobesilate Kalciumdobesilat 2.16.840.1.113883.6.73 2017-01 C05BX51 calcium dobesilate, combinations Kalciumdobesilat, kombinationer 2.16.840.1.113883.6.73 2017-01 C05C CAPILLARY STABILIZING Kapillärstabiliserande medel AGENTS 2.16.840.1.113883.6.73 2017-01 C05CA Bioflavonoids Bioflavonoider 2.16.840.1.113883.6.73 2017-01 C05CA01 rutoside Rutosid 2.16.840.1.113883.6.73 2017-01 C05CA02 monoxerutin Monoxerutin 2.16.840.1.113883.6.73 2017-01 C05CA03 diosmin Diosmin 2.16.840.1.113883.6.73 2017-01 C05CA04 troxerutin Troxerutin 2.16.840.1.113883.6.73 2017-01 C05CA05 hidrosmin Hidrosmin 2.16.840.1.113883.6.73 2017-01 C05CA51 rutoside, combinations Rutosid, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CA53 diosmin, combinations Diosmin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CA54 troxerutin, combinations Troxerutin, kombinationer 2.16.840.1.113883.6.73 2017-01 C05CX Other capillary stabilizing agents Övriga kapillärstabiliserande medel 2.16.840.1.113883.6.73 2017-01 C05CX01 tribenoside Tribenosid 2.16.840.1.113883.6.73 2017-01 C05CX02 naftazone Naftazon 2.16.840.1.113883.6.73 2017-01 C05CX03 Hippocastani semen Hippocastani semen 2.16.840.1.113883.6.73 2017-01 C07 BETA BLOCKING AGENTS Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07A BETA BLOCKING AGENTS Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07AA Beta blocking agents, non-selective Beta-receptorblockerande medel, icke-selektiva 2.16.840.1.113883.6.73 2017-01 C07AA01 alprenolol Alprenolol 2.16.840.1.113883.6.73 2017-01 C07AA02 oxprenolol Oxprenolol 2.16.840.1.113883.6.73 2017-01 C07AA03 pindolol Pindolol 2.16.840.1.113883.6.73 2017-01 C07AA05 propranolol Propranolol 2.16.840.1.113883.6.73 2017-01 C07AA06 timolol Timolol 2.16.840.1.113883.6.73 2017-01 C07AA07 sotalol Sotalol 2.16.840.1.113883.6.73 2017-01 C07AA12 nadolol Nadolol 2.16.840.1.113883.6.73 2017-01 C07AA14 mepindolol Mepindolol 2.16.840.1.113883.6.73 2017-01 C07AA15 carteolol Karteolol 2.16.840.1.113883.6.73 2017-01 C07AA16 tertatolol Tertatolol 2.16.840.1.113883.6.73 2017-01 C07AA17 bopindolol Bopindolol 2.16.840.1.113883.6.73 2017-01 C07AA19 bupranolol Bupranolol 2.16.840.1.113883.6.73 2017-01 C07AA23 penbutolol Penbutolol 2.16.840.1.113883.6.73 2017-01 C07AA27 cloranolol Kloranolol 2.16.840.1.113883.6.73 2017-01 C07AB Beta blocking agents, selective Beta-receptorblockerande medel, selektiva

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 48 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07AB01 practolol Praktolol 2.16.840.1.113883.6.73 2017-01 C07AB02 metoprolol Metoprolol 2.16.840.1.113883.6.73 2017-01 C07AB03 atenolol Atenolol 2.16.840.1.113883.6.73 2017-01 C07AB04 acebutolol Acebutolol 2.16.840.1.113883.6.73 2017-01 C07AB05 betaxolol Betaxolol 2.16.840.1.113883.6.73 2017-01 C07AB06 bevantolol Bevantolol 2.16.840.1.113883.6.73 2017-01 C07AB07 bisoprolol Bisoprolol 2.16.840.1.113883.6.73 2017-01 C07AB08 celiprolol Celiprolol 2.16.840.1.113883.6.73 2017-01 C07AB09 esmolol Esmolol 2.16.840.1.113883.6.73 2017-01 C07AB10 epanolol Epanolol 2.16.840.1.113883.6.73 2017-01 C07AB11 s-atenolol S-atenolol 2.16.840.1.113883.6.73 2017-01 C07AB12 nebivolol Nebivolol 2.16.840.1.113883.6.73 2017-01 C07AB13 talinolol Talinolol 2.16.840.1.113883.6.73 2017-01 C07AB14 landiolol Landiolol 2.16.840.1.113883.6.73 2017-01 C07AG Alpha and beta blocking agents Alfa- och beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 C07AG01 labetalol Labetalol 2.16.840.1.113883.6.73 2017-01 C07AG02 carvedilol Karvedilol 2.16.840.1.113883.6.73 2017-01 C07B BETA BLOCKING AGENTS AND Beta-receptorblockerande medel THIAZIDES och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA Beta blocking agents, non-selective, Icke-selektiva beta- and thiazides receptorblockerare och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA02 oxprenolol and thiazides Oxprenolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA05 propranolol and thiazides Propranolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA06 timolol and thiazides Timolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA07 sotalol and thiazides Sotalol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA12 nadolol and thiazides Nadolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BA68 metipranolol and thiazides, Metipranolol och tiazider, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07BB Beta blocking agents, selective, and Selektiva beta-receptorblockerare thiazides och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB02 metoprolol and thiazides Metoprolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB03 atenolol and thiazides Atenolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB04 acebutolol and thiazides Acebutolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB06 bevantolol and thiazides Bevantolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB07 bisoprolol and thiazides Bisoprolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB12 nebivolol and thiazides Nebivolol och tiazider 2.16.840.1.113883.6.73 2017-01 C07BB52 metoprolol and thiazides, Metoprolol och tiazider, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07BG Alpha and beta blocking agents and Alfa- och beta-receptorblockerande thiazides medel och tiazider 2.16.840.1.113883.6.73 2017-01 C07BG01 labetalol and thiazides Labetalol och tiazider 2.16.840.1.113883.6.73 2017-01 C07C BETA BLOCKING AGENTS AND Beta-receptorblockerande medel OTHER DIURETICS och övriga diuretika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 49 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07CA Beta blocking agents, non-selective, Icke-selektiva beta- and other diuretics receptorblockerare och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA02 oxprenolol and other diuretics Oxprenolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA03 pindolol and other diuretics Pindolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA17 bopindolol and other diuretics Bopindolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CA23 penbutolol and other diuretics Penbutolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB Beta blocking agents, selective, and Selektiva beta-receptorblockerare other diuretics och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB02 metoprolol and other diuretics Metoprolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB03 atenolol and other diuretics Atenolol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CB53 atenolol and other diuretics, Atenolol och övriga diuretika, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 C07CG Alpha and beta blocking agents and Alfa- och beta-receptorblockerande other diuretics medel och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07CG01 labetalol and other diuretics Labetalol och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07D BETA BLOCKING AGENTS, Beta-receptorblockerande medel, THIAZIDES AND OTHER tiazider och övriga diuretika DIURETICS 2.16.840.1.113883.6.73 2017-01 C07DA Beta blocking agents, non-selective, Icke-selektiva beta- thiazides and other diuretics receptorblockerare, tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DA06 timolol, thiazides and other diuretics Timolol, tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DB Beta blocking agents, selective, Selektiva beta-receptorblockerare, thiazides and other diuretics tiazider och övriga diuretika 2.16.840.1.113883.6.73 2017-01 C07DB01 atenolol, thiazides and other Atenolol, tiazider och övriga diuretics diuretika 2.16.840.1.113883.6.73 2017-01 C07E BETA BLOCKING AGENTS AND Beta-receptorblockerande medel VASODILATORS och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07EA Beta blocking agents, non-selective, Icke-selektiva beta- and vasodilators receptorblockerare och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07EB Beta blocking agents, selective, and Selektiva beta-receptorblockerare vasodilators och kärlvidgande medel 2.16.840.1.113883.6.73 2017-01 C07F BETA BLOCKING AGENTS, Beta-receptorblockerande medel, OTHER COMBINATIONS övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FB Beta blocking agents and calcium Beta-receptorblockerande medel channel blockers och kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C07FB02 metoprolol and felodipine Metoprolol och felodipin 2.16.840.1.113883.6.73 2017-01 C07FB03 atenolol and nifedipine Atenolol och nifedipin 2.16.840.1.113883.6.73 2017-01 C07FB07 bisoprolol and amlodipine Bisoprolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FB12 nevibolol and amlodipine Nevibolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FB13 metoprolol and amlodipine Metoprolol och amlodipin 2.16.840.1.113883.6.73 2017-01 C07FX Beta blocking agents, other Beta-receptorblockerande medel, combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FX01 propranolol and other combinations Propranolol och övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C07FX02 sotalol and acetylsalicylic acid Sotalol och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C07FX03 metoprolol and acetylsalicylic acid Metoprolol och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C07FX04 bisoprolol and acetylsalicylic acid Bisoprolol och acetylsalicylsyra © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 50 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07FX05 metoprolol and ivabradine Metoprolol och ivabradin 2.16.840.1.113883.6.73 2017-01 C07FX06 carvedilol and ivabradine Karvedilol och ivabradin 2.16.840.1.113883.6.73 2017-01 C08 CALCIUM CHANNEL BLOCKERS Kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C08C SELECTIVE CALCIUM CHANNEL Kalciumantagonister med BLOCKERS WITH MAINLY övervägande kärlselektiv effekt VASCULAR EFFECTS 2.16.840.1.113883.6.73 2017-01 C08CA Dihydropyridine derivatives Dihydropyridinderivat 2.16.840.1.113883.6.73 2017-01 C08CA01 amlodipine Amlodipin 2.16.840.1.113883.6.73 2017-01 C08CA02 felodipine Felodipin 2.16.840.1.113883.6.73 2017-01 C08CA03 isradipine Isradipin 2.16.840.1.113883.6.73 2017-01 C08CA04 nicardipine Nikardipin 2.16.840.1.113883.6.73 2017-01 C08CA05 nifedipine Nifedipin 2.16.840.1.113883.6.73 2017-01 C08CA06 nimodipine Nimodipin 2.16.840.1.113883.6.73 2017-01 C08CA07 nisoldipine Nisoldipin 2.16.840.1.113883.6.73 2017-01 C08CA08 nitrendipine Nitrendipin 2.16.840.1.113883.6.73 2017-01 C08CA09 lacidipine Lacidipin 2.16.840.1.113883.6.73 2017-01 C08CA10 nilvadipine Nilvadipin 2.16.840.1.113883.6.73 2017-01 C08CA11 manidipine Manidipin 2.16.840.1.113883.6.73 2017-01 C08CA12 barnidipine Barnidipin 2.16.840.1.113883.6.73 2017-01 C08CA13 lercanidipine Lerkanidipin 2.16.840.1.113883.6.73 2017-01 C08CA14 cilnidipine Cilnidipin 2.16.840.1.113883.6.73 2017-01 C08CA15 benidipine Benidipin 2.16.840.1.113883.6.73 2017-01 C08CA16 clevidipine Klevidipin 2.16.840.1.113883.6.73 2017-01 C08CA55 nifedipine, combinations Nifedipin, kombinationer 2.16.840.1.113883.6.73 2017-01 C08CX Other selective calcium channel Övriga selektiva blockers with mainly vascular effects kalciumantagonister med främst vaskulär effekt 2.16.840.1.113883.6.73 2017-01 C08CX01 mibefradil Mibefradil 2.16.840.1.113883.6.73 2017-01 C08D SELECTIVE CALCIUM CHANNEL Kalciumantagonister med direkt BLOCKERS WITH DIRECT hjärtselektiv effekt CARDIAC EFFECTS 2.16.840.1.113883.6.73 2017-01 C08DA Phenylalkylamine derivatives Fenylalkylaminderivat 2.16.840.1.113883.6.73 2017-01 C08DA01 verapamil Verapamil 2.16.840.1.113883.6.73 2017-01 C08DA02 gallopamil Gallopamil 2.16.840.1.113883.6.73 2017-01 C08DA51 verapamil, combinations Verapamil, kombinationer 2.16.840.1.113883.6.73 2017-01 C08DB Benzothiazepine derivatives Bensotiazepinderivat 2.16.840.1.113883.6.73 2017-01 C08DB01 diltiazem Diltiazem 2.16.840.1.113883.6.73 2017-01 C08E NON-SELECTIVE CALCIUM Icke-selektiva kalciumantagonister CHANNEL BLOCKERS 2.16.840.1.113883.6.73 2017-01 C08EA Phenylalkylamine derivatives Fenylalkylaminderivat 2.16.840.1.113883.6.73 2017-01 C08EA01 fendiline Fendilin 2.16.840.1.113883.6.73 2017-01 C08EA02 bepridil Bepridil 2.16.840.1.113883.6.73 2017-01 C08EX Other non-selective calcium channel Övriga icke-selektiva blockers kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C08EX01 lidoflazine Lidoflazin 2.16.840.1.113883.6.73 2017-01 C08EX02 perhexiline Perhexilin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 51 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C08G CALCIUM CHANNEL BLOCKERS Kalciumantagonister och diuretika AND DIURETICS 2.16.840.1.113883.6.73 2017-01 C08GA Calcium channel blockers and Kalciumantagonister och diuretika diuretics 2.16.840.1.113883.6.73 2017-01 C08GA01 nifedipine and diuretics Nifedipin och diuretika 2.16.840.1.113883.6.73 2017-01 C08GA02 amlodipine and diuretics Amlodipin och diuretika 2.16.840.1.113883.6.73 2017-01 C09 AGENTS ACTING ON THE RENIN- Medel som påverkar renin- ANGIOTENSIN SYSTEM angiotensinsystemet 2.16.840.1.113883.6.73 2017-01 C09A ACE INHIBITORS, PLAIN ACE-hämmare 2.16.840.1.113883.6.73 2017-01 C09AA ACE inhibitors, plain ACE-hämmare 2.16.840.1.113883.6.73 2017-01 C09AA01 captopril Kaptopril 2.16.840.1.113883.6.73 2017-01 C09AA02 enalapril Enalapril 2.16.840.1.113883.6.73 2017-01 C09AA03 lisinopril Lisinopril 2.16.840.1.113883.6.73 2017-01 C09AA04 perindopril Perindopril 2.16.840.1.113883.6.73 2017-01 C09AA05 ramipril Ramipril 2.16.840.1.113883.6.73 2017-01 C09AA06 quinapril Kinapril 2.16.840.1.113883.6.73 2017-01 C09AA07 benazepril Benazepril 2.16.840.1.113883.6.73 2017-01 C09AA08 cilazapril Cilazapril 2.16.840.1.113883.6.73 2017-01 C09AA09 fosinopril Fosinopril 2.16.840.1.113883.6.73 2017-01 C09AA10 trandolapril Trandolapril 2.16.840.1.113883.6.73 2017-01 C09AA11 spirapril Spirapril 2.16.840.1.113883.6.73 2017-01 C09AA12 delapril Delapril 2.16.840.1.113883.6.73 2017-01 C09AA13 moexipril Moexipril 2.16.840.1.113883.6.73 2017-01 C09AA14 temocapril Temokapril 2.16.840.1.113883.6.73 2017-01 C09AA15 zofenopril Zofenopril 2.16.840.1.113883.6.73 2017-01 C09AA16 imidapril Imidapril 2.16.840.1.113883.6.73 2017-01 C09B ACE INHIBITORS, ACE-hämmare, kombinationer COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C09BA ACE inhibitors and diuretics ACE-hämmare och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA01 captopril and diuretics Kaptopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA02 enalapril and diuretics Enalapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA03 lisinopril and diuretics Lisinopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA04 perindopril and diuretics Perindopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA05 ramipril and diuretics Ramipril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA06 quinapril and diuretics Kinapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA07 benazepril and diuretics Benazepril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA08 cilazapril and diuretics Cilazapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA09 fosinopril and diuretics Fosinopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA12 delapril and diuretics Delapril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA13 moexipril and diuretics Moexipril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BA15 zofenopril and diuretics Zofenopril och diuretika 2.16.840.1.113883.6.73 2017-01 C09BB ACE inhibitors and calcium channel ACE-hämmare och blockers kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C09BB02 enalapril and lercanidipine Enalapril och lerkanidipin 2.16.840.1.113883.6.73 2017-01 C09BB03 lisinopril and amlodipine Lisinopril och amlodipin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 52 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09BB04 perindopril and amlodipine Perindopril och amlodipin 2.16.840.1.113883.6.73 2017-01 C09BB05 ramipril and felodipine Ramipril och felodipin 2.16.840.1.113883.6.73 2017-01 C09BB06 enalapril and nitrendipine Enalapril och nitrendipin 2.16.840.1.113883.6.73 2017-01 C09BB07 ramipril and amlodipine Ramipril och amlodipin 2.16.840.1.113883.6.73 2017-01 C09BB10 trandolapril and verapamil Trandolapril och verapamil 2.16.840.1.113883.6.73 2017-01 C09BB12 delapril and manidipine Delapril och manidipin 2.16.840.1.113883.6.73 2017-01 C09BX ACE inhibitors, other combinations ACE-hämmare, övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C09BX01 perindopril, amlodipine and Perindopril, amlodipin och indapamide indapamid 2.16.840.1.113883.6.73 2017-01 C09BX02 perindopril and bisoprolol Perindopril och bisoprolol 2.16.840.1.113883.6.73 2017-01 C09C ANGIOTENSIN II ANTAGONISTS, Angiotensin II receptorblockerare PLAIN (ARBs) 2.16.840.1.113883.6.73 2017-01 C09CA Angiotensin II antagonists, plain Angiotensin II receptorblockerare (ARBs) 2.16.840.1.113883.6.73 2017-01 C09CA01 losartan Losartan 2.16.840.1.113883.6.73 2017-01 C09CA02 eprosartan Eprosartan 2.16.840.1.113883.6.73 2017-01 C09CA03 valsartan Valsartan 2.16.840.1.113883.6.73 2017-01 C09CA04 irbesartan Irbesartan 2.16.840.1.113883.6.73 2017-01 C09CA05 tasosartan Tasosartan 2.16.840.1.113883.6.73 2017-01 C09CA06 candesartan Kandesartan 2.16.840.1.113883.6.73 2017-01 C09CA07 telmisartan Telmisartan 2.16.840.1.113883.6.73 2017-01 C09CA08 olmesartan medoxomil Olmesartanmedoxomil 2.16.840.1.113883.6.73 2017-01 C09CA09 azilsartan medoxomil Azilsartanmedoxomil 2.16.840.1.113883.6.73 2017-01 C09CA10 fimasartan Fimasartan 2.16.840.1.113883.6.73 2017-01 C09D ANGIOTENSIN II ANTAGONISTS, Angiotensin II receptorblockerare COMBINATIONS (ARBs), kombinationer 2.16.840.1.113883.6.73 2017-01 C09DA Angiotensin II antagonists and Angiotensin II receptorblockerare diuretics (ARBs) och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA01 losartan and diuretics Losartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA02 eprosartan and diuretics Eprosartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA03 valsartan and diuretics Valsartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA04 irbesartan and diuretics Irbesartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA06 candesartan and diuretics Kandesartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA07 telmisartan and diuretics Telmisartan och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA08 olmesartan medoxomil and diuretics Olmesartanmedoxomil och diuretika 2.16.840.1.113883.6.73 2017-01 C09DA09 azilsartan medoxomil and diuretics Azilsartanmedoxomil och diuretika 2.16.840.1.113883.6.73 2017-01 C09DB Angiotensin II antagonists and Angiotensin II receptorblockerare calcium channel blockers (ARBs) och kalciumantagonister 2.16.840.1.113883.6.73 2017-01 C09DB01 valsartan and amlodipine Valsartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB02 olmesartan medoxomil and Olmesartanmedoxomil och amlodipine amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB04 telmisartan and amlodipine Telmisartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB05 irbesartan and amlodipine Irbesartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB06 losartan and amlodipine Losartan och amlodipin 2.16.840.1.113883.6.73 2017-01 C09DB07 candesartan and amlodipine Kandesartan och amlodipin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 53 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09DB08 valsartan and lercanidipine Valsartan och lerkanidipin 2.16.840.1.113883.6.73 2017-01 C09DX Angiotensin II antagonists, other Angiotensin II receptorblockerare combinations (ARBs), övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C09DX01 valsartan, amlodipine and Valsartan, amlodipin och hydrochlorothiazide hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09DX02 valsartan and aliskiren Valsartan och aliskiren 2.16.840.1.113883.6.73 2017-01 C09DX03 olmesartan medoxomil, amlodipine Olmesartanmedoxomil, amlodipin and hydrochlorothiazide och hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09DX04 valsartan and sacubitril Valsartan och sakubitril 2.16.840.1.113883.6.73 2017-01 C09X OTHER AGENTS ACTING ON THE Övriga medel som påverkar renin- RENIN-ANGIOTENSIN SYSTEM angiotensinsystemet 2.16.840.1.113883.6.73 2017-01 C09XA Renin-inhibitors Renin-hämmare 2.16.840.1.113883.6.73 2017-01 C09XA01 remikiren Remikiren 2.16.840.1.113883.6.73 2017-01 C09XA02 aliskiren Aliskiren 2.16.840.1.113883.6.73 2017-01 C09XA52 aliskiren and hydrochlorothiazide Aliskiren och hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C09XA53 aliskiren and amlodipine Aliskiren och amlodipin 2.16.840.1.113883.6.73 2017-01 C09XA54 aliskiren, amlodipine and Aliskiren, amlodipin och hydrochlorothiazide hydroklortiazid 2.16.840.1.113883.6.73 2017-01 C10 LIPID MODIFYING AGENTS Medel som påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10A LIPID MODIFYING AGENTS, Medel som påverkar PLAIN serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10AA HMG CoA reductase inhibitors HMG CoA reduktas-hämmare 2.16.840.1.113883.6.73 2017-01 C10AA01 simvastatin Simvastatin 2.16.840.1.113883.6.73 2017-01 C10AA02 lovastatin Lovastatin 2.16.840.1.113883.6.73 2017-01 C10AA03 pravastatin Pravastatin 2.16.840.1.113883.6.73 2017-01 C10AA04 fluvastatin Fluvastatin 2.16.840.1.113883.6.73 2017-01 C10AA05 atorvastatin Atorvastatin 2.16.840.1.113883.6.73 2017-01 C10AA06 cerivastatin Cerivastatin 2.16.840.1.113883.6.73 2017-01 C10AA07 rosuvastatin Rosuvastatin 2.16.840.1.113883.6.73 2017-01 C10AA08 pitavastatin Pitavastatin 2.16.840.1.113883.6.73 2017-01 C10AB Fibrates Fibrater 2.16.840.1.113883.6.73 2017-01 C10AB01 clofibrate Klofibrat 2.16.840.1.113883.6.73 2017-01 C10AB02 bezafibrate Bezafibrat 2.16.840.1.113883.6.73 2017-01 C10AB03 aluminium clofibrate Aluminiumklofibrat 2.16.840.1.113883.6.73 2017-01 C10AB04 gemfibrozil Gemfibrozil 2.16.840.1.113883.6.73 2017-01 C10AB05 fenofibrate Fenofibrat 2.16.840.1.113883.6.73 2017-01 C10AB06 simfibrate Simfibrat 2.16.840.1.113883.6.73 2017-01 C10AB07 ronifibrate Ronifibrat 2.16.840.1.113883.6.73 2017-01 C10AB08 ciprofibrate Ciprofibrat 2.16.840.1.113883.6.73 2017-01 C10AB09 etofibrate Etofibrat 2.16.840.1.113883.6.73 2017-01 C10AB10 clofibride Klofibrid 2.16.840.1.113883.6.73 2017-01 C10AB11 choline fenofibrate Kolinfenofibrat 2.16.840.1.113883.6.73 2017-01 C10AC Bile acid sequestrants Resiner 2.16.840.1.113883.6.73 2017-01 C10AC01 colestyramine Kolestyramin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 54 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10AC02 colestipol Kolestipol 2.16.840.1.113883.6.73 2017-01 C10AC03 colextran Kolextran 2.16.840.1.113883.6.73 2017-01 C10AC04 colesevelam Kolesevelam 2.16.840.1.113883.6.73 2017-01 C10AD Nicotinic acid and derivatives Nikotinsyra och derivat 2.16.840.1.113883.6.73 2017-01 C10AD01 niceritrol Niceritrol 2.16.840.1.113883.6.73 2017-01 C10AD02 nicotinic acid Nikotinsyra 2.16.840.1.113883.6.73 2017-01 C10AD03 nicofuranose Nikofuranos 2.16.840.1.113883.6.73 2017-01 C10AD04 aluminium nicotinate Aluminiumnikotinat 2.16.840.1.113883.6.73 2017-01 C10AD05 nicotinyl alcohol (pyridylcarbinol) Nikotinylalkohol (pyridylkarbinol) 2.16.840.1.113883.6.73 2017-01 C10AD06 acipimox Acipimox 2.16.840.1.113883.6.73 2017-01 C10AD52 nicotinic acid, combinations Nikotinsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 C10AX Other lipid modifying agents Övriga medel som påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10AX01 dextrothyroxine Dextrotyroxin 2.16.840.1.113883.6.73 2017-01 C10AX02 probucol Probukol 2.16.840.1.113883.6.73 2017-01 C10AX03 tiadenol Tiadenol 2.16.840.1.113883.6.73 2017-01 C10AX05 meglutol Meglutol 2.16.840.1.113883.6.73 2017-01 C10AX06 omega-3-triglycerides incl. other Omega-3-triglycerider inkl. övriga esters and acids estrar och syror 2.16.840.1.113883.6.73 2017-01 C10AX07 magnesium pyridoxal 5-phosphate Magnesium pyridoxal 5-fosfat glutamate glutamat 2.16.840.1.113883.6.73 2017-01 C10AX08 policosanol Polikosanol 2.16.840.1.113883.6.73 2017-01 C10AX09 ezetimibe Ezetimib 2.16.840.1.113883.6.73 2017-01 C10AX10 alipogene tiparvovec Alipogen-tiparvovek 2.16.840.1.113883.6.73 2017-01 C10AX11 mipomersen Mipomersen 2.16.840.1.113883.6.73 2017-01 C10AX12 lomitapide Lomitapid 2.16.840.1.113883.6.73 2017-01 C10AX13 evolocumab Evolokumab 2.16.840.1.113883.6.73 2017-01 C10AX14 alirocumab Alirokumab 2.16.840.1.113883.6.73 2017-01 C10B LIPID MODIFYING AGENTS, Medel som påverkar COMBINATIONS serumlipidnivåerna, kombinationer 2.16.840.1.113883.6.73 2017-01 C10BA HMG CoA reductase inhibitors in HMG CoA-reduktashämmare i combination with other lipid kombination med andra medel som modifying agents påverkar serumlipidnivåerna 2.16.840.1.113883.6.73 2017-01 C10BA01 lovastatin and nicotinic acid Lovastatin och nikotinsyra 2.16.840.1.113883.6.73 2017-01 C10BA02 simvastatin and ezetimibe Simvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BA03 pravastatin and fenofibrate Pravastatin och fenofibrat 2.16.840.1.113883.6.73 2017-01 C10BA04 simvastatin and fenofibrate Simvastatin och fenofibrat 2.16.840.1.113883.6.73 2017-01 C10BA05 atorvastatin and ezetimibe Atorvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BA06 rosuvastatin and ezetimibe Rosuvastatin och ezetimib 2.16.840.1.113883.6.73 2017-01 C10BX HMG CoA reductase inhibitors, HMG CoA-reduktashämmare, other combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 C10BX01 simvastatin and acetylsalicylic acid Simvastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX02 pravastatin and acetylsalicylic acid Pravastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX03 atorvastatin and amlodipine Atorvastatin och amlodipin 2.16.840.1.113883.6.73 2017-01 C10BX04 simvastatin, acetylsalicylic acid and Simvastatin, acetylsalicylsyra och ramipril ramipril © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 55 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10BX05 rosuvastatin and acetylsalicylic acid Rosuvastatin och acetylsalisylsyra 2.16.840.1.113883.6.73 2017-01 C10BX06 atorvastatin, acetylsalicylic acid and Atorvastatin, acetylsalicylsyra och ramipril ramipril 2.16.840.1.113883.6.73 2017-01 C10BX07 rosuvastatin, amlodipine and Rosuvastatin, amlodipin och lisinopril lisinopril 2.16.840.1.113883.6.73 2017-01 C10BX08 atorvastatin and acetylsalicylic acid Atorvastatin och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 C10BX09 rosuvastatin and amlodipine Rosuvastatin och amlodipin 2.16.840.1.113883.6.73 2017-01 C10BX10 rosuvastatin and valsartan Rosuvastatin och valsartan 2.16.840.1.113883.6.73 2017-01 C10BX11 atorvastatin, amlodipine and Atorvastatin, amlodipin och perindopril perindopril 2.16.840.1.113883.6.73 2017-01 C10BX12 atorvastatin, acetylsalicylic acid and Atorvastatin, acetylsalicylsyra och perindopril perindopril 2.16.840.1.113883.6.73 2017-01 D DERMATOLOGICALS Hudpreparat 2.16.840.1.113883.6.73 2017-01 D01 ANTIFUNGALS FOR Svampmedel för utvärtes bruk DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D01A ANTIFUNGALS FOR TOPICAL Svampmedel för utvärtes bruk USE 2.16.840.1.113883.6.73 2017-01 D01AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 D01AA01 nystatin Nystatin 2.16.840.1.113883.6.73 2017-01 D01AA02 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 D01AA03 hachimycin Hakimycin 2.16.840.1.113883.6.73 2017-01 D01AA04 pecilocin Pecilocin 2.16.840.1.113883.6.73 2017-01 D01AA06 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 D01AA07 pyrrolnitrin Pyrrolnitrin 2.16.840.1.113883.6.73 2017-01 D01AA08 griseofulvin Griseofulvin 2.16.840.1.113883.6.73 2017-01 D01AA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 D01AC Imidazole and triazole derivatives Imidazol- och triazolderivat 2.16.840.1.113883.6.73 2017-01 D01AC01 clotrimazole Klotrimazol 2.16.840.1.113883.6.73 2017-01 D01AC02 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 D01AC03 econazole Ekonazol 2.16.840.1.113883.6.73 2017-01 D01AC04 chlormidazole Klormidazol 2.16.840.1.113883.6.73 2017-01 D01AC05 isoconazole Isokonazol 2.16.840.1.113883.6.73 2017-01 D01AC06 tiabendazole Tiabendazol 2.16.840.1.113883.6.73 2017-01 D01AC07 tioconazole Tiokonazol 2.16.840.1.113883.6.73 2017-01 D01AC08 ketoconazole Ketokonazol 2.16.840.1.113883.6.73 2017-01 D01AC09 sulconazole Sulkonazol 2.16.840.1.113883.6.73 2017-01 D01AC10 bifonazole Bifonazol 2.16.840.1.113883.6.73 2017-01 D01AC11 oxiconazole Oxikonazol 2.16.840.1.113883.6.73 2017-01 D01AC12 fenticonazole Fentikonazol 2.16.840.1.113883.6.73 2017-01 D01AC13 omoconazole Omokonazol 2.16.840.1.113883.6.73 2017-01 D01AC14 sertaconazole Sertakonazol 2.16.840.1.113883.6.73 2017-01 D01AC15 fluconazole Flukonazol 2.16.840.1.113883.6.73 2017-01 D01AC16 flutrimazole Flutrimazol 2.16.840.1.113883.6.73 2017-01 D01AC17 eberconazole Eberkonazol 2.16.840.1.113883.6.73 2017-01 D01AC18 luliconazole Lulikonazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 56 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D01AC19 efinaconazole Efinakonazol 2.16.840.1.113883.6.73 2017-01 D01AC20 imidazoles/triazoles in combination Imidazoler/triazoler i kombination with corticosteroids med kortikosteroider 2.16.840.1.113883.6.73 2017-01 D01AC52 miconazole, combinations Mikonazol, kombinationer 2.16.840.1.113883.6.73 2017-01 D01AC60 bifonazole, combinations Bifonazol, kombinationer 2.16.840.1.113883.6.73 2017-01 D01AE Other antifungals for topical use Övriga utvärtes medel vid hudmykoser 2.16.840.1.113883.6.73 2017-01 D01AE01 bromochlorosalicylanilide Bromsalicylkloranilid 2.16.840.1.113883.6.73 2017-01 D01AE02 methylrosaniline Metylrosanilin 2.16.840.1.113883.6.73 2017-01 D01AE03 tribromometacresol Tribromometakresol 2.16.840.1.113883.6.73 2017-01 D01AE04 undecylenic acid Undecylensyra 2.16.840.1.113883.6.73 2017-01 D01AE05 polynoxylin Polynoxylin 2.16.840.1.113883.6.73 2017-01 D01AE06 2-(4-chlorphenoxy)-ethanol Klorfenoxietanol 2.16.840.1.113883.6.73 2017-01 D01AE07 chlorphenesin Klorfenesin 2.16.840.1.113883.6.73 2017-01 D01AE08 ticlatone Tiklaton 2.16.840.1.113883.6.73 2017-01 D01AE09 sulbentine Sulbentin 2.16.840.1.113883.6.73 2017-01 D01AE10 ethyl hydroxybenzoate Etylhydroxibensoat 2.16.840.1.113883.6.73 2017-01 D01AE11 haloprogin Haloprogin 2.16.840.1.113883.6.73 2017-01 D01AE12 salicylic acid Salicylsyra 2.16.840.1.113883.6.73 2017-01 D01AE13 selenium sulfide Selensulfid 2.16.840.1.113883.6.73 2017-01 D01AE14 ciclopirox Ciklopirox 2.16.840.1.113883.6.73 2017-01 D01AE15 terbinafine Terbinafin 2.16.840.1.113883.6.73 2017-01 D01AE16 amorolfine Amorolfin 2.16.840.1.113883.6.73 2017-01 D01AE17 dimazole Dimazol 2.16.840.1.113883.6.73 2017-01 D01AE18 tolnaftate Tolnaftat 2.16.840.1.113883.6.73 2017-01 D01AE19 tolciclate Tolciklat 2.16.840.1.113883.6.73 2017-01 D01AE20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 D01AE21 flucytosine Flucytosin 2.16.840.1.113883.6.73 2017-01 D01AE22 naftifine Naftifin 2.16.840.1.113883.6.73 2017-01 D01AE23 butenafine Butenafin 2.16.840.1.113883.6.73 2017-01 D01AE54 undecylenic acid, combinations Undecylensyra, kombinationer 2.16.840.1.113883.6.73 2017-01 D01B ANTIFUNGALS FOR SYSTEMIC Svampmedel för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 D01BA Antifungals for systemic use Svampmedel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D01BA01 griseofulvin Griseofulvin 2.16.840.1.113883.6.73 2017-01 D01BA02 terbinafine Terbinafin 2.16.840.1.113883.6.73 2017-01 D02 EMOLLIENTS AND PROTECTIVES Hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02A EMOLLIENTS AND PROTECTIVES Hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02AA Silicone products Silikonpreparat 2.16.840.1.113883.6.73 2017-01 D02AB Zinc products Zinkpreparat 2.16.840.1.113883.6.73 2017-01 D02AC Soft paraffin and fat products Mjukt paraffin och fettprodukter 2.16.840.1.113883.6.73 2017-01 D02AD Liquid plasters Flytande plåster 2.16.840.1.113883.6.73 2017-01 D02AE Carbamide products Karbamidpreparat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 57 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D02AE01 carbamide Karbamid 2.16.840.1.113883.6.73 2017-01 D02AE51 carbamide, combinations Karbamid, kombinationer 2.16.840.1.113883.6.73 2017-01 D02AF Salicylic acid preparations Salicylsyrapreparat 2.16.840.1.113883.6.73 2017-01 D02AX Other emollients and protectives Övriga hudskyddande och uppmjukande medel 2.16.840.1.113883.6.73 2017-01 D02B PROTECTIVES AGAINST UV- Medel som skyddar mot UV- RADIATION strålning 2.16.840.1.113883.6.73 2017-01 D02BA Protectives against UV-radiation for Medel som skyddar mot UV- topical use strålning, utvärtes 2.16.840.1.113883.6.73 2017-01 D02BA01 aminobenzoic acid Aminobensoesyra 2.16.840.1.113883.6.73 2017-01 D02BA02 octinoxate Oktinoxat 2.16.840.1.113883.6.73 2017-01 D02BB Protectives against UV-radiation for Medel som skyddar mot UV- systemic use strålning, systemiska 2.16.840.1.113883.6.73 2017-01 D02BB01 betacarotene Betakaroten 2.16.840.1.113883.6.73 2017-01 D02BB02 afamelanotide Afamelanotid 2.16.840.1.113883.6.73 2017-01 D03 PREPARATIONS FOR Medel vid sår- och brännskador TREATMENT OF WOUNDS AND ULCERS 2.16.840.1.113883.6.73 2017-01 D03A CICATRIZANTS Medel vid sår- och brännskador 2.16.840.1.113883.6.73 2017-01 D03AA Cod-liver oil ointments Torskleverolja, salva 2.16.840.1.113883.6.73 2017-01 D03AX Other cicatrizants Övriga medel vid sår-och brännskador 2.16.840.1.113883.6.73 2017-01 D03AX01 cadexomer iodine Kadexomerjod 2.16.840.1.113883.6.73 2017-01 D03AX02 dextranomer Dextranomer 2.16.840.1.113883.6.73 2017-01 D03AX03 dexpanthenol Dexapantenol 2.16.840.1.113883.6.73 2017-01 D03AX04 calcium pantothenate Kalciumpantotenat 2.16.840.1.113883.6.73 2017-01 D03AX05 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 D03AX06 becaplermin Bekaplermin 2.16.840.1.113883.6.73 2017-01 D03AX09 crilanomer Krilanomer 2.16.840.1.113883.6.73 2017-01 D03AX10 enoxolone Enoxolon 2.16.840.1.113883.6.73 2017-01 D03AX11 sodium chlorite Natriumklorit 2.16.840.1.113883.6.73 2017-01 D03AX12 trolamine Trolamin 2.16.840.1.113883.6.73 2017-01 D03AX13 Betulae cortex Björk, bark 2.16.840.1.113883.6.73 2017-01 D03B ENZYMES Enzymer 2.16.840.1.113883.6.73 2017-01 D03BA Proteolytic enzymes Proteolytiska enzymer 2.16.840.1.113883.6.73 2017-01 D03BA01 trypsin Trypsin 2.16.840.1.113883.6.73 2017-01 D03BA02 collagenase Kollagenas 2.16.840.1.113883.6.73 2017-01 D03BA03 bromelains Bromelainer 2.16.840.1.113883.6.73 2017-01 D03BA52 collagenase, combinations Kollagenas, kombinationer 2.16.840.1.113883.6.73 2017-01 D04 ANTIPRURITICS, INCL. Klådstillande medel, inkl. ANTIHISTAMINES, antihistaminer, anestetika etc. ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04A ANTIPRURITICS, INCL. Klådstillande medel, inkl. ANTIHISTAMINES, antihistaminer, anestetika etc. ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04AA Antihistamines for topical use Antihistaminer för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D04AA01 thonzylamine Tonzylamin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 58 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D04AA02 mepyramine Mepyramin 2.16.840.1.113883.6.73 2017-01 D04AA03 thenalidine Tenalidin 2.16.840.1.113883.6.73 2017-01 D04AA04 tripelennamine Tripelenamin 2.16.840.1.113883.6.73 2017-01 D04AA09 chloropyramine Kloropyramin 2.16.840.1.113883.6.73 2017-01 D04AA10 promethazine Prometazin 2.16.840.1.113883.6.73 2017-01 D04AA12 tolpropamine Tolpropamin 2.16.840.1.113883.6.73 2017-01 D04AA13 dimetindene Dimetinden 2.16.840.1.113883.6.73 2017-01 D04AA14 clemastine Klemastin 2.16.840.1.113883.6.73 2017-01 D04AA15 bamipine Bamipin 2.16.840.1.113883.6.73 2017-01 D04AA16 pheniramine Feniramin 2.16.840.1.113883.6.73 2017-01 D04AA22 isothipendyl Isotipendyl 2.16.840.1.113883.6.73 2017-01 D04AA32 diphenhydramine Difenhydramin 2.16.840.1.113883.6.73 2017-01 D04AA33 diphenhydramine methylbromide Difenhydraminmetylbromid 2.16.840.1.113883.6.73 2017-01 D04AA34 chlorphenoxamine Klorfenoxamin 2.16.840.1.113883.6.73 2017-01 D04AB Anesthetics for topical use Lokalanestetika för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D04AB01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 D04AB02 cinchocaine Cinkain 2.16.840.1.113883.6.73 2017-01 D04AB03 oxybuprocaine Oxibuprokain 2.16.840.1.113883.6.73 2017-01 D04AB04 benzocaine Bensokain 2.16.840.1.113883.6.73 2017-01 D04AB05 quinisocaine Kinisokain 2.16.840.1.113883.6.73 2017-01 D04AB06 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 D04AB07 pramocaine Pramokain 2.16.840.1.113883.6.73 2017-01 D04AX Other antipruritics Övriga klådstillande medel 2.16.840.1.113883.6.73 2017-01 D05 ANTIPSORIATICS Medel vid psoriasis 2.16.840.1.113883.6.73 2017-01 D05A ANTIPSORIATICS FOR TOPICAL Medel vid psoriasis för utvärtes bruk USE 2.16.840.1.113883.6.73 2017-01 D05AA Tars Tjäror 2.16.840.1.113883.6.73 2017-01 D05AC Antracen derivatives Antracenderivat 2.16.840.1.113883.6.73 2017-01 D05AC01 dithranol Ditranol 2.16.840.1.113883.6.73 2017-01 D05AC51 dithranol, combinations Ditranol, kombinationer 2.16.840.1.113883.6.73 2017-01 D05AD Psoralens for topical use Psoralener för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D05AD01 trioxysalen Trioxisalen 2.16.840.1.113883.6.73 2017-01 D05AD02 methoxsalen Metoxsalen 2.16.840.1.113883.6.73 2017-01 D05AX Other antipsoriatics for topical use Övriga medel vid psoriasis för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 D05AX01 fumaric acid Fumarsyra 2.16.840.1.113883.6.73 2017-01 D05AX02 calcipotriol Kalcipotriol 2.16.840.1.113883.6.73 2017-01 D05AX03 calcitriol Kalcitriol 2.16.840.1.113883.6.73 2017-01 D05AX04 tacalcitol Takalcitol 2.16.840.1.113883.6.73 2017-01 D05AX05 tazarotene Tazaroten 2.16.840.1.113883.6.73 2017-01 D05AX52 calcipotriol, combinations Kalcipotriol, kombinationer 2.16.840.1.113883.6.73 2017-01 D05B ANTIPSORIATICS FOR SYSTEMIC Medel vid psoriasis för systemiskt USE bruk 2.16.840.1.113883.6.73 2017-01 D05BA Psoralens for systemic use Psoralener för systemiskt bruk

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 59 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D05BA01 trioxysalen Trioxisalen 2.16.840.1.113883.6.73 2017-01 D05BA02 methoxsalen Metoxsalen 2.16.840.1.113883.6.73 2017-01 D05BA03 bergapten Bergapten 2.16.840.1.113883.6.73 2017-01 D05BB Retinoids for treatment of psoriasis Retinoider för behandling av psoriasis 2.16.840.1.113883.6.73 2017-01 D05BB01 etretinate Etretinat 2.16.840.1.113883.6.73 2017-01 D05BB02 acitretin Acitretin 2.16.840.1.113883.6.73 2017-01 D05BX Other antipsoriatics for systemic use Övriga medel vid psoriasis för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D05BX51 fumaric acid derivatives, Derivat av fumarsyra kombinationer combinations 2.16.840.1.113883.6.73 2017-01 D06 ANTIBIOTICS AND Antibiotika och kemoterapeutika för CHEMOTHERAPEUTICS FOR utvärtes bruk DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D06A ANTIBIOTICS FOR TOPICAL USE Antibiotika för topikal användning 2.16.840.1.113883.6.73 2017-01 D06AA Tetracycline and derivatives Tetracyklin och derivat 2.16.840.1.113883.6.73 2017-01 D06AA01 demeclocycline Demeklocyklin 2.16.840.1.113883.6.73 2017-01 D06AA02 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 D06AA03 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 D06AA04 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 D06AX Other antibiotics for topical use Övriga antibiotika för topikal användning 2.16.840.1.113883.6.73 2017-01 D06AX01 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 D06AX02 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 D06AX04 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 D06AX05 bacitracin Bacitracin 2.16.840.1.113883.6.73 2017-01 D06AX07 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 D06AX08 tyrothricin Tyrotricin 2.16.840.1.113883.6.73 2017-01 D06AX09 mupirocin Mupirocin 2.16.840.1.113883.6.73 2017-01 D06AX10 virginiamycin Virginiamycin 2.16.840.1.113883.6.73 2017-01 D06AX11 rifaximin Rifaximin 2.16.840.1.113883.6.73 2017-01 D06AX12 amikacin Amikacin 2.16.840.1.113883.6.73 2017-01 D06AX13 retapamulin Retapamulin 2.16.840.1.113883.6.73 2017-01 D06B CHEMOTHERAPEUTICS FOR Kemoterapeutika för topikal TOPICAL USE användning 2.16.840.1.113883.6.73 2017-01 D06BA Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 D06BA01 silver sulfadiazine Silversulfadiazin 2.16.840.1.113883.6.73 2017-01 D06BA02 sulfathiazole Sulfatiazol 2.16.840.1.113883.6.73 2017-01 D06BA03 mafenide Mafenid 2.16.840.1.113883.6.73 2017-01 D06BA04 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 D06BA05 sulfanilamide Sulfanilamid 2.16.840.1.113883.6.73 2017-01 D06BA06 sulfamerazine Sulfamerazin 2.16.840.1.113883.6.73 2017-01 D06BA51 silver sulfadiazine, combinations Silversulfadiazin, kombinationer 2.16.840.1.113883.6.73 2017-01 D06BB Antivirals Antivirala medel 2.16.840.1.113883.6.73 2017-01 D06BB01 idoxuridine Idoxuridin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 60 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D06BB02 tromantadine Tromantadin 2.16.840.1.113883.6.73 2017-01 D06BB03 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 D06BB04 podophyllotoxin Podofyllotoxin 2.16.840.1.113883.6.73 2017-01 D06BB05 inosine Inosin 2.16.840.1.113883.6.73 2017-01 D06BB06 penciclovir Penciklovir 2.16.840.1.113883.6.73 2017-01 D06BB07 lysozyme Lysozym 2.16.840.1.113883.6.73 2017-01 D06BB08 ibacitabine Ibacitabin 2.16.840.1.113883.6.73 2017-01 D06BB09 edoxudine Edoxudin 2.16.840.1.113883.6.73 2017-01 D06BB10 imiquimod Imikvimod 2.16.840.1.113883.6.73 2017-01 D06BB11 docosanol Docosanol 2.16.840.1.113883.6.73 2017-01 D06BB12 sinecatechins Sinekatekiner 2.16.840.1.113883.6.73 2017-01 D06BB53 aciclovir, combinations Aciklovir, kombinationer 2.16.840.1.113883.6.73 2017-01 D06BX Other chemotherapeutics Övriga kemoterapeutika 2.16.840.1.113883.6.73 2017-01 D06BX01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 D06BX02 ingenol mebutate Ingenolmebutat 2.16.840.1.113883.6.73 2017-01 D06C ANTIBIOTICS AND Antibiotika och kemoterapeutika i CHEMOTHERAPEUTICS, kombination COMBINATIONS 2.16.840.1.113883.6.73 2017-01 D07 CORTICOSTEROIDS, Kortikosteroider för utvärtes bruk DERMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D07A CORTICOSTEROIDS, PLAIN Kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07AA Corticosteroids, weak (group I) Kortikosteroider, milt verkande (grupp I) 2.16.840.1.113883.6.73 2017-01 D07AA01 methylprednisolone Metylprednisolon 2.16.840.1.113883.6.73 2017-01 D07AA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 D07AA03 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 D07AB Corticosteroids, moderately potent Kortikosteroider, medelstarkt (group II) verkande (grupp II) 2.16.840.1.113883.6.73 2017-01 D07AB01 clobetasone Klobetason 2.16.840.1.113883.6.73 2017-01 D07AB02 hydrocortisone butyrate Hydrokortisonbutyrat 2.16.840.1.113883.6.73 2017-01 D07AB03 flumetasone Flumetason 2.16.840.1.113883.6.73 2017-01 D07AB04 fluocortin Fluokortin 2.16.840.1.113883.6.73 2017-01 D07AB05 fluperolone Fluperolon 2.16.840.1.113883.6.73 2017-01 D07AB06 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D07AB07 fluprednidene Flupredniden 2.16.840.1.113883.6.73 2017-01 D07AB08 desonide Desonid 2.16.840.1.113883.6.73 2017-01 D07AB09 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 D07AB10 alclometasone Alklometason 2.16.840.1.113883.6.73 2017-01 D07AB11 hydrocortisone buteprate Hydrokortisonbuteprat 2.16.840.1.113883.6.73 2017-01 D07AB19 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D07AB21 clocortolone Klokortolone 2.16.840.1.113883.6.73 2017-01 D07AB30 combinations of corticosteroids Kombinationer av kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07AC Corticosteroids, potent (group III) Kortikosteroider, starkt verkande (grupp III)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 61 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07AC01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 D07AC02 fluclorolone Fluklorolon 2.16.840.1.113883.6.73 2017-01 D07AC03 desoximetasone Desoximetason 2.16.840.1.113883.6.73 2017-01 D07AC04 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 D07AC05 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 D07AC06 diflucortolone Diflukortolon 2.16.840.1.113883.6.73 2017-01 D07AC07 fludroxycortide Fludroxikortid 2.16.840.1.113883.6.73 2017-01 D07AC08 fluocinonide Fluocinonid 2.16.840.1.113883.6.73 2017-01 D07AC09 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 D07AC10 diflorasone Diflorason 2.16.840.1.113883.6.73 2017-01 D07AC11 amcinonide Amcinonid 2.16.840.1.113883.6.73 2017-01 D07AC12 halometasone Halometason 2.16.840.1.113883.6.73 2017-01 D07AC13 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 D07AC14 methylprednisolone aceponate Metylprednisolonaceponat 2.16.840.1.113883.6.73 2017-01 D07AC15 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 D07AC16 hydrocortisone aceponate Hydrokortisonaceponat 2.16.840.1.113883.6.73 2017-01 D07AC17 fluticasone Flutikason 2.16.840.1.113883.6.73 2017-01 D07AC18 prednicarbate Prednikarbat 2.16.840.1.113883.6.73 2017-01 D07AC19 difluprednate Difluprednat 2.16.840.1.113883.6.73 2017-01 D07AC21 ulobetasol Ulobetasol 2.16.840.1.113883.6.73 2017-01 D07AD Corticosteroids, very potent (group Kortikosteroider, extra starkt IV) verkande (grupp IV) 2.16.840.1.113883.6.73 2017-01 D07AD01 clobetasol Klobetasol 2.16.840.1.113883.6.73 2017-01 D07AD02 halcinonide Halcinonid 2.16.840.1.113883.6.73 2017-01 D07B CORTICOSTEROIDS, Kortikosteroider i kombination med COMBINATIONS WITH antiseptika ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 D07BA Corticosteroids, weak, combinations Kortikosteroider, milda, i with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BA01 prednisolone and antiseptics Prednisolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BA04 hydrocortisone and antiseptics Hydrokortison och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB Corticosteroids, moderately potent, Kortikosteroider, medelstarka, i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB01 flumetasone and antiseptics Flumetason och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB02 desonide and antiseptics Desonid och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB03 triamcinolone and antiseptics Triamcinolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BB04 hydrocortisone butyrate and Hydrokortisonbutyrat och antiseptika antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC Corticosteroids, potent, Kortikosteroider, starka, i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC01 betamethasone and antiseptics Betametason och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC02 fluocinolone acetonide and Fluocinolonacetonid och antiseptika antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC03 fluocortolone and antiseptics Fluokortolon och antiseptika 2.16.840.1.113883.6.73 2017-01 D07BC04 diflucortolone and antiseptics Diflukortolon och antiseptika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 62 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07BD Corticosteroids, very potent, Kortikosteroider, mycket potenta i combinations with antiseptics kombination med antiseptika 2.16.840.1.113883.6.73 2017-01 D07C CORTICOSTEROIDS, Kortikosteroider i kombination med COMBINATIONS WITH antibiotika ANTIBIOTICS 2.16.840.1.113883.6.73 2017-01 D07CA Corticosteroids, weak, combinations Kortikosteroider, milda, i with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA01 hydrocortisone and antibiotics Hydrokortison och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA02 methylprednisolone and antibiotics Metylprednisolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CA03 prednisolone and antibiotics Prednisolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB Corticosteroids, moderately potent, Kortikosteroider, medelstarka, i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB01 triamcinolone and antibiotics Triamcinolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB02 fluprednidene and antibiotics Flupredniden och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB03 fluorometholone and antibiotics Fluorometolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB04 dexamethasone and antibiotics Dexametason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CB05 flumetasone and antibiotics Flumetason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC Corticosteroids, potent, Kortikosteroider, starka, i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC01 betamethasone and antibiotics Betametason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC02 fluocinolone acetonide and Fluocinolonacetonid och antibiotika antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC03 fludroxycortide and antibiotics Fludroxikortid och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC04 beclometasone and antibiotics Beklometason och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC05 fluocinonide and antibiotics Fluocinonid och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CC06 fluocortolone and antibiotics Fluokortolon och antibiotika 2.16.840.1.113883.6.73 2017-01 D07CD Corticosteroids, very potent, Kortikosteroider, mycket potenta i combinations with antibiotics kombination med antibiotika 2.16.840.1.113883.6.73 2017-01 D07CD01 clobetasol and antibiotics Klobetasol och antibiotika 2.16.840.1.113883.6.73 2017-01 D07X CORTICOSTEROIDS, OTHER Kortikosteroider, övriga COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 D07XA Corticosteroids, weak, other Milda kortikosteroider, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 D07XA02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 D07XB Corticosteroids, moderately potent, Medelstarka kortikosteroider, övriga other combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XB01 flumetasone Flumetason 2.16.840.1.113883.6.73 2017-01 D07XB02 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 D07XB03 fluprednidene Flupredniden 2.16.840.1.113883.6.73 2017-01 D07XB04 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D07XB05 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D07XB30 combinations of corticosteroids Kombinationer av kortikosteroider 2.16.840.1.113883.6.73 2017-01 D07XC Corticosteroids, potent, other Starka kortikosteroider, övriga combinations kombinationer 2.16.840.1.113883.6.73 2017-01 D07XC01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 D07XC02 desoximetasone Desoximetason

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 63 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07XC03 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 D07XC04 diflucortolone Diflukortolon 2.16.840.1.113883.6.73 2017-01 D07XC05 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 D07XD Corticosteroids, very potent, other Mycket potenta kortikosteroider, combinations övriga kombinationer 2.16.840.1.113883.6.73 2017-01 D08 ANTISEPTICS AND Antiseptika och sårmedel DISINFECTANTS 2.16.840.1.113883.6.73 2017-01 D08A ANTISEPTICS AND Antiseptika och sårmedel DISINFECTANTS 2.16.840.1.113883.6.73 2017-01 D08AA Acridine derivatives Akridinderivat 2.16.840.1.113883.6.73 2017-01 D08AA01 ethacridine lactate Etakridinlaktat 2.16.840.1.113883.6.73 2017-01 D08AA02 aminoacridine Aminoakridin 2.16.840.1.113883.6.73 2017-01 D08AA03 euflavine Euflavin 2.16.840.1.113883.6.73 2017-01 D08AB Aluminium agents Aluminiumföreningar 2.16.840.1.113883.6.73 2017-01 D08AC Biguanides and amidines Biguanider och amidiner 2.16.840.1.113883.6.73 2017-01 D08AC01 dibrompropamidine Dibrompropamidin 2.16.840.1.113883.6.73 2017-01 D08AC02 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 D08AC03 propamidine Propamidin 2.16.840.1.113883.6.73 2017-01 D08AC04 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 D08AC05 polihexanide Polihexanid 2.16.840.1.113883.6.73 2017-01 D08AC52 chlorhexidine, combinations Klorhexidin, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AD Boric acid products Borsyrapreparat 2.16.840.1.113883.6.73 2017-01 D08AE Phenol and derivatives Fenol och fenolderivat 2.16.840.1.113883.6.73 2017-01 D08AE01 hexachlorophene Hexaklorofen 2.16.840.1.113883.6.73 2017-01 D08AE02 policresulen Polikresulen 2.16.840.1.113883.6.73 2017-01 D08AE03 phenol Fenol 2.16.840.1.113883.6.73 2017-01 D08AE04 triclosan Triklosan 2.16.840.1.113883.6.73 2017-01 D08AE05 chloroxylenol Kloroxylenol 2.16.840.1.113883.6.73 2017-01 D08AE06 biphenylol Bifenylol 2.16.840.1.113883.6.73 2017-01 D08AF Nitrofuran derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 D08AF01 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 D08AG Iodine products Jodpreparat 2.16.840.1.113883.6.73 2017-01 D08AG01 iodine/octylphenoxypolyglycolether Jod/oktylfenoxipolyglykoleter 2.16.840.1.113883.6.73 2017-01 D08AG02 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 D08AG03 iodine Jod 2.16.840.1.113883.6.73 2017-01 D08AG04 diiodohydroxypropane Dijodhydroxipropan 2.16.840.1.113883.6.73 2017-01 D08AH Quinoline derivatives Kinolinderivat 2.16.840.1.113883.6.73 2017-01 D08AH01 dequalinium Dekvalinium 2.16.840.1.113883.6.73 2017-01 D08AH02 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 D08AH03 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 D08AH30 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 D08AJ Quaternary ammonium compounds Kvartära ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 D08AJ01 benzalkonium Bensalkonium 2.16.840.1.113883.6.73 2017-01 D08AJ02 cetrimonium Cetrimonium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 64 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D08AJ03 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D08AJ04 cetrimide Cetrimid 2.16.840.1.113883.6.73 2017-01 D08AJ05 benzoxonium chloride Bensoxoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ06 didecyldimethylammonium chloride Didecyldimetylammoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ08 benzethonium chloride Bensetoniumklorid 2.16.840.1.113883.6.73 2017-01 D08AJ10 decamethoxine Dekametoxin 2.16.840.1.113883.6.73 2017-01 D08AJ57 octenidine, combinations Oktenidin, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AJ58 benzethonium chloride, Bensetoniumklorid, kombinationer combinations 2.16.840.1.113883.6.73 2017-01 D08AJ59 dodeclonium bromide, combinations Dodekloniumbromid, kombinationer 2.16.840.1.113883.6.73 2017-01 D08AK Mercurial products Kvicksilverföreningar 2.16.840.1.113883.6.73 2017-01 D08AK01 mercuric amidochloride Kvicksilveramidoklorid 2.16.840.1.113883.6.73 2017-01 D08AK02 phenylmercuric borate Fenylkvicksilverborat 2.16.840.1.113883.6.73 2017-01 D08AK03 mercuric chloride Kvicksilverdiklorid 2.16.840.1.113883.6.73 2017-01 D08AK04 mercurochrome Merbromin 2.16.840.1.113883.6.73 2017-01 D08AK05 mercury, metallic Kvicksilver, metallisk 2.16.840.1.113883.6.73 2017-01 D08AK06 thiomersal Tiomersal 2.16.840.1.113883.6.73 2017-01 D08AK30 mercuric iodide Kvicksilverdijodid 2.16.840.1.113883.6.73 2017-01 D08AL Silver compounds Silverpreparat 2.16.840.1.113883.6.73 2017-01 D08AL01 silver nitrate Silvernitrat 2.16.840.1.113883.6.73 2017-01 D08AL30 silver Silver 2.16.840.1.113883.6.73 2017-01 D08AX Other antiseptics and disinfectants Övriga antiseptika och sårmedel 2.16.840.1.113883.6.73 2017-01 D08AX01 hydrogen peroxide Väteperoxid 2.16.840.1.113883.6.73 2017-01 D08AX02 eosin Eosin 2.16.840.1.113883.6.73 2017-01 D08AX03 propanol Propanol 2.16.840.1.113883.6.73 2017-01 D08AX04 tosylchloramide sodium Tosylkloramidnatrium 2.16.840.1.113883.6.73 2017-01 D08AX05 isopropanol Isopropanol 2.16.840.1.113883.6.73 2017-01 D08AX06 potassium permanganate Kaliumpermanganat 2.16.840.1.113883.6.73 2017-01 D08AX07 sodium hypochlorite Natriumhypoklorit 2.16.840.1.113883.6.73 2017-01 D08AX08 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 D08AX53 propanol, combinations Propanol, kombinationer 2.16.840.1.113883.6.73 2017-01 D09 MEDICATED DRESSINGS Medicinska förband 2.16.840.1.113883.6.73 2017-01 D09A MEDICATED DRESSINGS Medicinska förband 2.16.840.1.113883.6.73 2017-01 D09AA Medicated dressings with Medicinska förband med antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 D09AA01 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 D09AA02 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 D09AA03 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 D09AA04 phenylmercuric nitrate Fenylmerkurinitrat 2.16.840.1.113883.6.73 2017-01 D09AA05 benzododecinium Bensododecinium 2.16.840.1.113883.6.73 2017-01 D09AA06 triclosan Triklosan 2.16.840.1.113883.6.73 2017-01 D09AA07 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D09AA08 aluminium chlorohydrate Aluminiumklorhydrat 2.16.840.1.113883.6.73 2017-01 D09AA09 povidone-iodine Povidon, joderad © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 65 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D09AA10 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 D09AA11 benzalkonium Bensalkonium 2.16.840.1.113883.6.73 2017-01 D09AA12 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 D09AA13 iodoform Jodoform 2.16.840.1.113883.6.73 2017-01 D09AB Zinc bandages Zinkbandage 2.16.840.1.113883.6.73 2017-01 D09AB01 zinc bandage without supplements Zinkbandage utan tillägg 2.16.840.1.113883.6.73 2017-01 D09AB02 zinc bandage with supplements Zinkbandage med tillägg 2.16.840.1.113883.6.73 2017-01 D09AX Soft paraffin dressings Mjuka paraffinkompresser 2.16.840.1.113883.6.73 2017-01 D10 ANTI-ACNE PREPARATIONS Medel mot akne 2.16.840.1.113883.6.73 2017-01 D10A ANTI-ACNE PREPARATIONS FOR Medel mot akne för utvärtes bruk TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D10AA Corticosteroids, combinations for Kortikosteroider, kombinationer för treatment of acne behandling av akne 2.16.840.1.113883.6.73 2017-01 D10AA01 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 D10AA02 methylprednisolone Metylprednisolon 2.16.840.1.113883.6.73 2017-01 D10AA03 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 D10AB Preparations containing sulfur Medel innehållande svavel 2.16.840.1.113883.6.73 2017-01 D10AB01 bithionol Bitionol 2.16.840.1.113883.6.73 2017-01 D10AB02 sulfur Svavel 2.16.840.1.113883.6.73 2017-01 D10AB03 tioxolone Tioxolon 2.16.840.1.113883.6.73 2017-01 D10AB05 mesulfen Mesulfen 2.16.840.1.113883.6.73 2017-01 D10AD Retinoids for topical use in acne Retinoider för utvärtes behandling mot akne 2.16.840.1.113883.6.73 2017-01 D10AD01 tretinoin Tretinoin 2.16.840.1.113883.6.73 2017-01 D10AD02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 D10AD03 adapalene Adapalen 2.16.840.1.113883.6.73 2017-01 D10AD04 isotretinoin Isotretinoin 2.16.840.1.113883.6.73 2017-01 D10AD05 motretinide Motretinid 2.16.840.1.113883.6.73 2017-01 D10AD51 tretinoin, combinations Tretinoin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AD53 adapalene, combinations Adapalen, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AD54 isotretinoin, combinations Isotretinoin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AE Peroxides Peroxider 2.16.840.1.113883.6.73 2017-01 D10AE01 benzoyl peroxide Bensoylperoxid 2.16.840.1.113883.6.73 2017-01 D10AE51 benzoyl peroxide, combinations Bensoylperoxid, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AF Antiinfectives for treatment of acne Antiinfektiva medel mot akne 2.16.840.1.113883.6.73 2017-01 D10AF01 clindamycin Klindamycin 2.16.840.1.113883.6.73 2017-01 D10AF02 erythromycin Erytromycin 2.16.840.1.113883.6.73 2017-01 D10AF03 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 D10AF04 meclocycline Meklocyklin 2.16.840.1.113883.6.73 2017-01 D10AF05 nadifloxacin Nadifloxacin 2.16.840.1.113883.6.73 2017-01 D10AF06 sulfacetamide Sulfacetamid 2.16.840.1.113883.6.73 2017-01 D10AF51 clindamycin, combinations Klindamycin, kombinationer 2.16.840.1.113883.6.73 2017-01 D10AF52 erythromycin, combinations Erytromycin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 66 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D10AX Other anti-acne preparations for Övriga medel mot akne för utvärtes topical use bruk 2.16.840.1.113883.6.73 2017-01 D10AX01 aluminium chloride Aluminiumklorid 2.16.840.1.113883.6.73 2017-01 D10AX02 resorcinol Resorcinol 2.16.840.1.113883.6.73 2017-01 D10AX03 azelaic acid Azelainsyra 2.16.840.1.113883.6.73 2017-01 D10AX04 aluminium oxide Aluminiumoxid 2.16.840.1.113883.6.73 2017-01 D10AX05 dapsone Dapson 2.16.840.1.113883.6.73 2017-01 D10AX30 various combinations Övriga kombinationer 2.16.840.1.113883.6.73 2017-01 D10B ANTI-ACNE PREPARATIONS FOR Medel mot akne för systemiskt bruk SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 D10BA Retinoids for treatment of acne Retinoider mot akne 2.16.840.1.113883.6.73 2017-01 D10BA01 isotretinoin Isotretinoin 2.16.840.1.113883.6.73 2017-01 D10BX Other anti-acne preparations for Övriga medel mot akne för systemic use systemiskt bruk 2.16.840.1.113883.6.73 2017-01 D10BX01 ichtasol Ichtasol 2.16.840.1.113883.6.73 2017-01 D11 OTHER DERMATOLOGICAL Övriga dermatologiska medel PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11A OTHER DERMATOLOGICAL Övriga dermatologiska medel PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11AA Antihidrotics Antitranspirationsmedel 2.16.840.1.113883.6.73 2017-01 D11AC Medicated shampoos Medicinska schampon 2.16.840.1.113883.6.73 2017-01 D11AC01 cetrimide Cetrimid 2.16.840.1.113883.6.73 2017-01 D11AC02 cadmium compounds Kadmiumföreningar 2.16.840.1.113883.6.73 2017-01 D11AC03 selenium compounds Selensulfid 2.16.840.1.113883.6.73 2017-01 D11AC06 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 D11AC08 sulfur compounds Svavelkombinationer 2.16.840.1.113883.6.73 2017-01 D11AC09 xenysalate Xenysalat 2.16.840.1.113883.6.73 2017-01 D11AC30 others Övrigt 2.16.840.1.113883.6.73 2017-01 D11AE Androgens for topical use Anabola steroider 2.16.840.1.113883.6.73 2017-01 D11AE01 metandienone Metandienon 2.16.840.1.113883.6.73 2017-01 D11AF Wart and anti-corn preparations Vårtmedel 2.16.840.1.113883.6.73 2017-01 D11AH Agents for dermatitis, excluding Medel vid dermatit, exkl. corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 D11AH01 tacrolimus Takrolimus 2.16.840.1.113883.6.73 2017-01 D11AH02 pimecrolimus Pimekrolimus 2.16.840.1.113883.6.73 2017-01 D11AH03 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 D11AH04 alitretinoin Alitretinoin 2.16.840.1.113883.6.73 2017-01 D11AX Other dermatologicals Övriga dermatologiska medel 2.16.840.1.113883.6.73 2017-01 D11AX01 minoxidil Minoxidil 2.16.840.1.113883.6.73 2017-01 D11AX02 gamolenic acid Gamolensyra 2.16.840.1.113883.6.73 2017-01 D11AX03 calcium gluconate Kalciumglukonat 2.16.840.1.113883.6.73 2017-01 D11AX04 lithium succinate Litiumsuccinat 2.16.840.1.113883.6.73 2017-01 D11AX05 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 D11AX06 mequinol Mekinol 2.16.840.1.113883.6.73 2017-01 D11AX08 tiratricol Tiratrikol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 67 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D11AX09 oxaceprol Oxaceprol 2.16.840.1.113883.6.73 2017-01 D11AX10 finasteride Finasterid 2.16.840.1.113883.6.73 2017-01 D11AX11 hydroquinone Hydrokinon 2.16.840.1.113883.6.73 2017-01 D11AX12 pyrithione zinc Pyrithion zink 2.16.840.1.113883.6.73 2017-01 D11AX13 monobenzone Monobenzon 2.16.840.1.113883.6.73 2017-01 D11AX16 eflornithine Eflornitin 2.16.840.1.113883.6.73 2017-01 D11AX18 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 D11AX21 brimonidine Brimonidin 2.16.840.1.113883.6.73 2017-01 D11AX22 ivermectin Ivermektin 2.16.840.1.113883.6.73 2017-01 D11AX23 aminobenzoate potassium Aminobensoatkalium 2.16.840.1.113883.6.73 2017-01 D11AX24 deoxycholic acid Deoxicholsyra 2.16.840.1.113883.6.73 2017-01 D11AX52 gamolenic acid, combinations Gamolensyra, kombinationer 2.16.840.1.113883.6.73 2017-01 D11AX57 collagen, combinations Kollagen, kombinationer 2.16.840.1.113883.6.73 2017-01 G GENITO URINARY SYSTEM AND Urin- och könsorgan samt SEX HORMONES könshormoner 2.16.840.1.113883.6.73 2017-01 G01 GYNECOLOGICAL Antiinfektiva och antiseptiska medel ANTIINFECTIVES AND för gynekologiskt bruk ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 G01A ANTIINFECTIVES AND Antiinfektiva och antiseptiska medel, ANTISEPTICS, EXCL. exkl. kombinationer med COMBINATIONS WITH kortikosteroider CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 G01AA01 nystatin Nystatin 2.16.840.1.113883.6.73 2017-01 G01AA02 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 G01AA03 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 G01AA04 candicidin Kandicidin 2.16.840.1.113883.6.73 2017-01 G01AA05 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 G01AA06 hachimycin Hakimycin 2.16.840.1.113883.6.73 2017-01 G01AA07 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 G01AA08 carfecillin Karfecillin 2.16.840.1.113883.6.73 2017-01 G01AA09 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 G01AA10 clindamycin Klindamycin 2.16.840.1.113883.6.73 2017-01 G01AA11 pentamycin Pentamycin 2.16.840.1.113883.6.73 2017-01 G01AA51 nystatin, combinations Nystatin, kombinationer 2.16.840.1.113883.6.73 2017-01 G01AB Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 G01AB01 acetarsol Acetarsol 2.16.840.1.113883.6.73 2017-01 G01AC Quinoline derivatives Kinolinderivat 2.16.840.1.113883.6.73 2017-01 G01AC01 diiodohydroxyquinoline Dijodhydroxikinolin 2.16.840.1.113883.6.73 2017-01 G01AC02 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 G01AC03 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 G01AC05 dequalinium Dekvalinium 2.16.840.1.113883.6.73 2017-01 G01AC06 broxyquinoline Broxikinolin 2.16.840.1.113883.6.73 2017-01 G01AC30 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 G01AD Organic acids Organiska syror

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 68 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G01AD01 lactic acid Mjölksyra 2.16.840.1.113883.6.73 2017-01 G01AD02 acetic acid Ättiksyra 2.16.840.1.113883.6.73 2017-01 G01AD03 ascorbic acid Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 G01AE Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 G01AE01 sulfatolamide Sulfatolamid 2.16.840.1.113883.6.73 2017-01 G01AE10 combinations of sulfonamides Kombinationer av sulfonamider 2.16.840.1.113883.6.73 2017-01 G01AF Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 G01AF01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 G01AF02 clotrimazole Klotrimazol 2.16.840.1.113883.6.73 2017-01 G01AF04 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 G01AF05 econazole Ekonazol 2.16.840.1.113883.6.73 2017-01 G01AF06 ornidazole Ornidazol 2.16.840.1.113883.6.73 2017-01 G01AF07 isoconazole Isokonazol 2.16.840.1.113883.6.73 2017-01 G01AF08 tioconazole Tiokonazol 2.16.840.1.113883.6.73 2017-01 G01AF11 ketoconazole Ketokonazol 2.16.840.1.113883.6.73 2017-01 G01AF12 fenticonazole Fentikonazol 2.16.840.1.113883.6.73 2017-01 G01AF13 azanidazole Azanidazol 2.16.840.1.113883.6.73 2017-01 G01AF14 propenidazole Propenidazol 2.16.840.1.113883.6.73 2017-01 G01AF15 butoconazole Butokonazol 2.16.840.1.113883.6.73 2017-01 G01AF16 omoconazole Omokonazol 2.16.840.1.113883.6.73 2017-01 G01AF17 oxiconazole Oxikonazol 2.16.840.1.113883.6.73 2017-01 G01AF18 flutrimazole Flutrimazol 2.16.840.1.113883.6.73 2017-01 G01AF19 sertaconazole Sertakonazol 2.16.840.1.113883.6.73 2017-01 G01AF20 combinations of imidazole Kombinationer av imidazolderivat derivatives 2.16.840.1.113883.6.73 2017-01 G01AG Triazole derivatives Triazolderivat 2.16.840.1.113883.6.73 2017-01 G01AG02 terconazole Terkonazol 2.16.840.1.113883.6.73 2017-01 G01AX Other antiinfectives and antiseptics Övriga antiinfektiva och antiseptiska medel 2.16.840.1.113883.6.73 2017-01 G01AX01 clodantoin Klodantoin 2.16.840.1.113883.6.73 2017-01 G01AX02 inosine Inosin 2.16.840.1.113883.6.73 2017-01 G01AX03 policresulen Polikresulen 2.16.840.1.113883.6.73 2017-01 G01AX05 nifuratel Nifuratel 2.16.840.1.113883.6.73 2017-01 G01AX06 furazolidone Furazolidon 2.16.840.1.113883.6.73 2017-01 G01AX09 methylrosaniline Metylrosanilin 2.16.840.1.113883.6.73 2017-01 G01AX11 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 G01AX12 ciclopirox Ciklopirox 2.16.840.1.113883.6.73 2017-01 G01AX13 protiofate Protiofat 2.16.840.1.113883.6.73 2017-01 G01AX14 lactobacillus fermentum Lactobacillus fermentum 2.16.840.1.113883.6.73 2017-01 G01AX15 copper usnate Kopparusnat 2.16.840.1.113883.6.73 2017-01 G01AX16 hexetidine Hexetidin 2.16.840.1.113883.6.73 2017-01 G01AX66 octenidine, combinations Oktenidin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 69 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G01B ANTIINFECTIVES/ANTISEPTICS Antiinfektiva och antiseptiska medel IN COMBINATION WITH i kombination med kortikosteroider CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01BA Antibiotics and corticosteroids Antibiotika och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BC Quinoline derivatives and Kinolinderivat och kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BD Antiseptics and corticosteroids Antiseptika och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BE Sulfonamides and corticosteroids Sulfonamider och kortikosteroider 2.16.840.1.113883.6.73 2017-01 G01BF Imidazole derivatives and Imidazolderivat och kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 G02 OTHER GYNECOLOGICALS Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02A UTEROTONICS Uteruskontraherande medel 2.16.840.1.113883.6.73 2017-01 G02AB Ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 G02AB01 methylergometrine Metylergometrin 2.16.840.1.113883.6.73 2017-01 G02AB02 ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 G02AB03 ergometrine Ergometrin 2.16.840.1.113883.6.73 2017-01 G02AC Ergot alkaloids and oxytocin incl. Mjöldrygealkaloider och oxytocin, analogues, in combination inkl analoger, i kombination 2.16.840.1.113883.6.73 2017-01 G02AC01 methylergometrine and oxytocin Metylergometrin och oxytocin 2.16.840.1.113883.6.73 2017-01 G02AD Prostaglandins Prostaglandiner 2.16.840.1.113883.6.73 2017-01 G02AD01 dinoprost Dinoprost 2.16.840.1.113883.6.73 2017-01 G02AD02 dinoprostone Dinoproston 2.16.840.1.113883.6.73 2017-01 G02AD03 gemeprost Gemeprost 2.16.840.1.113883.6.73 2017-01 G02AD04 carboprost Karboprost 2.16.840.1.113883.6.73 2017-01 G02AD05 sulprostone Sulproston 2.16.840.1.113883.6.73 2017-01 G02AD06 misoprostol Misoprostol 2.16.840.1.113883.6.73 2017-01 G02AX Other uterotonics Övriga uteruskontraherande medel 2.16.840.1.113883.6.73 2017-01 G02B CONTRACEPTIVES FOR TOPICAL Antikonceptionella medel för lokal USE användning 2.16.840.1.113883.6.73 2017-01 G02BA Intrauterine contraceptives Intrauterina preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BA01 plastic IUD Plastiskt intrauterint preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BA02 plastic IUD with copper Plastiskt intrauterint preventivmedel med koppar 2.16.840.1.113883.6.73 2017-01 G02BA03 plastic IUD with progestogen Plastiskt intrauterint preventivmedel med gestagen 2.16.840.1.113883.6.73 2017-01 G02BB Intravaginal contraceptives Intravaginala preventivmedel 2.16.840.1.113883.6.73 2017-01 G02BB01 vaginal ring with progestogen and Vaginalring med progestogen och estrogen östrogen 2.16.840.1.113883.6.73 2017-01 G02C OTHER GYNECOLOGICALS Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02CA Sympathomimetics, labour Sympatomimetika för repressants undertryckande av värkarbete 2.16.840.1.113883.6.73 2017-01 G02CA01 ritodrine Ritodrin 2.16.840.1.113883.6.73 2017-01 G02CA02 buphenine Bufenin 2.16.840.1.113883.6.73 2017-01 G02CA03 fenoterol Fenoterol 2.16.840.1.113883.6.73 2017-01 G02CB Prolactine inhibitors Prolaktinhämmare 2.16.840.1.113883.6.73 2017-01 G02CB01 bromocriptine Bromokriptin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 70 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G02CB02 lisuride Lisurid 2.16.840.1.113883.6.73 2017-01 G02CB03 cabergoline Kabergolin 2.16.840.1.113883.6.73 2017-01 G02CB04 quinagolide Kinagolid 2.16.840.1.113883.6.73 2017-01 G02CB05 metergoline Metergolin 2.16.840.1.113883.6.73 2017-01 G02CB06 terguride Tergurid 2.16.840.1.113883.6.73 2017-01 G02CC Antiinflammatory products for Antiinflammatoriska medel för vaginal administration vaginal administrering 2.16.840.1.113883.6.73 2017-01 G02CC01 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 G02CC02 naproxen Naproxen 2.16.840.1.113883.6.73 2017-01 G02CC03 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 G02CC04 flunoxaprofen Flunoxaprofen 2.16.840.1.113883.6.73 2017-01 G02CX Other gynecologicals Övriga medel för gynekologiskt bruk 2.16.840.1.113883.6.73 2017-01 G02CX01 atosiban Atosiban 2.16.840.1.113883.6.73 2017-01 G02CX02 flibanserin Flibanserin 2.16.840.1.113883.6.73 2017-01 G02CX03 Agni casti fructus Munkpeppar, frukt 2.16.840.1.113883.6.73 2017-01 G02CX04 Cimicifugae rhizoma Läkesilverax, jordstam 2.16.840.1.113883.6.73 2017-01 G03 SEX HORMONES AND Könshormoner och modulatorer av MODULATORS OF THE GENITAL könsorgan SYSTEM 2.16.840.1.113883.6.73 2017-01 G03A HORMONAL CONTRACEPTIVES Hormonella antikonceptionella FOR SYSTEMIC USE medel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 G03AA Progestogens and estrogens, fixed Gestagener och östrogener i fasta combinations kombinationer 2.16.840.1.113883.6.73 2017-01 G03AA01 etynodiol and ethinylestradiol Etynodiol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA02 quingestanol and ethinylestradiol Kingestanol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA03 lynestrenol and ethinylestradiol Lynestrenol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA04 megestrol and ethinylestradiol Megestrol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA05 norethisterone and ethinylestradiol Noretisteron och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA06 norgestrel and ethinylestradiol Norgestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA07 levonorgestrel and ethinylestradiol Levonorgestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA08 medroxyprogesterone and Medroxiprogesteron och ethinylestradiol etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA09 desogestrel and ethinylestradiol Desogestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA10 gestodene and ethinylestradiol Gestoden och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA11 norgestimate and ethinylestradiol Norgestimat och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA12 drospirenone and ethinylestradiol Drospirenon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA13 norelgestromin and ethinylestradiol Norelgestromin och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA14 nomegestrol and estradiol Nomegestrol och estradiol 2.16.840.1.113883.6.73 2017-01 G03AA15 chlormadinone and ethinylestradiol Klormadinon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA16 dienogest and ethinylestradiol Dienogest och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB Progestogens and estrogens, Gestagener och östrogener, sequential preparations sekvenspreparat 2.16.840.1.113883.6.73 2017-01 G03AB01 megestrol and ethinylestradiol Megestrol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB02 lynestrenol and ethinylestradiol Lynestrenol och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB03 levonorgestrel and ethinylestradiol Levonorgestrel och etinylestradiol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 71 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03AB04 norethisterone and ethinylestradiol Noretisteron och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB05 desogestrel and ethinylestradiol Desogestrel och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB06 gestodene and ethinylestradiol Gestoden och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB07 chlormadinone and ethinylestradiol Klormadinon och etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB08 dienogest and estradiol Dienogest och estradiol 2.16.840.1.113883.6.73 2017-01 G03AC Progestogens Gestagener 2.16.840.1.113883.6.73 2017-01 G03AC01 norethisterone Noretisteron 2.16.840.1.113883.6.73 2017-01 G03AC02 lynestrenol Lynestrenol 2.16.840.1.113883.6.73 2017-01 G03AC03 levonorgestrel Levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AC04 quingestanol Kvingestanol 2.16.840.1.113883.6.73 2017-01 G03AC05 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 G03AC06 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03AC07 norgestrienone Norgestrienon 2.16.840.1.113883.6.73 2017-01 G03AC08 etonogestrel Etonogestrel 2.16.840.1.113883.6.73 2017-01 G03AC09 desogestrel Desogestrel 2.16.840.1.113883.6.73 2017-01 G03AC10 drospirenone Drospirenon 2.16.840.1.113883.6.73 2017-01 G03AD Emergency contraceptives Akut preventivmedel 2.16.840.1.113883.6.73 2017-01 G03AD01 levonorgestrel Levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AD02 ulipristal Ulipristal 2.16.840.1.113883.6.73 2017-01 G03B ANDROGENS Androgener 2.16.840.1.113883.6.73 2017-01 G03BA 3-oxoandrosten (4) derivatives 3-Oxandrostenderivat 2.16.840.1.113883.6.73 2017-01 G03BA01 fluoxymesterone Fluoximesteron 2.16.840.1.113883.6.73 2017-01 G03BA02 methyltestosterone Metyltestosteron 2.16.840.1.113883.6.73 2017-01 G03BA03 testosterone Testosteron 2.16.840.1.113883.6.73 2017-01 G03BB 5-androstanon (3) derivatives 5-Androstanonderivat 2.16.840.1.113883.6.73 2017-01 G03BB01 mesterolone Mesterolon 2.16.840.1.113883.6.73 2017-01 G03BB02 androstanolone Androstanolon 2.16.840.1.113883.6.73 2017-01 G03C ESTROGENS Östrogener 2.16.840.1.113883.6.73 2017-01 G03CA Natural and semisynthetic Naturliga och halvsyntetiska estrogens, plain estrogener 2.16.840.1.113883.6.73 2017-01 G03CA01 ethinylestradiol Etinylestradiol 2.16.840.1.113883.6.73 2017-01 G03CA03 estradiol Estradiol 2.16.840.1.113883.6.73 2017-01 G03CA04 estriol Estriol 2.16.840.1.113883.6.73 2017-01 G03CA06 chlorotrianisene Klortrianisen 2.16.840.1.113883.6.73 2017-01 G03CA07 estrone Estron 2.16.840.1.113883.6.73 2017-01 G03CA09 promestriene Promestrien 2.16.840.1.113883.6.73 2017-01 G03CA53 estradiol, combinations Estradiol, kombinationer 2.16.840.1.113883.6.73 2017-01 G03CA57 conjugated estrogens Konjugerade estrogener 2.16.840.1.113883.6.73 2017-01 G03CB Synthetic estrogens, plain Syntetiska östrogener 2.16.840.1.113883.6.73 2017-01 G03CB01 dienestrol Dienestrol 2.16.840.1.113883.6.73 2017-01 G03CB02 diethylstilbestrol Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 G03CB03 methallenestril Metallenestril 2.16.840.1.113883.6.73 2017-01 G03CB04 moxestrol Moxestrol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 72 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03CC Estrogens, combinations with other Östrogener i kombination med drugs andra medel 2.16.840.1.113883.6.73 2017-01 G03CC02 dienestrol Dienestrol 2.16.840.1.113883.6.73 2017-01 G03CC03 methallenestril Metallenestril 2.16.840.1.113883.6.73 2017-01 G03CC04 estrone Estron 2.16.840.1.113883.6.73 2017-01 G03CC05 diethylstilbestrol Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 G03CC06 estriol Estriol 2.16.840.1.113883.6.73 2017-01 G03CC07 conjugated estrogens and Konjugerade östrogener och bazedoxifene bazedoxifen 2.16.840.1.113883.6.73 2017-01 G03CX Other estrogens Övriga estrogener 2.16.840.1.113883.6.73 2017-01 G03CX01 tibolone Tibolon 2.16.840.1.113883.6.73 2017-01 G03D PROGESTOGENS Gestagener 2.16.840.1.113883.6.73 2017-01 G03DA Pregnen (4) derivatives Pregnenderivat 2.16.840.1.113883.6.73 2017-01 G03DA01 gestonorone Gestonoron 2.16.840.1.113883.6.73 2017-01 G03DA02 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03DA03 hydroxyprogesterone Hydroxiprogesteron 2.16.840.1.113883.6.73 2017-01 G03DA04 progesterone Progesteron 2.16.840.1.113883.6.73 2017-01 G03DB Pregnadien derivatives Pregnadienderivat 2.16.840.1.113883.6.73 2017-01 G03DB01 dydrogesterone Dydrogesteron 2.16.840.1.113883.6.73 2017-01 G03DB02 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 G03DB03 medrogestone Medrogeston 2.16.840.1.113883.6.73 2017-01 G03DB04 nomegestrol Nomegestrol 2.16.840.1.113883.6.73 2017-01 G03DB05 demegestone Demegeston 2.16.840.1.113883.6.73 2017-01 G03DB06 chlormadinone Klormadinon 2.16.840.1.113883.6.73 2017-01 G03DB07 promegestone Promegeston 2.16.840.1.113883.6.73 2017-01 G03DB08 dienogest Dienogest 2.16.840.1.113883.6.73 2017-01 G03DC Estren derivatives Östrenderivat 2.16.840.1.113883.6.73 2017-01 G03DC01 allylestrenol Allylestrenol 2.16.840.1.113883.6.73 2017-01 G03DC02 norethisterone Noretisteron 2.16.840.1.113883.6.73 2017-01 G03DC03 lynestrenol Lynestrenol 2.16.840.1.113883.6.73 2017-01 G03DC04 ethisterone Etisteron 2.16.840.1.113883.6.73 2017-01 G03DC06 etynodiol Etynodiol 2.16.840.1.113883.6.73 2017-01 G03DC31 methylestrenolone Metylestrenolon 2.16.840.1.113883.6.73 2017-01 G03E ANDROGENS AND FEMALE SEX Androgener och kvinnliga HORMONES IN COMBINATION könshormoner, kombinationer 2.16.840.1.113883.6.73 2017-01 G03EA Androgens and estrogens Androgener och östrogener 2.16.840.1.113883.6.73 2017-01 G03EA01 methyltestosterone and estrogen Metyltestosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EA02 testosterone and estrogen Testosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EA03 prasterone and estrogen Prasteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03EB Androgen, progestogen and Androgener, gestagener och estrogen in combination östrogener, kombinationer 2.16.840.1.113883.6.73 2017-01 G03EK Androgens and female sex Androgener och kvinnliga hormones in combination with other könshormoner i kombination med drugs andra medel 2.16.840.1.113883.6.73 2017-01 G03EK01 methyltestosterone Metyltestosteron

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 73 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03F PROGESTOGENS AND Gestagener i kombination med ESTROGENS IN COMBINATION östrogener 2.16.840.1.113883.6.73 2017-01 G03FA Progestogens and estrogens, fixed Gestagener och östrogener i fasta combinations kombinationer 2.16.840.1.113883.6.73 2017-01 G03FA01 norethisterone and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA02 hydroxyprogesterone and estrogen Hydroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA03 ethisterone and estrogen Etisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA04 progesterone and estrogen Progesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA05 methylnortestosterone and estrogen Metylnortestosteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA06 etynodiol and estrogen Etynodiol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA07 lynestrenol and estrogen Lynestrenol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA08 megestrol and estrogen Megestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA09 noretynodrel and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA10 norgestrel and estrogen Norgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA11 levonorgestrel and estrogen Levonorgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA12 medroxyprogesterone and estrogen Medroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA13 norgestimate and estrogen Norgestimat och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA14 dydrogesterone and estrogen Dydrogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA15 dienogest and estrogen Dienogest och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA16 trimegestone and estrogen Trimegeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FA17 drospirenone and estrogen Drospirenon och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB Progestogens and estrogens, Gestagener och östrogener, sequential preparations sekvenspreparat 2.16.840.1.113883.6.73 2017-01 G03FB01 norgestrel and estrogen Norgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB02 lynestrenol and estrogen Lynestrenol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB03 chlormadinone and estrogen Klormadinon och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB04 megestrol and estrogen Megestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB05 norethisterone and estrogen Noretisteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB06 medroxyprogesterone and estrogen Medroxiprogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB07 medrogestone and estrogen Medrogeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB08 dydrogesterone and estrogen Dydrogesteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB09 levonorgestrel and estrogen Levonorgestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB10 desogestrel and estrogen Desogestrel och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB11 trimegestone and estrogen Trimegeston och östrogen 2.16.840.1.113883.6.73 2017-01 G03FB12 nomegestrol and estrogen Nomegestrol och östrogen 2.16.840.1.113883.6.73 2017-01 G03G GONADOTROPINS AND OTHER Gonadotropiner och andra OVULATION STIMULANTS ovulationsstimulerande medel 2.16.840.1.113883.6.73 2017-01 G03GA Gonadotropins Gonadotropiner 2.16.840.1.113883.6.73 2017-01 G03GA01 chorionic gonadotrophin Koriongonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA02 human menopausal gonadotrophin Menopausgonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA03 serum gonadotrophin Serumgonadotropin 2.16.840.1.113883.6.73 2017-01 G03GA04 urofollitropin Urofollitropin 2.16.840.1.113883.6.73 2017-01 G03GA05 follitropin alfa Follitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA06 follitropin beta Follitropin beta

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 74 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03GA07 lutropin alfa Lutropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA08 choriogonadotropin alfa Koriogonadotropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA09 corifollitropin alfa Korifollitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA10 follitropin delta Follitropin delta 2.16.840.1.113883.6.73 2017-01 G03GA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 G03GB Ovulation stimulants, synthetic Syntetiska ovulationsstimulerande medel 2.16.840.1.113883.6.73 2017-01 G03GB01 cyclofenil Cyklofenil 2.16.840.1.113883.6.73 2017-01 G03GB02 clomifene Klomifen 2.16.840.1.113883.6.73 2017-01 G03GB03 epimestrol Epimestrol 2.16.840.1.113883.6.73 2017-01 G03H ANTIANDROGENS Antiandrogener 2.16.840.1.113883.6.73 2017-01 G03HA Antiandrogens, plain Antiandrogener 2.16.840.1.113883.6.73 2017-01 G03HA01 cyproterone Cyproteron 2.16.840.1.113883.6.73 2017-01 G03HB Antiandrogens and estrogens Antiandrogener och östrogener 2.16.840.1.113883.6.73 2017-01 G03HB01 cyproterone and estrogen Cyproteron och östrogen 2.16.840.1.113883.6.73 2017-01 G03X OTHER SEX HORMONES AND Övriga könshormoner och MODULATORS OF THE GENITAL modulatorer av könsorgan SYSTEM 2.16.840.1.113883.6.73 2017-01 G03XA Antigonadotropins and similar Gonadotropinhämmare och liknande agents medel 2.16.840.1.113883.6.73 2017-01 G03XA01 danazol Danazol 2.16.840.1.113883.6.73 2017-01 G03XA02 gestrinone Gestrinon 2.16.840.1.113883.6.73 2017-01 G03XB Progesterone receptor modulators Progesteronreceptormodulatorer 2.16.840.1.113883.6.73 2017-01 G03XB01 mifepristone Mifepriston 2.16.840.1.113883.6.73 2017-01 G03XB02 ulipristal Ulipristal 2.16.840.1.113883.6.73 2017-01 G03XB51 mifepristone, combinations Mifepriston, kombinationer 2.16.840.1.113883.6.73 2017-01 G03XC Selective estrogen receptor Selektiva modulators östrogenreceptormodulatorer 2.16.840.1.113883.6.73 2017-01 G03XC01 raloxifene Raloxifen 2.16.840.1.113883.6.73 2017-01 G03XC02 bazedoxifene Bazedoxifen 2.16.840.1.113883.6.73 2017-01 G03XC03 lasofoxifene Lasofoxifen 2.16.840.1.113883.6.73 2017-01 G03XC04 ormeloxifene Ormeloxifen 2.16.840.1.113883.6.73 2017-01 G03XC05 ospemifene Ospemifen 2.16.840.1.113883.6.73 2017-01 G04 UROLOGICALS Urologiska medel 2.16.840.1.113883.6.73 2017-01 G04B UROLOGICALS Urologiska medel 2.16.840.1.113883.6.73 2017-01 G04BA Acidifiers Surgörande medel 2.16.840.1.113883.6.73 2017-01 G04BA01 ammonium chloride Ammoniumklorid 2.16.840.1.113883.6.73 2017-01 G04BA03 calcium chloride Kalciumklorid 2.16.840.1.113883.6.73 2017-01 G04BC Urinary concrement solvents Medel för upplösning av urinsyrakonkrement 2.16.840.1.113883.6.73 2017-01 G04BD Drugs for urinary frequency and Medel mot inkontinens och för incontinence kontroll av miktionsfrekvens 2.16.840.1.113883.6.73 2017-01 G04BD01 emepronium Emepron 2.16.840.1.113883.6.73 2017-01 G04BD02 flavoxate Flavoxat 2.16.840.1.113883.6.73 2017-01 G04BD03 meladrazine Meladrazin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 75 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G04BD04 oxybutynin Oxybutynin 2.16.840.1.113883.6.73 2017-01 G04BD05 terodiline Terodilin 2.16.840.1.113883.6.73 2017-01 G04BD06 propiverine Propiverin 2.16.840.1.113883.6.73 2017-01 G04BD07 tolterodine Tolterodin 2.16.840.1.113883.6.73 2017-01 G04BD08 solifenacin Solifenacin 2.16.840.1.113883.6.73 2017-01 G04BD09 trospium Trospium 2.16.840.1.113883.6.73 2017-01 G04BD10 darifenacin Darifenacin 2.16.840.1.113883.6.73 2017-01 G04BD11 fesoterodine Fesoterodin 2.16.840.1.113883.6.73 2017-01 G04BD12 mirabegron Mirabegron 2.16.840.1.113883.6.73 2017-01 G04BD13 desfesoterodine Desfesoterodin 2.16.840.1.113883.6.73 2017-01 G04BE Drugs used in erectile dysfunction Medel vid erektil dysfunktion 2.16.840.1.113883.6.73 2017-01 G04BE01 alprostadil Alprostadil 2.16.840.1.113883.6.73 2017-01 G04BE02 papaverine Papaverin 2.16.840.1.113883.6.73 2017-01 G04BE03 sildenafil Sildenafil 2.16.840.1.113883.6.73 2017-01 G04BE04 yohimbine Yohimbin 2.16.840.1.113883.6.73 2017-01 G04BE06 moxisylyte Moxisylyt 2.16.840.1.113883.6.73 2017-01 G04BE07 apomorphine Apomorfin 2.16.840.1.113883.6.73 2017-01 G04BE08 tadalafil Tadalafil 2.16.840.1.113883.6.73 2017-01 G04BE09 vardenafil Vardenafil 2.16.840.1.113883.6.73 2017-01 G04BE10 avanafil Avanafil 2.16.840.1.113883.6.73 2017-01 G04BE11 udenafil Udenafil 2.16.840.1.113883.6.73 2017-01 G04BE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 G04BE52 papaverine, combinations Papaverin, kombinationer 2.16.840.1.113883.6.73 2017-01 G04BX Other urologicals Övriga urologiska medel 2.16.840.1.113883.6.73 2017-01 G04BX01 magnesium hydroxide Magnesiumhydroxid 2.16.840.1.113883.6.73 2017-01 G04BX03 acetohydroxamic acid Acetohydroxamsyra 2.16.840.1.113883.6.73 2017-01 G04BX06 phenazopyridine Fenazopyridin 2.16.840.1.113883.6.73 2017-01 G04BX10 succinimide Succinimid 2.16.840.1.113883.6.73 2017-01 G04BX11 collagen Kollagen 2.16.840.1.113883.6.73 2017-01 G04BX12 phenyl salicylate Fenylsalicylat 2.16.840.1.113883.6.73 2017-01 G04BX13 dimethyl sulfoxide Dimetylsulfoxid 2.16.840.1.113883.6.73 2017-01 G04BX14 dapoxetine Dapoxetin 2.16.840.1.113883.6.73 2017-01 G04BX15 pentosan polysulfate sodium Pentosanpolysulfatnatrium 2.16.840.1.113883.6.73 2017-01 G04BX16 tiopronin Tiopronin 2.16.840.1.113883.6.73 2017-01 G04C DRUGS USED IN BENIGN Medel vid benign prostatahyperplasi PROSTATIC HYPERTROPHY 2.16.840.1.113883.6.73 2017-01 G04CA Alpha-adrenoreceptor antagonists Alfa-adrenoreceptorantagonister 2.16.840.1.113883.6.73 2017-01 G04CA01 alfuzosin Alfuzosin 2.16.840.1.113883.6.73 2017-01 G04CA02 tamsulosin Tamsulosin 2.16.840.1.113883.6.73 2017-01 G04CA03 terazosin Terazosin 2.16.840.1.113883.6.73 2017-01 G04CA04 silodosin Silodosin 2.16.840.1.113883.6.73 2017-01 G04CA51 alfuzosin and finasteride Alfuzosin och finasterid 2.16.840.1.113883.6.73 2017-01 G04CA52 tamsulosin and dutasteride Tamsulosin och dutasterid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 76 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G04CA53 tamsulosin and solifenacin Tamsulosin och solifenacin 2.16.840.1.113883.6.73 2017-01 G04CB Testosterone-5-alpha reductase Testosteron-5-alfa- inhibitors reduktashämmare 2.16.840.1.113883.6.73 2017-01 G04CB01 finasteride Finasterid 2.16.840.1.113883.6.73 2017-01 G04CB02 dutasteride Dutasterid 2.16.840.1.113883.6.73 2017-01 G04CX Other drugs used in benign prostatic Övriga medel vid benign hypertrophy prostatahyperplasi 2.16.840.1.113883.6.73 2017-01 G04CX01 Prunus africanae cortex Pygeum africanum, bark 2.16.840.1.113883.6.73 2017-01 G04CX02 Sabalis serrulatae fructus Sågpalmetto, frukt 2.16.840.1.113883.6.73 2017-01 G04CX03 mepartricin Mepartricin 2.16.840.1.113883.6.73 2017-01 H SYSTEMIC HORMONAL Systemiska hormonpreparat, exkl. PREPARATIONS, EXCL. SEX könshormoner och insuliner HORMONES AND INSULINS 2.16.840.1.113883.6.73 2017-01 H01 PITUITARY AND HYPOTHALAMIC Hypofys- och hypotalamushormoner HORMONES AND ANALOGUES och analoger 2.16.840.1.113883.6.73 2017-01 H01A ANTERIOR PITUITARY LOBE Hypofysframlobens hormoner samt HORMONES AND ANALOGUES analoger 2.16.840.1.113883.6.73 2017-01 H01AA ACTH ACTH 2.16.840.1.113883.6.73 2017-01 H01AA01 corticotropin Kortikotropin 2.16.840.1.113883.6.73 2017-01 H01AA02 tetracosactide Tetrakosaktid 2.16.840.1.113883.6.73 2017-01 H01AB Thyrotropin Tyrotropin 2.16.840.1.113883.6.73 2017-01 H01AB01 thyrotropin alfa Tyrotropin alfa 2.16.840.1.113883.6.73 2017-01 H01AC Somatropin and somatropin Somatropin, samt agonists somatropinagonister 2.16.840.1.113883.6.73 2017-01 H01AC01 somatropin Somatropin 2.16.840.1.113883.6.73 2017-01 H01AC02 somatrem Somatrem 2.16.840.1.113883.6.73 2017-01 H01AC03 mecasermin Mekasermin 2.16.840.1.113883.6.73 2017-01 H01AC04 sermorelin Sermorelin 2.16.840.1.113883.6.73 2017-01 H01AC05 mecasermin rinfabate Mekaserminrinfabat 2.16.840.1.113883.6.73 2017-01 H01AC06 tesamorelin Tesamorelin 2.16.840.1.113883.6.73 2017-01 H01AX Other anterior pituitary lobe Övriga hypofysframlobens hormoner hormones and analogues samt analoger 2.16.840.1.113883.6.73 2017-01 H01AX01 pegvisomant Pegvisomant 2.16.840.1.113883.6.73 2017-01 H01B POSTERIOR PITUITARY LOBE Hypofysbaklobens hormoner HORMONES 2.16.840.1.113883.6.73 2017-01 H01BA Vasopressin and analogues Vasopressin och analoger 2.16.840.1.113883.6.73 2017-01 H01BA01 vasopressin Vasopressin (argipressin) 2.16.840.1.113883.6.73 2017-01 H01BA02 desmopressin Desmopressin 2.16.840.1.113883.6.73 2017-01 H01BA03 lypressin Lypressin 2.16.840.1.113883.6.73 2017-01 H01BA04 terlipressin Terlipressin 2.16.840.1.113883.6.73 2017-01 H01BA05 ornipressin Ornipressin 2.16.840.1.113883.6.73 2017-01 H01BA06 argipressin Argipressin 2.16.840.1.113883.6.73 2017-01 H01BB Oxytocin and analogues Oxytocin och analoger 2.16.840.1.113883.6.73 2017-01 H01BB01 demoxytocin Demoxytocin 2.16.840.1.113883.6.73 2017-01 H01BB02 oxytocin Oxytocin 2.16.840.1.113883.6.73 2017-01 H01BB03 carbetocin Karbetocin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 77 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H01C HYPOTHALAMIC HORMONES Hypotalamushormoner 2.16.840.1.113883.6.73 2017-01 H01CA Gonadotropin-releasing hormones Gonadotropinfrisättande hormoner 2.16.840.1.113883.6.73 2017-01 H01CA01 gonadorelin Gonadorelin 2.16.840.1.113883.6.73 2017-01 H01CA02 nafarelin Nafarelin 2.16.840.1.113883.6.73 2017-01 H01CB Somatostatin and analogues Somatostatin och analoger 2.16.840.1.113883.6.73 2017-01 H01CB01 somatostatin Somatostatin 2.16.840.1.113883.6.73 2017-01 H01CB02 octreotide Oktreotid 2.16.840.1.113883.6.73 2017-01 H01CB03 lanreotide Lanreotid 2.16.840.1.113883.6.73 2017-01 H01CB04 vapreotide Vapreotid 2.16.840.1.113883.6.73 2017-01 H01CB05 pasireotide Pasireotid 2.16.840.1.113883.6.73 2017-01 H01CC Anti-gonadotropin-releasing Gonadotropinantagonister hormones 2.16.840.1.113883.6.73 2017-01 H01CC01 ganirelix Ganirelix 2.16.840.1.113883.6.73 2017-01 H01CC02 cetrorelix Cetrorelix 2.16.840.1.113883.6.73 2017-01 H02 CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 H02A CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk SYSTEMIC USE, PLAIN 2.16.840.1.113883.6.73 2017-01 H02AA Mineralocorticoids Mineralkortikoider 2.16.840.1.113883.6.73 2017-01 H02AA01 aldosterone Aldosteron 2.16.840.1.113883.6.73 2017-01 H02AA02 fludrocortisone Fludrokortison 2.16.840.1.113883.6.73 2017-01 H02AA03 desoxycortone Desoxikorton 2.16.840.1.113883.6.73 2017-01 H02AB Glucocorticoids Glukokortikoider 2.16.840.1.113883.6.73 2017-01 H02AB01 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 H02AB02 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 H02AB03 fluocortolone Fluokortolon 2.16.840.1.113883.6.73 2017-01 H02AB04 methylprednisolone Metylprednisolon 2.16.840.1.113883.6.73 2017-01 H02AB05 paramethasone Parametason 2.16.840.1.113883.6.73 2017-01 H02AB06 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 H02AB07 prednisone Prednison 2.16.840.1.113883.6.73 2017-01 H02AB08 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 H02AB09 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 H02AB10 cortisone Kortison 2.16.840.1.113883.6.73 2017-01 H02AB11 prednylidene Prednyliden 2.16.840.1.113883.6.73 2017-01 H02AB12 rimexolone Rimexolon 2.16.840.1.113883.6.73 2017-01 H02AB13 deflazacort Deflazakort 2.16.840.1.113883.6.73 2017-01 H02AB14 cloprednol Kloprednol 2.16.840.1.113883.6.73 2017-01 H02AB15 meprednisone Meprednison 2.16.840.1.113883.6.73 2017-01 H02AB17 cortivazol Kortivazol 2.16.840.1.113883.6.73 2017-01 H02B CORTICOSTEROIDS FOR Kortikosteroider för systemiskt bruk, SYSTEMIC USE, COMBINATIONS kombinationer 2.16.840.1.113883.6.73 2017-01 H02BX Corticosteroids for systemic use, Kortikosteroider för systemiskt bruk, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 H02BX01 methylprednisolone, combinations Metylprednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 H02C ANTIADRENAL PREPARATIONS Antiadrenerga preparat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 78 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H02CA Anticorticosteroids Antikortikosteroider 2.16.840.1.113883.6.73 2017-01 H02CA01 trilostane Trilostan 2.16.840.1.113883.6.73 2017-01 H03 THYROID THERAPY Tyreoideabehandling 2.16.840.1.113883.6.73 2017-01 H03A THYROID PREPARATIONS Tyreoideapreparat 2.16.840.1.113883.6.73 2017-01 H03AA Thyroid hormones Tyreoideahormoner 2.16.840.1.113883.6.73 2017-01 H03AA01 levothyroxine sodium Levotyroxinnatrium 2.16.840.1.113883.6.73 2017-01 H03AA02 liothyronine sodium Liotyroninnatrium 2.16.840.1.113883.6.73 2017-01 H03AA03 combinations of levothyroxine and Kombinationer av levotyroxin och liothyronine liotyronin 2.16.840.1.113883.6.73 2017-01 H03AA04 tiratricol Tiratrikol 2.16.840.1.113883.6.73 2017-01 H03AA05 thyroid gland preparations Sköldkörtelpreparat 2.16.840.1.113883.6.73 2017-01 H03B ANTITHYROID PREPARATIONS Antityreoida substanser, tyreostatika 2.16.840.1.113883.6.73 2017-01 H03BA Thiouracils Tiouraciler 2.16.840.1.113883.6.73 2017-01 H03BA01 methylthiouracil Metyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BA02 propylthiouracil Propyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BA03 benzylthiouracil Bensyltiouracil 2.16.840.1.113883.6.73 2017-01 H03BB Sulfur-containing imidazole Svavelhaltiga imidazolderivat derivatives 2.16.840.1.113883.6.73 2017-01 H03BB01 carbimazole Karbimazol 2.16.840.1.113883.6.73 2017-01 H03BB02 thiamazole Tiamazol 2.16.840.1.113883.6.73 2017-01 H03BB52 thiamazole, combinations Tiamazol, kombinationer 2.16.840.1.113883.6.73 2017-01 H03BC Perchlorates Perklorater 2.16.840.1.113883.6.73 2017-01 H03BC01 potassium perchlorate Kaliumperklorat 2.16.840.1.113883.6.73 2017-01 H03BX Other antithyroid preparations Övriga antityreoida substanser 2.16.840.1.113883.6.73 2017-01 H03BX01 diiodotyrosine Dijodtyrosin 2.16.840.1.113883.6.73 2017-01 H03BX02 dibromotyrosine Dibromotyrosin 2.16.840.1.113883.6.73 2017-01 H03C IODINE THERAPY Jodterapi 2.16.840.1.113883.6.73 2017-01 H03CA Iodine therapy Jodterapi 2.16.840.1.113883.6.73 2017-01 H04 PANCREATIC HORMONES Pankreashormoner 2.16.840.1.113883.6.73 2017-01 H04A GLYCOGENOLYTIC HORMONES Glukogenolytiskt hormon 2.16.840.1.113883.6.73 2017-01 H04AA Glycogenolytic hormones Glukogenolytiskt hormon 2.16.840.1.113883.6.73 2017-01 H04AA01 glucagon Glukagon 2.16.840.1.113883.6.73 2017-01 H05 CALCIUM HOMEOSTASIS Medel som reglerar kalciumomsättningen 2.16.840.1.113883.6.73 2017-01 H05A PARATHYROID HORMONES AND Paratyreoideahormoner och ANALOGUES analoger 2.16.840.1.113883.6.73 2017-01 H05AA Parathyroid hormones and Paratyreoideahormoner och analogues analoger 2.16.840.1.113883.6.73 2017-01 H05AA01 parathyroid gland extract Paratyreoideaextrakt 2.16.840.1.113883.6.73 2017-01 H05AA02 teriparatide Teriparatid 2.16.840.1.113883.6.73 2017-01 H05AA03 parathyroid hormone Paratyroidhormon 2.16.840.1.113883.6.73 2017-01 H05B ANTI-PARATHYROID AGENTS Antiparatyreoideamedel 2.16.840.1.113883.6.73 2017-01 H05BA Calcitonin preparations Kalcitoninpreparat 2.16.840.1.113883.6.73 2017-01 H05BA01 calcitonin (salmon synthetic) Kalcitonin, lax, syntetisk 2.16.840.1.113883.6.73 2017-01 H05BA02 calcitonin (pork natural) Kalcitonin (naturligt från gris) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 79 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H05BA03 calcitonin (human synthetic) Kalcitonin, human, syntetisk 2.16.840.1.113883.6.73 2017-01 H05BA04 elcatonin Elkatonin 2.16.840.1.113883.6.73 2017-01 H05BX Other anti-parathyroid agents Övriga antiparatyreoideamedel 2.16.840.1.113883.6.73 2017-01 H05BX01 cinacalcet Cinakalcet 2.16.840.1.113883.6.73 2017-01 H05BX02 paricalcitol Parikalcitol 2.16.840.1.113883.6.73 2017-01 H05BX03 doxercalciferol Doxerkalciferol 2.16.840.1.113883.6.73 2017-01 H05BX04 etelcalcetide Etelkalcetid 2.16.840.1.113883.6.73 2017-01 J ANTIINFECTIVES FOR SYSTEMIC Antiinfektiva medel för systemiskt USE bruk 2.16.840.1.113883.6.73 2017-01 J01 ANTIBACTERIALS FOR Antibakteriella medel för systemiskt SYSTEMIC USE bruk 2.16.840.1.113883.6.73 2017-01 J01A TETRACYCLINES Tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA Tetracyclines Tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA01 demeclocycline Demeklocyklin 2.16.840.1.113883.6.73 2017-01 J01AA02 doxycycline Doxycyklin 2.16.840.1.113883.6.73 2017-01 J01AA03 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA04 lymecycline Lymecyklin 2.16.840.1.113883.6.73 2017-01 J01AA05 metacycline Metacyklin 2.16.840.1.113883.6.73 2017-01 J01AA06 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA07 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA08 minocycline Minocyklin 2.16.840.1.113883.6.73 2017-01 J01AA09 rolitetracycline Rolitetracyklin 2.16.840.1.113883.6.73 2017-01 J01AA10 penimepicycline Penimepicyklin 2.16.840.1.113883.6.73 2017-01 J01AA11 clomocycline Klomocyklin 2.16.840.1.113883.6.73 2017-01 J01AA12 tigecycline Tigecyklin 2.16.840.1.113883.6.73 2017-01 J01AA20 combinations of tetracyclines Kombinationer av tetracykliner 2.16.840.1.113883.6.73 2017-01 J01AA56 oxytetracycline, combinations Oxitetracyklin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01B AMPHENICOLS Amfenikoler 2.16.840.1.113883.6.73 2017-01 J01BA Amphenicols Amfenikoler 2.16.840.1.113883.6.73 2017-01 J01BA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 J01BA02 thiamphenicol Tiamfenikol 2.16.840.1.113883.6.73 2017-01 J01BA52 thiamphenicol, combinations Tiamfenikol, kombinationer 2.16.840.1.113883.6.73 2017-01 J01C BETA-LACTAM ANTIBACTERIALS, Antibakteriella betalaktamer, PENICILLINS penicilliner 2.16.840.1.113883.6.73 2017-01 J01CA Penicillins with extended spectrum Penicilliner med utvidgat spektrum 2.16.840.1.113883.6.73 2017-01 J01CA01 ampicillin Ampicillin 2.16.840.1.113883.6.73 2017-01 J01CA02 pivampicillin Pivampicillin 2.16.840.1.113883.6.73 2017-01 J01CA03 carbenicillin Karbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA04 amoxicillin Amoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA05 carindacillin Karindacillin 2.16.840.1.113883.6.73 2017-01 J01CA06 bacampicillin Bakampicillin 2.16.840.1.113883.6.73 2017-01 J01CA07 epicillin Epicillin 2.16.840.1.113883.6.73 2017-01 J01CA08 pivmecillinam Pivmecillinam 2.16.840.1.113883.6.73 2017-01 J01CA09 azlocillin Azlocillin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 80 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01CA10 mezlocillin Mezlocillin 2.16.840.1.113883.6.73 2017-01 J01CA11 mecillinam Mecillinam 2.16.840.1.113883.6.73 2017-01 J01CA12 piperacillin Piperacillin 2.16.840.1.113883.6.73 2017-01 J01CA13 ticarcillin Tikarcillin 2.16.840.1.113883.6.73 2017-01 J01CA14 metampicillin Metampicillin 2.16.840.1.113883.6.73 2017-01 J01CA15 talampicillin Talampicillin 2.16.840.1.113883.6.73 2017-01 J01CA16 sulbenicillin Sulbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA17 temocillin Temocillin 2.16.840.1.113883.6.73 2017-01 J01CA18 hetacillin Hetacillin 2.16.840.1.113883.6.73 2017-01 J01CA19 aspoxicillin Aspoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01CA51 ampicillin, combinations Ampicillin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01CE Beta-lactamase sensitive penicillins Betalaktamaskänsliga penicilliner 2.16.840.1.113883.6.73 2017-01 J01CE01 benzylpenicillin Bensylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE02 phenoxymethylpenicillin Fenoximetylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE03 propicillin Propicillin 2.16.840.1.113883.6.73 2017-01 J01CE04 azidocillin Azidocillin 2.16.840.1.113883.6.73 2017-01 J01CE05 pheneticillin Feneticillin 2.16.840.1.113883.6.73 2017-01 J01CE06 penamecillin Penamecillin 2.16.840.1.113883.6.73 2017-01 J01CE07 clometocillin Klometocillin 2.16.840.1.113883.6.73 2017-01 J01CE08 benzathine benzylpenicillin Bensatin bensylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE09 procaine benzylpenicillin Bensylpenicillinprokain 2.16.840.1.113883.6.73 2017-01 J01CE10 benzathine phenoxymethylpenicillin Bensatin fenoximetylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01CF Beta-lactamase resistant penicillins Betalaktamasresistenta penicilliner 2.16.840.1.113883.6.73 2017-01 J01CF01 dicloxacillin Dikloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF02 cloxacillin Kloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF03 meticillin Meticillin 2.16.840.1.113883.6.73 2017-01 J01CF04 oxacillin Oxacillin 2.16.840.1.113883.6.73 2017-01 J01CF05 flucloxacillin Flukloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF06 nafcillin Nafcillin 2.16.840.1.113883.6.73 2017-01 J01CG Beta-lactamase inhibitors Betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CG01 sulbactam Sulbaktam 2.16.840.1.113883.6.73 2017-01 J01CG02 tazobactam Tazobaktam 2.16.840.1.113883.6.73 2017-01 J01CR Combinations of penicillins, incl. Kombinationer av penicilliner, inkl. beta-lactamase inhibitors betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR01 ampicillin and enzyme inhibitor Ampicillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR02 amoxicillin and enzyme inhibitor Amoxicillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR03 ticarcillin and enzyme inhibitor Tikarcillin och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01CR04 sultamicillin Sultamicillin 2.16.840.1.113883.6.73 2017-01 J01CR05 piperacillin and enzyme inhibitor Piperacillin och betalaktamashämmare © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 81 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01CR50 combinations of penicillins Kombinationer av penicilliner 2.16.840.1.113883.6.73 2017-01 J01D OTHER BETA-LACTAM Övriga antibakteriella betalaktamer ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01DB First-generation cephalosporins Cefalosporiner, första generationen 2.16.840.1.113883.6.73 2017-01 J01DB01 cefalexin Cefalexin 2.16.840.1.113883.6.73 2017-01 J01DB02 cefaloridine Cefaloridin 2.16.840.1.113883.6.73 2017-01 J01DB03 cefalotin Cefalotin 2.16.840.1.113883.6.73 2017-01 J01DB04 cefazolin Cefazolin 2.16.840.1.113883.6.73 2017-01 J01DB05 cefadroxil Cefadroxil 2.16.840.1.113883.6.73 2017-01 J01DB06 cefazedone Cefazedon 2.16.840.1.113883.6.73 2017-01 J01DB07 cefatrizine Cefatrizin 2.16.840.1.113883.6.73 2017-01 J01DB08 cefapirin Cefapirin 2.16.840.1.113883.6.73 2017-01 J01DB09 cefradine Cefradin 2.16.840.1.113883.6.73 2017-01 J01DB10 cefacetrile Cefacetril 2.16.840.1.113883.6.73 2017-01 J01DB11 cefroxadine Cefroxadin 2.16.840.1.113883.6.73 2017-01 J01DB12 ceftezole Ceftezol 2.16.840.1.113883.6.73 2017-01 J01DC Second-generation cephalosporins Cefalosporiner, andra generationen 2.16.840.1.113883.6.73 2017-01 J01DC01 cefoxitin Cefoxitin 2.16.840.1.113883.6.73 2017-01 J01DC02 cefuroxime Cefuroxim 2.16.840.1.113883.6.73 2017-01 J01DC03 cefamandole Cefamandol 2.16.840.1.113883.6.73 2017-01 J01DC04 cefaclor Cefaklor 2.16.840.1.113883.6.73 2017-01 J01DC05 cefotetan Cefotetan 2.16.840.1.113883.6.73 2017-01 J01DC06 cefonicid Cefonicid 2.16.840.1.113883.6.73 2017-01 J01DC07 cefotiam Cefotiam 2.16.840.1.113883.6.73 2017-01 J01DC08 loracarbef Lorakarbef 2.16.840.1.113883.6.73 2017-01 J01DC09 cefmetazole Cefmetazol 2.16.840.1.113883.6.73 2017-01 J01DC10 cefprozil Cefprozil 2.16.840.1.113883.6.73 2017-01 J01DC11 ceforanide Ceforanid 2.16.840.1.113883.6.73 2017-01 J01DC12 cefminox Cefminox 2.16.840.1.113883.6.73 2017-01 J01DC13 cefbuperazone Cefbuperazon 2.16.840.1.113883.6.73 2017-01 J01DC14 flomoxef Flomoxef 2.16.840.1.113883.6.73 2017-01 J01DD Third-generation cephalosporins Cefalosporiner, tredje generationen 2.16.840.1.113883.6.73 2017-01 J01DD01 cefotaxime Cefotaxim 2.16.840.1.113883.6.73 2017-01 J01DD02 ceftazidime Ceftazidim 2.16.840.1.113883.6.73 2017-01 J01DD03 cefsulodin Cefsulodin 2.16.840.1.113883.6.73 2017-01 J01DD04 ceftriaxone Ceftriaxon 2.16.840.1.113883.6.73 2017-01 J01DD05 cefmenoxime Cefmenoxim 2.16.840.1.113883.6.73 2017-01 J01DD06 latamoxef Latamoxef 2.16.840.1.113883.6.73 2017-01 J01DD07 ceftizoxime Ceftizoxim 2.16.840.1.113883.6.73 2017-01 J01DD08 cefixime Cefixim 2.16.840.1.113883.6.73 2017-01 J01DD09 cefodizime Cefodizim 2.16.840.1.113883.6.73 2017-01 J01DD10 cefetamet Cefetamet 2.16.840.1.113883.6.73 2017-01 J01DD11 cefpiramide Cefpiramid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 82 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01DD12 cefoperazone Cefoperazon 2.16.840.1.113883.6.73 2017-01 J01DD13 cefpodoxime Cefpodoxim 2.16.840.1.113883.6.73 2017-01 J01DD14 ceftibuten Ceftibuten 2.16.840.1.113883.6.73 2017-01 J01DD15 cefdinir Cefdinir 2.16.840.1.113883.6.73 2017-01 J01DD16 cefditoren Cefditoren 2.16.840.1.113883.6.73 2017-01 J01DD17 cefcapene Cefkapen 2.16.840.1.113883.6.73 2017-01 J01DD51 cefotaxime, combinations Cefotaxim och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DD52 ceftazidime, combinations Ceftazidim och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DD54 ceftriaxone, combinations Ceftriaxon, kombinationer 2.16.840.1.113883.6.73 2017-01 J01DD62 cefoperazone, combinations Cefoperazon och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01DE Fourth-generation cephalosporins Cefalosporiner, fjärde generationen 2.16.840.1.113883.6.73 2017-01 J01DE01 cefepime Cefepim 2.16.840.1.113883.6.73 2017-01 J01DE02 cefpirome Cefpirom 2.16.840.1.113883.6.73 2017-01 J01DE03 cefozopran Cefozopran 2.16.840.1.113883.6.73 2017-01 J01DF Monobactams Monobaktamer 2.16.840.1.113883.6.73 2017-01 J01DF01 aztreonam Aztreonam 2.16.840.1.113883.6.73 2017-01 J01DF02 carumonam Karumonam 2.16.840.1.113883.6.73 2017-01 J01DH Carbapenems Karbapenemer 2.16.840.1.113883.6.73 2017-01 J01DH02 meropenem Meropenem 2.16.840.1.113883.6.73 2017-01 J01DH03 ertapenem Ertapenem 2.16.840.1.113883.6.73 2017-01 J01DH04 doripenem Doripenem 2.16.840.1.113883.6.73 2017-01 J01DH05 biapenem Biapenem 2.16.840.1.113883.6.73 2017-01 J01DH51 imipenem and enzyme inhibitor Imipenem och cilastatin 2.16.840.1.113883.6.73 2017-01 J01DH55 panipenem and betamipron Panipenem och betamipron 2.16.840.1.113883.6.73 2017-01 J01DI Other cephalosporins and penems Övriga cefalosporiner och penemer 2.16.840.1.113883.6.73 2017-01 J01DI01 ceftobiprole medocaril Ceftobiprolmedokaril 2.16.840.1.113883.6.73 2017-01 J01DI02 ceftaroline fosamil Ceftarolinfosamil 2.16.840.1.113883.6.73 2017-01 J01DI03 faropenem Faropenem 2.16.840.1.113883.6.73 2017-01 J01DI54 ceftolozane and enzyme inhibitor Ceftolozan och betalaktamashämmare 2.16.840.1.113883.6.73 2017-01 J01E SULFONAMIDES AND Sulfonamider och trimetoprim TRIMETHOPRIM 2.16.840.1.113883.6.73 2017-01 J01EA Trimethoprim and derivatives Trimetoprim och derivat 2.16.840.1.113883.6.73 2017-01 J01EA01 trimethoprim Trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EA02 brodimoprim Brodimoprim 2.16.840.1.113883.6.73 2017-01 J01EA03 iclaprim Iklaprim 2.16.840.1.113883.6.73 2017-01 J01EB Short-acting sulfonamides Kortverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01EB01 sulfaisodimidine Sulfaisodimidin 2.16.840.1.113883.6.73 2017-01 J01EB02 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 J01EB03 sulfadimidine Sulfadimidin 2.16.840.1.113883.6.73 2017-01 J01EB04 sulfapyridine Sulfapyridin 2.16.840.1.113883.6.73 2017-01 J01EB05 sulfafurazole Sulfafurazol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 83 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01EB06 sulfanilamide Sulfanilamid 2.16.840.1.113883.6.73 2017-01 J01EB07 sulfathiazole Sulfatiazol 2.16.840.1.113883.6.73 2017-01 J01EB08 sulfathiourea Sulfatiourea 2.16.840.1.113883.6.73 2017-01 J01EB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01EC Intermediate-acting sulfonamides Medellångverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01EC01 sulfamethoxazole Sulfametoxazol 2.16.840.1.113883.6.73 2017-01 J01EC02 sulfadiazine Sulfadiazin 2.16.840.1.113883.6.73 2017-01 J01EC03 sulfamoxole Sulfamoxol 2.16.840.1.113883.6.73 2017-01 J01EC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01ED Long-acting sulfonamides Långverkande sulfonamider 2.16.840.1.113883.6.73 2017-01 J01ED01 sulfadimethoxine Sulfadimetoxin 2.16.840.1.113883.6.73 2017-01 J01ED02 sulfalene Sulfalen 2.16.840.1.113883.6.73 2017-01 J01ED03 sulfametomidine Sulfametomidin 2.16.840.1.113883.6.73 2017-01 J01ED04 sulfametoxydiazine Sulfametoxidiazin 2.16.840.1.113883.6.73 2017-01 J01ED05 sulfamethoxypyridazine Sulfametoxipyridazin 2.16.840.1.113883.6.73 2017-01 J01ED06 sulfaperin Sulfaperin 2.16.840.1.113883.6.73 2017-01 J01ED07 sulfamerazine Sulfamerazin 2.16.840.1.113883.6.73 2017-01 J01ED08 sulfaphenazole Sulfafenazol 2.16.840.1.113883.6.73 2017-01 J01ED09 sulfamazone Sulfamazon 2.16.840.1.113883.6.73 2017-01 J01ED20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J01EE Combinations of sulfonamides and Kombinationer av sulfonamider och trimethoprim, incl. derivatives trimetoprim, inkl derivat 2.16.840.1.113883.6.73 2017-01 J01EE01 sulfamethoxazole and trimethoprim Sulfametoxazol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE02 sulfadiazine and trimethoprim Sulfadiazin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE03 sulfametrole and trimethoprim Sulfametrol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE04 sulfamoxole and trimethoprim Sulfamoxol och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE05 sulfadimidine and trimethoprim Sulfadimidin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01EE06 sulfadiazine and tetroxoprim Sulfadiazin och tetroxoprim 2.16.840.1.113883.6.73 2017-01 J01EE07 sulfamerazine and trimethoprim Sulfamerazin och trimetoprim 2.16.840.1.113883.6.73 2017-01 J01F MACROLIDES, LINCOSAMIDES Makrolider, linkosamider och AND STREPTOGRAMINS streptograminer 2.16.840.1.113883.6.73 2017-01 J01FA Macrolides Makrolider 2.16.840.1.113883.6.73 2017-01 J01FA01 erythromycin Erytromycin 2.16.840.1.113883.6.73 2017-01 J01FA02 spiramycin Spiramycin 2.16.840.1.113883.6.73 2017-01 J01FA03 midecamycin Midekamycin 2.16.840.1.113883.6.73 2017-01 J01FA05 oleandomycin Oleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA06 roxithromycin Roxitromycin 2.16.840.1.113883.6.73 2017-01 J01FA07 josamycin Josamycin 2.16.840.1.113883.6.73 2017-01 J01FA08 troleandomycin Troleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA09 clarithromycin Klaritromycin 2.16.840.1.113883.6.73 2017-01 J01FA10 azithromycin Azitromycin 2.16.840.1.113883.6.73 2017-01 J01FA11 miocamycin Miocamycin 2.16.840.1.113883.6.73 2017-01 J01FA12 rokitamycin Rokitamycin 2.16.840.1.113883.6.73 2017-01 J01FA13 dirithromycin Diritromycin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 84 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01FA14 flurithromycin Fluritromycin 2.16.840.1.113883.6.73 2017-01 J01FA15 telithromycin Telitromycin 2.16.840.1.113883.6.73 2017-01 J01FA16 solithromycin Solitromycin 2.16.840.1.113883.6.73 2017-01 J01FF Lincosamides Linkosamider 2.16.840.1.113883.6.73 2017-01 J01FF01 clindamycin Klindamycin 2.16.840.1.113883.6.73 2017-01 J01FF02 lincomycin Linkomycin 2.16.840.1.113883.6.73 2017-01 J01FG Streptogramins Streptograminer 2.16.840.1.113883.6.73 2017-01 J01FG01 pristinamycin Pristinamycin 2.16.840.1.113883.6.73 2017-01 J01FG02 quinupristin/dalfopristin Kinupristin och dalfopristin 2.16.840.1.113883.6.73 2017-01 J01G AMINOGLYCOSIDE Antibakteriella aminoglykosider ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01GA Streptomycins Streptomyciner 2.16.840.1.113883.6.73 2017-01 J01GA01 streptomycin Streptomycin 2.16.840.1.113883.6.73 2017-01 J01GA02 streptoduocin Streptoduocin 2.16.840.1.113883.6.73 2017-01 J01GB Other aminoglycosides Övriga aminoglykosider 2.16.840.1.113883.6.73 2017-01 J01GB01 tobramycin Tobramycin 2.16.840.1.113883.6.73 2017-01 J01GB03 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 J01GB04 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 J01GB05 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 J01GB06 amikacin Amikacin 2.16.840.1.113883.6.73 2017-01 J01GB07 netilmicin Netilmicin 2.16.840.1.113883.6.73 2017-01 J01GB08 sisomicin Sisomicin 2.16.840.1.113883.6.73 2017-01 J01GB09 dibekacin Dibekacin 2.16.840.1.113883.6.73 2017-01 J01GB10 ribostamycin Ribostamycin 2.16.840.1.113883.6.73 2017-01 J01GB11 isepamicin Isepamicin 2.16.840.1.113883.6.73 2017-01 J01GB12 arbekacin Arbekacin 2.16.840.1.113883.6.73 2017-01 J01GB13 bekanamycin Bekanamycin 2.16.840.1.113883.6.73 2017-01 J01M QUINOLONE ANTIBACTERIALS Antibakteriella kinolonderivat 2.16.840.1.113883.6.73 2017-01 J01MA Fluoroquinolones Fluorokinoloner 2.16.840.1.113883.6.73 2017-01 J01MA01 ofloxacin Ofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA02 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA03 pefloxacin Pefloxacin 2.16.840.1.113883.6.73 2017-01 J01MA04 enoxacin Enoxacin 2.16.840.1.113883.6.73 2017-01 J01MA05 temafloxacin Temafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA06 norfloxacin Norfloxacin 2.16.840.1.113883.6.73 2017-01 J01MA07 lomefloxacin Lomefloxacin 2.16.840.1.113883.6.73 2017-01 J01MA08 fleroxacin Fleroxacin 2.16.840.1.113883.6.73 2017-01 J01MA09 sparfloxacin Sparfloxacin 2.16.840.1.113883.6.73 2017-01 J01MA10 rufloxacin Rufloxacin 2.16.840.1.113883.6.73 2017-01 J01MA11 grepafloxacin Grepafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA12 levofloxacin Levofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA13 trovafloxacin Trovafloxacin 2.16.840.1.113883.6.73 2017-01 J01MA14 moxifloxacin Moxifloxacin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 85 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01MA15 gemifloxacin Gemifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA16 gatifloxacin Gatifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA17 prulifloxacin Prulifloxacin 2.16.840.1.113883.6.73 2017-01 J01MA18 pazufloxacin Pazufloxacin 2.16.840.1.113883.6.73 2017-01 J01MA19 garenoxacin Garenoxacin 2.16.840.1.113883.6.73 2017-01 J01MA21 sitafloxacin Sitafloxacin 2.16.840.1.113883.6.73 2017-01 J01MB Other quinolones Övriga kinoloner 2.16.840.1.113883.6.73 2017-01 J01MB01 rosoxacin Rosoxacin 2.16.840.1.113883.6.73 2017-01 J01MB02 nalidixic acid Nalidixinsyra 2.16.840.1.113883.6.73 2017-01 J01MB03 piromidic acid Piromidinsyra 2.16.840.1.113883.6.73 2017-01 J01MB04 pipemidic acid Pipemidinsyra 2.16.840.1.113883.6.73 2017-01 J01MB05 oxolinic acid Oxolininsyra 2.16.840.1.113883.6.73 2017-01 J01MB06 cinoxacin Cinoxacin 2.16.840.1.113883.6.73 2017-01 J01MB07 flumequine Flumekin 2.16.840.1.113883.6.73 2017-01 J01MB08 nemonoxacin Nemonoxacin 2.16.840.1.113883.6.73 2017-01 J01R COMBINATIONS OF Antibakteriella medel, kombinationer ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01RA Combinations of antibacterials Antibakteriella medel, kombinationer 2.16.840.1.113883.6.73 2017-01 J01RA01 penicillins, combinations with other Penicilliner, kombinationer med antibacterials andra antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01RA02 sulfonamides, combinations with Sulfonamider, kombinationer med other antibacterials (excl. andra antibakteriella medel (exkl. trimethoprim) trimetoprim) 2.16.840.1.113883.6.73 2017-01 J01RA03 cefuroxime and metronidazole Cefuroxim och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA04 spiramycin and metronidazole Spiramycin och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA05 levofloxacin and ornidazole Levofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA06 cefepime and amikacin Cefepim och amikacin 2.16.840.1.113883.6.73 2017-01 J01RA07 azithromycin, fluconazole and Azitromycin, flukonazol och secnidazole seknidazol 2.16.840.1.113883.6.73 2017-01 J01RA08 tetracycline and oleandomycin Tetracyklin och oleandomycin 2.16.840.1.113883.6.73 2017-01 J01RA09 ofloxacin and ornidazole Ofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA10 ciprofloxacin and metronidazole Ciprofloxacin och metronidazol 2.16.840.1.113883.6.73 2017-01 J01RA11 ciprofloxacin and tinidazole Ciprofloxacin och tinidazol 2.16.840.1.113883.6.73 2017-01 J01RA12 ciprofloxacin and ornidazole Ciprofloxacin och ornidazol 2.16.840.1.113883.6.73 2017-01 J01RA13 norfloxacin and tinidazole Norfloxacin och tinidazol 2.16.840.1.113883.6.73 2017-01 J01X OTHER ANTIBACTERIALS Övriga antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01XA Glycopeptide antibacterials Antibakteriella glykopeptider 2.16.840.1.113883.6.73 2017-01 J01XA01 vancomycin Vankomycin 2.16.840.1.113883.6.73 2017-01 J01XA02 teicoplanin Teikoplanin 2.16.840.1.113883.6.73 2017-01 J01XA03 telavancin Telavancin 2.16.840.1.113883.6.73 2017-01 J01XA04 dalbavancin Dalbavancin 2.16.840.1.113883.6.73 2017-01 J01XA05 oritavancin Oritavancin 2.16.840.1.113883.6.73 2017-01 J01XB Polymyxins Polymyxiner 2.16.840.1.113883.6.73 2017-01 J01XB01 colistin Kolistin 2.16.840.1.113883.6.73 2017-01 J01XB02 polymyxin B Polymyxin B © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 86 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01XC Steroid antibacterials Antibakteriella steroider 2.16.840.1.113883.6.73 2017-01 J01XC01 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 J01XD Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 J01XD01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 J01XD02 tinidazole Tinidazol 2.16.840.1.113883.6.73 2017-01 J01XD03 ornidazole Ornidazol 2.16.840.1.113883.6.73 2017-01 J01XE Nitrofuran derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 J01XE01 nitrofurantoin Nitrofurantoin 2.16.840.1.113883.6.73 2017-01 J01XE02 nifurtoinol Nifurtoinol 2.16.840.1.113883.6.73 2017-01 J01XE03 furazidin Furazidin 2.16.840.1.113883.6.73 2017-01 J01XE51 nitrofurantoin, combinations Nitrofurantoin, kombinationer 2.16.840.1.113883.6.73 2017-01 J01XX Other antibacterials Övriga antibakteriella medel 2.16.840.1.113883.6.73 2017-01 J01XX01 fosfomycin Fosfomycin 2.16.840.1.113883.6.73 2017-01 J01XX02 xibornol Xibornol 2.16.840.1.113883.6.73 2017-01 J01XX03 clofoctol Klofoktol 2.16.840.1.113883.6.73 2017-01 J01XX04 spectinomycin Spektinomycin 2.16.840.1.113883.6.73 2017-01 J01XX05 methenamine Metenamin 2.16.840.1.113883.6.73 2017-01 J01XX06 mandelic acid Mandelinsyra 2.16.840.1.113883.6.73 2017-01 J01XX07 nitroxoline Nitroxolin 2.16.840.1.113883.6.73 2017-01 J01XX08 linezolid Linezolid 2.16.840.1.113883.6.73 2017-01 J01XX09 daptomycin Daptomycin 2.16.840.1.113883.6.73 2017-01 J01XX10 bacitracin Bacitracin 2.16.840.1.113883.6.73 2017-01 J01XX11 tedizolid Tedizolid 2.16.840.1.113883.6.73 2017-01 J02 ANTIMYCOTICS FOR SYSTEMIC Antimykotika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 J02A ANTIMYCOTICS FOR SYSTEMIC Antimykotika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 J02AA Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 J02AA01 amphotericin B Amfotericin B 2.16.840.1.113883.6.73 2017-01 J02AA02 hachimycin Hakimycin 2.16.840.1.113883.6.73 2017-01 J02AB Imidazole derivatives Imidazolderivat 2.16.840.1.113883.6.73 2017-01 J02AB01 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 J02AB02 ketoconazole Ketokonazol 2.16.840.1.113883.6.73 2017-01 J02AC Triazole derivatives Triazolderivat 2.16.840.1.113883.6.73 2017-01 J02AC01 fluconazole Flukonazol 2.16.840.1.113883.6.73 2017-01 J02AC02 itraconazole Itrakonazol 2.16.840.1.113883.6.73 2017-01 J02AC03 voriconazole Vorikonazol 2.16.840.1.113883.6.73 2017-01 J02AC04 posaconazole Posakonazol 2.16.840.1.113883.6.73 2017-01 J02AC05 isavuconazole Isavukonazol 2.16.840.1.113883.6.73 2017-01 J02AX Other antimycotics for systemic use Övriga antimykotika för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 J02AX01 flucytosine Flucytosin 2.16.840.1.113883.6.73 2017-01 J02AX04 caspofungin Kaspofungin 2.16.840.1.113883.6.73 2017-01 J02AX05 micafungin Mikafungin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 87 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J02AX06 anidulafungin Anidulafungin 2.16.840.1.113883.6.73 2017-01 J04 ANTIMYCOBACTERIALS Medel mot mykobakterier 2.16.840.1.113883.6.73 2017-01 J04A DRUGS FOR TREATMENT OF Medel för behandling av tuberkulos TUBERCULOSIS 2.16.840.1.113883.6.73 2017-01 J04AA Aminosalicylic acid and derivatives Aminosalicylsyra och derivat 2.16.840.1.113883.6.73 2017-01 J04AA01 4-aminosalicylic acid 4-Aminosalicylsyra 2.16.840.1.113883.6.73 2017-01 J04AA02 sodium aminosalicylate Natriumaminosalicylat 2.16.840.1.113883.6.73 2017-01 J04AA03 calcium aminosalicylate Kalciumaminosalicylat 2.16.840.1.113883.6.73 2017-01 J04AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 J04AB01 cycloserine Cykloserin 2.16.840.1.113883.6.73 2017-01 J04AB02 rifampicin Rifampicin 2.16.840.1.113883.6.73 2017-01 J04AB03 rifamycin Rifamycin 2.16.840.1.113883.6.73 2017-01 J04AB04 rifabutin Rifabutin 2.16.840.1.113883.6.73 2017-01 J04AB05 rifapentine Rifapentin 2.16.840.1.113883.6.73 2017-01 J04AB30 capreomycin Kapreomycin 2.16.840.1.113883.6.73 2017-01 J04AC Hydrazides Hydrazider 2.16.840.1.113883.6.73 2017-01 J04AC01 isoniazid Isoniazid 2.16.840.1.113883.6.73 2017-01 J04AC51 isoniazid, combinations Isoniazid, kombinationer 2.16.840.1.113883.6.73 2017-01 J04AD Thiocarbamide derivatives Tiokarbamidderivat 2.16.840.1.113883.6.73 2017-01 J04AD01 protionamide Protionamid 2.16.840.1.113883.6.73 2017-01 J04AD02 tiocarlide Tiokarlid 2.16.840.1.113883.6.73 2017-01 J04AD03 ethionamide Etionamid 2.16.840.1.113883.6.73 2017-01 J04AK Other drugs for treatment of Övriga medel för behandling av tuberculosis tuberkulos 2.16.840.1.113883.6.73 2017-01 J04AK01 pyrazinamide Pyrazinamid 2.16.840.1.113883.6.73 2017-01 J04AK02 ethambutol Etambutol 2.16.840.1.113883.6.73 2017-01 J04AK03 terizidone Terizidon 2.16.840.1.113883.6.73 2017-01 J04AK04 morinamide Morinamid 2.16.840.1.113883.6.73 2017-01 J04AK05 bedaquiline Bedakilin 2.16.840.1.113883.6.73 2017-01 J04AK06 delamanid Delamanid 2.16.840.1.113883.6.73 2017-01 J04AK07 thioacetazone Tioacetazon 2.16.840.1.113883.6.73 2017-01 J04AM Combinations of drugs for treatment Medel mot tuberkulos, of tuberculosis kombinationer 2.16.840.1.113883.6.73 2017-01 J04AM01 streptomycin and isoniazid Streptomycin och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM02 rifampicin and isoniazid Rifampicin och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM03 ethambutol and isoniazid Etambutol och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM04 thioacetazone and isoniazid Tioacetazon och isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM05 rifampicin, pyrazinamide and Rifampicin, pyrazinamid och isoniazid isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM06 rifampicin, pyrazinamide, Rifampicin, pyrazinamid, etambutol ethambutol and isoniazid och isoniazid 2.16.840.1.113883.6.73 2017-01 J04B DRUGS FOR TREATMENT OF Medel för behandling av lepra LEPRA 2.16.840.1.113883.6.73 2017-01 J04BA Drugs for treatment of lepra Medel för behandling av lepra 2.16.840.1.113883.6.73 2017-01 J04BA01 clofazimine Klofazimin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 88 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J04BA02 dapsone Dapson 2.16.840.1.113883.6.73 2017-01 J04BA03 aldesulfone sodium Aldesulfonnatrium 2.16.840.1.113883.6.73 2017-01 J05 ANTIVIRALS FOR SYSTEMIC USE Virushämmande medel för systemiskt bruk 2.16.840.1.113883.6.73 2017-01 J05A DIRECT ACTING ANTIVIRALS Virushämmande medel, direktverkande 2.16.840.1.113883.6.73 2017-01 J05AA Thiosemicarbazones Tiosemikarbazoner 2.16.840.1.113883.6.73 2017-01 J05AA01 metisazone Metisazon 2.16.840.1.113883.6.73 2017-01 J05AB Nucleosides and nucleotides excl. Nukleosider och nukleotider, exkl. reverse transcriptase inhibitors hämmare av omvänt transkriptas 2.16.840.1.113883.6.73 2017-01 J05AB01 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 J05AB02 idoxuridine Idoxuridin 2.16.840.1.113883.6.73 2017-01 J05AB03 vidarabine Vidarabin 2.16.840.1.113883.6.73 2017-01 J05AB04 ribavirin Ribavirin 2.16.840.1.113883.6.73 2017-01 J05AB06 ganciclovir Ganciklovir 2.16.840.1.113883.6.73 2017-01 J05AB09 famciclovir Famciklovir 2.16.840.1.113883.6.73 2017-01 J05AB11 valaciclovir Valaciklovir 2.16.840.1.113883.6.73 2017-01 J05AB12 cidofovir Cidofovir 2.16.840.1.113883.6.73 2017-01 J05AB13 penciclovir Penciklovir 2.16.840.1.113883.6.73 2017-01 J05AB14 valganciclovir Valganciklovir 2.16.840.1.113883.6.73 2017-01 J05AB15 brivudine Brivudin 2.16.840.1.113883.6.73 2017-01 J05AC Cyclic amines Cykliska aminer 2.16.840.1.113883.6.73 2017-01 J05AC02 rimantadine Rimantadin 2.16.840.1.113883.6.73 2017-01 J05AC03 tromantadine Tromantadin 2.16.840.1.113883.6.73 2017-01 J05AD Phosphonic acid derivatives Fosfonsyraderivat 2.16.840.1.113883.6.73 2017-01 J05AD01 foscarnet Foskarnet 2.16.840.1.113883.6.73 2017-01 J05AD02 fosfonet Fosfonet 2.16.840.1.113883.6.73 2017-01 J05AE Protease inhibitors Proteashämmare 2.16.840.1.113883.6.73 2017-01 J05AE01 saquinavir Sakvinavir 2.16.840.1.113883.6.73 2017-01 J05AE02 indinavir Indinavir 2.16.840.1.113883.6.73 2017-01 J05AE03 ritonavir Ritonavir 2.16.840.1.113883.6.73 2017-01 J05AE04 nelfinavir Nelfinavir 2.16.840.1.113883.6.73 2017-01 J05AE05 amprenavir Amprenavir 2.16.840.1.113883.6.73 2017-01 J05AE07 fosamprenavir Fosamprenavir 2.16.840.1.113883.6.73 2017-01 J05AE08 atazanavir Atazanavir 2.16.840.1.113883.6.73 2017-01 J05AE09 tipranavir Tipranavir 2.16.840.1.113883.6.73 2017-01 J05AE10 darunavir Darunavir 2.16.840.1.113883.6.73 2017-01 J05AE11 telaprevir Telaprevir 2.16.840.1.113883.6.73 2017-01 J05AE12 boceprevir Boceprevir 2.16.840.1.113883.6.73 2017-01 J05AE13 faldaprevir Faldaprevir 2.16.840.1.113883.6.73 2017-01 J05AE14 simeprevir Simeprevir 2.16.840.1.113883.6.73 2017-01 J05AE15 asunaprevir Asunaprevir 2.16.840.1.113883.6.73 2017-01 J05AF Nucleoside and nucleotide reverse Nukleosider och nukleotider, transcriptase inhibitors hämmare av omvänt transkriptas

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 89 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AF01 zidovudine Zidovudin 2.16.840.1.113883.6.73 2017-01 J05AF02 didanosine Didanosin 2.16.840.1.113883.6.73 2017-01 J05AF03 zalcitabine Zalcitabin 2.16.840.1.113883.6.73 2017-01 J05AF04 stavudine Stavudin 2.16.840.1.113883.6.73 2017-01 J05AF05 lamivudine Lamivudin 2.16.840.1.113883.6.73 2017-01 J05AF06 abacavir Abakavir 2.16.840.1.113883.6.73 2017-01 J05AF07 tenofovir disoproxil Tenofovirdisoproxil 2.16.840.1.113883.6.73 2017-01 J05AF08 adefovir dipivoxil Adefovir dipivoxil 2.16.840.1.113883.6.73 2017-01 J05AF09 emtricitabine Emtricitabin 2.16.840.1.113883.6.73 2017-01 J05AF10 entecavir Entekavir 2.16.840.1.113883.6.73 2017-01 J05AF11 telbivudine Telbivudin 2.16.840.1.113883.6.73 2017-01 J05AF12 clevudine Klevudin 2.16.840.1.113883.6.73 2017-01 J05AF13 tenofovir alafenamide Tenofoviralafenamid 2.16.840.1.113883.6.73 2017-01 J05AG Non-nucleoside reverse Ickenukleosider, hämmare av transcriptase inhibitors omvänt transkriptas 2.16.840.1.113883.6.73 2017-01 J05AG01 nevirapine Nevirapin 2.16.840.1.113883.6.73 2017-01 J05AG02 delavirdine Delavirdin 2.16.840.1.113883.6.73 2017-01 J05AG03 efavirenz Efavirenz 2.16.840.1.113883.6.73 2017-01 J05AG04 etravirine Etravirin 2.16.840.1.113883.6.73 2017-01 J05AG05 rilpivirine Rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AH Neuraminidase inhibitors Neuraminidashämmare 2.16.840.1.113883.6.73 2017-01 J05AH01 zanamivir Zanamivir 2.16.840.1.113883.6.73 2017-01 J05AH02 oseltamivir Oseltamivir 2.16.840.1.113883.6.73 2017-01 J05AR Antivirals for treatment of HIV Virushämmande medel mot infections, combinations hivinfektioner, kombinationer 2.16.840.1.113883.6.73 2017-01 J05AR01 zidovudine and lamivudine Zidovudin och lamivudin 2.16.840.1.113883.6.73 2017-01 J05AR02 lamivudine and abacavir Lamivudin och abakavir 2.16.840.1.113883.6.73 2017-01 J05AR03 tenofovir disoproxil and Tenofovirdisoproxil och emtricitabin emtricitabine 2.16.840.1.113883.6.73 2017-01 J05AR04 zidovudine, lamivudine and abacavir Zidovudin, lamivudin och abakavir 2.16.840.1.113883.6.73 2017-01 J05AR05 zidovudine, lamivudine and Zidovudin, lamivudin och nevirapin nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR06 emtricitabine, tenofovir disoproxil Emtricitabin, tenofovirdisoproxil och and efavirenz efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR07 stavudine, lamivudine and Stavudin, lamivudin och nevirapin nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR08 emtricitabine, tenofovir disoproxil Emtricitabin, tenofovirdisoproxil och and rilpivirine rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AR09 emtricitabine, tenofovir disoproxil, Emtricitabin, tenofovirdisoproxil, elvitegravir and cobicistat elvitegravir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR10 lopinavir and ritonavir Lopinavir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AR11 lamivudine, tenofovir disoproxil and Lamivudin, tenofovirdisoproxil och efavirenz efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR12 lamivudine and tenofovir disoproxil Lamivudin och tenofovirdisoproxil 2.16.840.1.113883.6.73 2017-01 J05AR13 lamivudine, abacavir and Lamivudin, abakavir och dolutegravir dolutegravir

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 90 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AR14 darunavir and cobicistat Darunavir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR15 atazanavir and cobicistat Atazanavir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR16 lamivudine and raltegravir Lamivudin och raltegravir 2.16.840.1.113883.6.73 2017-01 J05AR17 emtricitabine and tenofovir Emtricitabin och tenofoviralafenamid alafenamide 2.16.840.1.113883.6.73 2017-01 J05AR18 emtricitabine, tenofovir alafenamide, Emtricitabin, tenofoviralafenamid, elvitegravir and cobicistat elvitegravir och kobicistat 2.16.840.1.113883.6.73 2017-01 J05AR19 emtricitabine, tenofovir alafenamide Emtricitabin, tenofoviralafenamid and rilpivirine och rilpivirin 2.16.840.1.113883.6.73 2017-01 J05AX Other antivirals Övriga virushämmande medel 2.16.840.1.113883.6.73 2017-01 J05AX01 moroxydine Moroxydin 2.16.840.1.113883.6.73 2017-01 J05AX02 lysozyme Lysozym 2.16.840.1.113883.6.73 2017-01 J05AX05 inosine pranobex Inosin pranobex 2.16.840.1.113883.6.73 2017-01 J05AX06 pleconaril Plekonaril 2.16.840.1.113883.6.73 2017-01 J05AX07 enfuvirtide Enfuvirtid 2.16.840.1.113883.6.73 2017-01 J05AX08 raltegravir Raltegravir 2.16.840.1.113883.6.73 2017-01 J05AX09 maraviroc Maravirok 2.16.840.1.113883.6.73 2017-01 J05AX10 maribavir Maribavir 2.16.840.1.113883.6.73 2017-01 J05AX11 elvitegravir Elvitegravir 2.16.840.1.113883.6.73 2017-01 J05AX12 dolutegravir Dolutegravir 2.16.840.1.113883.6.73 2017-01 J05AX13 umifenovir Umifenovir 2.16.840.1.113883.6.73 2017-01 J05AX14 daclatasvir Daklatasvir 2.16.840.1.113883.6.73 2017-01 J05AX15 sofosbuvir Sofosbuvir 2.16.840.1.113883.6.73 2017-01 J05AX16 dasabuvir Dasabuvir 2.16.840.1.113883.6.73 2017-01 J05AX65 sofosbuvir and ledipasvir Sofosbuvir och ledipasvir 2.16.840.1.113883.6.73 2017-01 J05AX66 dasabuvir, ombitasvir, paritaprevir Dasabuvir, ombitasvir, paritaprevir and ritonavir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX67 ombitasvir, paritaprevir and ritonavir Ombitasvir, paritaprevir och ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX68 elbasvir and grazoprevir Elbasvir och grazoprevir 2.16.840.1.113883.6.73 2017-01 J06 IMMUNE SERA AND Immunsera och immunglobuliner IMMUNOGLOBULINS 2.16.840.1.113883.6.73 2017-01 J06A IMMUNE SERA Immunsera 2.16.840.1.113883.6.73 2017-01 J06AA Immune sera Immunsera 2.16.840.1.113883.6.73 2017-01 J06AA01 diphtheria antitoxin Difteriantitoxin 2.16.840.1.113883.6.73 2017-01 J06AA02 tetanus antitoxin Stelkrampsantitoxin 2.16.840.1.113883.6.73 2017-01 J06AA03 snake venom antiserum Serum mot ormgift 2.16.840.1.113883.6.73 2017-01 J06AA04 botulinum antitoxin Antitoxin mot botulism 2.16.840.1.113883.6.73 2017-01 J06AA05 gas-gangrene sera Serum mot gasgangrän 2.16.840.1.113883.6.73 2017-01 J06AA06 rabies serum Serum mot rabies 2.16.840.1.113883.6.73 2017-01 J06B IMMUNOGLOBULINS Immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BA Immunoglobulins, normal human Humant, normalt immunglobulin 2.16.840.1.113883.6.73 2017-01 J06BA01 immunoglobulins, normal human, for Humant, normalt immunglobulin för extravascular adm. extravaskulärt bruk 2.16.840.1.113883.6.73 2017-01 J06BA02 immunoglobulins, normal human, for Humant, normalt immunglobulin för intravascular adm. intravaskulärt bruk

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 91 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J06BB Specific immunoglobulins Specifika immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BB01 anti-D (rh) immunoglobulin Immunglobulin mot Rh- immunisering 2.16.840.1.113883.6.73 2017-01 J06BB02 tetanus immunoglobulin Immunglobulin mot stelkramp 2.16.840.1.113883.6.73 2017-01 J06BB03 varicella/zoster immunoglobulin Immunglobulin mot varicella/zoster 2.16.840.1.113883.6.73 2017-01 J06BB04 hepatitis B immunoglobulin Immunglobulin mot hepatit B 2.16.840.1.113883.6.73 2017-01 J06BB05 rabies immunoglobulin Immunglobulin mot rabies 2.16.840.1.113883.6.73 2017-01 J06BB06 rubella immunoglobulin Immunglobulin mot röda hund 2.16.840.1.113883.6.73 2017-01 J06BB07 vaccinia immunoglobulin Immunglobulinvaccin 2.16.840.1.113883.6.73 2017-01 J06BB08 staphylococcus immunoglobulin Immunglobulin mot stafylokocker 2.16.840.1.113883.6.73 2017-01 J06BB09 cytomegalovirus immunoglobulin Immunglobulin mot cytomegalovirus-infektion 2.16.840.1.113883.6.73 2017-01 J06BB10 diphtheria immunoglobulin Immunglobulin mot difteri 2.16.840.1.113883.6.73 2017-01 J06BB11 hepatitis A immunoglobulin Immunglobulin mot hepatit A 2.16.840.1.113883.6.73 2017-01 J06BB12 encephalitis, tick borne Immunglobulin mot encefalit, immunoglobulin fästingburet 2.16.840.1.113883.6.73 2017-01 J06BB13 pertussis immunoglobulin Immunglobulin mot kikhosta 2.16.840.1.113883.6.73 2017-01 J06BB14 measles immunoglobulin Immunglobulin mot mässling 2.16.840.1.113883.6.73 2017-01 J06BB15 mumps immunoglobulin Immunglobulin mot påssjuka 2.16.840.1.113883.6.73 2017-01 J06BB16 palivizumab Palivizumab 2.16.840.1.113883.6.73 2017-01 J06BB17 motavizumab Motavizumab 2.16.840.1.113883.6.73 2017-01 J06BB18 raxibacumab Raxibakumab 2.16.840.1.113883.6.73 2017-01 J06BB19 anthrax immunoglobulin Immunglobulin mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J06BB21 bezlotoxumab Bezlotoxumab 2.16.840.1.113883.6.73 2017-01 J06BB30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J06BC Other immunoglobulins Övriga immunglobuliner 2.16.840.1.113883.6.73 2017-01 J06BC01 nebacumab Nebakumab 2.16.840.1.113883.6.73 2017-01 J07 VACCINES Vacciner 2.16.840.1.113883.6.73 2017-01 J07A BACTERIAL VACCINES Vacciner mot bakteriella infektioner 2.16.840.1.113883.6.73 2017-01 J07AC Anthrax vaccines Vaccin mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J07AC01 anthrax antigen Antigen mot mjältbrand 2.16.840.1.113883.6.73 2017-01 J07AD Brucellosis vaccines Vaccin mot brucella 2.16.840.1.113883.6.73 2017-01 J07AD01 brucella antigen Antigen mot brucella 2.16.840.1.113883.6.73 2017-01 J07AE Cholera vaccines Vaccin mot kolera 2.16.840.1.113883.6.73 2017-01 J07AE01 cholera, inactivated, whole cell Vaccin mot kolera, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AE02 cholera, live attenuated Vaccin mot kolera, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AE51 cholera, combinations with typhoid Vaccin mot kolera, kombinationer vaccine, inactivated, whole cell med vaccin mot tyfoid, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AF Diphtheria vaccines Vaccin mot difteri 2.16.840.1.113883.6.73 2017-01 J07AF01 diphtheria toxoid Difteritoxoid 2.16.840.1.113883.6.73 2017-01 J07AG Hemophilus influenzae B vaccines Vaccin mot haemophilus influenzae B

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 92 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AG01 hemophilus influenzae B, purified Vaccin mot haemophilus influenzae antigen conjugated B, konjugerat renat antigen 2.16.840.1.113883.6.73 2017-01 J07AG51 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with toxoids B i kombination med toxoider 2.16.840.1.113883.6.73 2017-01 J07AG52 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with pertussis and B, i kombination med kikhosta och toxoids toxoider 2.16.840.1.113883.6.73 2017-01 J07AG53 hemophilus influenzae B, Vaccin mot haemophilus influenzae combinations with meningococcus B, i kombination med C, conjugated meningococcus C, konjugerad 2.16.840.1.113883.6.73 2017-01 J07AH Meningococcal vaccines Vaccin mot meningokockinfektioner 2.16.840.1.113883.6.73 2017-01 J07AH01 meningococcus A, purified Vaccin mot meningokockinfektion polysaccharides antigen typ A, renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH02 other meningococcal monovalent Vaccin mot meningokockinfektioner, purified polysaccharides antigen övriga monovalenta renade polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH03 meningococcus A,C, bivalent Vaccin mot meningokockinfektioner purified polysaccharides antigen A,C, bivalent renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH04 meningococcus A,C,Y,W-135, Vaccin mot meningokockinfektioner tetravalent purified polysaccharides A,C,Y,W-135, tetravalent renat antigen polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH05 other meningococcal polyvalent Vaccin mot meningokockinfektioner, purified polysaccharides antigen övriga polyvalenta renade polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH06 meningococcus B, outer membrane Vaccin mot meningokockinfektion vesicle vaccine typ B, yttermembranvesikel 2.16.840.1.113883.6.73 2017-01 J07AH07 meningococcus C, purified Vaccin mot meningokockinfektion polysaccharides antigen conjugated typ C, konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH08 meningococcus A,C,Y,W-135, Vaccin mot meningokockinfektioner tetravalent purified polysaccharides A,C,Y,W-135, tetravalent konjugerat antigen conjugated renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AH09 meningococcus B, multicomponent Vaccin mot meningokockinfektion vaccine typ B, multikomponent vaccin 2.16.840.1.113883.6.73 2017-01 J07AH10 meningococcus A, purified Vaccin mot meningokockinfektion polysaccharides antigen conjugated typ A, konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AJ Pertussis vaccines Vaccin mot kikhosta 2.16.840.1.113883.6.73 2017-01 J07AJ01 pertussis, inactivated, whole cell Vaccin mot kikhosta, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AJ02 pertussis, purified antigen Vaccin mot kikhosta, renat antigen 2.16.840.1.113883.6.73 2017-01 J07AJ51 pertussis, inactivated, whole cell, Vaccin mot kikhosta, inaktiverat combinations with toxoids helcellsvaccin, kombinationer med toxoider 2.16.840.1.113883.6.73 2017-01 J07AJ52 pertussis, purified antigen, Vaccin mot kikhosta, renat antigen, combinations with toxoids kombinationer med toxoider 2.16.840.1.113883.6.73 2017-01 J07AK Plague vaccines Vaccin mot pest 2.16.840.1.113883.6.73 2017-01 J07AK01 plague, inactivated, whole cell Vaccin mot pest, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AL Pneumococcal vaccines Vaccin mot pneumokockinfektioner 2.16.840.1.113883.6.73 2017-01 J07AL01 pneumococcus, purified Vaccin mot pneumokockinfektioner, polysaccharides antigen renade polysackaridantigener

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 93 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AL02 pneumococcus, purified Vaccin mot pneumokockinfektioner, polysaccharides antigen conjugated konjugerat renat polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AL52 pneumococcus purified Vaccin mot pneumokockinfektioner, polysaccharides antigen and renade polysackaridantigener och haemophilus influenzae, conjugated Haemophilus influenzae, konjugerat 2.16.840.1.113883.6.73 2017-01 J07AM Tetanus vaccines Vaccin mot stelkramp 2.16.840.1.113883.6.73 2017-01 J07AM01 tetanus toxoid Stelkrampstoxoid 2.16.840.1.113883.6.73 2017-01 J07AM51 tetanus toxoid, combinations with Stelkrampstoxoid, kombinationer diphtheria toxoid med difteritoxoid 2.16.840.1.113883.6.73 2017-01 J07AM52 tetanus toxoid, combinations with Stelkrampstoxoid, kombinationer tetanus immunoglobulin med stelkrampsimmunglobulin 2.16.840.1.113883.6.73 2017-01 J07AN Tuberculosis vaccines Vaccin mot tuberkulos 2.16.840.1.113883.6.73 2017-01 J07AN01 tuberculosis, live attenuated Vaccin mot tuberkulos, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AP Typhoid vaccines Vaccin mot tyfoid 2.16.840.1.113883.6.73 2017-01 J07AP01 typhoid, oral, live attenuated Vaccin mot tyfoid, oralt, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07AP02 typhoid, inactivated, whole cell Vaccin mot tyfoid, inaktiverat helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AP03 typhoid, purified polysaccharide Vaccin mot tyfoid, renat antigen polysackaridantigen 2.16.840.1.113883.6.73 2017-01 J07AP10 typhoid, combinations with paratyphi Vaccin mot tyfoid, kombinationer types med paratyfityper 2.16.840.1.113883.6.73 2017-01 J07AR Typhus (exanthematicus) vaccines Vaccin mot fläcktyfus 2.16.840.1.113883.6.73 2017-01 J07AR01 typhus exanthematicus, inactivated, Vaccin mot fläcktyfus, inaktiverat whole cell helcellsvaccin 2.16.840.1.113883.6.73 2017-01 J07AX Other bacterial vaccines Övriga bakteriella vacciner 2.16.840.1.113883.6.73 2017-01 J07B VIRAL VACCINES Vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07BA Encephalitis vaccines Vaccin mot encefalit 2.16.840.1.113883.6.73 2017-01 J07BA01 encephalitis, tick borne, inactivated, Vaccin mot fästingburen encefalit, whole virus inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BA02 encephalitis, Japanese, inactivated, Vaccin mot japansk encefalit, whole virus inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BA03 encephalitis, Japanese, live Vaccin mot japansk encefalit, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BB Influenza vaccines Vaccin mot influensa 2.16.840.1.113883.6.73 2017-01 J07BB01 influenza, inactivated, whole virus Vaccin mot influensa, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BB02 influenza, inactivated, split virus or Vaccin mot influensa, inaktiverat, surface antigen spjälkat virus eller ytantigen 2.16.840.1.113883.6.73 2017-01 J07BB03 influenza, live attenuated Vaccin mot influensa, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BC Hepatitis vaccines Vaccin mot hepatit 2.16.840.1.113883.6.73 2017-01 J07BC01 hepatitis B, purified antigen Vaccin mot hepatit B, renat antigen 2.16.840.1.113883.6.73 2017-01 J07BC02 hepatitis A, inactivated, whole virus Vaccin mot hepatit A, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BC20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 J07BD Measles vaccines Vaccin mot mässling

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 94 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07BD01 measles, live attenuated Vaccin mot mässling, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD51 measles, combinations with mumps, Vaccin mot mässling och påssjuka, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD52 measles, combinations with mumps Vaccin mot mässling, påssjuka och and rubella, live attenuated röda hund, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD53 measles, combinations with rubella, Vaccin mot mässling och röda hund, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BD54 measles, combinations with mumps, Vaccin mot mässling, påssjuka, rubella and varicella, live attenuated röda hund och vattkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BE Mumps vaccines Vaccin mot påssjuka 2.16.840.1.113883.6.73 2017-01 J07BE01 mumps, live attenuated Vaccin mot påssjuka, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF Poliomyelitis vaccines Vaccin mot polio 2.16.840.1.113883.6.73 2017-01 J07BF01 poliomyelitis oral, monovalent, live Vaccin mot polio, oralt, monovalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF02 poliomyelitis oral, trivalent, live Vaccin mot polio, oralt, trivalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BF03 poliomyelitis, trivalent, inactivated, Vaccin mot polio, trivalent, whole virus inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BF04 poliomyelitis oral, bivalent, live Vaccin mot polio, oralt, bivalent, attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BG Rabies vaccines Vaccin mot rabies 2.16.840.1.113883.6.73 2017-01 J07BG01 rabies, inactivated, whole virus Vaccin mot rabies, inaktiverat helvirusvaccin 2.16.840.1.113883.6.73 2017-01 J07BH Rota virus diarrhea vaccines Vaccin mot rotavirusdiarré 2.16.840.1.113883.6.73 2017-01 J07BH01 rota virus, live attenuated Vaccin mot rotavirus, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BH02 rota virus, pentavalent, live, Vaccin mot rotavirus, pentavalent, reassorted levande, reassortant 2.16.840.1.113883.6.73 2017-01 J07BJ Rubella vaccines Vaccin mot röda hund 2.16.840.1.113883.6.73 2017-01 J07BJ01 rubella, live attenuated Vaccin mot röda hund, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BJ51 rubella, combinations with mumps, Vaccin mot röda hund och påssjuka, live attenuated levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BK Varicella zoster vaccines Varicella zoster vacciner 2.16.840.1.113883.6.73 2017-01 J07BK01 varicella, live attenuated Vaccin mot vattkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BK02 zoster, live attenuated Vaccin mot bältros, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BL Yellow fever vaccines Vaccin mot gula febern 2.16.840.1.113883.6.73 2017-01 J07BL01 yellow fever, live attenuated Vaccin mot gula febern, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07BM Papillomavirus vaccines Papillomvirusvacciner 2.16.840.1.113883.6.73 2017-01 J07BM01 papillomavirus (human types 6, 11, Papillomvirus (humant, typ 6, 11, 16, 18) 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM02 papillomavirus (human types 16, 18) Papillomvirus (humant, typ 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM03 papillomavirus (human types 6, 11, Papillomvirus (humant, typ 6, 11, 16, 18, 31, 33, 45, 52, 58) 16, 18, 31, 33, 45, 52, 58)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 95 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07BX Other viral vaccines Övriga vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07BX01 smallpox, live attenuated Vaccin mot smittkoppor, levande försvagat 2.16.840.1.113883.6.73 2017-01 J07C BACTERIAL AND VIRAL Vacciner mot bakteriella infektioner i VACCINES, COMBINED kombination med vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07CA Bacterial and viral vaccines, Vacciner mot bakteriella infektioner i combined kombination med vacciner mot virusinfektioner 2.16.840.1.113883.6.73 2017-01 J07CA01 diphtheria-poliomyelitis-tetanus Vaccin mot difteri, polio och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA02 diphtheria-pertussis-poliomyelitis- Vaccin mot difteri, kikhosta, polio tetanus och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA03 diphtheria-rubella-tetanus Vaccin mot difteri, röda hund och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA04 hemophilus influenzae B and Vaccin mot haemophilus influenzae poliomyelitis B och polio 2.16.840.1.113883.6.73 2017-01 J07CA05 diphtheria-hepatitis B-pertussis- Vaccin mot difteri, hepatit B, tetanus kikhosta och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA06 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-poliomyelitis-tetanus influenzae B, kikhosta, polio och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA07 diphtheria-hepatitis B-tetanus Vaccin mot difteri, hepatit B och stelkramp 2.16.840.1.113883.6.73 2017-01 J07CA08 hemophilus influenzae B and Vaccin mot haemophilus influenzae hepatitis B B och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA09 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-poliomyelitis-tetanus- influenzae B, kikhosta, polio, hepatitis B stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA10 typhoid-hepatitis A Vaccin mot tyfoid och hepatit A 2.16.840.1.113883.6.73 2017-01 J07CA11 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-tetanus-hepatitis B influnzae B, kikhosta, stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA12 diphtheria-pertussis-poliomyelitis- Vaccin mot difteri, kikhosta, polio, tetanus-hepatitis B stelkramp och hepatit B 2.16.840.1.113883.6.73 2017-01 J07CA13 diphtheria-hemophilus influenzae B- Vaccin mot difteri, haemophilus pertussis-tetanus-hepatitis B- influenzae B, kikhosta, stelkramp, meningococcus A + C hepatit B och meningococcus A + C 2.16.840.1.113883.6.73 2017-01 J07X OTHER VACCINES Övriga vacciner 2.16.840.1.113883.6.73 2017-01 L ANTINEOPLASTIC AND Tumörer och rubbningar i IMMUNOMODULATING AGENTS immunsystemet 2.16.840.1.113883.6.73 2017-01 L01 ANTINEOPLASTIC AGENTS Antineoplastiska medel 2.16.840.1.113883.6.73 2017-01 L01A ALKYLATING AGENTS Alkylerande medel 2.16.840.1.113883.6.73 2017-01 L01AA Nitrogen mustard analogues Kvävesenapsgasanaloger 2.16.840.1.113883.6.73 2017-01 L01AA01 cyclophosphamide Cyklofosfamid 2.16.840.1.113883.6.73 2017-01 L01AA02 chlorambucil Klorambucil 2.16.840.1.113883.6.73 2017-01 L01AA03 melphalan Melfalan 2.16.840.1.113883.6.73 2017-01 L01AA05 chlormethine Klormetin 2.16.840.1.113883.6.73 2017-01 L01AA06 ifosfamide Ifosfamid 2.16.840.1.113883.6.73 2017-01 L01AA07 trofosfamide Trofosfamid 2.16.840.1.113883.6.73 2017-01 L01AA08 prednimustine Prednimustin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 96 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01AA09 bendamustine Bendamustin 2.16.840.1.113883.6.73 2017-01 L01AB Alkyl sulfonates Alkylsulfonater 2.16.840.1.113883.6.73 2017-01 L01AB01 busulfan Busulfan 2.16.840.1.113883.6.73 2017-01 L01AB02 treosulfan Treosulfan 2.16.840.1.113883.6.73 2017-01 L01AB03 mannosulfan Mannosulfan 2.16.840.1.113883.6.73 2017-01 L01AC Ethylene imines Aziridiner 2.16.840.1.113883.6.73 2017-01 L01AC01 thiotepa Tiotepa 2.16.840.1.113883.6.73 2017-01 L01AC02 triaziquone Triazikvon 2.16.840.1.113883.6.73 2017-01 L01AC03 carboquone Karbokvon 2.16.840.1.113883.6.73 2017-01 L01AD Nitrosoureas Nitrosureaföreningar 2.16.840.1.113883.6.73 2017-01 L01AD01 carmustine Karmustin 2.16.840.1.113883.6.73 2017-01 L01AD02 lomustine Lomustin 2.16.840.1.113883.6.73 2017-01 L01AD03 semustine Semustin 2.16.840.1.113883.6.73 2017-01 L01AD04 streptozocin Streptozocin 2.16.840.1.113883.6.73 2017-01 L01AD05 fotemustine Fotemustin 2.16.840.1.113883.6.73 2017-01 L01AD06 nimustine Nimustin 2.16.840.1.113883.6.73 2017-01 L01AD07 ranimustine Ranimustin 2.16.840.1.113883.6.73 2017-01 L01AG Epoxides Epoxider 2.16.840.1.113883.6.73 2017-01 L01AG01 etoglucid Etoglucid 2.16.840.1.113883.6.73 2017-01 L01AX Other alkylating agents Övriga alkylerande medel 2.16.840.1.113883.6.73 2017-01 L01AX01 mitobronitol Mitobronitol 2.16.840.1.113883.6.73 2017-01 L01AX02 pipobroman Pipobroman 2.16.840.1.113883.6.73 2017-01 L01AX03 temozolomide Temozolomid 2.16.840.1.113883.6.73 2017-01 L01AX04 dacarbazine Dakarbazin 2.16.840.1.113883.6.73 2017-01 L01B ANTIMETABOLITES Antimetaboliter 2.16.840.1.113883.6.73 2017-01 L01BA Folic acid analogues Folsyraanaloger 2.16.840.1.113883.6.73 2017-01 L01BA01 methotrexate Metotrexat 2.16.840.1.113883.6.73 2017-01 L01BA03 raltitrexed Raltitrexed 2.16.840.1.113883.6.73 2017-01 L01BA04 pemetrexed Pemetrexed 2.16.840.1.113883.6.73 2017-01 L01BA05 pralatrexate Pralatrexat 2.16.840.1.113883.6.73 2017-01 L01BB Purine analogues Purinanaloger 2.16.840.1.113883.6.73 2017-01 L01BB02 mercaptopurine Merkaptopurin 2.16.840.1.113883.6.73 2017-01 L01BB03 tioguanine Tioguanin 2.16.840.1.113883.6.73 2017-01 L01BB04 cladribine Kladribin 2.16.840.1.113883.6.73 2017-01 L01BB05 fludarabine Fludarabin 2.16.840.1.113883.6.73 2017-01 L01BB06 clofarabine Klofarabin 2.16.840.1.113883.6.73 2017-01 L01BB07 nelarabine Nelarabin 2.16.840.1.113883.6.73 2017-01 L01BC Pyrimidine analogues Pyrimidinanaloger 2.16.840.1.113883.6.73 2017-01 L01BC01 cytarabine Cytarabin 2.16.840.1.113883.6.73 2017-01 L01BC02 fluorouracil Fluorouracil 2.16.840.1.113883.6.73 2017-01 L01BC03 tegafur Tegafur 2.16.840.1.113883.6.73 2017-01 L01BC04 carmofur Karmofur 2.16.840.1.113883.6.73 2017-01 L01BC05 gemcitabine Gemcitabin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 97 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01BC06 capecitabine Kapecitabin 2.16.840.1.113883.6.73 2017-01 L01BC07 azacitidine Azacitidin 2.16.840.1.113883.6.73 2017-01 L01BC08 decitabine Decitabin 2.16.840.1.113883.6.73 2017-01 L01BC52 fluorouracil, combinations Fluorouracil, kombinationer 2.16.840.1.113883.6.73 2017-01 L01BC53 tegafur, combinations Tegafur, kombinationer 2.16.840.1.113883.6.73 2017-01 L01BC59 trifluridine, combinations Trifluridin, kombinationer 2.16.840.1.113883.6.73 2017-01 L01C PLANT ALKALOIDS AND OTHER Växtalkaloider och andra NATURAL PRODUCTS naturprodukter 2.16.840.1.113883.6.73 2017-01 L01CA Vinca alkaloids and analogues Vinca-alkaloider och analoger 2.16.840.1.113883.6.73 2017-01 L01CA01 vinblastine Vinblastin 2.16.840.1.113883.6.73 2017-01 L01CA02 vincristine Vinkristin 2.16.840.1.113883.6.73 2017-01 L01CA03 vindesine Vindesin 2.16.840.1.113883.6.73 2017-01 L01CA04 vinorelbine Vinorelbin 2.16.840.1.113883.6.73 2017-01 L01CA05 vinflunine Vinflunin 2.16.840.1.113883.6.73 2017-01 L01CA06 vintafolide Vintafolid 2.16.840.1.113883.6.73 2017-01 L01CB Podophyllotoxin derivatives Podofyllotoxinderivat 2.16.840.1.113883.6.73 2017-01 L01CB01 etoposide Etoposid 2.16.840.1.113883.6.73 2017-01 L01CB02 teniposide Teniposid 2.16.840.1.113883.6.73 2017-01 L01CC Colchicine derivatives Kolkicinderivat 2.16.840.1.113883.6.73 2017-01 L01CC01 demecolcine Demekolcin 2.16.840.1.113883.6.73 2017-01 L01CD Taxanes Taxaner 2.16.840.1.113883.6.73 2017-01 L01CD01 paclitaxel Paklitaxel 2.16.840.1.113883.6.73 2017-01 L01CD02 docetaxel Docetaxel 2.16.840.1.113883.6.73 2017-01 L01CD03 paclitaxel poliglumex Paklitaxelpoliglumex 2.16.840.1.113883.6.73 2017-01 L01CD04 cabazitaxel Kabazitaxel 2.16.840.1.113883.6.73 2017-01 L01CX Other plant alkaloids and natural Övriga växtalkaloider och products naturprodukter 2.16.840.1.113883.6.73 2017-01 L01CX01 trabectedin Trabektedin 2.16.840.1.113883.6.73 2017-01 L01D CYTOTOXIC ANTIBIOTICS AND Cytotoxiska antibiotika och RELATED SUBSTANCES närbesläktade substanser 2.16.840.1.113883.6.73 2017-01 L01DA Actinomycines Aktinomyciner 2.16.840.1.113883.6.73 2017-01 L01DA01 dactinomycin Daktinomycin 2.16.840.1.113883.6.73 2017-01 L01DB Anthracyclines and related Antracykliner och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 L01DB01 doxorubicin Doxorubicin 2.16.840.1.113883.6.73 2017-01 L01DB02 daunorubicin Daunorubicin 2.16.840.1.113883.6.73 2017-01 L01DB03 epirubicin Epirubicin 2.16.840.1.113883.6.73 2017-01 L01DB04 aclarubicin Aklarubicin 2.16.840.1.113883.6.73 2017-01 L01DB05 zorubicin Zorubicin 2.16.840.1.113883.6.73 2017-01 L01DB06 idarubicin Idarubicin 2.16.840.1.113883.6.73 2017-01 L01DB07 mitoxantrone Mitoxantron 2.16.840.1.113883.6.73 2017-01 L01DB08 pirarubicin Pirarubicin 2.16.840.1.113883.6.73 2017-01 L01DB09 valrubicin Valrubicin 2.16.840.1.113883.6.73 2017-01 L01DB10 amrubicin Amrubicin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 98 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01DB11 pixantrone Pixantron 2.16.840.1.113883.6.73 2017-01 L01DC Other cytotoxic antibiotics Övriga cytotoxiska antibiotika 2.16.840.1.113883.6.73 2017-01 L01DC01 bleomycin Bleomycin 2.16.840.1.113883.6.73 2017-01 L01DC02 plicamycin Plikamycin 2.16.840.1.113883.6.73 2017-01 L01DC03 mitomycin Mitomycin 2.16.840.1.113883.6.73 2017-01 L01DC04 ixabepilone Ixabepilon 2.16.840.1.113883.6.73 2017-01 L01X OTHER ANTINEOPLASTIC Övriga antineoplastiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 L01XA Platinum compounds Platinaföreningar 2.16.840.1.113883.6.73 2017-01 L01XA01 cisplatin Cisplatin 2.16.840.1.113883.6.73 2017-01 L01XA02 carboplatin Karboplatin 2.16.840.1.113883.6.73 2017-01 L01XA03 oxaliplatin Oxaliplatin 2.16.840.1.113883.6.73 2017-01 L01XA04 satraplatin Satraplatin 2.16.840.1.113883.6.73 2017-01 L01XA05 polyplatillen Polyplatillen 2.16.840.1.113883.6.73 2017-01 L01XB Methylhydrazines Metylhydraziner 2.16.840.1.113883.6.73 2017-01 L01XB01 procarbazine Prokarbazin 2.16.840.1.113883.6.73 2017-01 L01XC Monoclonal antibodies Monoklonala antikroppar 2.16.840.1.113883.6.73 2017-01 L01XC01 edrecolomab Edrekolomab 2.16.840.1.113883.6.73 2017-01 L01XC02 rituximab Rituximab 2.16.840.1.113883.6.73 2017-01 L01XC03 trastuzumab Trastuzumab 2.16.840.1.113883.6.73 2017-01 L01XC05 gemtuzumab Gemtuzumabozogamicin 2.16.840.1.113883.6.73 2017-01 L01XC06 cetuximab Cetuximab 2.16.840.1.113883.6.73 2017-01 L01XC07 bevacizumab Bevacizumab 2.16.840.1.113883.6.73 2017-01 L01XC08 panitumumab Panitumumab 2.16.840.1.113883.6.73 2017-01 L01XC09 catumaxomab Katumaxomab 2.16.840.1.113883.6.73 2017-01 L01XC10 ofatumumab Ofatumumab 2.16.840.1.113883.6.73 2017-01 L01XC11 ipilimumab Ipilimumab 2.16.840.1.113883.6.73 2017-01 L01XC12 brentuximab vedotin Brentuximab vedotin 2.16.840.1.113883.6.73 2017-01 L01XC13 pertuzumab Pertuzumab 2.16.840.1.113883.6.73 2017-01 L01XC14 trastuzumab emtansine Trastuzumabemtansin 2.16.840.1.113883.6.73 2017-01 L01XC15 obinutuzumab Obinutuzumab 2.16.840.1.113883.6.73 2017-01 L01XC16 dinutuximab Dinutuximab beta 2.16.840.1.113883.6.73 2017-01 L01XC17 nivolumab Nivolumab 2.16.840.1.113883.6.73 2017-01 L01XC18 pembrolizumab Pembrolizumab 2.16.840.1.113883.6.73 2017-01 L01XC19 blinatumomab Blinatumomab 2.16.840.1.113883.6.73 2017-01 L01XC21 ramucirumab Ramucirumab 2.16.840.1.113883.6.73 2017-01 L01XC22 necitumumab Necitumumab 2.16.840.1.113883.6.73 2017-01 L01XC23 elotuzumab Elotuzumab 2.16.840.1.113883.6.73 2017-01 L01XC24 daratumumab Daratumumab 2.16.840.1.113883.6.73 2017-01 L01XC25 mogamulizumab Mogamulizumab 2.16.840.1.113883.6.73 2017-01 L01XC26 inotuzumab ozogamicin Inotuzumabozogamicin 2.16.840.1.113883.6.73 2017-01 L01XD Sensitizers used in Sensibiliserande ämnen för photodynamic/radiation therapy strålning/fotodynamisk behandling 2.16.840.1.113883.6.73 2017-01 L01XD01 porfimer sodium Porfimernatrium © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 99 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XD03 methyl aminolevulinate Metylaminolevulinat 2.16.840.1.113883.6.73 2017-01 L01XD04 aminolevulinic acid Aminolevulinsyra 2.16.840.1.113883.6.73 2017-01 L01XD05 temoporfin Temoporfin 2.16.840.1.113883.6.73 2017-01 L01XD06 efaproxiral Efaproxiral 2.16.840.1.113883.6.73 2017-01 L01XE Protein kinase inhibitors Proteinkinashämmare 2.16.840.1.113883.6.73 2017-01 L01XE01 imatinib Imatinib 2.16.840.1.113883.6.73 2017-01 L01XE02 gefitinib Gefitinib 2.16.840.1.113883.6.73 2017-01 L01XE03 erlotinib Erlotinib 2.16.840.1.113883.6.73 2017-01 L01XE04 sunitinib Sunitinib 2.16.840.1.113883.6.73 2017-01 L01XE05 sorafenib Sorafenib 2.16.840.1.113883.6.73 2017-01 L01XE06 dasatinib Dasatinib 2.16.840.1.113883.6.73 2017-01 L01XE07 lapatinib Lapatinib 2.16.840.1.113883.6.73 2017-01 L01XE08 nilotinib Nilotinib 2.16.840.1.113883.6.73 2017-01 L01XE09 temsirolimus Temsirolimus 2.16.840.1.113883.6.73 2017-01 L01XE10 everolimus Everolimus 2.16.840.1.113883.6.73 2017-01 L01XE11 pazopanib Pazopanib 2.16.840.1.113883.6.73 2017-01 L01XE12 vandetanib Vandetanib 2.16.840.1.113883.6.73 2017-01 L01XE13 afatinib Afatinib 2.16.840.1.113883.6.73 2017-01 L01XE14 bosutinib Bosutinib 2.16.840.1.113883.6.73 2017-01 L01XE15 vemurafenib Vemurafenib 2.16.840.1.113883.6.73 2017-01 L01XE16 crizotinib Krizotinib 2.16.840.1.113883.6.73 2017-01 L01XE17 axitinib Axitinib 2.16.840.1.113883.6.73 2017-01 L01XE18 ruxolitinib Ruxolitinib 2.16.840.1.113883.6.73 2017-01 L01XE19 ridaforolimus Ridaforolimus 2.16.840.1.113883.6.73 2017-01 L01XE21 regorafenib Regorafenib 2.16.840.1.113883.6.73 2017-01 L01XE22 masitinib Masitinib 2.16.840.1.113883.6.73 2017-01 L01XE23 dabrafenib Dabrafenib 2.16.840.1.113883.6.73 2017-01 L01XE24 ponatinib Ponatinib 2.16.840.1.113883.6.73 2017-01 L01XE25 trametinib Trametinib 2.16.840.1.113883.6.73 2017-01 L01XE26 cabozantinib Kabozantinib 2.16.840.1.113883.6.73 2017-01 L01XE27 ibrutinib Ibrutinib 2.16.840.1.113883.6.73 2017-01 L01XE28 ceritinib Ceritinib 2.16.840.1.113883.6.73 2017-01 L01XE29 lenvatinib Lenvatinib 2.16.840.1.113883.6.73 2017-01 L01XE31 nintedanib Nintedanib 2.16.840.1.113883.6.73 2017-01 L01XE32 cediranib Cediranib 2.16.840.1.113883.6.73 2017-01 L01XE33 palbociclib Palbociklib 2.16.840.1.113883.6.73 2017-01 L01XE34 tivozanib Tivozanib 2.16.840.1.113883.6.73 2017-01 L01XE35 osimertinib Osimertinib 2.16.840.1.113883.6.73 2017-01 L01XE36 alectinib Alektinib 2.16.840.1.113883.6.73 2017-01 L01XE37 rociletinib Rociletinib 2.16.840.1.113883.6.73 2017-01 L01XE38 cobimetinib Kobimetinib 2.16.840.1.113883.6.73 2017-01 L01XE39 midostaurin Midostaurin 2.16.840.1.113883.6.73 2017-01 L01XE40 olmutinib Olmutinib © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 100 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XX Other antineoplastic agents Övriga antineoplastiska medel 2.16.840.1.113883.6.73 2017-01 L01XX01 amsacrine Amsakrin 2.16.840.1.113883.6.73 2017-01 L01XX02 asparaginase Asparginas 2.16.840.1.113883.6.73 2017-01 L01XX03 altretamine Altretamin 2.16.840.1.113883.6.73 2017-01 L01XX05 hydroxycarbamide Hydroxikarbamid 2.16.840.1.113883.6.73 2017-01 L01XX07 lonidamine Lonidamin 2.16.840.1.113883.6.73 2017-01 L01XX08 pentostatin Pentostatin 2.16.840.1.113883.6.73 2017-01 L01XX09 miltefosine Miltefosin 2.16.840.1.113883.6.73 2017-01 L01XX10 masoprocol Masoprokol 2.16.840.1.113883.6.73 2017-01 L01XX11 estramustine Estramustin 2.16.840.1.113883.6.73 2017-01 L01XX14 tretinoin Tretinoin 2.16.840.1.113883.6.73 2017-01 L01XX16 mitoguazone Mitoguazon 2.16.840.1.113883.6.73 2017-01 L01XX17 topotecan Topotekan 2.16.840.1.113883.6.73 2017-01 L01XX18 tiazofurine Tiazofurin 2.16.840.1.113883.6.73 2017-01 L01XX19 irinotecan Irinotekan 2.16.840.1.113883.6.73 2017-01 L01XX22 alitretinoin Alitretinoin 2.16.840.1.113883.6.73 2017-01 L01XX23 mitotane Mitotan 2.16.840.1.113883.6.73 2017-01 L01XX24 pegaspargase Pegaspargas 2.16.840.1.113883.6.73 2017-01 L01XX25 bexarotene Bexaroten 2.16.840.1.113883.6.73 2017-01 L01XX27 arsenic trioxide Arseniktrioxid 2.16.840.1.113883.6.73 2017-01 L01XX29 denileukin diftitox Denileukin diftitox 2.16.840.1.113883.6.73 2017-01 L01XX32 bortezomib Bortezomib 2.16.840.1.113883.6.73 2017-01 L01XX33 celecoxib Celecoxib 2.16.840.1.113883.6.73 2017-01 L01XX35 anagrelide Anagrelid 2.16.840.1.113883.6.73 2017-01 L01XX36 oblimersen Oblimersen 2.16.840.1.113883.6.73 2017-01 L01XX37 sitimagene ceradenovec Sitimagen-ceradenovek 2.16.840.1.113883.6.73 2017-01 L01XX38 vorinostat Vorinostat 2.16.840.1.113883.6.73 2017-01 L01XX39 romidepsin Romidepsin 2.16.840.1.113883.6.73 2017-01 L01XX40 omacetaxine mepesuccinate Omacetaxinmepesuccinat 2.16.840.1.113883.6.73 2017-01 L01XX41 eribulin Eribulin 2.16.840.1.113883.6.73 2017-01 L01XX42 panobinostat Panobinostat 2.16.840.1.113883.6.73 2017-01 L01XX43 vismodegib Vismodegib 2.16.840.1.113883.6.73 2017-01 L01XX44 aflibercept Aflibercept 2.16.840.1.113883.6.73 2017-01 L01XX45 carfilzomib Karfilzomib 2.16.840.1.113883.6.73 2017-01 L01XX46 olaparib Olaparib 2.16.840.1.113883.6.73 2017-01 L01XX47 idelalisib Idelalisib 2.16.840.1.113883.6.73 2017-01 L01XX48 sonidegib Sonidegib 2.16.840.1.113883.6.73 2017-01 L01XX49 belinostat Belinostat 2.16.840.1.113883.6.73 2017-01 L01XX50 ixazomib Ixazomib 2.16.840.1.113883.6.73 2017-01 L01XX51 talimogene laherparepvec Talimogen-laherparepvek 2.16.840.1.113883.6.73 2017-01 L01XX52 venetoclax Venetoklax 2.16.840.1.113883.6.73 2017-01 L01XX53 vosaroxin Vosaroxin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 101 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XY Combinations of antineoplastic Kombinationer av antineoplastiska agents medel 2.16.840.1.113883.6.73 2017-01 L02 ENDOCRINE THERAPY Endokrinterapi 2.16.840.1.113883.6.73 2017-01 L02A HORMONES AND RELATED Hormoner AGENTS 2.16.840.1.113883.6.73 2017-01 L02AA Estrogens Östrogener 2.16.840.1.113883.6.73 2017-01 L02AA01 diethylstilbestrol Dietylstilbestrol 2.16.840.1.113883.6.73 2017-01 L02AA02 polyestradiol phosphate Polyöstradiolfosfat 2.16.840.1.113883.6.73 2017-01 L02AA03 ethinylestradiol Etinylestradiol 2.16.840.1.113883.6.73 2017-01 L02AA04 fosfestrol Fosfestrol 2.16.840.1.113883.6.73 2017-01 L02AB Progestogens Gestagener 2.16.840.1.113883.6.73 2017-01 L02AB01 megestrol Megestrol 2.16.840.1.113883.6.73 2017-01 L02AB02 medroxyprogesterone Medroxiprogesteron 2.16.840.1.113883.6.73 2017-01 L02AB03 gestonorone Gestonoron 2.16.840.1.113883.6.73 2017-01 L02AE Gonadotropin releasing hormone Gonadotropinfrisättande analogues hormonanaloger 2.16.840.1.113883.6.73 2017-01 L02AE01 buserelin Buserelin 2.16.840.1.113883.6.73 2017-01 L02AE02 leuprorelin Leuprorelin 2.16.840.1.113883.6.73 2017-01 L02AE03 goserelin Goserelin 2.16.840.1.113883.6.73 2017-01 L02AE04 triptorelin Triptorelin 2.16.840.1.113883.6.73 2017-01 L02AE05 histrelin Histrelin 2.16.840.1.113883.6.73 2017-01 L02AX Other hormones Övriga hormoner 2.16.840.1.113883.6.73 2017-01 L02B HORMONE ANTAGONISTS AND Antihormoner och relaterade medel RELATED AGENTS 2.16.840.1.113883.6.73 2017-01 L02BA Anti-estrogens Antiöstrogener 2.16.840.1.113883.6.73 2017-01 L02BA01 tamoxifen Tamoxifen 2.16.840.1.113883.6.73 2017-01 L02BA02 toremifene Toremifen 2.16.840.1.113883.6.73 2017-01 L02BA03 fulvestrant Fulvestrant 2.16.840.1.113883.6.73 2017-01 L02BB Anti-androgens Antiandrogener 2.16.840.1.113883.6.73 2017-01 L02BB01 flutamide Flutamid 2.16.840.1.113883.6.73 2017-01 L02BB02 nilutamide Nilutamid 2.16.840.1.113883.6.73 2017-01 L02BB03 bicalutamide Bikalutamid 2.16.840.1.113883.6.73 2017-01 L02BB04 enzalutamide Enzalutamid 2.16.840.1.113883.6.73 2017-01 L02BG Aromatase inhibitors Aromatashämmare 2.16.840.1.113883.6.73 2017-01 L02BG01 aminoglutethimide Aminoglutetimid 2.16.840.1.113883.6.73 2017-01 L02BG02 formestane Formestan 2.16.840.1.113883.6.73 2017-01 L02BG03 anastrozole Anastrozol 2.16.840.1.113883.6.73 2017-01 L02BG04 letrozole Letrozol 2.16.840.1.113883.6.73 2017-01 L02BG05 vorozole Vorozol 2.16.840.1.113883.6.73 2017-01 L02BG06 exemestane Exemestan 2.16.840.1.113883.6.73 2017-01 L02BX Other hormone antagonists and Övriga antihormoner och relaterade related agents medel 2.16.840.1.113883.6.73 2017-01 L02BX01 abarelix Abarelix 2.16.840.1.113883.6.73 2017-01 L02BX02 degarelix Degarelix 2.16.840.1.113883.6.73 2017-01 L02BX03 abiraterone Abirateron © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 102 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L03 IMMUNOSTIMULANTS Immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03A IMMUNOSTIMULANTS Immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03AA Colony stimulating factors Hematopoetiska tillväxtfaktorer 2.16.840.1.113883.6.73 2017-01 L03AA02 filgrastim Filgrastim 2.16.840.1.113883.6.73 2017-01 L03AA03 molgramostim Molgramostim 2.16.840.1.113883.6.73 2017-01 L03AA09 sargramostim Sargramostim 2.16.840.1.113883.6.73 2017-01 L03AA10 lenograstim Lenograstim 2.16.840.1.113883.6.73 2017-01 L03AA12 ancestim Ancestim 2.16.840.1.113883.6.73 2017-01 L03AA13 pegfilgrastim Pegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AA14 lipegfilgrastim Lipegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AA15 balugrastim Balugrastim 2.16.840.1.113883.6.73 2017-01 L03AA16 empegfilgrastim Empegfilgrastim 2.16.840.1.113883.6.73 2017-01 L03AB Interferons Interferoner 2.16.840.1.113883.6.73 2017-01 L03AB01 interferon alfa natural Interferon alfa, naturlig 2.16.840.1.113883.6.73 2017-01 L03AB02 interferon beta natural Interferon beta, naturlig 2.16.840.1.113883.6.73 2017-01 L03AB03 interferon gamma Interferon gamma 2.16.840.1.113883.6.73 2017-01 L03AB04 interferon alfa-2a Interferon alfa-2a 2.16.840.1.113883.6.73 2017-01 L03AB05 interferon alfa-2b Interferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB06 interferon alfa-n1 Interferon alfa-n1 2.16.840.1.113883.6.73 2017-01 L03AB07 interferon beta-1a Interferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB08 interferon beta-1b Interferon beta-1b 2.16.840.1.113883.6.73 2017-01 L03AB09 interferon alfacon-1 Interferon alfacon-1 2.16.840.1.113883.6.73 2017-01 L03AB10 peginterferon alfa-2b Peginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB11 peginterferon alfa-2a Peginterferon alfa-2a 2.16.840.1.113883.6.73 2017-01 L03AB12 albinterferon alfa-2b Albinterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB13 peginterferon beta-1a Peginterferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB14 cepeginterferon alfa-2b Cepeginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB60 peginterferon alfa-2b, combinations Peginterferon alfa-2b, kombinationer 2.16.840.1.113883.6.73 2017-01 L03AB61 peginterferon alfa-2a, combinations Peginterferon alfa-2a, kombinationer 2.16.840.1.113883.6.73 2017-01 L03AC Interleukins Interleukiner 2.16.840.1.113883.6.73 2017-01 L03AC01 aldesleukin Aldesleukin 2.16.840.1.113883.6.73 2017-01 L03AC02 oprelvekin Oprelvekin 2.16.840.1.113883.6.73 2017-01 L03AX Other immunostimulants Övriga immunstimulerande medel 2.16.840.1.113883.6.73 2017-01 L03AX01 lentinan Lentinan 2.16.840.1.113883.6.73 2017-01 L03AX02 roquinimex Rokinimex 2.16.840.1.113883.6.73 2017-01 L03AX03 BCG vaccine Vaccin mot Bacillus Calmette- Guerin (BCG) 2.16.840.1.113883.6.73 2017-01 L03AX04 pegademase Pegademas 2.16.840.1.113883.6.73 2017-01 L03AX05 pidotimod Pidotimod 2.16.840.1.113883.6.73 2017-01 L03AX07 poly I:C Poly I:C 2.16.840.1.113883.6.73 2017-01 L03AX08 poly ICLC Poly ICLC 2.16.840.1.113883.6.73 2017-01 L03AX09 thymopentin Tymopentin 2.16.840.1.113883.6.73 2017-01 L03AX10 immunocyanin Immunocyanin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 103 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L03AX11 tasonermin Tasonermin 2.16.840.1.113883.6.73 2017-01 L03AX12 melanoma vaccine Melanomvaccin 2.16.840.1.113883.6.73 2017-01 L03AX13 glatiramer acetate Glatirameracetat 2.16.840.1.113883.6.73 2017-01 L03AX14 histamine dihydrochloride Histamindihydroklorid 2.16.840.1.113883.6.73 2017-01 L03AX15 mifamurtide Mifamurtid 2.16.840.1.113883.6.73 2017-01 L03AX16 plerixafor Plerixafor 2.16.840.1.113883.6.73 2017-01 L03AX17 sipuleucel-T Sipuleucel-T 2.16.840.1.113883.6.73 2017-01 L03AX18 cridanimod Kridanimod 2.16.840.1.113883.6.73 2017-01 L03AX19 dasiprotimut-T Dasiprotimut-T 2.16.840.1.113883.6.73 2017-01 L04 IMMUNOSUPPRESSANTS Immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04A IMMUNOSUPPRESSANTS Immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AA Selective immunosuppressants Selektiva immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AA02 muromonab-CD3 Muromonab CD3 2.16.840.1.113883.6.73 2017-01 L04AA03 antilymphocyte immunoglobulin Anti-lymfoocyt-immunoglobulin (horse) (häst) 2.16.840.1.113883.6.73 2017-01 L04AA04 antithymocyte immunoglobulin Anti-tymocyt-immunoglobulin (kanin) (rabbit) 2.16.840.1.113883.6.73 2017-01 L04AA06 mycophenolic acid Mykofenolsyra 2.16.840.1.113883.6.73 2017-01 L04AA10 sirolimus Sirolimus 2.16.840.1.113883.6.73 2017-01 L04AA13 leflunomide Leflunomid 2.16.840.1.113883.6.73 2017-01 L04AA15 alefacept Alefacept 2.16.840.1.113883.6.73 2017-01 L04AA18 everolimus Everolimus 2.16.840.1.113883.6.73 2017-01 L04AA19 gusperimus Gusperimus 2.16.840.1.113883.6.73 2017-01 L04AA21 efalizumab Efalizumab 2.16.840.1.113883.6.73 2017-01 L04AA22 abetimus Abetimus 2.16.840.1.113883.6.73 2017-01 L04AA23 natalizumab Natalizumab 2.16.840.1.113883.6.73 2017-01 L04AA24 abatacept Abatacept 2.16.840.1.113883.6.73 2017-01 L04AA25 eculizumab Ekulizumab 2.16.840.1.113883.6.73 2017-01 L04AA26 belimumab Belimumab 2.16.840.1.113883.6.73 2017-01 L04AA27 fingolimod Fingolimod 2.16.840.1.113883.6.73 2017-01 L04AA28 belatacept Belatacept 2.16.840.1.113883.6.73 2017-01 L04AA29 tofacitinib Tofacitinib 2.16.840.1.113883.6.73 2017-01 L04AA31 teriflunomide Teriflunomid 2.16.840.1.113883.6.73 2017-01 L04AA32 apremilast Apremilast 2.16.840.1.113883.6.73 2017-01 L04AA33 vedolizumab Vedolizumab 2.16.840.1.113883.6.73 2017-01 L04AA34 alemtuzumab Alemtuzumab 2.16.840.1.113883.6.73 2017-01 L04AA35 begelomab Begelomab 2.16.840.1.113883.6.73 2017-01 L04AA36 ocrelizumab Okrelizumab 2.16.840.1.113883.6.73 2017-01 L04AA37 baricitinib Baricitinib 2.16.840.1.113883.6.73 2017-01 L04AB Tumor necrosis factor alpha (TNF-) Tumörnekrosfaktor alfa (TNF-) inhibitors hämmare 2.16.840.1.113883.6.73 2017-01 L04AB01 etanercept Etanercept 2.16.840.1.113883.6.73 2017-01 L04AB02 infliximab Infliximab 2.16.840.1.113883.6.73 2017-01 L04AB03 afelimomab Afelimomab

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 104 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L04AB04 adalimumab Adalimumab 2.16.840.1.113883.6.73 2017-01 L04AB05 certolizumab pegol Certolizumabpegol 2.16.840.1.113883.6.73 2017-01 L04AB06 golimumab Golimumab 2.16.840.1.113883.6.73 2017-01 L04AC Interleukin inhibitors Interleukinhämmare 2.16.840.1.113883.6.73 2017-01 L04AC01 daclizumab Daklizumab 2.16.840.1.113883.6.73 2017-01 L04AC02 basiliximab Basiliximab 2.16.840.1.113883.6.73 2017-01 L04AC03 anakinra Anakinra 2.16.840.1.113883.6.73 2017-01 L04AC04 rilonacept Rilonacept 2.16.840.1.113883.6.73 2017-01 L04AC05 ustekinumab Ustekinumab 2.16.840.1.113883.6.73 2017-01 L04AC07 tocilizumab Tocilizumab 2.16.840.1.113883.6.73 2017-01 L04AC08 canakinumab Kanakinumab 2.16.840.1.113883.6.73 2017-01 L04AC09 briakinumab Briakinumab 2.16.840.1.113883.6.73 2017-01 L04AC10 secukinumab Sekukinumab 2.16.840.1.113883.6.73 2017-01 L04AC11 siltuximab Siltuximab 2.16.840.1.113883.6.73 2017-01 L04AC12 brodalumab Brodalumab 2.16.840.1.113883.6.73 2017-01 L04AC13 ixekizumab Ixekizumab 2.16.840.1.113883.6.73 2017-01 L04AC14 sarilumab Sarilumab 2.16.840.1.113883.6.73 2017-01 L04AD Calcineurin inhibitors Kalcineurinhämmare 2.16.840.1.113883.6.73 2017-01 L04AD01 ciclosporin Ciklosporin 2.16.840.1.113883.6.73 2017-01 L04AD02 tacrolimus Takrolimus 2.16.840.1.113883.6.73 2017-01 L04AD03 voclosporin Voklosporin 2.16.840.1.113883.6.73 2017-01 L04AX Other immunosuppressants Övriga immunsuppressiva medel 2.16.840.1.113883.6.73 2017-01 L04AX01 azathioprine Azatioprin 2.16.840.1.113883.6.73 2017-01 L04AX02 thalidomide Talidomid 2.16.840.1.113883.6.73 2017-01 L04AX03 methotrexate Metotrexat 2.16.840.1.113883.6.73 2017-01 L04AX04 lenalidomide Lenalidomid 2.16.840.1.113883.6.73 2017-01 L04AX05 pirfenidone Pirfenidon 2.16.840.1.113883.6.73 2017-01 L04AX06 pomalidomide Pomalidomid 2.16.840.1.113883.6.73 2017-01 M MUSCULO-SKELETAL SYSTEM Rörelseapparaten 2.16.840.1.113883.6.73 2017-01 M01 ANTIINFLAMMATORY AND Antiinflammatoriska och ANTIRHEUMATIC PRODUCTS antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M01A ANTIINFLAMMATORY AND Antiinflammatoriska och ANTIRHEUMATIC PRODUCTS, antireumatiska medel, icke-steroida NON-STEROIDS 2.16.840.1.113883.6.73 2017-01 M01AA Butylpyrazolidines Butylpyrazolidiner 2.16.840.1.113883.6.73 2017-01 M01AA01 phenylbutazone Fenylbutazon 2.16.840.1.113883.6.73 2017-01 M01AA02 mofebutazone Mofebutazon 2.16.840.1.113883.6.73 2017-01 M01AA03 oxyphenbutazone Oxifenbutazon 2.16.840.1.113883.6.73 2017-01 M01AA05 clofezone Klofezon 2.16.840.1.113883.6.73 2017-01 M01AA06 kebuzone Kebuzon 2.16.840.1.113883.6.73 2017-01 M01AB Acetic acid derivatives and related Ättiksyraderivat och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 M01AB01 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 M01AB02 sulindac Sulindak

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 105 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AB03 tolmetin Tolmetin 2.16.840.1.113883.6.73 2017-01 M01AB04 zomepirac Zomepirak 2.16.840.1.113883.6.73 2017-01 M01AB05 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 M01AB06 alclofenac Alklofenak 2.16.840.1.113883.6.73 2017-01 M01AB07 bumadizone Bumadizon 2.16.840.1.113883.6.73 2017-01 M01AB08 etodolac Etodolak 2.16.840.1.113883.6.73 2017-01 M01AB09 lonazolac Lonazolak 2.16.840.1.113883.6.73 2017-01 M01AB10 fentiazac Fentiazak 2.16.840.1.113883.6.73 2017-01 M01AB11 acemetacin Acemetacin 2.16.840.1.113883.6.73 2017-01 M01AB12 difenpiramide Difenpiramid 2.16.840.1.113883.6.73 2017-01 M01AB13 oxametacin Oxametacin 2.16.840.1.113883.6.73 2017-01 M01AB14 proglumetacin Proglumetacin 2.16.840.1.113883.6.73 2017-01 M01AB15 ketorolac Ketorolak 2.16.840.1.113883.6.73 2017-01 M01AB16 aceclofenac Aceklofenak 2.16.840.1.113883.6.73 2017-01 M01AB17 bufexamac Bufexamak 2.16.840.1.113883.6.73 2017-01 M01AB51 indometacin, combinations Indometacin, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AB55 diclofenac, combinations Diklofenak, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AC Oxicams Oxikamer 2.16.840.1.113883.6.73 2017-01 M01AC01 piroxicam Piroxikam 2.16.840.1.113883.6.73 2017-01 M01AC02 tenoxicam Tenoxikam 2.16.840.1.113883.6.73 2017-01 M01AC04 droxicam Droxikam 2.16.840.1.113883.6.73 2017-01 M01AC05 lornoxicam Lornoxikam 2.16.840.1.113883.6.73 2017-01 M01AC06 meloxicam Meloxikam 2.16.840.1.113883.6.73 2017-01 M01AC56 meloxicam, combinations Meloxikam, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE Propionic acid derivatives Propionsyraderivat 2.16.840.1.113883.6.73 2017-01 M01AE01 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 M01AE02 naproxen Naproxen 2.16.840.1.113883.6.73 2017-01 M01AE03 ketoprofen Ketoprofen 2.16.840.1.113883.6.73 2017-01 M01AE04 fenoprofen Fenoprofen 2.16.840.1.113883.6.73 2017-01 M01AE05 fenbufen Fenbufen 2.16.840.1.113883.6.73 2017-01 M01AE06 benoxaprofen Benoxaprofen 2.16.840.1.113883.6.73 2017-01 M01AE07 suprofen Suprofen 2.16.840.1.113883.6.73 2017-01 M01AE08 pirprofen Pirprofen 2.16.840.1.113883.6.73 2017-01 M01AE09 flurbiprofen Flurbiprofen 2.16.840.1.113883.6.73 2017-01 M01AE10 indoprofen Indoprofen 2.16.840.1.113883.6.73 2017-01 M01AE11 tiaprofenic acid Tiaprofensyra 2.16.840.1.113883.6.73 2017-01 M01AE12 oxaprozin Oxaprozin 2.16.840.1.113883.6.73 2017-01 M01AE13 ibuproxam Ibuproxam 2.16.840.1.113883.6.73 2017-01 M01AE14 dexibuprofen Dexibuprofen 2.16.840.1.113883.6.73 2017-01 M01AE15 flunoxaprofen Flunoxaprofen 2.16.840.1.113883.6.73 2017-01 M01AE16 alminoprofen Alminoprofen 2.16.840.1.113883.6.73 2017-01 M01AE17 dexketoprofen Dexketoprofen 2.16.840.1.113883.6.73 2017-01 M01AE18 naproxcinod Naproxcinod © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 106 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AE51 ibuprofen, combinations Ibuprofen, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE52 naproxen and esomeprazole Naproxen och esomeprazol 2.16.840.1.113883.6.73 2017-01 M01AE53 ketoprofen, combinations Ketoprofen, kombinationer 2.16.840.1.113883.6.73 2017-01 M01AE56 naproxen and misoprostol Naproxen och misoprostol 2.16.840.1.113883.6.73 2017-01 M01AG Fenamates Fenamater 2.16.840.1.113883.6.73 2017-01 M01AG01 mefenamic acid Mefenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG02 tolfenamic acid Tolfenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG03 flufenamic acid Flufenamsyra 2.16.840.1.113883.6.73 2017-01 M01AG04 meclofenamic acid Meklofenamsyra 2.16.840.1.113883.6.73 2017-01 M01AH Coxibs Coxiber 2.16.840.1.113883.6.73 2017-01 M01AH01 celecoxib Celecoxib 2.16.840.1.113883.6.73 2017-01 M01AH02 rofecoxib Rofecoxib 2.16.840.1.113883.6.73 2017-01 M01AH03 valdecoxib Valdecoxib 2.16.840.1.113883.6.73 2017-01 M01AH04 parecoxib Parecoxib 2.16.840.1.113883.6.73 2017-01 M01AH05 etoricoxib Etoricoxib 2.16.840.1.113883.6.73 2017-01 M01AH06 lumiracoxib Lumiracoxib 2.16.840.1.113883.6.73 2017-01 M01AX Other antiinflammatory and Övriga icke-steroida antirheumatic agents, non-steroids antiinflammatoriska och antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M01AX01 nabumetone Nabumeton 2.16.840.1.113883.6.73 2017-01 M01AX02 niflumic acid Nifluminsyra 2.16.840.1.113883.6.73 2017-01 M01AX04 azapropazone Azapropazon 2.16.840.1.113883.6.73 2017-01 M01AX05 glucosamine Glukosamin 2.16.840.1.113883.6.73 2017-01 M01AX07 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 M01AX12 glucosaminoglycan polysulfate Glukosaminoglykanpolysulfat 2.16.840.1.113883.6.73 2017-01 M01AX13 proquazone Prokvazon 2.16.840.1.113883.6.73 2017-01 M01AX14 orgotein Orgotein 2.16.840.1.113883.6.73 2017-01 M01AX17 nimesulide Nimesulid 2.16.840.1.113883.6.73 2017-01 M01AX18 feprazone Feprazon 2.16.840.1.113883.6.73 2017-01 M01AX21 diacerein Diacerein 2.16.840.1.113883.6.73 2017-01 M01AX22 morniflumate Morniflumat 2.16.840.1.113883.6.73 2017-01 M01AX23 tenidap Tenidap 2.16.840.1.113883.6.73 2017-01 M01AX24 oxaceprol Oxaceprol 2.16.840.1.113883.6.73 2017-01 M01AX25 chondroitin sulfate Kondroitinsulfat 2.16.840.1.113883.6.73 2017-01 M01AX26 avocado and soyabean oil, Avokado- och sojaolja, ej förtvålbara unsaponifiables 2.16.840.1.113883.6.73 2017-01 M01AX68 feprazone, combinations Feprazon, kombinationer 2.16.840.1.113883.6.73 2017-01 M01B ANTIINFLAMMATORY/ANTIRHEU Antiinflammatoriska/antireumatiska MATIC AGENTS IN COMBINATION medel i kombination 2.16.840.1.113883.6.73 2017-01 M01BA Antiinflammatory/antirheumatic Antiinflammatoriska/antireumatiska agents in combination with medel i kombination med corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BA01 phenylbutazone and corticosteroids Fenylbutazon och kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BA02 dipyrocetyl and corticosteroids Dipyrocetyl och kortikosteroider

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 107 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01BA03 acetylsalicylic acid and Acetylsalicylsyra och corticosteroids kortikosteroider 2.16.840.1.113883.6.73 2017-01 M01BX Other Övriga kombinationer med antiinflammatory/antirheumatic antiinflammatoriska/antireumatiska agents in combination with other medel drugs 2.16.840.1.113883.6.73 2017-01 M01C SPECIFIC ANTIRHEUMATIC Specifika antireumatiska medel AGENTS 2.16.840.1.113883.6.73 2017-01 M01CA Quinolines Kinolinderivat 2.16.840.1.113883.6.73 2017-01 M01CA03 oxycinchophen Oxycinkofen 2.16.840.1.113883.6.73 2017-01 M01CB Gold preparations Guldpreparat 2.16.840.1.113883.6.73 2017-01 M01CB01 sodium aurothiomalate Natriumaurotiomalat 2.16.840.1.113883.6.73 2017-01 M01CB02 sodium aurotiosulfate Natriumaurotiosulfat 2.16.840.1.113883.6.73 2017-01 M01CB03 auranofin Auranofin 2.16.840.1.113883.6.73 2017-01 M01CB04 aurothioglucose Aurotioglukos 2.16.840.1.113883.6.73 2017-01 M01CB05 aurotioprol Aurotioprol 2.16.840.1.113883.6.73 2017-01 M01CC Penicillamine and similar agents Penicillamin och liknande medel 2.16.840.1.113883.6.73 2017-01 M01CC01 penicillamine Penicillamin 2.16.840.1.113883.6.73 2017-01 M01CC02 bucillamine Bucillamin 2.16.840.1.113883.6.73 2017-01 M01CX Other specific antirheumatic agents Övriga specifika antireumatiska medel 2.16.840.1.113883.6.73 2017-01 M02 TOPICAL PRODUCTS FOR JOINT Utvärtes medel vid led- och AND MUSCULAR PAIN muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02A TOPICAL PRODUCTS FOR JOINT Utvärtes medel vid led- och AND MUSCULAR PAIN muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02AA Antiinflammatory preparations, non- Antiinflammatoriska medel, icke- steroids for topical use steroider för utvärtes bruk 2.16.840.1.113883.6.73 2017-01 M02AA01 phenylbutazone Fenylbutazon 2.16.840.1.113883.6.73 2017-01 M02AA02 mofebutazone Mofebutazon 2.16.840.1.113883.6.73 2017-01 M02AA03 clofezone Klofezon 2.16.840.1.113883.6.73 2017-01 M02AA04 oxyphenbutazone Oxyfenbutazon 2.16.840.1.113883.6.73 2017-01 M02AA05 benzydamine Bensydamin 2.16.840.1.113883.6.73 2017-01 M02AA06 etofenamate Etofenamat 2.16.840.1.113883.6.73 2017-01 M02AA07 piroxicam Piroxikam 2.16.840.1.113883.6.73 2017-01 M02AA08 felbinac Felbinak 2.16.840.1.113883.6.73 2017-01 M02AA09 bufexamac Bufexamak 2.16.840.1.113883.6.73 2017-01 M02AA10 ketoprofen Ketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA11 bendazac Bendazak 2.16.840.1.113883.6.73 2017-01 M02AA12 naproxen Naproxen 2.16.840.1.113883.6.73 2017-01 M02AA13 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 M02AA14 fentiazac Fentiazak 2.16.840.1.113883.6.73 2017-01 M02AA15 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 M02AA16 feprazone Feprazon 2.16.840.1.113883.6.73 2017-01 M02AA17 niflumic acid Nifluminsyra 2.16.840.1.113883.6.73 2017-01 M02AA18 meclofenamic acid Meklofenamsyra 2.16.840.1.113883.6.73 2017-01 M02AA19 flurbiprofen Flurbiprofen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 108 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M02AA21 tolmetin Tolmetin 2.16.840.1.113883.6.73 2017-01 M02AA22 suxibuzone Suxibuzon 2.16.840.1.113883.6.73 2017-01 M02AA23 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 M02AA24 nifenazone Nifenazon 2.16.840.1.113883.6.73 2017-01 M02AA25 aceclofenac Aceklofenak 2.16.840.1.113883.6.73 2017-01 M02AA26 nimesulide Nimesulid 2.16.840.1.113883.6.73 2017-01 M02AA27 dexketoprofen Dexketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA28 piketoprofen Piketoprofen 2.16.840.1.113883.6.73 2017-01 M02AB Capsaicin and similar agents Kapsaicin och liknande medel 2.16.840.1.113883.6.73 2017-01 M02AB01 capsaicin Kapsaicin 2.16.840.1.113883.6.73 2017-01 M02AB02 zucapsaicin Zukapsaicin 2.16.840.1.113883.6.73 2017-01 M02AC Preparations with salicylic acid Salicylsyraderivat derivatives 2.16.840.1.113883.6.73 2017-01 M02AX Other topical products for joint and Övriga utvärtes medel för led- och muscular pain muskelsmärtor 2.16.840.1.113883.6.73 2017-01 M02AX02 tolazoline Tolazolin 2.16.840.1.113883.6.73 2017-01 M02AX03 dimethyl sulfoxide Dimetylsulfoxid 2.16.840.1.113883.6.73 2017-01 M02AX05 idrocilamide Idrocilamid 2.16.840.1.113883.6.73 2017-01 M02AX06 tolperisone Tolperison 2.16.840.1.113883.6.73 2017-01 M02AX10 various Övrigt 2.16.840.1.113883.6.73 2017-01 M03 MUSCLE RELAXANTS Muskelavslappande medel 2.16.840.1.113883.6.73 2017-01 M03A MUSCLE RELAXANTS, Muskelavslappande medel, perifert PERIPHERALLY ACTING AGENTS verkande 2.16.840.1.113883.6.73 2017-01 M03AA Curare alkaloids Kurarealkaloider 2.16.840.1.113883.6.73 2017-01 M03AA01 alcuronium Alkuron 2.16.840.1.113883.6.73 2017-01 M03AA02 tubocurarine Tubokurarin 2.16.840.1.113883.6.73 2017-01 M03AA04 dimethyltubocurarine Dimetyltubokurarin 2.16.840.1.113883.6.73 2017-01 M03AB Choline derivatives Kolinderivat 2.16.840.1.113883.6.73 2017-01 M03AB01 suxamethonium Suxametonium 2.16.840.1.113883.6.73 2017-01 M03AC Other quaternary ammonium Övriga kvartära compounds ammoniumföreningar 2.16.840.1.113883.6.73 2017-01 M03AC01 pancuronium Pankuronium 2.16.840.1.113883.6.73 2017-01 M03AC02 gallamine Gallamin 2.16.840.1.113883.6.73 2017-01 M03AC03 vecuronium Vekuronium 2.16.840.1.113883.6.73 2017-01 M03AC04 atracurium Atrakurium 2.16.840.1.113883.6.73 2017-01 M03AC05 hexafluronium Hexafluronium 2.16.840.1.113883.6.73 2017-01 M03AC06 pipecuronium bromide Pipekuronbromid 2.16.840.1.113883.6.73 2017-01 M03AC07 doxacurium chloride Doxakuriumklorid 2.16.840.1.113883.6.73 2017-01 M03AC08 fazadinium bromide Fazadiniumbromid 2.16.840.1.113883.6.73 2017-01 M03AC09 rocuronium bromide Rokuroniumbromid 2.16.840.1.113883.6.73 2017-01 M03AC10 mivacurium chloride Mivakuriumklorid 2.16.840.1.113883.6.73 2017-01 M03AC11 cisatracurium Cisatrakurium 2.16.840.1.113883.6.73 2017-01 M03AX Other muscle relaxants, peripherally Övriga muskelavslappande medel, acting agents perifert verkande 2.16.840.1.113883.6.73 2017-01 M03AX01 botulinum toxin Botulinum toxin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 109 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03B MUSCLE RELAXANTS, Muskelavslappande medel, centralt CENTRALLY ACTING AGENTS verkande 2.16.840.1.113883.6.73 2017-01 M03BA Carbamic acid esters Karbaminsyraestrar 2.16.840.1.113883.6.73 2017-01 M03BA01 phenprobamate Fenprobamat 2.16.840.1.113883.6.73 2017-01 M03BA02 carisoprodol Karisoprodol 2.16.840.1.113883.6.73 2017-01 M03BA03 methocarbamol Metokarbamol 2.16.840.1.113883.6.73 2017-01 M03BA04 styramate Styramat 2.16.840.1.113883.6.73 2017-01 M03BA05 febarbamate Febarbamat 2.16.840.1.113883.6.73 2017-01 M03BA51 phenprobamate, combinations excl. Fenprobamat, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA52 carisoprodol, combinations excl. Karisoprodol, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA53 methocarbamol, combinations excl. Metokarbamol, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA71 phenprobamate, combinations with Fenprobamat i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA72 carisoprodol, combinations with Karisoprodol, kombinationer med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BA73 methocarbamol, combinations with Metokarbamol i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB Oxazol, thiazine, and triazine Oxazol-, tiazin- och triazinderivat derivatives 2.16.840.1.113883.6.73 2017-01 M03BB02 chlormezanone Klormezanon 2.16.840.1.113883.6.73 2017-01 M03BB03 chlorzoxazone Klorzoxazon 2.16.840.1.113883.6.73 2017-01 M03BB52 chlormezanone, combinations excl. Klormezanon, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB53 chlorzoxazone, combinations excl. Klorzoxazon, kombinationer exkl. psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB72 chlormezanone, combinations with Klormezanon i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BB73 chlorzoxazone, combinations with Klorzoxazon, kombinationer med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 M03BC Ethers, chemically close to Etrar, kemiskt besläktade med antihistamines antihistaminer 2.16.840.1.113883.6.73 2017-01 M03BC01 orphenadrine (citrate) Orfenadrin 2.16.840.1.113883.6.73 2017-01 M03BC51 orphenadrine, combinations Orfenadrin, kombinationer 2.16.840.1.113883.6.73 2017-01 M03BX Other centrally acting agents Övriga muskelavslappande medel, centralt verkande 2.16.840.1.113883.6.73 2017-01 M03BX01 baclofen Baklofen 2.16.840.1.113883.6.73 2017-01 M03BX02 tizanidine Tizanidin 2.16.840.1.113883.6.73 2017-01 M03BX03 pridinol Pridinol 2.16.840.1.113883.6.73 2017-01 M03BX04 tolperisone Tolperison 2.16.840.1.113883.6.73 2017-01 M03BX05 thiocolchicoside Tiokolkikosid 2.16.840.1.113883.6.73 2017-01 M03BX06 mephenesin Mefenesin 2.16.840.1.113883.6.73 2017-01 M03BX07 tetrazepam Tetrazepam 2.16.840.1.113883.6.73 2017-01 M03BX08 cyclobenzaprine Cyklobenzaprin 2.16.840.1.113883.6.73 2017-01 M03BX09 eperisone Eperison 2.16.840.1.113883.6.73 2017-01 M03BX30 fenyramidol Feniramidol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 110 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03BX55 thiocolchicoside, combinations Tiokolkikosid, kombinationer 2.16.840.1.113883.6.73 2017-01 M03C MUSCLE RELAXANTS, DIRECTLY Muskelavslappande medel, ACTING AGENTS direktverkande 2.16.840.1.113883.6.73 2017-01 M03CA Dantrolene and derivatives Dantrolen och derivat 2.16.840.1.113883.6.73 2017-01 M03CA01 dantrolene Dantrolen 2.16.840.1.113883.6.73 2017-01 M04 ANTIGOUT PREPARATIONS Giktmedel 2.16.840.1.113883.6.73 2017-01 M04A ANTIGOUT PREPARATIONS Giktmedel 2.16.840.1.113883.6.73 2017-01 M04AA Preparations inhibiting uric acid Medel som hämmar produktionen production av urinsyra 2.16.840.1.113883.6.73 2017-01 M04AA01 allopurinol Allopurinol 2.16.840.1.113883.6.73 2017-01 M04AA02 tisopurine Tisopurin 2.16.840.1.113883.6.73 2017-01 M04AA03 febuxostat Febuxostat 2.16.840.1.113883.6.73 2017-01 M04AA51 allopurinol, combinations Allopurinol, kombinationer 2.16.840.1.113883.6.73 2017-01 M04AB Preparations increasing uric acid Medel som ökar utsöndringen av excretion urinsyra 2.16.840.1.113883.6.73 2017-01 M04AB01 probenecid Probenecid 2.16.840.1.113883.6.73 2017-01 M04AB02 sulfinpyrazone Sulfinpyrazon 2.16.840.1.113883.6.73 2017-01 M04AB03 benzbromarone Bensbromaron 2.16.840.1.113883.6.73 2017-01 M04AB04 isobromindione Isobromindion 2.16.840.1.113883.6.73 2017-01 M04AB05 lesinurad Lesinurad 2.16.840.1.113883.6.73 2017-01 M04AC Preparations with no effect on uric Medel utan effekt på acid metabolism urinsyrametabolismen 2.16.840.1.113883.6.73 2017-01 M04AC01 colchicine Kolkicin 2.16.840.1.113883.6.73 2017-01 M04AC02 cinchophen Cinkofen 2.16.840.1.113883.6.73 2017-01 M04AX Other antigout preparations Övriga giktmedel 2.16.840.1.113883.6.73 2017-01 M04AX01 urate oxidase Uratoxidas 2.16.840.1.113883.6.73 2017-01 M04AX02 pegloticase Peglotikas 2.16.840.1.113883.6.73 2017-01 M05 DRUGS FOR TREATMENT OF Medel för behandling av BONE DISEASES skelettsjukdomar 2.16.840.1.113883.6.73 2017-01 M05B DRUGS AFFECTING BONE Medel som påverkar benvävnad och STRUCTURE AND mineralisering MINERALIZATION 2.16.840.1.113883.6.73 2017-01 M05BA Bisphosphonates Bisfosfonater 2.16.840.1.113883.6.73 2017-01 M05BA01 etidronic acid Etidronat 2.16.840.1.113883.6.73 2017-01 M05BA02 clodronic acid Klodronat 2.16.840.1.113883.6.73 2017-01 M05BA03 pamidronic acid Pamidronat 2.16.840.1.113883.6.73 2017-01 M05BA04 alendronic acid Alendronsyra 2.16.840.1.113883.6.73 2017-01 M05BA05 tiludronic acid Tiludronsyra 2.16.840.1.113883.6.73 2017-01 M05BA06 ibandronic acid Ibandronsyra 2.16.840.1.113883.6.73 2017-01 M05BA07 risedronic acid Risedronsyra 2.16.840.1.113883.6.73 2017-01 M05BA08 zoledronic acid Zoledronsyra 2.16.840.1.113883.6.73 2017-01 M05BB Bisphosphonates, combinations Bisfosfonater, kombinationer 2.16.840.1.113883.6.73 2017-01 M05BB01 etidronic acid and calcium, Etidronsyra och kalcium, sequential sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB02 risedronic acid and calcium, Risedronsyra och kalcium, sequential sekvenspreparat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 111 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M05BB03 alendronic acid and colecalciferol Alendronsyra och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M05BB04 risedronic acid, calcium and Risedronsyra, kalcium och colecalciferol, sequential kolekalciferol, sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB05 alendronic acid, calcium and Alendronsyra, kalcium och colecalciferol, sequential kolekalciferol sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB06 alendronic acid and alfacalcidol, Alendronsyra och alfakalcidol, sequential sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BB07 risedronic acid and colecalciferol Risedronsyra och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M05BB08 zoledronic acid, calcium and Zoledronsyra, kalcium och colecalciferol, sequential kolekalciferol, sekvenspreparat 2.16.840.1.113883.6.73 2017-01 M05BC Bone morphogenetic proteins Benmorfogenetiska proteiner 2.16.840.1.113883.6.73 2017-01 M05BC01 dibotermin alfa Dibotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BC02 eptotermin alfa Eptotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BX Other drugs affecting bone structure Övriga medel som påverkar and mineralization benstruktur och mineralisering 2.16.840.1.113883.6.73 2017-01 M05BX01 ipriflavone Ipriflavon 2.16.840.1.113883.6.73 2017-01 M05BX02 aluminium chlorohydrate Aluminiumklorhydrat 2.16.840.1.113883.6.73 2017-01 M05BX03 strontium ranelate Strontiumranelat 2.16.840.1.113883.6.73 2017-01 M05BX04 denosumab Denosumab 2.16.840.1.113883.6.73 2017-01 M05BX05 burosumab Burosumab 2.16.840.1.113883.6.73 2017-01 M05BX53 strontium ranelate and colecalciferol Strontiumranelat och kolekalciferol 2.16.840.1.113883.6.73 2017-01 M09 OTHER DRUGS FOR DISORDERS Övriga medel för sjukdomar i OF THE MUSCULO-SKELETAL rörelseapparaten SYSTEM 2.16.840.1.113883.6.73 2017-01 M09A OTHER DRUGS FOR DISORDERS Övriga medel för sjukdomar i OF THE MUSCULO-SKELETAL rörelseapparaten SYSTEM 2.16.840.1.113883.6.73 2017-01 M09AA Quinine and derivatives Kinin och derivat 2.16.840.1.113883.6.73 2017-01 M09AA01 hydroquinine Hydrokinin 2.16.840.1.113883.6.73 2017-01 M09AA72 quinine, combinations with Kinin i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 M09AB Enzymes Enzymer 2.16.840.1.113883.6.73 2017-01 M09AB01 chymopapain Kymopapain 2.16.840.1.113883.6.73 2017-01 M09AB02 collagenase clostridium histolyticum Kollagenas, Clostridium histolyticum 2.16.840.1.113883.6.73 2017-01 M09AB03 bromelains Bromelainer 2.16.840.1.113883.6.73 2017-01 M09AB52 trypsin, combinations Trypsin, kombinationer 2.16.840.1.113883.6.73 2017-01 M09AX Other drugs for disorders of the Övriga medel för sjukdomar i musculo-skeletal system rörelseapparaten 2.16.840.1.113883.6.73 2017-01 M09AX01 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 M09AX02 chondrocytes, autologous Kondrocyter, autologa 2.16.840.1.113883.6.73 2017-01 M09AX03 ataluren Ataluren 2.16.840.1.113883.6.73 2017-01 M09AX04 drisapersen Drisapersen 2.16.840.1.113883.6.73 2017-01 M09AX05 aceneuramic acid Aceneuraminsyra 2.16.840.1.113883.6.73 2017-01 N NERVOUS SYSTEM Nervsystemet 2.16.840.1.113883.6.73 2017-01 N01 ANESTHETICS Anestetika 2.16.840.1.113883.6.73 2017-01 N01A ANESTHETICS, GENERAL Allmänanestetika 2.16.840.1.113883.6.73 2017-01 N01AA Ethers Etrar © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 112 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01AA01 diethyl ether Dietyleter 2.16.840.1.113883.6.73 2017-01 N01AA02 vinyl ether Vinyleter 2.16.840.1.113883.6.73 2017-01 N01AB Halogenated hydrocarbons Halogenerade kolväten 2.16.840.1.113883.6.73 2017-01 N01AB01 halothane Halotan 2.16.840.1.113883.6.73 2017-01 N01AB02 chloroform Kloroform 2.16.840.1.113883.6.73 2017-01 N01AB04 enflurane Enfluran 2.16.840.1.113883.6.73 2017-01 N01AB05 trichloroethylene Trikloretylen 2.16.840.1.113883.6.73 2017-01 N01AB06 isoflurane Isofluran 2.16.840.1.113883.6.73 2017-01 N01AB07 desflurane Desfluran 2.16.840.1.113883.6.73 2017-01 N01AB08 sevoflurane Sevofluran 2.16.840.1.113883.6.73 2017-01 N01AF Barbiturates, plain Barbiturater 2.16.840.1.113883.6.73 2017-01 N01AF01 methohexital Metohexital 2.16.840.1.113883.6.73 2017-01 N01AF02 hexobarbital Hexobarbital 2.16.840.1.113883.6.73 2017-01 N01AF03 thiopental Tiopental 2.16.840.1.113883.6.73 2017-01 N01AG Barbiturates in combination with Barbitursyraderivat i kombination other drugs med andra medel 2.16.840.1.113883.6.73 2017-01 N01AG01 narcobarbital Narkobarbital 2.16.840.1.113883.6.73 2017-01 N01AH Opioid anesthetics Opioidanestetika 2.16.840.1.113883.6.73 2017-01 N01AH01 fentanyl Fentanyl 2.16.840.1.113883.6.73 2017-01 N01AH02 alfentanil Alfentanil 2.16.840.1.113883.6.73 2017-01 N01AH03 sufentanil Sufentanil 2.16.840.1.113883.6.73 2017-01 N01AH04 phenoperidine Fenoperidin 2.16.840.1.113883.6.73 2017-01 N01AH05 anileridine Anileridin 2.16.840.1.113883.6.73 2017-01 N01AH06 remifentanil Remifentanil 2.16.840.1.113883.6.73 2017-01 N01AH51 fentanyl, combinations Fentanyl, kombinationer 2.16.840.1.113883.6.73 2017-01 N01AX Other general anesthetics Övriga allmänanestetika 2.16.840.1.113883.6.73 2017-01 N01AX03 ketamine Ketamin 2.16.840.1.113883.6.73 2017-01 N01AX04 propanidid Propanidid 2.16.840.1.113883.6.73 2017-01 N01AX05 alfaxalone Alfaxalon 2.16.840.1.113883.6.73 2017-01 N01AX07 etomidate Etomidat 2.16.840.1.113883.6.73 2017-01 N01AX10 propofol Propofol 2.16.840.1.113883.6.73 2017-01 N01AX11 sodium oxybate Natriumoxibat 2.16.840.1.113883.6.73 2017-01 N01AX13 nitrous oxide Dikväveoxid 2.16.840.1.113883.6.73 2017-01 N01AX14 esketamine Esketamin 2.16.840.1.113883.6.73 2017-01 N01AX15 xenon Xenon 2.16.840.1.113883.6.73 2017-01 N01AX63 nitrous oxide, combinations Dikväveoxid, kombinationer 2.16.840.1.113883.6.73 2017-01 N01B ANESTHETICS, LOCAL Lokalanestetika 2.16.840.1.113883.6.73 2017-01 N01BA Esters of aminobenzoic acid Aminosyrabensoestrar 2.16.840.1.113883.6.73 2017-01 N01BA01 metabutethamine Metabuteamin 2.16.840.1.113883.6.73 2017-01 N01BA02 procaine Prokain 2.16.840.1.113883.6.73 2017-01 N01BA03 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 N01BA04 chloroprocaine Kloroprokain 2.16.840.1.113883.6.73 2017-01 N01BA05 benzocaine Bensokain

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 113 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01BA52 procaine, combinations Prokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB Amides Amider 2.16.840.1.113883.6.73 2017-01 N01BB01 bupivacaine Bupivakain 2.16.840.1.113883.6.73 2017-01 N01BB02 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 N01BB03 mepivacaine Mepivakain 2.16.840.1.113883.6.73 2017-01 N01BB04 prilocaine Prilokain 2.16.840.1.113883.6.73 2017-01 N01BB05 butanilicaine Butanilikain 2.16.840.1.113883.6.73 2017-01 N01BB06 cinchocaine Cinkain 2.16.840.1.113883.6.73 2017-01 N01BB07 etidocaine Etidokain 2.16.840.1.113883.6.73 2017-01 N01BB08 articaine Artikain 2.16.840.1.113883.6.73 2017-01 N01BB09 ropivacaine Ropivakain 2.16.840.1.113883.6.73 2017-01 N01BB10 levobupivacaine Levobupivakain 2.16.840.1.113883.6.73 2017-01 N01BB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB51 bupivacaine, combinations Bupivakain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB52 lidocaine, combinations Lidokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB53 mepivacaine, combinations Mepivakain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB54 prilocaine, combinations Prilokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB57 etidocaine, combinations Etidokain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BB58 articaine, combinations Artikain, kombinationer 2.16.840.1.113883.6.73 2017-01 N01BC Esters of benzoic acid Estrar av bensoesyra 2.16.840.1.113883.6.73 2017-01 N01BC01 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 N01BX Other local anesthetics Övriga lokalanestetika 2.16.840.1.113883.6.73 2017-01 N01BX01 ethyl chloride Etylklorid 2.16.840.1.113883.6.73 2017-01 N01BX02 dyclonine Dyklonin 2.16.840.1.113883.6.73 2017-01 N01BX03 phenol Fenol 2.16.840.1.113883.6.73 2017-01 N01BX04 capsaicin Kapsaicin 2.16.840.1.113883.6.73 2017-01 N02 ANALGESICS Analgetika 2.16.840.1.113883.6.73 2017-01 N02A OPIOIDS Opioider 2.16.840.1.113883.6.73 2017-01 N02AA Natural opium alkaloids Naturliga opiumalkaloider, opiater 2.16.840.1.113883.6.73 2017-01 N02AA01 morphine Morfin 2.16.840.1.113883.6.73 2017-01 N02AA02 opium Opium 2.16.840.1.113883.6.73 2017-01 N02AA03 hydromorphone Hydromorfon 2.16.840.1.113883.6.73 2017-01 N02AA04 nicomorphine Nikomorfin 2.16.840.1.113883.6.73 2017-01 N02AA05 oxycodone Oxikodon 2.16.840.1.113883.6.73 2017-01 N02AA08 dihydrocodeine Dihydrokodein 2.16.840.1.113883.6.73 2017-01 N02AA10 papaveretum Papaveretum 2.16.840.1.113883.6.73 2017-01 N02AA51 morphine, combinations Morfin, kombinationer 2.16.840.1.113883.6.73 2017-01 N02AA55 oxycodone and naloxone Oxikodon och naloxon 2.16.840.1.113883.6.73 2017-01 N02AA58 dihydrocodeine, combinations Dihydrokodein, kombinationer 2.16.840.1.113883.6.73 2017-01 N02AA59 codeine, combinations excl. Kodein, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AA79 codeine, combinations with Kodein, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AB Phenylpiperidine derivatives Fenylpiperidinderivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 114 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02AB01 ketobemidone Ketobemidon 2.16.840.1.113883.6.73 2017-01 N02AB02 pethidine Petidin 2.16.840.1.113883.6.73 2017-01 N02AB03 fentanyl Fentanyl 2.16.840.1.113883.6.73 2017-01 N02AB52 pethidine, combinations excl. Petidin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AB72 pethidine, combinations with Petidin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC Diphenylpropylamine derivatives Difenylpropylaminderivat 2.16.840.1.113883.6.73 2017-01 N02AC01 dextromoramide Dextromoramid 2.16.840.1.113883.6.73 2017-01 N02AC03 piritramide Piritramid 2.16.840.1.113883.6.73 2017-01 N02AC04 dextropropoxyphene Dextropropoxifen 2.16.840.1.113883.6.73 2017-01 N02AC05 bezitramide Bezitramid 2.16.840.1.113883.6.73 2017-01 N02AC52 methadone, combinations excl. Metadon, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC54 dextropropoxyphene, combinations Dextropropoxifen, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AC74 dextropropoxyphene, combinations Dextropropoxifen, kombinationer with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02AD Benzomorphan derivatives Bensomorfanderivat 2.16.840.1.113883.6.73 2017-01 N02AD01 pentazocine Pentazocin 2.16.840.1.113883.6.73 2017-01 N02AD02 phenazocine Fenazocin 2.16.840.1.113883.6.73 2017-01 N02AE Oripavine derivatives Oripavinderivat 2.16.840.1.113883.6.73 2017-01 N02AE01 buprenorphine Buprenorfin 2.16.840.1.113883.6.73 2017-01 N02AF Morphinan derivatives Morfinderivat 2.16.840.1.113883.6.73 2017-01 N02AF01 butorphanol Butorfanol 2.16.840.1.113883.6.73 2017-01 N02AF02 nalbuphine Nalbufin 2.16.840.1.113883.6.73 2017-01 N02AG Opioids in combination with Opiater och opioider i kombination antispasmodics med spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG01 morphine and antispasmodics Morfin och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG02 ketobemidone and antispasmodics Ketobemidon och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG03 pethidine and antispasmodics Petidin och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AG04 hydromorphone and antispasmodics Hydromorfon och spasmolytika 2.16.840.1.113883.6.73 2017-01 N02AJ Opioids in combination with non- Opioider i kombination med icke- opioid analgesics opioida analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ01 dihydrocodeine and paracetamol Dihydrokodein och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ02 dihydrocodeine and acetylsalicylic Dihydrokodein och acetylsalicylsyra acid 2.16.840.1.113883.6.73 2017-01 N02AJ03 dihydrocodeine and other non- Dihydrokodein och övriga icke- opioid analgesics opioida analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ06 codeine and paracetamol Kodein och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ07 codeine and acetylsalicylic acid Kodein och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02AJ08 codeine and ibuprofen Kodein och ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AJ09 codeine and other non-opioid Kodein och övriga icke-opioida analgesics analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ13 tramadol and paracetamol Tramadol och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ14 tramadol and dexketoprofen Tramadol och dexketoprofen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 115 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02AJ15 tramadol and other non-opioid Tramadol och övriga icke-opioida analgesics analgetika 2.16.840.1.113883.6.73 2017-01 N02AJ17 oxycodone and paracetamol Oxikodon och paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ18 oxycodone and acetylsalicylic acid Oxikodon och acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02AJ19 oxycodone and ibuprofen Oxikodon och ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AX Other opioids Övriga opioider 2.16.840.1.113883.6.73 2017-01 N02AX01 tilidine Tilidin 2.16.840.1.113883.6.73 2017-01 N02AX02 tramadol Tramadol 2.16.840.1.113883.6.73 2017-01 N02AX03 dezocine Dezocin 2.16.840.1.113883.6.73 2017-01 N02AX05 meptazinol Meptazinol 2.16.840.1.113883.6.73 2017-01 N02AX06 tapentadol Tapentadol 2.16.840.1.113883.6.73 2017-01 N02B OTHER ANALGESICS AND Övriga analgetika och antipyretika ANTIPYRETICS 2.16.840.1.113883.6.73 2017-01 N02BA Salicylic acid and derivatives Salicylsyra och derivat 2.16.840.1.113883.6.73 2017-01 N02BA01 acetylsalicylic acid Acetylsalicylsyra 2.16.840.1.113883.6.73 2017-01 N02BA02 aloxiprin Aloxiprin 2.16.840.1.113883.6.73 2017-01 N02BA03 choline salicylate Kolinsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA04 sodium salicylate Natriumsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA05 salicylamide Salicylamid 2.16.840.1.113883.6.73 2017-01 N02BA06 salsalate Salsalat 2.16.840.1.113883.6.73 2017-01 N02BA07 ethenzamide Etenzamid 2.16.840.1.113883.6.73 2017-01 N02BA08 morpholine salicylate Morfolinsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA09 dipyrocetyl Dipyricetyl 2.16.840.1.113883.6.73 2017-01 N02BA10 benorilate Benorilat 2.16.840.1.113883.6.73 2017-01 N02BA11 diflunisal Diflunisal 2.16.840.1.113883.6.73 2017-01 N02BA12 potassium salicylate Kaliumsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA14 guacetisal Guacetisal 2.16.840.1.113883.6.73 2017-01 N02BA15 carbasalate calcium Karbasalatkalcium 2.16.840.1.113883.6.73 2017-01 N02BA16 imidazole salicylate Imidazolsalicylat 2.16.840.1.113883.6.73 2017-01 N02BA51 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA55 salicylamide, combinations excl. Salicylamid, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA57 ethenzamide, combinations excl. Etenzamid, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA59 dipyrocetyl, combinations excl. Dipyricetyl, kombinationer exkl psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA65 carbasalate calcium combinations Karbasalatkalciumkombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA71 acetylsalicylic acid, combinations Acetylsalicylsyra, kombinationer with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA75 salicylamide, combinations with Salicylamid i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA77 ethenzamide, combinations with Etenzamid i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BA79 dipyrocetyl, combinations with Dipyricetyl i kombination med psycholeptics neuroleptika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 116 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BB Pyrazolones Pyrazolonderivat 2.16.840.1.113883.6.73 2017-01 N02BB01 phenazone Fenazon 2.16.840.1.113883.6.73 2017-01 N02BB02 metamizole sodium Metamizolnatrium 2.16.840.1.113883.6.73 2017-01 N02BB03 aminophenazone Aminofenazon 2.16.840.1.113883.6.73 2017-01 N02BB04 propyphenazone Propyfenazon 2.16.840.1.113883.6.73 2017-01 N02BB05 nifenazone Nifenazon 2.16.840.1.113883.6.73 2017-01 N02BB51 phenazone, combinations excl. Fenazon, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB52 metamizole sodium, combinations Metamizolnatrium, kombinationer excl. psycholeptics exkl. neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB53 aminophenazone, combinations Aminofenazon, kombinationer exkl excl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB54 propyphenazone, combinations Propyfenazon, kombinationer exkl. excl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB71 phenazone, combinations with Fenazon i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB72 metamizole sodium, combinations Metamizolnatrium i kombination with psycholeptics med neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB73 aminophenazone, combinations with Aminofenazon i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BB74 propyphenazone, combinations with Propyfenazon, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE Anilides Anilider, inkl kombinationer 2.16.840.1.113883.6.73 2017-01 N02BE01 paracetamol Paracetamol 2.16.840.1.113883.6.73 2017-01 N02BE03 phenacetin Fenacetin 2.16.840.1.113883.6.73 2017-01 N02BE04 bucetin Bucetin 2.16.840.1.113883.6.73 2017-01 N02BE05 propacetamol Propacetamol 2.16.840.1.113883.6.73 2017-01 N02BE51 paracetamol, combinations excl. Paracetamol, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE53 phenacetin, combinations excl. Fenacetin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE54 bucetin, combinations excl. Bucetin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE71 paracetamol, combinations with Paracetamol, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE73 phenacetin, combinations with Fenacetin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BE74 bucetin, combinations with Bucetin i kombination med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02BG Other analgesics and antipyretics Övriga analgetika och antipyretika 2.16.840.1.113883.6.73 2017-01 N02BG02 rimazolium Rimazolium 2.16.840.1.113883.6.73 2017-01 N02BG03 glafenine Glafenin 2.16.840.1.113883.6.73 2017-01 N02BG04 floctafenine Floktafenin 2.16.840.1.113883.6.73 2017-01 N02BG05 viminol Viminol 2.16.840.1.113883.6.73 2017-01 N02BG06 nefopam Nefopam 2.16.840.1.113883.6.73 2017-01 N02BG07 flupirtine Flupirtin 2.16.840.1.113883.6.73 2017-01 N02BG08 ziconotide Zikonotid 2.16.840.1.113883.6.73 2017-01 N02BG09 methoxyflurane Metoxyfluran

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 117 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BG10 cannabinoids Kannabinoider 2.16.840.1.113883.6.73 2017-01 N02C ANTIMIGRAINE PREPARATIONS Medel vid migrän 2.16.840.1.113883.6.73 2017-01 N02CA Ergot alkaloids Mjöldrygealkaloider 2.16.840.1.113883.6.73 2017-01 N02CA01 dihydroergotamine Dihydroergotamin 2.16.840.1.113883.6.73 2017-01 N02CA02 ergotamine Ergotamin 2.16.840.1.113883.6.73 2017-01 N02CA04 methysergide Metysergid 2.16.840.1.113883.6.73 2017-01 N02CA07 lisuride Lisurid 2.16.840.1.113883.6.73 2017-01 N02CA51 dihydroergotamine, combinations Dihydroergotamin, kombinationer 2.16.840.1.113883.6.73 2017-01 N02CA52 ergotamine, combinations excl. Ergotamin, kombinationer exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02CA72 ergotamine, combinations with Ergotamin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N02CB Corticosteroid derivatives Progesteronderivat 2.16.840.1.113883.6.73 2017-01 N02CB01 flumedroxone Flumedroxon 2.16.840.1.113883.6.73 2017-01 N02CC Selective serotonin (5HT1) agonists Selektiva serotonin(5HT1)agonister 2.16.840.1.113883.6.73 2017-01 N02CC01 sumatriptan Sumatriptan 2.16.840.1.113883.6.73 2017-01 N02CC02 naratriptan Naratriptan 2.16.840.1.113883.6.73 2017-01 N02CC03 zolmitriptan Zolmitriptan 2.16.840.1.113883.6.73 2017-01 N02CC04 rizatriptan Rizatriptan 2.16.840.1.113883.6.73 2017-01 N02CC05 almotriptan Almotriptan 2.16.840.1.113883.6.73 2017-01 N02CC06 eletriptan Eletriptan 2.16.840.1.113883.6.73 2017-01 N02CC07 frovatriptan Frovatriptan 2.16.840.1.113883.6.73 2017-01 N02CX Other antimigraine preparations Övriga migränmedel 2.16.840.1.113883.6.73 2017-01 N02CX01 pizotifen Pizotifen 2.16.840.1.113883.6.73 2017-01 N02CX02 clonidine Klonidin 2.16.840.1.113883.6.73 2017-01 N02CX03 iprazochrome Iprazokrom 2.16.840.1.113883.6.73 2017-01 N02CX05 dimetotiazine Dimetotiazin 2.16.840.1.113883.6.73 2017-01 N02CX06 oxetorone Oxetoron 2.16.840.1.113883.6.73 2017-01 N03 ANTIEPILEPTICS Antiepileptika 2.16.840.1.113883.6.73 2017-01 N03A ANTIEPILEPTICS Antiepileptika 2.16.840.1.113883.6.73 2017-01 N03AA Barbiturates and derivatives Barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N03AA01 methylphenobarbital Metylfenobarbital 2.16.840.1.113883.6.73 2017-01 N03AA02 phenobarbital Fenobarbital 2.16.840.1.113883.6.73 2017-01 N03AA03 primidone Primidon 2.16.840.1.113883.6.73 2017-01 N03AA04 barbexaclone Barbexaklon 2.16.840.1.113883.6.73 2017-01 N03AA30 metharbital Metarbital 2.16.840.1.113883.6.73 2017-01 N03AB Hydantoin derivatives Hydantoinderivat 2.16.840.1.113883.6.73 2017-01 N03AB01 ethotoin Etotoin 2.16.840.1.113883.6.73 2017-01 N03AB02 phenytoin Fenytoin 2.16.840.1.113883.6.73 2017-01 N03AB03 amino(diphenylhydantoin) valeric Aminovaleriansyra acid 2.16.840.1.113883.6.73 2017-01 N03AB04 mephenytoin Mefenytoin 2.16.840.1.113883.6.73 2017-01 N03AB05 fosphenytoin Fosfenytoin 2.16.840.1.113883.6.73 2017-01 N03AB52 phenytoin, combinations Fenytoin, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 118 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N03AB54 mephenytoin, combinations Mefenytoin, kombinationer 2.16.840.1.113883.6.73 2017-01 N03AC Oxazolidine derivatives Oxazolidindionderivat 2.16.840.1.113883.6.73 2017-01 N03AC01 paramethadione Parametadion 2.16.840.1.113883.6.73 2017-01 N03AC02 trimethadione Trimetadion 2.16.840.1.113883.6.73 2017-01 N03AC03 ethadione Etadion 2.16.840.1.113883.6.73 2017-01 N03AD Succinimide derivatives Succinimidderivat 2.16.840.1.113883.6.73 2017-01 N03AD01 ethosuximide Etosuximid 2.16.840.1.113883.6.73 2017-01 N03AD02 phensuximide Fensuximid 2.16.840.1.113883.6.73 2017-01 N03AD03 mesuximide Mesuximid 2.16.840.1.113883.6.73 2017-01 N03AD51 ethosuximide, combinations Etosuximid, kombinationer 2.16.840.1.113883.6.73 2017-01 N03AE Benzodiazepine derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N03AE01 clonazepam Klonazepam 2.16.840.1.113883.6.73 2017-01 N03AF Carboxamide derivatives Karboxamidderivat 2.16.840.1.113883.6.73 2017-01 N03AF01 carbamazepine Karbamazepin 2.16.840.1.113883.6.73 2017-01 N03AF02 oxcarbazepine Oxkarbazepin 2.16.840.1.113883.6.73 2017-01 N03AF03 rufinamide Rufinamid 2.16.840.1.113883.6.73 2017-01 N03AF04 eslicarbazepine Eslikarbazepin 2.16.840.1.113883.6.73 2017-01 N03AG Fatty acid derivatives Fettsyraderivat 2.16.840.1.113883.6.73 2017-01 N03AG01 valproic acid Valproinsyra 2.16.840.1.113883.6.73 2017-01 N03AG02 valpromide Valpromid 2.16.840.1.113883.6.73 2017-01 N03AG03 aminobutyric acid Aminosmörsyra 2.16.840.1.113883.6.73 2017-01 N03AG04 vigabatrin Vigabatrin 2.16.840.1.113883.6.73 2017-01 N03AG05 progabide Progabid 2.16.840.1.113883.6.73 2017-01 N03AG06 tiagabine Tiagabin 2.16.840.1.113883.6.73 2017-01 N03AX Other antiepileptics Övriga antiepileptika 2.16.840.1.113883.6.73 2017-01 N03AX03 sultiame Sultiam 2.16.840.1.113883.6.73 2017-01 N03AX07 phenacemide Fenacemid 2.16.840.1.113883.6.73 2017-01 N03AX09 lamotrigine Lamotrigin 2.16.840.1.113883.6.73 2017-01 N03AX10 felbamate Felbamat 2.16.840.1.113883.6.73 2017-01 N03AX11 topiramate Topiramat 2.16.840.1.113883.6.73 2017-01 N03AX12 gabapentin Gabapentin 2.16.840.1.113883.6.73 2017-01 N03AX13 pheneturide Feneturid 2.16.840.1.113883.6.73 2017-01 N03AX14 levetiracetam Levetiracetam 2.16.840.1.113883.6.73 2017-01 N03AX15 zonisamide Zonisamid 2.16.840.1.113883.6.73 2017-01 N03AX16 pregabalin Pregabalin 2.16.840.1.113883.6.73 2017-01 N03AX17 stiripentol Stiripentol 2.16.840.1.113883.6.73 2017-01 N03AX18 lacosamide Lakosamid 2.16.840.1.113883.6.73 2017-01 N03AX19 carisbamate Karisbamat 2.16.840.1.113883.6.73 2017-01 N03AX21 retigabine Retigabin 2.16.840.1.113883.6.73 2017-01 N03AX22 perampanel Perampanel 2.16.840.1.113883.6.73 2017-01 N03AX23 brivaracetam Brivaracetam 2.16.840.1.113883.6.73 2017-01 N03AX30 beclamide Beklamid 2.16.840.1.113883.6.73 2017-01 N04 ANTI-PARKINSON DRUGS Medel vid parkinsonism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 119 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N04A ANTICHOLINERGIC AGENTS Antikolinergika 2.16.840.1.113883.6.73 2017-01 N04AA Tertiary amines Antikolinergika, tertiära aminer 2.16.840.1.113883.6.73 2017-01 N04AA01 trihexyphenidyl Trihexyfenidyl 2.16.840.1.113883.6.73 2017-01 N04AA02 biperiden Biperiden 2.16.840.1.113883.6.73 2017-01 N04AA03 metixene Metixen 2.16.840.1.113883.6.73 2017-01 N04AA04 procyclidine Procyklidin 2.16.840.1.113883.6.73 2017-01 N04AA05 profenamine Profenamin 2.16.840.1.113883.6.73 2017-01 N04AA08 dexetimide Dexetimid 2.16.840.1.113883.6.73 2017-01 N04AA09 phenglutarimide Fenglutarimid 2.16.840.1.113883.6.73 2017-01 N04AA10 mazaticol Mazatikol 2.16.840.1.113883.6.73 2017-01 N04AA11 bornaprine Bornaprin 2.16.840.1.113883.6.73 2017-01 N04AA12 tropatepine Tropatepin 2.16.840.1.113883.6.73 2017-01 N04AB Ethers chemically close to Antikolinergika, kemiskt närstående antihistamines antihistaminer 2.16.840.1.113883.6.73 2017-01 N04AB01 etanautine Etanautin 2.16.840.1.113883.6.73 2017-01 N04AB02 orphenadrine (chloride) Orfenadrin 2.16.840.1.113883.6.73 2017-01 N04AC Ethers of tropine or tropine Antikolinergika, etrar av tropin derivatives 2.16.840.1.113883.6.73 2017-01 N04AC01 benzatropine Bensatropin 2.16.840.1.113883.6.73 2017-01 N04AC30 etybenzatropine Etybensatropin 2.16.840.1.113883.6.73 2017-01 N04B DOPAMINERGIC AGENTS Dopaminerga medel 2.16.840.1.113883.6.73 2017-01 N04BA Dopa and dopa derivatives Dopa och dopaderivat 2.16.840.1.113883.6.73 2017-01 N04BA01 levodopa Levodopa 2.16.840.1.113883.6.73 2017-01 N04BA02 levodopa and decarboxylase Levodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BA03 levodopa, decarboxylase inhibitor Levodopa, dekarboxylashämmare and COMT inhibitor och COMT-hämmare 2.16.840.1.113883.6.73 2017-01 N04BA04 melevodopa Melevodopa 2.16.840.1.113883.6.73 2017-01 N04BA05 melevodopa and decarboxylase Melevodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BA06 etilevodopa and decarboxylase Etilevodopa och inhibitor dekarboxylashämmare 2.16.840.1.113883.6.73 2017-01 N04BB Adamantane derivatives Adamantanderivat 2.16.840.1.113883.6.73 2017-01 N04BB01 amantadine Amantadin 2.16.840.1.113883.6.73 2017-01 N04BC Dopamine agonists Dopaminagonister 2.16.840.1.113883.6.73 2017-01 N04BC01 bromocriptine Bromokriptin 2.16.840.1.113883.6.73 2017-01 N04BC02 pergolide Pergolid 2.16.840.1.113883.6.73 2017-01 N04BC03 dihydroergocryptine mesylate Dihydroergokryptinmesylat 2.16.840.1.113883.6.73 2017-01 N04BC04 ropinirole Ropinirol 2.16.840.1.113883.6.73 2017-01 N04BC05 pramipexole Pramipexol 2.16.840.1.113883.6.73 2017-01 N04BC06 cabergoline Kabergolin 2.16.840.1.113883.6.73 2017-01 N04BC07 apomorphine Apomorfin 2.16.840.1.113883.6.73 2017-01 N04BC08 piribedil Piribedil 2.16.840.1.113883.6.73 2017-01 N04BC09 rotigotine Rotigotin 2.16.840.1.113883.6.73 2017-01 N04BD Monoamine oxidase B inhibitors MAO-B hämmare

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 120 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N04BD01 selegiline Selegilin 2.16.840.1.113883.6.73 2017-01 N04BD02 rasagiline Rasagilin 2.16.840.1.113883.6.73 2017-01 N04BD03 safinamide Safinamid 2.16.840.1.113883.6.73 2017-01 N04BX Other dopaminergic agents Övriga dopaminerga medel 2.16.840.1.113883.6.73 2017-01 N04BX01 tolcapone Tolkapon 2.16.840.1.113883.6.73 2017-01 N04BX02 entacapone Entakapon 2.16.840.1.113883.6.73 2017-01 N04BX03 budipine Budipin 2.16.840.1.113883.6.73 2017-01 N05 PSYCHOLEPTICS Neuroleptika, lugnande medel och sömnmedel 2.16.840.1.113883.6.73 2017-01 N05A ANTIPSYCHOTICS Neuroleptika 2.16.840.1.113883.6.73 2017-01 N05AA Phenothiazines with aliphatic side- Fentiazinderivat med alifatisk chain sidokedja 2.16.840.1.113883.6.73 2017-01 N05AA01 chlorpromazine Klorpromazin 2.16.840.1.113883.6.73 2017-01 N05AA02 levomepromazine Levomepromazin 2.16.840.1.113883.6.73 2017-01 N05AA03 promazine Promazin 2.16.840.1.113883.6.73 2017-01 N05AA04 acepromazine Acepromazin 2.16.840.1.113883.6.73 2017-01 N05AA05 triflupromazine Triflupromazin 2.16.840.1.113883.6.73 2017-01 N05AA06 cyamemazine Cyamemazin 2.16.840.1.113883.6.73 2017-01 N05AA07 chlorproethazine Klorproetazin 2.16.840.1.113883.6.73 2017-01 N05AB Phenothiazines with piperazine Fentiazinderivat med piperazinring structure 2.16.840.1.113883.6.73 2017-01 N05AB01 dixyrazine Dixyrazin 2.16.840.1.113883.6.73 2017-01 N05AB02 fluphenazine Flufenazin 2.16.840.1.113883.6.73 2017-01 N05AB03 perphenazine Perfenazin 2.16.840.1.113883.6.73 2017-01 N05AB04 prochlorperazine Proklorperazin 2.16.840.1.113883.6.73 2017-01 N05AB05 thiopropazate Tiopropazat 2.16.840.1.113883.6.73 2017-01 N05AB06 trifluoperazine Trifluoperazin 2.16.840.1.113883.6.73 2017-01 N05AB07 acetophenazine Acetofenazin 2.16.840.1.113883.6.73 2017-01 N05AB08 thioproperazine Tioproperazin 2.16.840.1.113883.6.73 2017-01 N05AB09 butaperazine Butaperazin 2.16.840.1.113883.6.73 2017-01 N05AB10 perazine Perazin 2.16.840.1.113883.6.73 2017-01 N05AC Phenothiazines with piperidine Fentiazinderivat med piperidinring structure 2.16.840.1.113883.6.73 2017-01 N05AC01 periciazine Periciazin 2.16.840.1.113883.6.73 2017-01 N05AC02 thioridazine Tioridazin 2.16.840.1.113883.6.73 2017-01 N05AC03 mesoridazine Mesoridazin 2.16.840.1.113883.6.73 2017-01 N05AC04 pipotiazine Pipotiazin 2.16.840.1.113883.6.73 2017-01 N05AD Butyrophenone derivatives Butyrofenonderivat 2.16.840.1.113883.6.73 2017-01 N05AD01 haloperidol Haloperidol 2.16.840.1.113883.6.73 2017-01 N05AD02 trifluperidol Trifluperidol 2.16.840.1.113883.6.73 2017-01 N05AD03 melperone Melperon 2.16.840.1.113883.6.73 2017-01 N05AD04 moperone Moperon 2.16.840.1.113883.6.73 2017-01 N05AD05 pipamperone Pipamperon 2.16.840.1.113883.6.73 2017-01 N05AD06 bromperidol Bromperidol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 121 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AD07 benperidol Benperidol 2.16.840.1.113883.6.73 2017-01 N05AD08 droperidol Droperidol 2.16.840.1.113883.6.73 2017-01 N05AD09 fluanisone Fluanison 2.16.840.1.113883.6.73 2017-01 N05AE Indole derivatives Indolderivat 2.16.840.1.113883.6.73 2017-01 N05AE01 oxypertine Oxipertin 2.16.840.1.113883.6.73 2017-01 N05AE02 molindone Molindon 2.16.840.1.113883.6.73 2017-01 N05AE03 sertindole Sertindol 2.16.840.1.113883.6.73 2017-01 N05AE04 ziprasidone Ziprasidon 2.16.840.1.113883.6.73 2017-01 N05AE05 lurasidone Lurasidon 2.16.840.1.113883.6.73 2017-01 N05AF Thioxanthene derivatives Tioxantenderivat 2.16.840.1.113883.6.73 2017-01 N05AF01 flupentixol Flupentixol 2.16.840.1.113883.6.73 2017-01 N05AF02 clopenthixol Klopentixol 2.16.840.1.113883.6.73 2017-01 N05AF03 chlorprothixene Klorprotixen 2.16.840.1.113883.6.73 2017-01 N05AF04 tiotixene Tiotixen 2.16.840.1.113883.6.73 2017-01 N05AF05 zuclopenthixol Zuklopentixol 2.16.840.1.113883.6.73 2017-01 N05AG Diphenylbutylpiperidine derivatives Difenylbutylpiperidinderivat 2.16.840.1.113883.6.73 2017-01 N05AG01 fluspirilene Fluspirilen 2.16.840.1.113883.6.73 2017-01 N05AG02 pimozide Pimozid 2.16.840.1.113883.6.73 2017-01 N05AG03 penfluridol Penfluridol 2.16.840.1.113883.6.73 2017-01 N05AH Diazepines, oxazepines, thiazepines Diazepiner, oxazepiner, tiazepiner and oxepines och oxepiner 2.16.840.1.113883.6.73 2017-01 N05AH01 loxapine Loxapin 2.16.840.1.113883.6.73 2017-01 N05AH02 clozapine Klozapin 2.16.840.1.113883.6.73 2017-01 N05AH03 olanzapine Olanzapin 2.16.840.1.113883.6.73 2017-01 N05AH04 quetiapine Kvetiapin 2.16.840.1.113883.6.73 2017-01 N05AH05 asenapine Asenapin 2.16.840.1.113883.6.73 2017-01 N05AH06 clotiapine Klotiapin 2.16.840.1.113883.6.73 2017-01 N05AL Benzamides Bensamider 2.16.840.1.113883.6.73 2017-01 N05AL01 sulpiride Sulpirid 2.16.840.1.113883.6.73 2017-01 N05AL02 sultopride Sultoprid 2.16.840.1.113883.6.73 2017-01 N05AL03 tiapride Tiaprid 2.16.840.1.113883.6.73 2017-01 N05AL04 remoxipride Remoxiprid 2.16.840.1.113883.6.73 2017-01 N05AL05 amisulpride Amisulprid 2.16.840.1.113883.6.73 2017-01 N05AL06 veralipride Veraliprid 2.16.840.1.113883.6.73 2017-01 N05AL07 levosulpiride Levosulpirid 2.16.840.1.113883.6.73 2017-01 N05AN Lithium Litium 2.16.840.1.113883.6.73 2017-01 N05AN01 lithium Litium 2.16.840.1.113883.6.73 2017-01 N05AX Other antipsychotics Övriga neuroleptika 2.16.840.1.113883.6.73 2017-01 N05AX07 prothipendyl Protipendyl 2.16.840.1.113883.6.73 2017-01 N05AX08 risperidone Risperidon 2.16.840.1.113883.6.73 2017-01 N05AX10 mosapramine Mosapramin 2.16.840.1.113883.6.73 2017-01 N05AX11 zotepine Zotepin 2.16.840.1.113883.6.73 2017-01 N05AX12 aripiprazole Aripiprazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 122 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AX13 paliperidone Paliperidon 2.16.840.1.113883.6.73 2017-01 N05AX14 iloperidone Iloperidon 2.16.840.1.113883.6.73 2017-01 N05AX15 cariprazine Kariprazin 2.16.840.1.113883.6.73 2017-01 N05AX16 brexpiprazole Brexpiprazol 2.16.840.1.113883.6.73 2017-01 N05AX17 pimavanserin Pimavanserin 2.16.840.1.113883.6.73 2017-01 N05B ANXIOLYTICS Lugnande medel, ataraktika 2.16.840.1.113883.6.73 2017-01 N05BA Benzodiazepine derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N05BA01 diazepam Diazepam 2.16.840.1.113883.6.73 2017-01 N05BA02 chlordiazepoxide Klordiazepoxid 2.16.840.1.113883.6.73 2017-01 N05BA03 medazepam Medazepam 2.16.840.1.113883.6.73 2017-01 N05BA04 oxazepam Oxazepam 2.16.840.1.113883.6.73 2017-01 N05BA05 potassium clorazepate Dikaliumklorazepat 2.16.840.1.113883.6.73 2017-01 N05BA06 lorazepam Lorazepam 2.16.840.1.113883.6.73 2017-01 N05BA07 adinazolam Adinazolam 2.16.840.1.113883.6.73 2017-01 N05BA08 bromazepam Bromazepam 2.16.840.1.113883.6.73 2017-01 N05BA09 clobazam Klobazam 2.16.840.1.113883.6.73 2017-01 N05BA10 ketazolam Ketazolam 2.16.840.1.113883.6.73 2017-01 N05BA11 prazepam Prazepam 2.16.840.1.113883.6.73 2017-01 N05BA12 alprazolam Alprazolam 2.16.840.1.113883.6.73 2017-01 N05BA13 halazepam Halazepam 2.16.840.1.113883.6.73 2017-01 N05BA14 pinazepam Pinazepam 2.16.840.1.113883.6.73 2017-01 N05BA15 camazepam Kamazepam 2.16.840.1.113883.6.73 2017-01 N05BA16 nordazepam Nordazepam 2.16.840.1.113883.6.73 2017-01 N05BA17 fludiazepam Fludiazepam 2.16.840.1.113883.6.73 2017-01 N05BA18 ethyl loflazepate Etylloflazepat 2.16.840.1.113883.6.73 2017-01 N05BA19 etizolam Etizolam 2.16.840.1.113883.6.73 2017-01 N05BA21 clotiazepam Klotiazepam 2.16.840.1.113883.6.73 2017-01 N05BA22 cloxazolam Kloxazolam 2.16.840.1.113883.6.73 2017-01 N05BA23 tofisopam Tofisopam 2.16.840.1.113883.6.73 2017-01 N05BA24 bentazepam Bentazepam 2.16.840.1.113883.6.73 2017-01 N05BA56 lorazepam, combinations Lorazepam, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BB Diphenylmethane derivatives Difenylmetylpiperazinderivat 2.16.840.1.113883.6.73 2017-01 N05BB01 hydroxyzine Hydroxizin 2.16.840.1.113883.6.73 2017-01 N05BB02 captodiame Kaptodiam 2.16.840.1.113883.6.73 2017-01 N05BB51 hydroxyzine, combinations Hydroxizin, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BC Carbamates Propandiolderivat 2.16.840.1.113883.6.73 2017-01 N05BC01 meprobamate Meprobamat 2.16.840.1.113883.6.73 2017-01 N05BC03 emylcamate Emylkamat 2.16.840.1.113883.6.73 2017-01 N05BC04 mebutamate Mebutamat 2.16.840.1.113883.6.73 2017-01 N05BC51 meprobamate, combinations Meprobamat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05BD Dibenzo-bicyclo-octadiene Dibenso-bicyklo-oktadienderivat derivatives 2.16.840.1.113883.6.73 2017-01 N05BD01 benzoctamine Bensoktamin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 123 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05BE Azaspirodecanedione derivatives Azaspironderivat 2.16.840.1.113883.6.73 2017-01 N05BE01 buspirone Buspiron 2.16.840.1.113883.6.73 2017-01 N05BX Other anxiolytics Övriga lugnande medel 2.16.840.1.113883.6.73 2017-01 N05BX01 mephenoxalone Mefenoxalon 2.16.840.1.113883.6.73 2017-01 N05BX02 gedocarnil Gedocarnil 2.16.840.1.113883.6.73 2017-01 N05BX03 etifoxine Etifoxin 2.16.840.1.113883.6.73 2017-01 N05BX04 fabomotizole Fabomotizol 2.16.840.1.113883.6.73 2017-01 N05C HYPNOTICS AND SEDATIVES Sömnmedel och lugnande medel 2.16.840.1.113883.6.73 2017-01 N05CA Barbiturates, plain Barbiturater 2.16.840.1.113883.6.73 2017-01 N05CA01 pentobarbital Pentobarbital 2.16.840.1.113883.6.73 2017-01 N05CA02 amobarbital Amobarbital 2.16.840.1.113883.6.73 2017-01 N05CA03 butobarbital Butobarbital 2.16.840.1.113883.6.73 2017-01 N05CA04 barbital Barbital 2.16.840.1.113883.6.73 2017-01 N05CA05 aprobarbital Allpropymal 2.16.840.1.113883.6.73 2017-01 N05CA06 secobarbital Secobarbital 2.16.840.1.113883.6.73 2017-01 N05CA07 talbutal Talbumal 2.16.840.1.113883.6.73 2017-01 N05CA08 vinylbital Vinylbital 2.16.840.1.113883.6.73 2017-01 N05CA09 vinbarbital Vinbarbital 2.16.840.1.113883.6.73 2017-01 N05CA10 cyclobarbital Cyklobarbital 2.16.840.1.113883.6.73 2017-01 N05CA11 heptabarbital Heptabarbital 2.16.840.1.113883.6.73 2017-01 N05CA12 reposal Reposal 2.16.840.1.113883.6.73 2017-01 N05CA15 methohexital Metohexital 2.16.840.1.113883.6.73 2017-01 N05CA16 hexobarbital Hexobarbital 2.16.840.1.113883.6.73 2017-01 N05CA19 thiopental Tiopental 2.16.840.1.113883.6.73 2017-01 N05CA20 etallobarbital Etallobarbital 2.16.840.1.113883.6.73 2017-01 N05CA21 allobarbital Allobarbital 2.16.840.1.113883.6.73 2017-01 N05CA22 proxibarbal Proxibarbal 2.16.840.1.113883.6.73 2017-01 N05CB Barbiturates, combinations Barbitursyraderivat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CB01 combinations of barbiturates Kombinationer av barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N05CB02 barbiturates in combination with Barbitursyraderivat i kombination other drugs med andra medel 2.16.840.1.113883.6.73 2017-01 N05CC Aldehydes and derivatives Aldehyder, inkl derivat 2.16.840.1.113883.6.73 2017-01 N05CC01 chloral hydrate Kloralhydrat 2.16.840.1.113883.6.73 2017-01 N05CC02 chloralodol Kloralodol 2.16.840.1.113883.6.73 2017-01 N05CC03 acetylglycinamide chloral hydrate Acetylglycinamidkloralhydrat 2.16.840.1.113883.6.73 2017-01 N05CC04 dichloralphenazone Dikloralfenazon 2.16.840.1.113883.6.73 2017-01 N05CC05 paraldehyde Paraldehyd 2.16.840.1.113883.6.73 2017-01 N05CD Benzodiazepine derivatives Bensodiazepinderivat 2.16.840.1.113883.6.73 2017-01 N05CD01 flurazepam Flurazepam 2.16.840.1.113883.6.73 2017-01 N05CD02 nitrazepam Nitrazepam 2.16.840.1.113883.6.73 2017-01 N05CD03 flunitrazepam Flunitrazepam 2.16.840.1.113883.6.73 2017-01 N05CD04 estazolam Estazolam 2.16.840.1.113883.6.73 2017-01 N05CD05 triazolam Triazolam © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 124 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CD06 lormetazepam Lormetazepam 2.16.840.1.113883.6.73 2017-01 N05CD07 temazepam Temazepam 2.16.840.1.113883.6.73 2017-01 N05CD08 midazolam Midazolam 2.16.840.1.113883.6.73 2017-01 N05CD09 brotizolam Brotizolam 2.16.840.1.113883.6.73 2017-01 N05CD10 quazepam Kvazepam 2.16.840.1.113883.6.73 2017-01 N05CD11 loprazolam Loprazolam 2.16.840.1.113883.6.73 2017-01 N05CD12 doxefazepam Doxefazepam 2.16.840.1.113883.6.73 2017-01 N05CD13 cinolazepam Cinolazepam 2.16.840.1.113883.6.73 2017-01 N05CE Piperidinedione derivatives Piperidindionderivat 2.16.840.1.113883.6.73 2017-01 N05CE01 glutethimide Glutetimid 2.16.840.1.113883.6.73 2017-01 N05CE02 methyprylon Metyprylon 2.16.840.1.113883.6.73 2017-01 N05CE03 pyrithyldione Pyrityldion 2.16.840.1.113883.6.73 2017-01 N05CF Benzodiazepine related drugs Bensodiazepinbesläktade medel 2.16.840.1.113883.6.73 2017-01 N05CF01 zopiclone Zopiklon 2.16.840.1.113883.6.73 2017-01 N05CF02 zolpidem Zolpidem 2.16.840.1.113883.6.73 2017-01 N05CF03 zaleplon Zaleplon 2.16.840.1.113883.6.73 2017-01 N05CF04 eszopiclone Eszopiklon 2.16.840.1.113883.6.73 2017-01 N05CH Melatonin receptor agonists Melatoninreceptor agonister 2.16.840.1.113883.6.73 2017-01 N05CH01 melatonin Melatonin 2.16.840.1.113883.6.73 2017-01 N05CH02 ramelteon Ramelteon 2.16.840.1.113883.6.73 2017-01 N05CH03 tasimelteon Tasimelteon 2.16.840.1.113883.6.73 2017-01 N05CM Other hypnotics and sedatives Övriga sömnmedel och lugnande medel 2.16.840.1.113883.6.73 2017-01 N05CM01 methaqualone Metakvalon 2.16.840.1.113883.6.73 2017-01 N05CM02 clomethiazole Klometiazol 2.16.840.1.113883.6.73 2017-01 N05CM03 bromisoval Bromisoval 2.16.840.1.113883.6.73 2017-01 N05CM04 carbromal Karbromal 2.16.840.1.113883.6.73 2017-01 N05CM05 scopolamine Skopolamin 2.16.840.1.113883.6.73 2017-01 N05CM06 propiomazine Propiomazin 2.16.840.1.113883.6.73 2017-01 N05CM07 triclofos Triklofos 2.16.840.1.113883.6.73 2017-01 N05CM08 ethchlorvynol Klorvinylpentinol 2.16.840.1.113883.6.73 2017-01 N05CM09 Valerianae radix Vänderot, rot 2.16.840.1.113883.6.73 2017-01 N05CM10 hexapropymate Hexapropymat 2.16.840.1.113883.6.73 2017-01 N05CM11 bromides Bromider 2.16.840.1.113883.6.73 2017-01 N05CM12 apronal Apronal 2.16.840.1.113883.6.73 2017-01 N05CM13 valnoctamide Valnoktamid 2.16.840.1.113883.6.73 2017-01 N05CM15 methylpentynol Metylpentynol 2.16.840.1.113883.6.73 2017-01 N05CM16 niaprazine Niaprazin 2.16.840.1.113883.6.73 2017-01 N05CM18 dexmedetomidine Dexmedetomidin 2.16.840.1.113883.6.73 2017-01 N05CX Hypnotics and sedatives in Kombinationer, exkl. combination, excl. barbiturates barbitursyraderivat 2.16.840.1.113883.6.73 2017-01 N05CX01 meprobamate, combinations Meprobamat, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX02 methaqualone, combinations Metkvalon, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX03 methylpentynol, combinations Metylpentynol, kombinationer © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 125 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CX04 clomethiazole, combinations Klometiazol, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX05 emepronium, combinations Emepron, kombinationer 2.16.840.1.113883.6.73 2017-01 N05CX06 dipiperonylaminoethanol, Dipiperonylaminoetanol, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 N06 PSYCHOANALEPTICS Psykoanaleptika 2.16.840.1.113883.6.73 2017-01 N06A ANTIDEPRESSANTS Antidepressiva medel 2.16.840.1.113883.6.73 2017-01 N06AA Non-selective monoamine reuptake Icke-selektiva inhibitors monoaminåterupptagshämmare 2.16.840.1.113883.6.73 2017-01 N06AA01 desipramine Desipramin 2.16.840.1.113883.6.73 2017-01 N06AA02 imipramine Imipramin 2.16.840.1.113883.6.73 2017-01 N06AA03 imipramine oxide Imipraminoxid 2.16.840.1.113883.6.73 2017-01 N06AA04 clomipramine Klomipramin 2.16.840.1.113883.6.73 2017-01 N06AA05 opipramol Opipramol 2.16.840.1.113883.6.73 2017-01 N06AA06 trimipramine Trimipramin 2.16.840.1.113883.6.73 2017-01 N06AA07 lofepramine Lofepramin 2.16.840.1.113883.6.73 2017-01 N06AA08 dibenzepin Dibensepin 2.16.840.1.113883.6.73 2017-01 N06AA09 amitriptyline Amitriptylin 2.16.840.1.113883.6.73 2017-01 N06AA10 nortriptyline Nortriptylin 2.16.840.1.113883.6.73 2017-01 N06AA11 protriptyline Protriptylin 2.16.840.1.113883.6.73 2017-01 N06AA12 doxepin Doxepin 2.16.840.1.113883.6.73 2017-01 N06AA13 iprindole Iprindol 2.16.840.1.113883.6.73 2017-01 N06AA14 melitracen Melitracen 2.16.840.1.113883.6.73 2017-01 N06AA15 butriptyline Butriptylin 2.16.840.1.113883.6.73 2017-01 N06AA16 dosulepin Dosulepin 2.16.840.1.113883.6.73 2017-01 N06AA17 amoxapine Amoxapin 2.16.840.1.113883.6.73 2017-01 N06AA18 dimetacrine Dimetakrin 2.16.840.1.113883.6.73 2017-01 N06AA19 amineptine Amineptin 2.16.840.1.113883.6.73 2017-01 N06AA21 maprotiline Maprotilin 2.16.840.1.113883.6.73 2017-01 N06AA23 quinupramine Kinupramin 2.16.840.1.113883.6.73 2017-01 N06AB Selective serotonin reuptake Selektiva inhibitors serotoninåterupptagshämmare 2.16.840.1.113883.6.73 2017-01 N06AB02 zimeldine Zimelidin 2.16.840.1.113883.6.73 2017-01 N06AB03 fluoxetine Fluoxetin 2.16.840.1.113883.6.73 2017-01 N06AB04 citalopram Citalopram 2.16.840.1.113883.6.73 2017-01 N06AB05 paroxetine Paroxetin 2.16.840.1.113883.6.73 2017-01 N06AB06 sertraline Sertralin 2.16.840.1.113883.6.73 2017-01 N06AB07 alaproclate Alaproklat 2.16.840.1.113883.6.73 2017-01 N06AB08 fluvoxamine Fluvoxamin 2.16.840.1.113883.6.73 2017-01 N06AB09 etoperidone Etoperidon 2.16.840.1.113883.6.73 2017-01 N06AB10 escitalopram Escitalopram 2.16.840.1.113883.6.73 2017-01 N06AF Monoamine oxidase inhibitors, non- MAO-hämmare, ickeselektiva selective 2.16.840.1.113883.6.73 2017-01 N06AF01 isocarboxazid Isokarboxazid 2.16.840.1.113883.6.73 2017-01 N06AF02 nialamide Nialamid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 126 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06AF03 phenelzine Fenelzin 2.16.840.1.113883.6.73 2017-01 N06AF04 tranylcypromine Tranylcypromin 2.16.840.1.113883.6.73 2017-01 N06AF05 iproniazide Iproniazid 2.16.840.1.113883.6.73 2017-01 N06AF06 iproclozide Iproklozid 2.16.840.1.113883.6.73 2017-01 N06AG Monoamine oxidase A inhibitors MAO-hämmare, selektiva typ A hämmare 2.16.840.1.113883.6.73 2017-01 N06AG02 moclobemide Moklobemid 2.16.840.1.113883.6.73 2017-01 N06AG03 toloxatone Toloxaton 2.16.840.1.113883.6.73 2017-01 N06AX Other antidepressants Övriga antidepressiva medel 2.16.840.1.113883.6.73 2017-01 N06AX01 oxitriptan Oxitriptan 2.16.840.1.113883.6.73 2017-01 N06AX02 tryptophan Tryptofan 2.16.840.1.113883.6.73 2017-01 N06AX03 mianserin Mianserin 2.16.840.1.113883.6.73 2017-01 N06AX04 nomifensine Nomifensin 2.16.840.1.113883.6.73 2017-01 N06AX05 trazodone Trazodon 2.16.840.1.113883.6.73 2017-01 N06AX06 nefazodone Nefazodon 2.16.840.1.113883.6.73 2017-01 N06AX07 minaprine Minaprin 2.16.840.1.113883.6.73 2017-01 N06AX08 bifemelane Bifemelan 2.16.840.1.113883.6.73 2017-01 N06AX09 viloxazine Viloxazin 2.16.840.1.113883.6.73 2017-01 N06AX10 oxaflozane Oxaflozan 2.16.840.1.113883.6.73 2017-01 N06AX11 mirtazapine Mirtazapin 2.16.840.1.113883.6.73 2017-01 N06AX12 bupropion Bupropion 2.16.840.1.113883.6.73 2017-01 N06AX13 medifoxamine Medifoxamin 2.16.840.1.113883.6.73 2017-01 N06AX14 tianeptine Tianeptin 2.16.840.1.113883.6.73 2017-01 N06AX15 pivagabine Pivagabin 2.16.840.1.113883.6.73 2017-01 N06AX16 venlafaxine Venlafaxin 2.16.840.1.113883.6.73 2017-01 N06AX17 milnacipran Milnacipran 2.16.840.1.113883.6.73 2017-01 N06AX18 reboxetine Reboxetin 2.16.840.1.113883.6.73 2017-01 N06AX19 gepirone Gepiron 2.16.840.1.113883.6.73 2017-01 N06AX21 duloxetine Duloxetin 2.16.840.1.113883.6.73 2017-01 N06AX22 agomelatine Agomelatin 2.16.840.1.113883.6.73 2017-01 N06AX23 desvenlafaxine Desvenlafaxin 2.16.840.1.113883.6.73 2017-01 N06AX24 vilazodone Vilazodon 2.16.840.1.113883.6.73 2017-01 N06AX25 Hyperici herba Hyperici herba 2.16.840.1.113883.6.73 2017-01 N06AX26 vortioxetine Vortioxetin 2.16.840.1.113883.6.73 2017-01 N06B PSYCHOSTIMULANTS, AGENTS Psykostimulantia, medel vid ADHD USED FOR ADHD AND och nootropika NOOTROPICS 2.16.840.1.113883.6.73 2017-01 N06BA Centrally acting sympathomimetics Centralt verkande sympatomimetika 2.16.840.1.113883.6.73 2017-01 N06BA01 amfetamine Amfetamin 2.16.840.1.113883.6.73 2017-01 N06BA02 dexamfetamine Dexamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA03 metamfetamine Metamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA04 methylphenidate Metylfenidat 2.16.840.1.113883.6.73 2017-01 N06BA05 pemoline Pemolin 2.16.840.1.113883.6.73 2017-01 N06BA06 fencamfamin Fenkamfamin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 127 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06BA07 modafinil Modafinil 2.16.840.1.113883.6.73 2017-01 N06BA08 fenozolone Fenozolon 2.16.840.1.113883.6.73 2017-01 N06BA09 atomoxetine Atomoxetin 2.16.840.1.113883.6.73 2017-01 N06BA10 fenetylline Fenetyllin 2.16.840.1.113883.6.73 2017-01 N06BA11 dexmethylphenidate Dexmetylfenidat 2.16.840.1.113883.6.73 2017-01 N06BA12 lisdexamfetamine Lisdexamfetamin 2.16.840.1.113883.6.73 2017-01 N06BA13 armodafinil Armodafinil 2.16.840.1.113883.6.73 2017-01 N06BC Xanthine derivatives Xantinderivat 2.16.840.1.113883.6.73 2017-01 N06BC01 caffeine Koffein 2.16.840.1.113883.6.73 2017-01 N06BC02 propentofylline Propentofyllin 2.16.840.1.113883.6.73 2017-01 N06BX Other psychostimulants and Övriga psykostimulantia och nootropics nootropika 2.16.840.1.113883.6.73 2017-01 N06BX01 meclofenoxate Meklofenoxat 2.16.840.1.113883.6.73 2017-01 N06BX02 pyritinol Pyritinol 2.16.840.1.113883.6.73 2017-01 N06BX03 piracetam Piracetam 2.16.840.1.113883.6.73 2017-01 N06BX04 deanol Deanol 2.16.840.1.113883.6.73 2017-01 N06BX05 fipexide Fipexid 2.16.840.1.113883.6.73 2017-01 N06BX06 citicoline Citikolin 2.16.840.1.113883.6.73 2017-01 N06BX07 oxiracetam Oxiracetam 2.16.840.1.113883.6.73 2017-01 N06BX08 pirisudanol Pirisudanol 2.16.840.1.113883.6.73 2017-01 N06BX09 linopirdine Linopirdin 2.16.840.1.113883.6.73 2017-01 N06BX10 nizofenone Nizofenon 2.16.840.1.113883.6.73 2017-01 N06BX11 aniracetam Aniracetam 2.16.840.1.113883.6.73 2017-01 N06BX12 acetylcarnitine Acetylcarnitin 2.16.840.1.113883.6.73 2017-01 N06BX13 idebenone Idebenon 2.16.840.1.113883.6.73 2017-01 N06BX14 prolintane Prolintan 2.16.840.1.113883.6.73 2017-01 N06BX15 pipradrol Pipradol 2.16.840.1.113883.6.73 2017-01 N06BX16 pramiracetam Pramiracetam 2.16.840.1.113883.6.73 2017-01 N06BX17 adrafinil Adrafinil 2.16.840.1.113883.6.73 2017-01 N06BX18 vinpocetine Vinpocetin 2.16.840.1.113883.6.73 2017-01 N06BX21 mebicar Mebikar 2.16.840.1.113883.6.73 2017-01 N06BX22 phenibut Fenibut 2.16.840.1.113883.6.73 2017-01 N06C PSYCHOLEPTICS AND Psykoleptika-psykoanaleptika, PSYCHOANALEPTICS IN kombinationer COMBINATION 2.16.840.1.113883.6.73 2017-01 N06CA Antidepressants in combination with Antidepressiva i kombination med psycholeptics psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CA01 amitriptyline and psycholeptics Amitriptylin och neuroleptika 2.16.840.1.113883.6.73 2017-01 N06CA02 melitracen and psycholeptics Melitracen och psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CA03 fluoxetine and psycholeptics Fluoxetin och psykoleptika 2.16.840.1.113883.6.73 2017-01 N06CB Psychostimulants in combination Psykostimulantia i kombination med with psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 N06D ANTI-DEMENTIA DRUGS Medel vid demenssjukdomar 2.16.840.1.113883.6.73 2017-01 N06DA Anticholinesterases Kolinesterashämmare 2.16.840.1.113883.6.73 2017-01 N06DA01 tacrine Takrin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 128 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06DA02 donepezil Donepezil 2.16.840.1.113883.6.73 2017-01 N06DA03 rivastigmine Rivastigmin 2.16.840.1.113883.6.73 2017-01 N06DA04 galantamine Galantamin 2.16.840.1.113883.6.73 2017-01 N06DA05 ipidacrine Ipidakrin 2.16.840.1.113883.6.73 2017-01 N06DA52 donepezil and memantine Donepezil och memantin 2.16.840.1.113883.6.73 2017-01 N06DA53 donepezil, memantine and Ginkgo Donepezil, memantin och Ginkgo, folium blad 2.16.840.1.113883.6.73 2017-01 N06DX Other anti-dementia drugs Övriga medel vid demenssjukdomar 2.16.840.1.113883.6.73 2017-01 N06DX01 memantine Memantin 2.16.840.1.113883.6.73 2017-01 N06DX02 Ginkgo folium Ginkgo, blad 2.16.840.1.113883.6.73 2017-01 N06DX30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 N07 OTHER NERVOUS SYSTEM Övriga medel med verkan på DRUGS nervsystemet 2.16.840.1.113883.6.73 2017-01 N07A PARASYMPATHOMIMETICS Parasympatomimetika 2.16.840.1.113883.6.73 2017-01 N07AA Anticholinesterases Kolinesterashämmare 2.16.840.1.113883.6.73 2017-01 N07AA01 neostigmine Neostigmin 2.16.840.1.113883.6.73 2017-01 N07AA02 pyridostigmine Pyridostigmin 2.16.840.1.113883.6.73 2017-01 N07AA03 distigmine Distigmin 2.16.840.1.113883.6.73 2017-01 N07AA30 ambenonium Ambenonium 2.16.840.1.113883.6.73 2017-01 N07AA51 neostigmine, combinations Neostigmin, kombinationer 2.16.840.1.113883.6.73 2017-01 N07AB Choline esters Kolinestrar 2.16.840.1.113883.6.73 2017-01 N07AB01 carbachol Karbakol 2.16.840.1.113883.6.73 2017-01 N07AB02 bethanechol Betanekol 2.16.840.1.113883.6.73 2017-01 N07AX Other parasympathomimetics Övriga parasympatomimetika 2.16.840.1.113883.6.73 2017-01 N07AX01 pilocarpine Pilokarpin 2.16.840.1.113883.6.73 2017-01 N07AX02 choline alfoscerate Kolinalfoscerat 2.16.840.1.113883.6.73 2017-01 N07AX03 cevimeline Cevimelin 2.16.840.1.113883.6.73 2017-01 N07B DRUGS USED IN ADDICTIVE Medel vid behandling av DISORDERS beroendetillstånd 2.16.840.1.113883.6.73 2017-01 N07BA Drugs used in nicotine dependence Medel vid nikotinberoende 2.16.840.1.113883.6.73 2017-01 N07BA01 nicotine Nikotin 2.16.840.1.113883.6.73 2017-01 N07BA03 varenicline Vareniklin 2.16.840.1.113883.6.73 2017-01 N07BB Drugs used in alcohol dependence Medel vid alkoholberoende 2.16.840.1.113883.6.73 2017-01 N07BB01 disulfiram Disulfiram 2.16.840.1.113883.6.73 2017-01 N07BB02 calcium carbimide Kalciumkarbimid 2.16.840.1.113883.6.73 2017-01 N07BB03 acamprosate Akamprosat 2.16.840.1.113883.6.73 2017-01 N07BB04 naltrexone Naltrexon 2.16.840.1.113883.6.73 2017-01 N07BB05 nalmefene Nalmefen 2.16.840.1.113883.6.73 2017-01 N07BC Drugs used in opioid dependence Medel vid opioidberoende 2.16.840.1.113883.6.73 2017-01 N07BC01 buprenorphine Buprenorfin 2.16.840.1.113883.6.73 2017-01 N07BC02 methadone Metadon 2.16.840.1.113883.6.73 2017-01 N07BC03 levacetylmethadol Levacetylmetadol 2.16.840.1.113883.6.73 2017-01 N07BC04 lofexidine Lofexidin 2.16.840.1.113883.6.73 2017-01 N07BC05 levomethadone Levometadon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 129 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N07BC06 diamorphine Diamorfin 2.16.840.1.113883.6.73 2017-01 N07BC51 buprenorphine, combinations Buprenorfin, kombinationer 2.16.840.1.113883.6.73 2017-01 N07C ANTIVERTIGO PREPARATIONS Medel mot yrsel 2.16.840.1.113883.6.73 2017-01 N07CA Antivertigo preparations Medel mot yrsel 2.16.840.1.113883.6.73 2017-01 N07CA01 betahistine Betahistin 2.16.840.1.113883.6.73 2017-01 N07CA02 cinnarizine Cinnarizin 2.16.840.1.113883.6.73 2017-01 N07CA03 flunarizine Flunarizin 2.16.840.1.113883.6.73 2017-01 N07CA04 acetylleucine Acetylleucin 2.16.840.1.113883.6.73 2017-01 N07CA52 cinnarizine, combinations Cinnarizin kombinationer 2.16.840.1.113883.6.73 2017-01 N07X OTHER NERVOUS SYSTEM Övriga läkemedel med verkan på DRUGS nervsystemet 2.16.840.1.113883.6.73 2017-01 N07XA Gangliosides and ganglioside Gangliosider och gangliosidderivat derivatives 2.16.840.1.113883.6.73 2017-01 N07XX Other nervous system drugs Övriga medel med verkan på nervsystemet 2.16.840.1.113883.6.73 2017-01 N07XX01 tirilazad Tirilazad 2.16.840.1.113883.6.73 2017-01 N07XX02 riluzole Riluzol 2.16.840.1.113883.6.73 2017-01 N07XX03 xaliproden Xaliproden 2.16.840.1.113883.6.73 2017-01 N07XX04 sodium oxybate Natriumoxibat 2.16.840.1.113883.6.73 2017-01 N07XX05 amifampridine Amifampridin 2.16.840.1.113883.6.73 2017-01 N07XX06 tetrabenazine Tetrabenazin 2.16.840.1.113883.6.73 2017-01 N07XX07 fampridine Fampridin 2.16.840.1.113883.6.73 2017-01 N07XX08 tafamidis Tafamidis 2.16.840.1.113883.6.73 2017-01 N07XX09 dimethyl fumarate Dimetylfumarat 2.16.840.1.113883.6.73 2017-01 N07XX10 laquinimod Lakinimod 2.16.840.1.113883.6.73 2017-01 N07XX11 pitolisant Pitolisant 2.16.840.1.113883.6.73 2017-01 N07XX59 dextromethorphan, combinations Dextrometorfan, kombinationer 2.16.840.1.113883.6.73 2017-01 P ANTIPARASITIC PRODUCTS, Antiparasitära, insektsdödande och INSECTICIDES AND REPELLENTS repellerande medel 2.16.840.1.113883.6.73 2017-01 P01 ANTIPROTOZOALS Medel mot protozoer 2.16.840.1.113883.6.73 2017-01 P01A AGENTS AGAINST AMOEBIASIS Medel mot protozoer AND OTHER PROTOZOAL DISEASES 2.16.840.1.113883.6.73 2017-01 P01AA Hydroxyquinoline derivatives Hydroxikinolinderivat 2.16.840.1.113883.6.73 2017-01 P01AA01 broxyquinoline Broxikinolin 2.16.840.1.113883.6.73 2017-01 P01AA02 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 P01AA04 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 P01AA05 tilbroquinol Tilbrokinol 2.16.840.1.113883.6.73 2017-01 P01AA52 clioquinol, combinations Kliokinol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AB Nitroimidazole derivatives Nitroimidazolderivat 2.16.840.1.113883.6.73 2017-01 P01AB01 metronidazole Metronidazol 2.16.840.1.113883.6.73 2017-01 P01AB02 tinidazole Tinidazol 2.16.840.1.113883.6.73 2017-01 P01AB03 ornidazole Ornidazol 2.16.840.1.113883.6.73 2017-01 P01AB04 azanidazole Azanidazol 2.16.840.1.113883.6.73 2017-01 P01AB05 propenidazole Propenidazol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 130 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01AB06 nimorazole Nimorazol 2.16.840.1.113883.6.73 2017-01 P01AB07 secnidazole Seknidazol 2.16.840.1.113883.6.73 2017-01 P01AB51 metronidazole, combinations Metronidazol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AC Dichloroacetamide derivatives Dikloracetamid derivat 2.16.840.1.113883.6.73 2017-01 P01AC01 diloxanide Diloxanid 2.16.840.1.113883.6.73 2017-01 P01AC02 clefamide Klefamid 2.16.840.1.113883.6.73 2017-01 P01AC03 etofamide Etofamid 2.16.840.1.113883.6.73 2017-01 P01AC04 teclozan Teklozan 2.16.840.1.113883.6.73 2017-01 P01AR Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 P01AR01 arsthinol Arstinol 2.16.840.1.113883.6.73 2017-01 P01AR02 difetarsone Difetarson 2.16.840.1.113883.6.73 2017-01 P01AR03 glycobiarsol Glykobiarsol 2.16.840.1.113883.6.73 2017-01 P01AR53 glycobiarsol, combinations Glykobiarsol, kombinationer 2.16.840.1.113883.6.73 2017-01 P01AX Other agents against amoebiasis Övriga medel mot protozoer and other protozoal diseases 2.16.840.1.113883.6.73 2017-01 P01AX01 chiniofon Kiniofon 2.16.840.1.113883.6.73 2017-01 P01AX02 emetine Emetin 2.16.840.1.113883.6.73 2017-01 P01AX04 phanquinone Fankinon 2.16.840.1.113883.6.73 2017-01 P01AX05 mepacrine Mepakrin 2.16.840.1.113883.6.73 2017-01 P01AX06 atovaquone Atovakvon 2.16.840.1.113883.6.73 2017-01 P01AX07 trimetrexate Trimetrexat 2.16.840.1.113883.6.73 2017-01 P01AX08 tenonitrozole Tenonitrozol 2.16.840.1.113883.6.73 2017-01 P01AX09 dehydroemetine Dihydroemetin 2.16.840.1.113883.6.73 2017-01 P01AX10 fumagillin Fumagillin 2.16.840.1.113883.6.73 2017-01 P01AX11 nitazoxanide Nitazoxanid 2.16.840.1.113883.6.73 2017-01 P01AX52 emetine, combinations Emetin, kombinationer 2.16.840.1.113883.6.73 2017-01 P01B ANTIMALARIALS Malariamedel 2.16.840.1.113883.6.73 2017-01 P01BA Aminoquinolines Aminokinoliner 2.16.840.1.113883.6.73 2017-01 P01BA01 chloroquine Klorokin 2.16.840.1.113883.6.73 2017-01 P01BA02 hydroxychloroquine Hydroxiklorokin 2.16.840.1.113883.6.73 2017-01 P01BA03 primaquine Primakin 2.16.840.1.113883.6.73 2017-01 P01BA06 amodiaquine Amodiakin 2.16.840.1.113883.6.73 2017-01 P01BB Biguanides Biguanider 2.16.840.1.113883.6.73 2017-01 P01BB01 proguanil Proguanil 2.16.840.1.113883.6.73 2017-01 P01BB02 cycloguanil embonate Cykloguanilembonat 2.16.840.1.113883.6.73 2017-01 P01BB51 proguanil, combinations Proguanil, kombinationer 2.16.840.1.113883.6.73 2017-01 P01BC Methanolquinolines Metanolkinoliner 2.16.840.1.113883.6.73 2017-01 P01BC01 quinine Kinin 2.16.840.1.113883.6.73 2017-01 P01BC02 mefloquine Meflokin 2.16.840.1.113883.6.73 2017-01 P01BD Diaminopyrimidines Diaminopyrimidiner 2.16.840.1.113883.6.73 2017-01 P01BD01 pyrimethamine Pyrimetamin 2.16.840.1.113883.6.73 2017-01 P01BD51 pyrimethamine, combinations Pyrimetamin, kombinationer 2.16.840.1.113883.6.73 2017-01 P01BE Artemisinin and derivatives, plain Artemisinin och derivat

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 131 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01BE01 artemisinin Artemisinin 2.16.840.1.113883.6.73 2017-01 P01BE02 artemether Artemeter 2.16.840.1.113883.6.73 2017-01 P01BE03 artesunate Artesunat 2.16.840.1.113883.6.73 2017-01 P01BE04 artemotil Artemotil 2.16.840.1.113883.6.73 2017-01 P01BE05 artenimol Artenimol 2.16.840.1.113883.6.73 2017-01 P01BF Artemisinin and derivatives, Artemisinin och derivat, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 P01BF01 artemether and lumefantrine Artemeter och lumefantrin 2.16.840.1.113883.6.73 2017-01 P01BF02 artesunate and mefloquine Artesunat och meflokin 2.16.840.1.113883.6.73 2017-01 P01BF03 artesunate and amodiaquine Artesunat och amodiakin 2.16.840.1.113883.6.73 2017-01 P01BF04 artesunate, sulphamethopyrazine Artesunat, sulfametopyrazin och and pyrimethamine pyrimetamin 2.16.840.1.113883.6.73 2017-01 P01BF05 artenimol and piperaquine Artenimol och piperakin 2.16.840.1.113883.6.73 2017-01 P01BF06 artesunate and pyronaridine Artesunat och pyronaridin 2.16.840.1.113883.6.73 2017-01 P01BX Other antimalarials Övriga malariamedel 2.16.840.1.113883.6.73 2017-01 P01BX01 halofantrine Halofantrin 2.16.840.1.113883.6.73 2017-01 P01BX02 arterolane and piperaquine Arterolan och piperakin 2.16.840.1.113883.6.73 2017-01 P01C AGENTS AGAINST Medel mot leishmaniasis och LEISHMANIASIS AND trypanosomiasis TRYPANOSOMIASIS 2.16.840.1.113883.6.73 2017-01 P01CA Nitroimidazole derivatives Nitroimidazolderivat 2.16.840.1.113883.6.73 2017-01 P01CA02 benznidazole Bensnidazol 2.16.840.1.113883.6.73 2017-01 P01CB Antimony compounds Antimonföreningar 2.16.840.1.113883.6.73 2017-01 P01CB01 meglumine antimonate Meglumin 2.16.840.1.113883.6.73 2017-01 P01CB02 sodium stibogluconate Natrium stiboglukonat 2.16.840.1.113883.6.73 2017-01 P01CC Nitrofuran derivatives Nitrofuranderivat 2.16.840.1.113883.6.73 2017-01 P01CC01 nifurtimox Nifurtimox 2.16.840.1.113883.6.73 2017-01 P01CC02 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 P01CD Arsenic compounds Arsenikföreningar 2.16.840.1.113883.6.73 2017-01 P01CD01 melarsoprol Melarsoprol 2.16.840.1.113883.6.73 2017-01 P01CD02 acetarsol Acetarsol 2.16.840.1.113883.6.73 2017-01 P01CX Other agents against leishmaniasis Övriga medel mot leishmaniasis och and trypanosomiasis trypanosomiasis 2.16.840.1.113883.6.73 2017-01 P01CX01 pentamidine isethionate Pentamidin 2.16.840.1.113883.6.73 2017-01 P01CX02 suramin sodium Suraminnatrium 2.16.840.1.113883.6.73 2017-01 P01CX03 eflornithine Eflornitin 2.16.840.1.113883.6.73 2017-01 P02 ANTHELMINTICS Medel vid maskinfektion 2.16.840.1.113883.6.73 2017-01 P02B ANTITREMATODALS Medel mot trematoder 2.16.840.1.113883.6.73 2017-01 P02BA Quinoline derivatives and related Kinolinderivat och närbesläktade substances substanser 2.16.840.1.113883.6.73 2017-01 P02BA01 praziquantel Prazikvantel 2.16.840.1.113883.6.73 2017-01 P02BA02 oxamniquine Oxamnikin 2.16.840.1.113883.6.73 2017-01 P02BB Organophosphorous compounds Organiska fosforföreningar 2.16.840.1.113883.6.73 2017-01 P02BB01 metrifonate Metrifonat 2.16.840.1.113883.6.73 2017-01 P02BX Other antitrematodal agents Övriga medel mot trematoder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 132 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P02BX01 bithionol Bitionol 2.16.840.1.113883.6.73 2017-01 P02BX02 niridazole Niridazol 2.16.840.1.113883.6.73 2017-01 P02BX03 stibophen Stibofen 2.16.840.1.113883.6.73 2017-01 P02BX04 triclabendazole Triklabendazol 2.16.840.1.113883.6.73 2017-01 P02C ANTINEMATODAL AGENTS Medel mot nematoder 2.16.840.1.113883.6.73 2017-01 P02CA Benzimidazole derivatives Bensimidazolderivat 2.16.840.1.113883.6.73 2017-01 P02CA01 mebendazole Mebendazol 2.16.840.1.113883.6.73 2017-01 P02CA02 tiabendazole Tiabendazol 2.16.840.1.113883.6.73 2017-01 P02CA03 albendazole Albendazol 2.16.840.1.113883.6.73 2017-01 P02CA04 ciclobendazole Ciclobendazol 2.16.840.1.113883.6.73 2017-01 P02CA05 flubendazole Flubendazol 2.16.840.1.113883.6.73 2017-01 P02CA06 fenbendazole Fenbendazol 2.16.840.1.113883.6.73 2017-01 P02CA51 mebendazole, combinations Mebendazol, kombinationer 2.16.840.1.113883.6.73 2017-01 P02CB Piperazine and derivatives Piperazin och derivat 2.16.840.1.113883.6.73 2017-01 P02CB01 piperazine Piperazin 2.16.840.1.113883.6.73 2017-01 P02CB02 diethylcarbamazine Dietylkarbamazin 2.16.840.1.113883.6.73 2017-01 P02CC Tetrahydropyrimidine derivatives Tetrahydropyrimidinderivat 2.16.840.1.113883.6.73 2017-01 P02CC01 pyrantel Pyrantel 2.16.840.1.113883.6.73 2017-01 P02CC02 oxantel Oxantel 2.16.840.1.113883.6.73 2017-01 P02CE Imidazothiazole derivatives Imidazotiazolderivat 2.16.840.1.113883.6.73 2017-01 P02CE01 levamisole Levamisol 2.16.840.1.113883.6.73 2017-01 P02CF Avermectines Avermektiner 2.16.840.1.113883.6.73 2017-01 P02CF01 ivermectin Ivermektin 2.16.840.1.113883.6.73 2017-01 P02CX Other antinematodals Övriga medel mot nematoder 2.16.840.1.113883.6.73 2017-01 P02CX01 pyrvinium Pyrvin 2.16.840.1.113883.6.73 2017-01 P02CX02 bephenium Befen 2.16.840.1.113883.6.73 2017-01 P02D ANTICESTODALS Medel mot cestoder 2.16.840.1.113883.6.73 2017-01 P02DA Salicylic acid derivatives Salicylsyraderivat 2.16.840.1.113883.6.73 2017-01 P02DA01 niclosamide Niklosamid 2.16.840.1.113883.6.73 2017-01 P02DX Other anticestodals Övriga medel mot cestoder 2.16.840.1.113883.6.73 2017-01 P02DX01 desaspidin Desaspidin 2.16.840.1.113883.6.73 2017-01 P02DX02 dichlorophen Diklorofen 2.16.840.1.113883.6.73 2017-01 P03 ECTOPARASITICIDES, INCL. Medel mot ektoparasiter, inkl. SCABICIDES, INSECTICIDES AND skabb-, insektsdödande och REPELLENTS repellerande medel 2.16.840.1.113883.6.73 2017-01 P03A ECTOPARASITICIDES, INCL. Medel mot ektoparasiter, inkl. SCABICIDES skabbmedel 2.16.840.1.113883.6.73 2017-01 P03AA Sulfur containing products Svavelhaltiga preparat 2.16.840.1.113883.6.73 2017-01 P03AA01 dixanthogen Dixantogen 2.16.840.1.113883.6.73 2017-01 P03AA02 potassium polysulfide Kaliumpolysulfid 2.16.840.1.113883.6.73 2017-01 P03AA03 mesulfen Mesulfen 2.16.840.1.113883.6.73 2017-01 P03AA04 disulfiram Disulfiram 2.16.840.1.113883.6.73 2017-01 P03AA05 thiram Tiram 2.16.840.1.113883.6.73 2017-01 P03AA54 disulfiram, combinations Disulfiram, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 133 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P03AB Chlorine containing products Klorhaltiga preparat 2.16.840.1.113883.6.73 2017-01 P03AB01 clofenotane Klofenotan 2.16.840.1.113883.6.73 2017-01 P03AB02 lindane Lindan 2.16.840.1.113883.6.73 2017-01 P03AB51 clofenotane, combinations Klofenotan, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC Pyrethrines, incl. synthetic Pyretriner, inkl. syntetiska föreningar compounds 2.16.840.1.113883.6.73 2017-01 P03AC01 pyrethrum Pyretrum 2.16.840.1.113883.6.73 2017-01 P03AC02 bioallethrin Bioalletrin 2.16.840.1.113883.6.73 2017-01 P03AC03 phenothrin Fenotrin 2.16.840.1.113883.6.73 2017-01 P03AC04 permethrin Permetrin 2.16.840.1.113883.6.73 2017-01 P03AC51 pyrethrum, combinations Pyretrum, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC52 bioallethrin, combinations Bioalletrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC53 phenothrin, combinations Fenotrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AC54 permethrin, combinations Permetrin, kombinationer 2.16.840.1.113883.6.73 2017-01 P03AX Other ectoparasiticides, incl. Övriga medel mot ektoparasiter, scabicides inkl. skabbmedel 2.16.840.1.113883.6.73 2017-01 P03AX01 benzyl benzoate Bensylbensoat 2.16.840.1.113883.6.73 2017-01 P03AX02 copper oleinate Kopparoleinat 2.16.840.1.113883.6.73 2017-01 P03AX03 malathion Malation 2.16.840.1.113883.6.73 2017-01 P03AX04 quassia Kvassia 2.16.840.1.113883.6.73 2017-01 P03AX05 dimeticone Dimetikon 2.16.840.1.113883.6.73 2017-01 P03AX06 benzyl alcohol Bensylalkohol 2.16.840.1.113883.6.73 2017-01 P03B INSECTICIDES AND REPELLENTS Insektsdödande och repellerande medel 2.16.840.1.113883.6.73 2017-01 P03BA Pyrethrines Pyretriner 2.16.840.1.113883.6.73 2017-01 P03BA01 cyfluthrin Cyflutrin 2.16.840.1.113883.6.73 2017-01 P03BA02 cypermethrin Cypermetrin 2.16.840.1.113883.6.73 2017-01 P03BA03 decamethrin Dekametrin 2.16.840.1.113883.6.73 2017-01 P03BA04 tetramethrin Tetrametrin 2.16.840.1.113883.6.73 2017-01 P03BX Other insecticides and repellents Övriga insektsdödande och repellerande medel 2.16.840.1.113883.6.73 2017-01 P03BX01 diethyltoluamide Dietyltoluamid 2.16.840.1.113883.6.73 2017-01 P03BX02 dimethylphthalate Dimetylftalat 2.16.840.1.113883.6.73 2017-01 P03BX03 dibutylphthalate Dibutylftalat 2.16.840.1.113883.6.73 2017-01 P03BX04 dibutylsuccinate Dibutylsuccinat 2.16.840.1.113883.6.73 2017-01 P03BX05 dimethylcarbate Dimetylkarbat 2.16.840.1.113883.6.73 2017-01 P03BX06 etohexadiol Etohexadiol 2.16.840.1.113883.6.73 2017-01 R RESPIRATORY SYSTEM Andningsorgan 2.16.840.1.113883.6.73 2017-01 R01 NASAL PREPARATIONS Medel vid nässjukdomar 2.16.840.1.113883.6.73 2017-01 R01A DECONGESTANTS AND OTHER Avsvällande och övriga medel för NASAL PREPARATIONS FOR lokal behandling vid nässjukdomar TOPICAL USE 2.16.840.1.113883.6.73 2017-01 R01AA Sympathomimetics, plain Sympatomimetika 2.16.840.1.113883.6.73 2017-01 R01AA02 cyclopentamine Cyklopentamin 2.16.840.1.113883.6.73 2017-01 R01AA03 ephedrine Efedrin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 134 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01AA04 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01AA05 oxymetazoline Oximetazolin 2.16.840.1.113883.6.73 2017-01 R01AA06 tetryzoline Tetryzolin 2.16.840.1.113883.6.73 2017-01 R01AA07 xylometazoline Xylometazolin 2.16.840.1.113883.6.73 2017-01 R01AA08 naphazoline Nafazolin 2.16.840.1.113883.6.73 2017-01 R01AA09 tramazoline Tramazolin 2.16.840.1.113883.6.73 2017-01 R01AA10 metizoline Metizolin 2.16.840.1.113883.6.73 2017-01 R01AA11 tuaminoheptane Tuaminoheptan 2.16.840.1.113883.6.73 2017-01 R01AA12 fenoxazoline Fenoxazolin 2.16.840.1.113883.6.73 2017-01 R01AA13 tymazoline Tymazolin 2.16.840.1.113883.6.73 2017-01 R01AA14 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 R01AA15 indanazoline Indanazolin 2.16.840.1.113883.6.73 2017-01 R01AB Sympathomimetics, combinations Sympatomimetika, kombinationer excl. corticosteroids exkl. kortikosteroider 2.16.840.1.113883.6.73 2017-01 R01AB01 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01AB02 naphazoline Nafazolin 2.16.840.1.113883.6.73 2017-01 R01AB03 tetryzoline Tetryzolin 2.16.840.1.113883.6.73 2017-01 R01AB05 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 R01AB06 xylometazoline Xylometazolin 2.16.840.1.113883.6.73 2017-01 R01AB07 oxymetazoline Oximetazolin 2.16.840.1.113883.6.73 2017-01 R01AB08 tuaminoheptane Tuaminoheptan 2.16.840.1.113883.6.73 2017-01 R01AC Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 R01AC01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R01AC02 levocabastine Levokabastin 2.16.840.1.113883.6.73 2017-01 R01AC03 azelastine Azelastin 2.16.840.1.113883.6.73 2017-01 R01AC04 antazoline Antazolin 2.16.840.1.113883.6.73 2017-01 R01AC05 spaglumic acid Spagluminsyra 2.16.840.1.113883.6.73 2017-01 R01AC06 thonzylamine Tonzylamin 2.16.840.1.113883.6.73 2017-01 R01AC07 nedocromil Nedokromil 2.16.840.1.113883.6.73 2017-01 R01AC08 olopatadine Olopatadin 2.16.840.1.113883.6.73 2017-01 R01AC51 cromoglicic acid, combinations Natriumkromoglikat, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 R01AD01 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 R01AD02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 R01AD03 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 R01AD04 flunisolide Flunisolid 2.16.840.1.113883.6.73 2017-01 R01AD05 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 R01AD06 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 R01AD07 tixocortol Tixokortol 2.16.840.1.113883.6.73 2017-01 R01AD08 fluticasone Flutikason 2.16.840.1.113883.6.73 2017-01 R01AD09 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 R01AD11 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 R01AD12 fluticasone furoate Flutikasonfuroat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 135 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01AD13 ciclesonide Ciklesonid 2.16.840.1.113883.6.73 2017-01 R01AD52 prednisolone, combinations Prednisolon, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD53 dexamethasone, combinations Dexametason, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD57 tixocortol, combinations Tixokortol, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD58 fluticasone, combinations Flutikason, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AD60 hydrocortisone, combinations Hydrokortison, kombinationer 2.16.840.1.113883.6.73 2017-01 R01AX Other nasal preparations Övriga medel vid nässjukdomar 2.16.840.1.113883.6.73 2017-01 R01AX01 calcium hexamine thiocyanate Kalciumhexamintiocyanat 2.16.840.1.113883.6.73 2017-01 R01AX02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 R01AX03 ipratropium bromide Ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R01AX05 ritiometan Ritiometan 2.16.840.1.113883.6.73 2017-01 R01AX06 mupirocin Mupirocin 2.16.840.1.113883.6.73 2017-01 R01AX07 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 R01AX08 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 R01AX09 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 R01AX10 various Övrigt 2.16.840.1.113883.6.73 2017-01 R01AX30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R01B NASAL DECONGESTANTS FOR Avsvällande medel, perorala SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R01BA Sympathomimetics Sympatomimetika 2.16.840.1.113883.6.73 2017-01 R01BA01 phenylpropanolamine Fenylpropanolamin 2.16.840.1.113883.6.73 2017-01 R01BA02 pseudoephedrine Pseudoefedrin 2.16.840.1.113883.6.73 2017-01 R01BA03 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 R01BA51 phenylpropanolamine, combinations Fenylpropanolamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R01BA52 pseudoephedrine, combinations Pseudoefedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 R01BA53 phenylephrine, combinations Fenylefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 R02 THROAT PREPARATIONS Medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02A THROAT PREPARATIONS Medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02AA Antiseptics Antiseptika 2.16.840.1.113883.6.73 2017-01 R02AA01 ambazone Ambazon 2.16.840.1.113883.6.73 2017-01 R02AA02 dequalinium Dekvalinium 2.16.840.1.113883.6.73 2017-01 R02AA03 dichlorobenzyl alcohol 2,4-Diklorobensylalkohol 2.16.840.1.113883.6.73 2017-01 R02AA05 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 R02AA06 cetylpyridinium Cetylpyridinium 2.16.840.1.113883.6.73 2017-01 R02AA09 benzethonium Bensetonium 2.16.840.1.113883.6.73 2017-01 R02AA10 myristyl-benzalkonium Myristylbensalkon 2.16.840.1.113883.6.73 2017-01 R02AA11 chlorquinaldol Klorkinaldol 2.16.840.1.113883.6.73 2017-01 R02AA12 hexylresorcinol Hexylresorcinol 2.16.840.1.113883.6.73 2017-01 R02AA13 acriflavinium chloride Akriflaviniumklorid 2.16.840.1.113883.6.73 2017-01 R02AA14 oxyquinoline Hydroxikinolin 2.16.840.1.113883.6.73 2017-01 R02AA15 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 R02AA16 benzalkonium Bensalkonium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 136 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R02AA17 cetrimonium Cetrimonium 2.16.840.1.113883.6.73 2017-01 R02AA18 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 R02AA19 phenol Fenol 2.16.840.1.113883.6.73 2017-01 R02AA20 various Övrigt 2.16.840.1.113883.6.73 2017-01 R02AA21 octenidine Oktenidin 2.16.840.1.113883.6.73 2017-01 R02AB Antibiotics Antibiotika 2.16.840.1.113883.6.73 2017-01 R02AB01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 R02AB02 tyrothricin Tyrotricin 2.16.840.1.113883.6.73 2017-01 R02AB03 fusafungine Fusafungin 2.16.840.1.113883.6.73 2017-01 R02AB04 bacitracin Bacitracin 2.16.840.1.113883.6.73 2017-01 R02AB30 gramicidin Gramicidin 2.16.840.1.113883.6.73 2017-01 R02AD Anesthetics, local Lokalanestetika 2.16.840.1.113883.6.73 2017-01 R02AD01 benzocaine Bensokain 2.16.840.1.113883.6.73 2017-01 R02AD02 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 R02AD03 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 R02AD04 dyclonine Dyklonin 2.16.840.1.113883.6.73 2017-01 R02AX Other throat preparations Övriga medel vid sjukdomar i strupe och svalg 2.16.840.1.113883.6.73 2017-01 R02AX01 flurbiprofen Flurbiprofen 2.16.840.1.113883.6.73 2017-01 R02AX02 ibuprofen Ibuprofen 2.16.840.1.113883.6.73 2017-01 R03 DRUGS FOR OBSTRUCTIVE Medel vid obstruktiva AIRWAY DISEASES luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03A ADRENERGICS, INHALANTS Adrenergika, inhalationer 2.16.840.1.113883.6.73 2017-01 R03AA Alpha- and beta-adrenoreceptor Alfa- och beta- agonists adrenoreceptoragonister 2.16.840.1.113883.6.73 2017-01 R03AA01 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 R03AB Non-selective beta-adrenoreceptor Icke-selektiva beta-adrenoceptor agonists agonister 2.16.840.1.113883.6.73 2017-01 R03AB02 isoprenaline Isoprenalin 2.16.840.1.113883.6.73 2017-01 R03AB03 orciprenaline Orkiprenalin 2.16.840.1.113883.6.73 2017-01 R03AC Selective beta-2-adrenoreceptor Selektiva beta-2-stimulerande agonists medel 2.16.840.1.113883.6.73 2017-01 R03AC02 salbutamol Salbutamol 2.16.840.1.113883.6.73 2017-01 R03AC03 terbutaline Terbutalin 2.16.840.1.113883.6.73 2017-01 R03AC04 fenoterol Fenoterol 2.16.840.1.113883.6.73 2017-01 R03AC05 rimiterol Rimiterol 2.16.840.1.113883.6.73 2017-01 R03AC06 hexoprenaline Hexoprenalin 2.16.840.1.113883.6.73 2017-01 R03AC07 isoetarine Isoetarin 2.16.840.1.113883.6.73 2017-01 R03AC08 pirbuterol Pirbuterol 2.16.840.1.113883.6.73 2017-01 R03AC09 tretoquinol Tretokinol 2.16.840.1.113883.6.73 2017-01 R03AC10 carbuterol Karbuterol 2.16.840.1.113883.6.73 2017-01 R03AC11 tulobuterol Tulobuterol 2.16.840.1.113883.6.73 2017-01 R03AC12 salmeterol Salmeterol 2.16.840.1.113883.6.73 2017-01 R03AC13 formoterol Formoterol 2.16.840.1.113883.6.73 2017-01 R03AC14 clenbuterol Klenbuterol © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 137 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03AC15 reproterol Reproterol 2.16.840.1.113883.6.73 2017-01 R03AC16 procaterol Prokaterol 2.16.840.1.113883.6.73 2017-01 R03AC17 bitolterol Bitolterol 2.16.840.1.113883.6.73 2017-01 R03AC18 indacaterol Indakaterol 2.16.840.1.113883.6.73 2017-01 R03AC19 olodaterol Olodaterol 2.16.840.1.113883.6.73 2017-01 R03AH Combinations of adrenergics Kombinationer av adrenergika 2.16.840.1.113883.6.73 2017-01 R03AK Adrenergics in combination with Adrenergika i kombination med corticosteroids or other drugs, excl. kortikosteroider eller övriga medel, anticholinergics exkl. antikolinergika 2.16.840.1.113883.6.73 2017-01 R03AK01 epinephrine and other drugs for Adrenalin och övriga medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03AK02 isoprenaline and other drugs for Isoprenalin och övriga medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03AK04 salbutamol and sodium Salbutamol och natriumkromoglikat cromoglicate 2.16.840.1.113883.6.73 2017-01 R03AK05 reproterol and sodium cromoglicate Reproterol och natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R03AK06 salmeterol and fluticasone Salmeterol och flutikason 2.16.840.1.113883.6.73 2017-01 R03AK07 formoterol and budesonide Formoterol och budesonid 2.16.840.1.113883.6.73 2017-01 R03AK08 formoterol and beclometasone Formoterol och beklometason 2.16.840.1.113883.6.73 2017-01 R03AK09 formoterol and mometasone Formoterol och mometason 2.16.840.1.113883.6.73 2017-01 R03AK10 vilanterol and fluticasone furoate Vilanterol och flutikasonfuroat 2.16.840.1.113883.6.73 2017-01 R03AK11 formoterol and fluticasone Formoterol och flutikason 2.16.840.1.113883.6.73 2017-01 R03AK12 salmeterol and budesonide Salmeterol och budesonid 2.16.840.1.113883.6.73 2017-01 R03AK13 salbutamol and beclometasone Salbutamol och beklometason 2.16.840.1.113883.6.73 2017-01 R03AL Adrenergics in combination with Adrenergika i kombination med anticholinergics antikolinergika inkl. trippelkombinationer med kortikosteroider 2.16.840.1.113883.6.73 2017-01 R03AL01 fenoterol and ipratropium bromide Fenoterol och ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL02 salbutamol and ipratropium bromide Salbutamol och ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL03 vilanterol and umeclidinium bromide Vilanterol och umeklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL04 indacaterol and glycopyrronium Indakaterol och bromide glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL05 formoterol and aclidinium bromide Formoterol och aklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03AL06 olodaterol and tiotropium bromide Olodaterol och tiotropiumbromid 2.16.840.1.113883.6.73 2017-01 R03AL07 formoterol and glycopyrronium Formoterol och bromide glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03B OTHER DRUGS FOR Övriga medel vid obstruktiva OBSTRUCTIVE AIRWAY luftvägssjukdomar, inhalationer DISEASES, INHALANTS 2.16.840.1.113883.6.73 2017-01 R03BA Glucocorticoids Glukokortikoider 2.16.840.1.113883.6.73 2017-01 R03BA01 beclometasone Beklometason 2.16.840.1.113883.6.73 2017-01 R03BA02 budesonide Budesonid 2.16.840.1.113883.6.73 2017-01 R03BA03 flunisolide Flunisolid 2.16.840.1.113883.6.73 2017-01 R03BA04 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 R03BA05 fluticasone Flutikason 2.16.840.1.113883.6.73 2017-01 R03BA06 triamcinolone Triamcinolon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 138 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03BA07 mometasone Mometason 2.16.840.1.113883.6.73 2017-01 R03BA08 ciclesonide Ciklesonid 2.16.840.1.113883.6.73 2017-01 R03BA09 fluticasone furoate Flutikasonfuroat 2.16.840.1.113883.6.73 2017-01 R03BB Anticholinergics Antikolinergika 2.16.840.1.113883.6.73 2017-01 R03BB01 ipratropium bromide Ipratropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB02 oxitropium bromide Oxitropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB03 stramoni preparations Stramonimedel 2.16.840.1.113883.6.73 2017-01 R03BB04 tiotropium bromide Tiotropiumbromid 2.16.840.1.113883.6.73 2017-01 R03BB05 aclidinium bromide Aklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB06 glycopyrronium bromide Glykopyrroniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB07 umeclidinium bromide Umeklidiniumbromid 2.16.840.1.113883.6.73 2017-01 R03BB54 tiotropium bromide, combinations Tiotropiumbromid, kombinationer 2.16.840.1.113883.6.73 2017-01 R03BC Antiallergic agents, excl. Antiallergika, exkl. kortikosteroider corticosteroids 2.16.840.1.113883.6.73 2017-01 R03BC01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 R03BC03 nedocromil Nedokromil 2.16.840.1.113883.6.73 2017-01 R03BX Other drugs for obstructive airway Övriga medel vid obstruktiva diseases, inhalants luftvägssjukdomar, inhalationer 2.16.840.1.113883.6.73 2017-01 R03BX01 fenspiride Fenspirid 2.16.840.1.113883.6.73 2017-01 R03C ADRENERGICS FOR SYSTEMIC Adrenergika för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R03CA Alpha- and beta-adrenoreceptor Alfa- och beta- agonists adrenoreceptoragonister 2.16.840.1.113883.6.73 2017-01 R03CA02 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 R03CB Non-selective beta-adrenoreceptor Icke-selektiva beta-adrenoceptor agonists agonister 2.16.840.1.113883.6.73 2017-01 R03CB01 isoprenaline Isoprenalin 2.16.840.1.113883.6.73 2017-01 R03CB02 methoxyphenamine Metoxifenamin 2.16.840.1.113883.6.73 2017-01 R03CB03 orciprenaline Orkiprenalin 2.16.840.1.113883.6.73 2017-01 R03CB51 isoprenaline, combinations Isoprenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CB53 orciprenaline, combinations Orkiprenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CC Selective beta-2-adrenoreceptor Selektiva beta-2-stimulerande agonists medel 2.16.840.1.113883.6.73 2017-01 R03CC02 salbutamol Salbutamol 2.16.840.1.113883.6.73 2017-01 R03CC03 terbutaline Terbutalin 2.16.840.1.113883.6.73 2017-01 R03CC04 fenoterol Fenoterol 2.16.840.1.113883.6.73 2017-01 R03CC05 hexoprenaline Hexoprenalin 2.16.840.1.113883.6.73 2017-01 R03CC06 isoetarine Isoetarin 2.16.840.1.113883.6.73 2017-01 R03CC07 pirbuterol Pirbuterol 2.16.840.1.113883.6.73 2017-01 R03CC08 procaterol Prokaterol 2.16.840.1.113883.6.73 2017-01 R03CC09 tretoquinol Tretokinol 2.16.840.1.113883.6.73 2017-01 R03CC10 carbuterol Karbuterol 2.16.840.1.113883.6.73 2017-01 R03CC11 tulobuterol Tulobuterol 2.16.840.1.113883.6.73 2017-01 R03CC12 bambuterol Bambuterol 2.16.840.1.113883.6.73 2017-01 R03CC13 clenbuterol Klenbuterol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 139 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03CC14 reproterol Reproterol 2.16.840.1.113883.6.73 2017-01 R03CC53 terbutaline, combinations Terbutalin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03CK Adrenergics and other drugs for Adrenergika och andra medel vid obstructive airway diseases obstruktiva luftvägssjukdomar 2.16.840.1.113883.6.73 2017-01 R03D OTHER SYSTEMIC DRUGS FOR Övriga systemiska medel för OBSTRUCTIVE AIRWAY obstruktiva lungsjukdomar DISEASES 2.16.840.1.113883.6.73 2017-01 R03DA Xanthines Xantiner 2.16.840.1.113883.6.73 2017-01 R03DA01 diprophylline Diprofyllin 2.16.840.1.113883.6.73 2017-01 R03DA02 choline theophyllinate Kolinteofyllinat 2.16.840.1.113883.6.73 2017-01 R03DA03 proxyphylline Proxifyllin 2.16.840.1.113883.6.73 2017-01 R03DA04 theophylline Teofyllin 2.16.840.1.113883.6.73 2017-01 R03DA05 aminophylline Aminofyllin 2.16.840.1.113883.6.73 2017-01 R03DA06 etamiphylline Etamifyllin 2.16.840.1.113883.6.73 2017-01 R03DA07 theobromine Teobromin 2.16.840.1.113883.6.73 2017-01 R03DA08 bamifylline Bamifyllin 2.16.840.1.113883.6.73 2017-01 R03DA09 acefylline piperazine Acefyllinpiperazin 2.16.840.1.113883.6.73 2017-01 R03DA10 bufylline Bufyllin 2.16.840.1.113883.6.73 2017-01 R03DA11 doxofylline Doxofyllin 2.16.840.1.113883.6.73 2017-01 R03DA20 combinations of xanthines Kombinationer av xantinderivat 2.16.840.1.113883.6.73 2017-01 R03DA51 diprophylline, combinations Diprofyllin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA54 theophylline, combinations excl. Teofyllin, kombinationer, exkl. psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 R03DA55 aminophylline, combinations Aminofyllin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA57 theobromine, combinations Teobromin, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DA74 theophylline, combinations with Teofyllin, kombinationer med psycholeptics neuroleptika 2.16.840.1.113883.6.73 2017-01 R03DB Xanthines and adrenergics Xantiner och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB01 diprophylline and adrenergics Diprofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB02 choline theophyllinate and Kolinteofyllinat och adrenergika adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB03 proxyphylline and adrenergics Proxyfyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB04 theophylline and adrenergics Teofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB05 aminophylline and adrenergics Aminofyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DB06 etamiphylline and adrenergics Etamifyllin och adrenergika 2.16.840.1.113883.6.73 2017-01 R03DC Leukotriene receptor antagonists Leukotrienreceptorantagonister 2.16.840.1.113883.6.73 2017-01 R03DC01 zafirlukast Zafirlukast 2.16.840.1.113883.6.73 2017-01 R03DC02 pranlukast Pranlukast 2.16.840.1.113883.6.73 2017-01 R03DC03 montelukast Montelukast 2.16.840.1.113883.6.73 2017-01 R03DC04 ibudilast Ibudilast 2.16.840.1.113883.6.73 2017-01 R03DC53 montelukast, combinations Montelukast, kombinationer 2.16.840.1.113883.6.73 2017-01 R03DX Other systemic drugs for obstructive Övriga systemiska medel för airway diseases obstruktiva lungsjukdomar 2.16.840.1.113883.6.73 2017-01 R03DX01 amlexanox Amlexanox 2.16.840.1.113883.6.73 2017-01 R03DX02 eprozinol Eprozinol

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 140 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03DX03 fenspiride Fenspirid 2.16.840.1.113883.6.73 2017-01 R03DX05 omalizumab Omalizumab 2.16.840.1.113883.6.73 2017-01 R03DX06 seratrodast Seratrodast 2.16.840.1.113883.6.73 2017-01 R03DX07 roflumilast Roflumilast 2.16.840.1.113883.6.73 2017-01 R03DX08 reslizumab Reslizumab 2.16.840.1.113883.6.73 2017-01 R03DX09 mepolizumab Mepolizumab 2.16.840.1.113883.6.73 2017-01 R05 COUGH AND COLD Medel mot hosta och förkylning PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R05C EXPECTORANTS, EXCL. Expektorantia, exkl. kombinationer COMBINATIONS WITH COUGH med hostdämpande medel SUPPRESSANTS 2.16.840.1.113883.6.73 2017-01 R05CA Expectorants Expektorantia, exkl. mukolytika 2.16.840.1.113883.6.73 2017-01 R05CA01 tyloxapol Tyloxapol 2.16.840.1.113883.6.73 2017-01 R05CA02 potassium iodide Kaliumjodid 2.16.840.1.113883.6.73 2017-01 R05CA03 guaifenesin Guajfenesin 2.16.840.1.113883.6.73 2017-01 R05CA04 ipecacuanha Ipekakuanharot 2.16.840.1.113883.6.73 2017-01 R05CA05 althea root Altearot 2.16.840.1.113883.6.73 2017-01 R05CA06 senega Senega 2.16.840.1.113883.6.73 2017-01 R05CA07 antimony pentasulfide Antimonpentasulfid 2.16.840.1.113883.6.73 2017-01 R05CA08 creosote Kreosot 2.16.840.1.113883.6.73 2017-01 R05CA09 guaiacolsulfonate Guajakolsulfonat 2.16.840.1.113883.6.73 2017-01 R05CA10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05CA11 levoverbenone Levoverbenon 2.16.840.1.113883.6.73 2017-01 R05CA12 Hederae helicis folium Murgröna, blad 2.16.840.1.113883.6.73 2017-01 R05CA13 cineole Cineol 2.16.840.1.113883.6.73 2017-01 R05CB Mucolytics Mukolytika 2.16.840.1.113883.6.73 2017-01 R05CB01 acetylcysteine Acetylcystein 2.16.840.1.113883.6.73 2017-01 R05CB02 bromhexine Bromhexin 2.16.840.1.113883.6.73 2017-01 R05CB03 carbocisteine Karbocystein 2.16.840.1.113883.6.73 2017-01 R05CB04 eprazinone Eprazinon 2.16.840.1.113883.6.73 2017-01 R05CB05 mesna Mesna 2.16.840.1.113883.6.73 2017-01 R05CB06 ambroxol Ambroxol 2.16.840.1.113883.6.73 2017-01 R05CB07 sobrerol Sobrerol 2.16.840.1.113883.6.73 2017-01 R05CB08 domiodol Domiodol 2.16.840.1.113883.6.73 2017-01 R05CB09 letosteine Letostein 2.16.840.1.113883.6.73 2017-01 R05CB10 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05CB11 stepronin Stepronin 2.16.840.1.113883.6.73 2017-01 R05CB13 dornase alfa (desoxyribonuclease) Dornas alfa (deoxiribonukleas) 2.16.840.1.113883.6.73 2017-01 R05CB14 neltenexine Neltenexin 2.16.840.1.113883.6.73 2017-01 R05CB15 erdosteine Erdostein 2.16.840.1.113883.6.73 2017-01 R05CB16 mannitol Mannitol 2.16.840.1.113883.6.73 2017-01 R05D COUGH SUPPRESSANTS, EXCL. Hosthämmande medel, exkl COMBINATIONS WITH kombinationer med expektorantia EXPECTORANTS 2.16.840.1.113883.6.73 2017-01 R05DA Opium alkaloids and derivatives Opiumalkaloider och derivat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 141 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05DA01 ethylmorphine Etylmorfin 2.16.840.1.113883.6.73 2017-01 R05DA03 hydrocodone Hydrokodon 2.16.840.1.113883.6.73 2017-01 R05DA04 codeine Kodein 2.16.840.1.113883.6.73 2017-01 R05DA05 opium alkaloids with morphine Opiumalkaloider med morfin 2.16.840.1.113883.6.73 2017-01 R05DA06 normethadone Normetadon 2.16.840.1.113883.6.73 2017-01 R05DA07 noscapine Noskapin 2.16.840.1.113883.6.73 2017-01 R05DA08 pholcodine Folkodin 2.16.840.1.113883.6.73 2017-01 R05DA09 dextromethorphan Dextrometorfan 2.16.840.1.113883.6.73 2017-01 R05DA10 thebacon Tebakon 2.16.840.1.113883.6.73 2017-01 R05DA11 dimemorfan Dimemorfan 2.16.840.1.113883.6.73 2017-01 R05DA12 acetyldihydrocodeine Acetyldihydrokodein 2.16.840.1.113883.6.73 2017-01 R05DA20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05DB Other cough suppressants Övriga hostdämpande medel 2.16.840.1.113883.6.73 2017-01 R05DB01 benzonatate Bensonatat 2.16.840.1.113883.6.73 2017-01 R05DB02 benproperine Benproperin 2.16.840.1.113883.6.73 2017-01 R05DB03 clobutinol Klobutinol 2.16.840.1.113883.6.73 2017-01 R05DB04 isoaminile Isoaminil 2.16.840.1.113883.6.73 2017-01 R05DB05 pentoxyverine Pentoxiverin 2.16.840.1.113883.6.73 2017-01 R05DB07 oxolamine Oxolamin 2.16.840.1.113883.6.73 2017-01 R05DB09 oxeladin Oxeladin 2.16.840.1.113883.6.73 2017-01 R05DB10 clofedanol Klofedanol 2.16.840.1.113883.6.73 2017-01 R05DB11 pipazetate Pipazetat 2.16.840.1.113883.6.73 2017-01 R05DB12 bibenzonium bromide Bibenzoniumbromid 2.16.840.1.113883.6.73 2017-01 R05DB13 butamirate Butamirat 2.16.840.1.113883.6.73 2017-01 R05DB14 fedrilate Fedrilat 2.16.840.1.113883.6.73 2017-01 R05DB15 zipeprol Zipeprol 2.16.840.1.113883.6.73 2017-01 R05DB16 dibunate Dibunat 2.16.840.1.113883.6.73 2017-01 R05DB17 droxypropine Droxypropin 2.16.840.1.113883.6.73 2017-01 R05DB18 prenoxdiazine Prenoxdiazin 2.16.840.1.113883.6.73 2017-01 R05DB19 dropropizine Dropropizin 2.16.840.1.113883.6.73 2017-01 R05DB20 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R05DB21 cloperastine Kloperastin 2.16.840.1.113883.6.73 2017-01 R05DB22 meprotixol Meprotixol 2.16.840.1.113883.6.73 2017-01 R05DB23 piperidione Piperidion 2.16.840.1.113883.6.73 2017-01 R05DB24 tipepidine Tipepidin 2.16.840.1.113883.6.73 2017-01 R05DB25 morclofone Morklofon 2.16.840.1.113883.6.73 2017-01 R05DB26 nepinalone Nepinalon 2.16.840.1.113883.6.73 2017-01 R05DB27 levodropropizine Levodropropizin 2.16.840.1.113883.6.73 2017-01 R05DB28 dimethoxanate Dimetoxanat 2.16.840.1.113883.6.73 2017-01 R05F COUGH SUPPRESSANTS AND Hosthämmande medel i EXPECTORANTS, kombination med expektorantia COMBINATIONS 2.16.840.1.113883.6.73 2017-01 R05FA Opium derivatives and expectorants Opiumderivat och expektorantia 2.16.840.1.113883.6.73 2017-01 R05FA01 opium derivatives and mucolytics Opiumderivat och mukolytika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 142 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05FA02 opium derivatives and expectorants Opiumderivat och expektorantia 2.16.840.1.113883.6.73 2017-01 R05FB Other cough suppressants and Övriga hosthämmande medel i expectorants kombination med expektorantia 2.16.840.1.113883.6.73 2017-01 R05FB01 cough suppressants and mucolytics Hosthämmande medel och mukolytika 2.16.840.1.113883.6.73 2017-01 R05FB02 cough suppressants and Hosthämmande medel i expectorants kombination med expektorantia, exkl mukolytika 2.16.840.1.113883.6.73 2017-01 R05X OTHER COLD PREPARATIONS Övriga medel mot förkylning 2.16.840.1.113883.6.73 2017-01 R06 ANTIHISTAMINES FOR SYSTEMIC Antihistaminer för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R06A ANTIHISTAMINES FOR SYSTEMIC Antihistaminer för systemiskt bruk USE 2.16.840.1.113883.6.73 2017-01 R06AA Aminoalkyl ethers Aminoalkyletrar 2.16.840.1.113883.6.73 2017-01 R06AA01 bromazine Bromdifenhydramin 2.16.840.1.113883.6.73 2017-01 R06AA02 diphenhydramine Dimenhydrinat 2.16.840.1.113883.6.73 2017-01 R06AA04 clemastine Klemastin 2.16.840.1.113883.6.73 2017-01 R06AA06 chlorphenoxamine Klorfenoxamin 2.16.840.1.113883.6.73 2017-01 R06AA07 diphenylpyraline Difenylpyralin 2.16.840.1.113883.6.73 2017-01 R06AA08 carbinoxamine Karbinoxamin 2.16.840.1.113883.6.73 2017-01 R06AA09 doxylamine Doxylamin 2.16.840.1.113883.6.73 2017-01 R06AA10 trimethobenzamide Trimetobenzamid 2.16.840.1.113883.6.73 2017-01 R06AA52 diphenhydramine, combinations Difenhydramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA54 clemastine, combinations Klemastin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA56 chlorphenoxamine, combinations Klorfenoxamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA57 diphenylpyraline, combinations Difenylpyralin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AA59 doxylamine, combinations Doxylamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB Substituted alkylamines Alkylaminer, substituerade 2.16.840.1.113883.6.73 2017-01 R06AB01 brompheniramine Bromfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB02 dexchlorpheniramine Dexklorfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB03 dimetindene Dimetinden 2.16.840.1.113883.6.73 2017-01 R06AB04 chlorphenamine Klorfenamin 2.16.840.1.113883.6.73 2017-01 R06AB05 pheniramine Feniramin 2.16.840.1.113883.6.73 2017-01 R06AB06 dexbrompheniramine Dexbromfeniramin 2.16.840.1.113883.6.73 2017-01 R06AB07 talastine Talastin 2.16.840.1.113883.6.73 2017-01 R06AB51 brompheniramine, combinations Bromfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB52 dexchlorpheniramine, combinations Dexklorfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB54 chlorphenamine, combinations Klorfenamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AB56 dexbrompheniramine, combinations Dexbromfeniramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AC Substituted ethylene diamines Etylendiaminer, substituerade 2.16.840.1.113883.6.73 2017-01 R06AC01 mepyramine Mepyramin 2.16.840.1.113883.6.73 2017-01 R06AC02 histapyrrodine Histapyrrodin 2.16.840.1.113883.6.73 2017-01 R06AC03 chloropyramine Kloropyramin 2.16.840.1.113883.6.73 2017-01 R06AC04 tripelennamine Tripelennamin 2.16.840.1.113883.6.73 2017-01 R06AC05 methapyrilene Metapyrilen

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 143 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AC06 thonzylamine Tonzylamin 2.16.840.1.113883.6.73 2017-01 R06AC52 histapyrrodine, combinations Histapyrrodin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AC53 chloropyramine, combinations Kloropyramin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AD Phenothiazine derivatives Fentiazinderivat 2.16.840.1.113883.6.73 2017-01 R06AD01 alimemazine Alimemazin 2.16.840.1.113883.6.73 2017-01 R06AD02 promethazine Prometazin 2.16.840.1.113883.6.73 2017-01 R06AD03 thiethylperazine Tietylperazin 2.16.840.1.113883.6.73 2017-01 R06AD04 methdilazine Metdilazin 2.16.840.1.113883.6.73 2017-01 R06AD05 hydroxyethylpromethazine Hydroxietylprometazin 2.16.840.1.113883.6.73 2017-01 R06AD06 thiazinam Tiazinam 2.16.840.1.113883.6.73 2017-01 R06AD07 mequitazine Mekitazin 2.16.840.1.113883.6.73 2017-01 R06AD08 oxomemazine Oxomemazin 2.16.840.1.113883.6.73 2017-01 R06AD09 isothipendyl Isotipendyl 2.16.840.1.113883.6.73 2017-01 R06AD52 promethazine, combinations Prometazin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AD55 hydroxyethylpromethazine, Hydroxietylprometazin, combinations kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE Piperazine derivatives Piperazinderivat 2.16.840.1.113883.6.73 2017-01 R06AE01 buclizine Buklizin 2.16.840.1.113883.6.73 2017-01 R06AE03 cyclizine Cyklizin 2.16.840.1.113883.6.73 2017-01 R06AE04 chlorcyclizine Klorcyklizin 2.16.840.1.113883.6.73 2017-01 R06AE05 meclozine Meklozin 2.16.840.1.113883.6.73 2017-01 R06AE06 oxatomide Oxatomid 2.16.840.1.113883.6.73 2017-01 R06AE07 cetirizine Cetirizin 2.16.840.1.113883.6.73 2017-01 R06AE09 levocetirizine Levocetirizin 2.16.840.1.113883.6.73 2017-01 R06AE51 buclizine, combinations Buklizin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE53 cyclizine, combinations Cyklizin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AE55 meclozine, combinations Meklozin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AK Combinations of antihistamines Kombinationer av antihistaminer 2.16.840.1.113883.6.73 2017-01 R06AX Other antihistamines for systemic Övriga antihistaminer för systemiskt use bruk 2.16.840.1.113883.6.73 2017-01 R06AX01 bamipine Bamipin 2.16.840.1.113883.6.73 2017-01 R06AX02 cyproheptadine Cyproheptadin 2.16.840.1.113883.6.73 2017-01 R06AX03 thenalidine Tenalidin 2.16.840.1.113883.6.73 2017-01 R06AX04 phenindamine Fenindamin 2.16.840.1.113883.6.73 2017-01 R06AX05 antazoline Antazolin 2.16.840.1.113883.6.73 2017-01 R06AX07 triprolidine Triprolidin 2.16.840.1.113883.6.73 2017-01 R06AX08 pyrrobutamine Pyrrobutamin 2.16.840.1.113883.6.73 2017-01 R06AX09 azatadine Azatadin 2.16.840.1.113883.6.73 2017-01 R06AX11 astemizole Astemizol 2.16.840.1.113883.6.73 2017-01 R06AX12 terfenadine Terfenadin 2.16.840.1.113883.6.73 2017-01 R06AX13 loratadine Loratadin 2.16.840.1.113883.6.73 2017-01 R06AX15 mebhydrolin Mebhydrolin 2.16.840.1.113883.6.73 2017-01 R06AX16 deptropine Deptropin 2.16.840.1.113883.6.73 2017-01 R06AX17 ketotifen Ketotifen © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 144 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AX18 acrivastine Akrivastin 2.16.840.1.113883.6.73 2017-01 R06AX19 azelastine Azelastin 2.16.840.1.113883.6.73 2017-01 R06AX21 tritoqualine Tritokvalin 2.16.840.1.113883.6.73 2017-01 R06AX22 ebastine Ebastin 2.16.840.1.113883.6.73 2017-01 R06AX23 pimethixene Pimetixen 2.16.840.1.113883.6.73 2017-01 R06AX24 epinastine Epinastin 2.16.840.1.113883.6.73 2017-01 R06AX25 mizolastine Mizolastin 2.16.840.1.113883.6.73 2017-01 R06AX26 fexofenadine Fexofenadin 2.16.840.1.113883.6.73 2017-01 R06AX27 desloratadine Desloratadin 2.16.840.1.113883.6.73 2017-01 R06AX28 rupatadine Rupatadin 2.16.840.1.113883.6.73 2017-01 R06AX29 bilastine Bilastin 2.16.840.1.113883.6.73 2017-01 R06AX31 quifenadine Kifenadin 2.16.840.1.113883.6.73 2017-01 R06AX32 sequifenadine Sekifenadin 2.16.840.1.113883.6.73 2017-01 R06AX53 thenalidine, combinations Tenalidin, kombinationer 2.16.840.1.113883.6.73 2017-01 R06AX58 pyrrobutamine, combinations Pyrrobutamin, kombinationer 2.16.840.1.113883.6.73 2017-01 R07 OTHER RESPIRATORY SYSTEM Övriga medel vid sjukdomar i PRODUCTS andningsorganen 2.16.840.1.113883.6.73 2017-01 R07A OTHER RESPIRATORY SYSTEM Övriga medel vid sjukdomar i PRODUCTS andningsorganen 2.16.840.1.113883.6.73 2017-01 R07AA Lung surfactants Ytaktiva medel (lunga) 2.16.840.1.113883.6.73 2017-01 R07AA01 colfosceril palmitate Kolfoskeril 2.16.840.1.113883.6.73 2017-01 R07AA02 natural phospholipids Naturliga fosfolipider 2.16.840.1.113883.6.73 2017-01 R07AA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 R07AB Respiratory stimulants Andningsstimulerande medel 2.16.840.1.113883.6.73 2017-01 R07AB01 doxapram Doxapram 2.16.840.1.113883.6.73 2017-01 R07AB02 nikethamide Niketamid 2.16.840.1.113883.6.73 2017-01 R07AB03 pentetrazol Pentetrazol 2.16.840.1.113883.6.73 2017-01 R07AB04 etamivan Etamivan 2.16.840.1.113883.6.73 2017-01 R07AB05 bemegride Bemegrid 2.16.840.1.113883.6.73 2017-01 R07AB06 prethcamide Pretkamid 2.16.840.1.113883.6.73 2017-01 R07AB07 almitrine Almitrin 2.16.840.1.113883.6.73 2017-01 R07AB08 dimefline Dimeflin 2.16.840.1.113883.6.73 2017-01 R07AB09 mepixanox Mepixanox 2.16.840.1.113883.6.73 2017-01 R07AB52 nikethamide, combinations Niketamid, kombinationer 2.16.840.1.113883.6.73 2017-01 R07AB53 pentetrazol, combinations Pentetrazol, kombinationer 2.16.840.1.113883.6.73 2017-01 R07AX Other respiratory system products Övriga medel vid sjukdomar i andningsorganen 2.16.840.1.113883.6.73 2017-01 R07AX01 nitric oxide Kväveoxid 2.16.840.1.113883.6.73 2017-01 R07AX02 ivacaftor Ivakaftor 2.16.840.1.113883.6.73 2017-01 R07AX30 ivacaftor and lumacaftor Ivakaftor och lumakaftor 2.16.840.1.113883.6.73 2017-01 S SENSORY ORGANS Ögon och öron 2.16.840.1.113883.6.73 2017-01 S01 OPHTHALMOLOGICALS Medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01AA Antibiotics Antibiotika

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 145 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S01AA02 chlortetracycline Klortetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA03 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S01AA04 oxytetracycline Oxitetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA05 tyrothricin Tyrotricin 2.16.840.1.113883.6.73 2017-01 S01AA07 framycetin Framycetin 2.16.840.1.113883.6.73 2017-01 S01AA09 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S01AA10 natamycin Natamycin 2.16.840.1.113883.6.73 2017-01 S01AA11 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S01AA12 tobramycin Tobramycin 2.16.840.1.113883.6.73 2017-01 S01AA13 fusidic acid Fusidinsyra 2.16.840.1.113883.6.73 2017-01 S01AA14 benzylpenicillin Bensylpenicillin 2.16.840.1.113883.6.73 2017-01 S01AA15 dihydrostreptomycin Dihydrostreptomycin 2.16.840.1.113883.6.73 2017-01 S01AA16 rifamycin Rifamycin 2.16.840.1.113883.6.73 2017-01 S01AA17 erythromycin Erytromycin 2.16.840.1.113883.6.73 2017-01 S01AA18 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S01AA19 ampicillin Ampicillin 2.16.840.1.113883.6.73 2017-01 S01AA20 antibiotics in combination with other Antibiotika i kombination med andra drugs läkemedel 2.16.840.1.113883.6.73 2017-01 S01AA21 amikacin Amikacin 2.16.840.1.113883.6.73 2017-01 S01AA22 micronomicin Mikronomicin 2.16.840.1.113883.6.73 2017-01 S01AA23 netilmicin Netilmicin 2.16.840.1.113883.6.73 2017-01 S01AA24 kanamycin Kanamycin 2.16.840.1.113883.6.73 2017-01 S01AA25 azidamfenicol Azidamfenikol 2.16.840.1.113883.6.73 2017-01 S01AA26 azithromycin Azitromycin 2.16.840.1.113883.6.73 2017-01 S01AA27 cefuroxime Cefuroxim 2.16.840.1.113883.6.73 2017-01 S01AA30 combinations of different antibiotics Kombinationer av olika antibiotika 2.16.840.1.113883.6.73 2017-01 S01AB Sulfonamides Sulfonamider 2.16.840.1.113883.6.73 2017-01 S01AB01 sulfamethizole Sulfametizol 2.16.840.1.113883.6.73 2017-01 S01AB02 sulfafurazole Sulfafurazol 2.16.840.1.113883.6.73 2017-01 S01AB03 sulfadicramide Sulfadikramid 2.16.840.1.113883.6.73 2017-01 S01AB04 sulfacetamide Sulfacetamid 2.16.840.1.113883.6.73 2017-01 S01AB05 sulfafenazol Sulfafenazol 2.16.840.1.113883.6.73 2017-01 S01AD Antivirals Antivirala medel 2.16.840.1.113883.6.73 2017-01 S01AD01 idoxuridine Idoxuridin 2.16.840.1.113883.6.73 2017-01 S01AD02 trifluridine Trifluridin 2.16.840.1.113883.6.73 2017-01 S01AD03 aciclovir Aciklovir 2.16.840.1.113883.6.73 2017-01 S01AD05 interferon Interferon 2.16.840.1.113883.6.73 2017-01 S01AD06 vidarabine Vidarabin 2.16.840.1.113883.6.73 2017-01 S01AD07 famciclovir Famciklovir 2.16.840.1.113883.6.73 2017-01 S01AD08 fomivirsen Fomiversen 2.16.840.1.113883.6.73 2017-01 S01AD09 ganciclovir Ganciklovir 2.16.840.1.113883.6.73 2017-01 S01AE Fluoroquinolones Fluorokinoloner

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 146 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AE01 ofloxacin Ofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE02 norfloxacin Norfloxacin 2.16.840.1.113883.6.73 2017-01 S01AE03 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE04 lomefloxacin Lomefloxacin 2.16.840.1.113883.6.73 2017-01 S01AE05 levofloxacin Levofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE06 gatifloxacin Gatifloxacin 2.16.840.1.113883.6.73 2017-01 S01AE07 moxifloxacin Moxifloxacin 2.16.840.1.113883.6.73 2017-01 S01AE08 besifloxacin Besifloxacin 2.16.840.1.113883.6.73 2017-01 S01AX Other antiinfectives Övriga antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01AX01 mercury compounds Kvicksilverföreningar 2.16.840.1.113883.6.73 2017-01 S01AX02 silver compounds Silverföreningar 2.16.840.1.113883.6.73 2017-01 S01AX03 zinc compounds Zinkföreningar 2.16.840.1.113883.6.73 2017-01 S01AX04 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 S01AX05 bibrocathol Bibrokatol 2.16.840.1.113883.6.73 2017-01 S01AX06 resorcinol Resorcinol 2.16.840.1.113883.6.73 2017-01 S01AX07 sodium borate Natriumborat 2.16.840.1.113883.6.73 2017-01 S01AX08 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 S01AX09 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S01AX10 sodium propionate Natriumpropionat 2.16.840.1.113883.6.73 2017-01 S01AX14 dibrompropamidine Dibrompropamidin 2.16.840.1.113883.6.73 2017-01 S01AX15 propamidine Propamidin 2.16.840.1.113883.6.73 2017-01 S01AX16 picloxydine Pikloxydin 2.16.840.1.113883.6.73 2017-01 S01AX18 povidone-iodine Povidon, joderad 2.16.840.1.113883.6.73 2017-01 S01B ANTIINFLAMMATORY AGENTS Antiinflammatoriska medel 2.16.840.1.113883.6.73 2017-01 S01BA Corticosteroids, plain Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S01BA01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S01BA02 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S01BA03 cortisone Kortison 2.16.840.1.113883.6.73 2017-01 S01BA04 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S01BA05 triamcinolone Triamcinolon 2.16.840.1.113883.6.73 2017-01 S01BA06 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S01BA07 fluorometholone Fluorometolon 2.16.840.1.113883.6.73 2017-01 S01BA08 medrysone Medryson 2.16.840.1.113883.6.73 2017-01 S01BA09 clobetasone Klobetason 2.16.840.1.113883.6.73 2017-01 S01BA10 alclometasone Alklometason 2.16.840.1.113883.6.73 2017-01 S01BA11 desonide Desonid 2.16.840.1.113883.6.73 2017-01 S01BA12 formocortal Formokortal 2.16.840.1.113883.6.73 2017-01 S01BA13 rimexolone Rimexolon 2.16.840.1.113883.6.73 2017-01 S01BA14 loteprednol Loteprednol 2.16.840.1.113883.6.73 2017-01 S01BA15 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 S01BB Corticosteroids and mydriatics in Kortikosteroider och mydriatika i combination kombination 2.16.840.1.113883.6.73 2017-01 S01BB01 hydrocortisone and mydriatics Hydrokortison och mydratikum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 147 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01BB02 prednisolone and mydriatics Prednisolon och mydriaktika 2.16.840.1.113883.6.73 2017-01 S01BB03 fluorometholone and mydriatics Fluorometolon och mydriatika 2.16.840.1.113883.6.73 2017-01 S01BB04 betamethasone and mydriatics Betametason och mydriatika 2.16.840.1.113883.6.73 2017-01 S01BC Antiinflammatory agents, non- Icke-steroida antiinflammatoriska steroids medel 2.16.840.1.113883.6.73 2017-01 S01BC01 indometacin Indometacin 2.16.840.1.113883.6.73 2017-01 S01BC02 oxyphenbutazone Oxifenbutazon 2.16.840.1.113883.6.73 2017-01 S01BC03 diclofenac Diklofenak 2.16.840.1.113883.6.73 2017-01 S01BC04 flurbiprofen Flurbiprofen 2.16.840.1.113883.6.73 2017-01 S01BC05 ketorolac Ketorolak 2.16.840.1.113883.6.73 2017-01 S01BC06 piroxicam Piroxikam 2.16.840.1.113883.6.73 2017-01 S01BC07 bendazac Bendazak 2.16.840.1.113883.6.73 2017-01 S01BC08 salicylic acid Salicylsyra 2.16.840.1.113883.6.73 2017-01 S01BC09 pranoprofen Pranoprofen 2.16.840.1.113883.6.73 2017-01 S01BC10 nepafenac Nepafenak 2.16.840.1.113883.6.73 2017-01 S01BC11 bromfenac Bromfenak 2.16.840.1.113883.6.73 2017-01 S01C ANTIINFLAMMATORY AGENTS Antiinflammatoriska och antiinfektiva AND ANTIINFECTIVES IN medel i kombination COMBINATION 2.16.840.1.113883.6.73 2017-01 S01CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA01 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA02 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA03 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA04 fluocortolone and antiinfectives Fluokortolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA05 betamethasone and antiinfectives Betametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA06 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA07 fluorometholone and antiinfectives Fluorometolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA08 methylprednisolone and Metylprednisolon och antiinfektiva antiinfectives medel 2.16.840.1.113883.6.73 2017-01 S01CA09 chloroprednisone and antiinfectives Klorprednison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA10 fluocinolone acetonide and Fluocinolonacetonid och antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CA11 clobetasone and antiinfectives Klobetason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CB Corticosteroids/antiinfectives/mydria Kortikosteroider/antiinfektiva/mydriat tics in combination ika i kombination 2.16.840.1.113883.6.73 2017-01 S01CB01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S01CB02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S01CB03 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S01CB04 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S01CB05 fluorometholone Fluorometolon

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 148 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01CC Antiinflammatory agents, non- Icke-steroida antiinflammatoriska steroids and antiinfectives in medel och antiinfektiva medel i combination kombination 2.16.840.1.113883.6.73 2017-01 S01CC01 diclofenac and antiinfectives Diklofenak och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01CC02 indometacin and antiinfectives Indometacin och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S01E ANTIGLAUCOMA PREPARATIONS Medel vid glaukom samt miotika AND MIOTICS 2.16.840.1.113883.6.73 2017-01 S01EA Sympathomimetics in glaucoma Sympatomimetika vid glaukom therapy1) 2.16.840.1.113883.6.73 2017-01 S01EA01 epinephrine Adrenalin 2.16.840.1.113883.6.73 2017-01 S01EA02 dipivefrine Dipivefrin 2.16.840.1.113883.6.73 2017-01 S01EA03 apraclonidine Apraklonidin 2.16.840.1.113883.6.73 2017-01 S01EA04 clonidine Klonidin 2.16.840.1.113883.6.73 2017-01 S01EA05 brimonidine Brimonidin 2.16.840.1.113883.6.73 2017-01 S01EA51 epinephrine, combinations Adrenalin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EB Parasympathomimetics Parasympatomimetika 2.16.840.1.113883.6.73 2017-01 S01EB01 pilocarpine Pilokarpin 2.16.840.1.113883.6.73 2017-01 S01EB02 carbachol Karbakol 2.16.840.1.113883.6.73 2017-01 S01EB03 ecothiopate Ekotiopat 2.16.840.1.113883.6.73 2017-01 S01EB04 demecarium Demekar 2.16.840.1.113883.6.73 2017-01 S01EB05 physostigmine Fysostigmin 2.16.840.1.113883.6.73 2017-01 S01EB06 neostigmine Neostigmin 2.16.840.1.113883.6.73 2017-01 S01EB07 fluostigmine Fluostigmin 2.16.840.1.113883.6.73 2017-01 S01EB08 aceclidine Aceklidin 2.16.840.1.113883.6.73 2017-01 S01EB09 acetylcholine Acetylkolin 2.16.840.1.113883.6.73 2017-01 S01EB10 paraoxon Paraoxon 2.16.840.1.113883.6.73 2017-01 S01EB51 pilocarpine, combinations Pilokarpin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EB58 aceclidine, combinations Aceklidin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EC Carbonic anhydrase inhibitors Karbanhydrashämmare 2.16.840.1.113883.6.73 2017-01 S01EC01 acetazolamide Acetazolamid 2.16.840.1.113883.6.73 2017-01 S01EC02 diclofenamide Diklofenamid 2.16.840.1.113883.6.73 2017-01 S01EC03 dorzolamide Dorzolamid 2.16.840.1.113883.6.73 2017-01 S01EC04 brinzolamide Brinzolamid 2.16.840.1.113883.6.73 2017-01 S01EC05 methazolamide Metazolamid 2.16.840.1.113883.6.73 2017-01 S01EC54 brinzolamide, combinations Brinzolamid, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED Beta blocking agents1) Beta-receptorblockerande medel 2.16.840.1.113883.6.73 2017-01 S01ED01 timolol Timolol 2.16.840.1.113883.6.73 2017-01 S01ED02 betaxolol Betaxolol 2.16.840.1.113883.6.73 2017-01 S01ED03 levobunolol Levobunolol 2.16.840.1.113883.6.73 2017-01 S01ED04 metipranolol Metipranolol 2.16.840.1.113883.6.73 2017-01 S01ED05 carteolol Karteolol 2.16.840.1.113883.6.73 2017-01 S01ED06 befunolol Befunolol 2.16.840.1.113883.6.73 2017-01 S01ED51 timolol, combinations Timolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED52 betaxolol, combinations Betoxalol, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 149 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01ED54 metipranolol, combinations Metipranolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01ED55 carteolol, combinations Karteolol, kombinationer 2.16.840.1.113883.6.73 2017-01 S01EE Prostaglandin analogues1) Prostaglandinanaloger 2.16.840.1.113883.6.73 2017-01 S01EE01 latanoprost Latanoprost 2.16.840.1.113883.6.73 2017-01 S01EE02 unoprostone Unoproston 2.16.840.1.113883.6.73 2017-01 S01EE03 bimatoprost Bimatoprost 2.16.840.1.113883.6.73 2017-01 S01EE04 travoprost Travoprost 2.16.840.1.113883.6.73 2017-01 S01EE05 tafluprost Tafluprost 2.16.840.1.113883.6.73 2017-01 S01EX Other antiglaucoma preparations Övriga medel vid glaukom samt miotika 2.16.840.1.113883.6.73 2017-01 S01EX01 guanethidine Guanetidin 2.16.840.1.113883.6.73 2017-01 S01EX02 dapiprazole Dapiprazol 2.16.840.1.113883.6.73 2017-01 S01F MYDRIATICS AND Mydriatika och cykloplegika CYCLOPLEGICS 2.16.840.1.113883.6.73 2017-01 S01FA Anticholinergics Antikolinergika 2.16.840.1.113883.6.73 2017-01 S01FA01 atropine Atropin 2.16.840.1.113883.6.73 2017-01 S01FA02 scopolamine Skopolamin 2.16.840.1.113883.6.73 2017-01 S01FA03 methylscopolamine Metylskopolamin 2.16.840.1.113883.6.73 2017-01 S01FA04 cyclopentolate Cyklopentolat 2.16.840.1.113883.6.73 2017-01 S01FA05 homatropine Homatropin 2.16.840.1.113883.6.73 2017-01 S01FA06 tropicamide Tropikamid 2.16.840.1.113883.6.73 2017-01 S01FA54 cyclopentolate, combinations Cyklopentolat, kombinationer 2.16.840.1.113883.6.73 2017-01 S01FA56 tropicamide, combinations Tropikamid, kombinationer 2.16.840.1.113883.6.73 2017-01 S01FB Sympathomimetics excl. Sympatomimetika, exkl. medel vid antiglaucoma preparations glaukom 2.16.840.1.113883.6.73 2017-01 S01FB01 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 S01FB02 ephedrine Efedrin 2.16.840.1.113883.6.73 2017-01 S01FB03 ibopamine Ibopamin 2.16.840.1.113883.6.73 2017-01 S01FB51 phenylephrine and ketorolac Fenylefrin och ketorolak 2.16.840.1.113883.6.73 2017-01 S01G DECONGESTANTS AND Avsvällande medel och antiallergika ANTIALLERGICS 2.16.840.1.113883.6.73 2017-01 S01GA Sympathomimetics used as Sympatomimetika som avsvällande decongestants medel 2.16.840.1.113883.6.73 2017-01 S01GA01 naphazoline Nafazolin 2.16.840.1.113883.6.73 2017-01 S01GA02 tetryzoline Tetryzolin 2.16.840.1.113883.6.73 2017-01 S01GA03 xylometazoline Xylometazolin 2.16.840.1.113883.6.73 2017-01 S01GA04 oxymetazoline Oximetazolin 2.16.840.1.113883.6.73 2017-01 S01GA05 phenylephrine Fenylefrin 2.16.840.1.113883.6.73 2017-01 S01GA06 oxedrine Oxedrin 2.16.840.1.113883.6.73 2017-01 S01GA51 naphazoline, combinations Nafazolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA52 tetryzoline, combinations Tetryzolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA53 xylometazoline, combinations Xylometazolin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA55 phenylephrine, combinations Fenylefrin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GA56 oxedrine, combinations Oxedrin, kombinationer 2.16.840.1.113883.6.73 2017-01 S01GX Other antiallergics Övriga antiallergika © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 150 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01GX01 cromoglicic acid Natriumkromoglikat 2.16.840.1.113883.6.73 2017-01 S01GX02 levocabastine Levokabastin 2.16.840.1.113883.6.73 2017-01 S01GX03 spaglumic acid Spagluminsyra 2.16.840.1.113883.6.73 2017-01 S01GX04 nedocromil Nedokromil 2.16.840.1.113883.6.73 2017-01 S01GX05 lodoxamide Lodoxamid 2.16.840.1.113883.6.73 2017-01 S01GX06 emedastine Emedastin 2.16.840.1.113883.6.73 2017-01 S01GX07 azelastine Azelastin 2.16.840.1.113883.6.73 2017-01 S01GX08 ketotifen Ketotifen 2.16.840.1.113883.6.73 2017-01 S01GX09 olopatadine Olopatadin 2.16.840.1.113883.6.73 2017-01 S01GX10 epinastine Epinastin 2.16.840.1.113883.6.73 2017-01 S01GX11 alcaftadine Alkaftadin 2.16.840.1.113883.6.73 2017-01 S01GX51 cromoglicic acid, combinations Natriumkromoglikat, kombinationer 2.16.840.1.113883.6.73 2017-01 S01H LOCAL ANESTHETICS Lokalanestetika 2.16.840.1.113883.6.73 2017-01 S01HA Local anesthetics Lokalanestetika 2.16.840.1.113883.6.73 2017-01 S01HA01 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 S01HA02 oxybuprocaine Oxibuprokain 2.16.840.1.113883.6.73 2017-01 S01HA03 tetracaine Tetrakain 2.16.840.1.113883.6.73 2017-01 S01HA04 proxymetacaine Proximetakain 2.16.840.1.113883.6.73 2017-01 S01HA05 procaine Prokain 2.16.840.1.113883.6.73 2017-01 S01HA06 cinchocaine Cinkokain 2.16.840.1.113883.6.73 2017-01 S01HA07 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 S01HA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 S01J DIAGNOSTIC AGENTS Diagnostiska medel 2.16.840.1.113883.6.73 2017-01 S01JA Colouring agents Färgämnen 2.16.840.1.113883.6.73 2017-01 S01JA01 fluorescein Fluorescein 2.16.840.1.113883.6.73 2017-01 S01JA02 rose bengal sodium Bengalrosanatrium 2.16.840.1.113883.6.73 2017-01 S01JA51 fluorescein, combinations Fluorescein, kombinationer 2.16.840.1.113883.6.73 2017-01 S01JX Other ophthalmological diagnostic Övriga diagnostiska medel vid agents ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01K SURGICAL AIDS Hjälpmedel vid operationer 2.16.840.1.113883.6.73 2017-01 S01KA Viscoelastic substances Viskoelastiska substanser 2.16.840.1.113883.6.73 2017-01 S01KA01 hyaluronic acid Hyaluronsyra 2.16.840.1.113883.6.73 2017-01 S01KA02 hypromellose Hypromellos 2.16.840.1.113883.6.73 2017-01 S01KA51 hyaluronic acid, combinations Hyaluronsyra, kombinationer 2.16.840.1.113883.6.73 2017-01 S01KX Other surgical aids Övriga hjälpmedel vid operationer 2.16.840.1.113883.6.73 2017-01 S01KX01 chymotrypsin Kymotrypsin 2.16.840.1.113883.6.73 2017-01 S01L OCULAR VASCULAR DISORDER Medel vid kärlsjukdomar i ögat AGENTS 2.16.840.1.113883.6.73 2017-01 S01LA Antineovascularisation agents Medel mot kärlnybildning 2.16.840.1.113883.6.73 2017-01 S01LA01 verteporfin Verteporfin 2.16.840.1.113883.6.73 2017-01 S01LA02 anecortave Anekortav 2.16.840.1.113883.6.73 2017-01 S01LA03 pegaptanib Pegaptanib 2.16.840.1.113883.6.73 2017-01 S01LA04 ranibizumab Ranibizumab 2.16.840.1.113883.6.73 2017-01 S01LA05 aflibercept Aflibercept © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 151 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01X OTHER OPHTHALMOLOGICALS Övriga medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01XA Other ophthalmologicals Övriga medel vid ögonsjukdomar 2.16.840.1.113883.6.73 2017-01 S01XA01 guaiazulen Guajazulen 2.16.840.1.113883.6.73 2017-01 S01XA02 retinol Retinol (vitamin A) 2.16.840.1.113883.6.73 2017-01 S01XA03 sodium chloride, hypertonic Natriumklorid, hyperton 2.16.840.1.113883.6.73 2017-01 S01XA04 potassium iodide Kaliumjodid 2.16.840.1.113883.6.73 2017-01 S01XA05 sodium edetate Natriumedetat 2.16.840.1.113883.6.73 2017-01 S01XA06 ethylmorphine Etylmorfin 2.16.840.1.113883.6.73 2017-01 S01XA07 alum Alum 2.16.840.1.113883.6.73 2017-01 S01XA08 acetylcysteine Acetylcystein 2.16.840.1.113883.6.73 2017-01 S01XA09 iodoheparinate Jodoheparinat 2.16.840.1.113883.6.73 2017-01 S01XA10 inosine Inosin 2.16.840.1.113883.6.73 2017-01 S01XA11 nandrolone Nandrolon 2.16.840.1.113883.6.73 2017-01 S01XA12 dexpanthenol Dexpantenol 2.16.840.1.113883.6.73 2017-01 S01XA13 alteplase Alteplas 2.16.840.1.113883.6.73 2017-01 S01XA14 heparin Heparin 2.16.840.1.113883.6.73 2017-01 S01XA15 ascorbic acid Askorbinsyra (vitamin C) 2.16.840.1.113883.6.73 2017-01 S01XA18 ciclosporin Ciklosporin 2.16.840.1.113883.6.73 2017-01 S01XA19 limbal stems cells, autologous Autologa limbala stamceller 2.16.840.1.113883.6.73 2017-01 S01XA20 artificial tears and other indifferent Tårsubstitut och övriga indifferenta preparations medel 2.16.840.1.113883.6.73 2017-01 S01XA21 mercaptamine Merkaptamin 2.16.840.1.113883.6.73 2017-01 S01XA22 ocriplasmin Okriplasmin 2.16.840.1.113883.6.73 2017-01 S01XA23 sirolimus Sirolimus 2.16.840.1.113883.6.73 2017-01 S02 OTOLOGICALS Medel vid öronsjukdomar 2.16.840.1.113883.6.73 2017-01 S02A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02AA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02AA01 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S02AA02 nitrofural Nitrofural 2.16.840.1.113883.6.73 2017-01 S02AA03 boric acid Borsyra 2.16.840.1.113883.6.73 2017-01 S02AA04 aluminium acetotartrate Aluminiumacetotartrat 2.16.840.1.113883.6.73 2017-01 S02AA05 clioquinol Kliokinol 2.16.840.1.113883.6.73 2017-01 S02AA06 hydrogen peroxide Väteperoxid 2.16.840.1.113883.6.73 2017-01 S02AA07 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S02AA08 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S02AA09 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S02AA10 acetic acid Ättiksyra 2.16.840.1.113883.6.73 2017-01 S02AA11 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S02AA12 rifamycin Rifamycin 2.16.840.1.113883.6.73 2017-01 S02AA13 miconazole Mikonazol 2.16.840.1.113883.6.73 2017-01 S02AA14 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S02AA15 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S02AA16 ofloxacin Ofloxacin

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 152 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S02AA30 antiinfectives, combinations Antiinfektiva medel, kombinationer 2.16.840.1.113883.6.73 2017-01 S02B CORTICOSTEROIDS Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S02BA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S02BA01 hydrocortisone Hydrokortison 2.16.840.1.113883.6.73 2017-01 S02BA03 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S02BA06 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S02BA07 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S02BA08 fluocinolone acetonide Fluocinolonacetonid 2.16.840.1.113883.6.73 2017-01 S02C CORTICOSTEROIDS AND Kortikosteroider i kombination med ANTIINFECTIVES IN antiinfektiva medel COMBINATION 2.16.840.1.113883.6.73 2017-01 S02CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA01 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA02 flumetasone and antiinfectives Flumetason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA03 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA04 triamcinolone and antiinfectives Triamcinolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA05 fluocinolone acetonide and Fluocinolonacetonid och antiinfectives antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA06 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02CA07 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S02D OTHER OTOLOGICALS Övriga medel vid öronsjukdomar 2.16.840.1.113883.6.73 2017-01 S02DA Analgesics and anesthetics Analgetika och anestetika 2.16.840.1.113883.6.73 2017-01 S02DA01 lidocaine Lidokain 2.16.840.1.113883.6.73 2017-01 S02DA02 cocaine Kokain 2.16.840.1.113883.6.73 2017-01 S02DA03 phenazone Fenazon 2.16.840.1.113883.6.73 2017-01 S02DA04 cinchocaine Cinkokain 2.16.840.1.113883.6.73 2017-01 S02DA30 combinations Kombinationer 2.16.840.1.113883.6.73 2017-01 S02DC Indifferent preparations Indifferenta medel 2.16.840.1.113883.6.73 2017-01 S03 OPHTHALMOLOGICAL AND Medel vid ögon- och öronsjukdomar OTOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 S03A ANTIINFECTIVES Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03AA Antiinfectives Antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03AA01 neomycin Neomycin 2.16.840.1.113883.6.73 2017-01 S03AA02 tetracycline Tetracyklin 2.16.840.1.113883.6.73 2017-01 S03AA03 polymyxin B Polymyxin B 2.16.840.1.113883.6.73 2017-01 S03AA04 chlorhexidine Klorhexidin 2.16.840.1.113883.6.73 2017-01 S03AA05 hexamidine Hexamidin 2.16.840.1.113883.6.73 2017-01 S03AA06 gentamicin Gentamicin 2.16.840.1.113883.6.73 2017-01 S03AA07 ciprofloxacin Ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S03AA08 chloramphenicol Kloramfenikol 2.16.840.1.113883.6.73 2017-01 S03AA30 antiinfectives, combinations Antiinfektiva, kombinationer 2.16.840.1.113883.6.73 2017-01 S03B CORTICOSTEROIDS Kortikosteroider © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 153 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S03BA Corticosteroids Kortikosteroider 2.16.840.1.113883.6.73 2017-01 S03BA01 dexamethasone Dexametason 2.16.840.1.113883.6.73 2017-01 S03BA02 prednisolone Prednisolon 2.16.840.1.113883.6.73 2017-01 S03BA03 betamethasone Betametason 2.16.840.1.113883.6.73 2017-01 S03C CORTICOSTEROIDS AND Kortikosteroider i kombination med ANTIINFECTIVES IN antiinfektiva medel COMBINATION 2.16.840.1.113883.6.73 2017-01 S03CA Corticosteroids and antiinfectives in Kortikosteroider i kombination med combination antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA01 dexamethasone and antiinfectives Dexametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA02 prednisolone and antiinfectives Prednisolon och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA04 hydrocortisone and antiinfectives Hydrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA05 fludrocortisone and antiinfectives Fludrokortison och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03CA06 betamethasone and antiinfectives Betametason och antiinfektiva medel 2.16.840.1.113883.6.73 2017-01 S03D OTHER OPHTHALMOLOGICAL Övriga medel vid ögon- och AND OTOLOGICAL öronsjukdomar PREPARATIONS 2.16.840.1.113883.6.73 2017-01 V VARIOUS Övrigt 2.16.840.1.113883.6.73 2017-01 V01 ALLERGENS Allergener 2.16.840.1.113883.6.73 2017-01 V01A ALLERGENS Allergener 2.16.840.1.113883.6.73 2017-01 V01AA Allergen extracts Allergenextrakt 2.16.840.1.113883.6.73 2017-01 V01AA01 feather Fjädrar 2.16.840.1.113883.6.73 2017-01 V01AA02 grass pollen Gräspollen 2.16.840.1.113883.6.73 2017-01 V01AA03 house dust mites Husdammskvalster 2.16.840.1.113883.6.73 2017-01 V01AA04 mould fungus and yeast fungus Mögelsvampar och jästsvampar 2.16.840.1.113883.6.73 2017-01 V01AA05 tree pollen Pollen från träd 2.16.840.1.113883.6.73 2017-01 V01AA07 insects Insekter 2.16.840.1.113883.6.73 2017-01 V01AA08 food Födoämnen 2.16.840.1.113883.6.73 2017-01 V01AA09 textiles Textilier 2.16.840.1.113883.6.73 2017-01 V01AA10 flowers Örter 2.16.840.1.113883.6.73 2017-01 V01AA11 animals Djur 2.16.840.1.113883.6.73 2017-01 V01AA20 various Övrigt 2.16.840.1.113883.6.73 2017-01 V03 ALL OTHER THERAPEUTIC Medel vid förgiftningar, PRODUCTS överdoseringar m.m. 2.16.840.1.113883.6.73 2017-01 V03A ALL OTHER THERAPEUTIC Medel vid förgiftningar, PRODUCTS överdoseringar m.m. 2.16.840.1.113883.6.73 2017-01 V03AB Antidotes Medel vid förgiftningar 2.16.840.1.113883.6.73 2017-01 V03AB01 ipecacuanha Ipekakuanharot 2.16.840.1.113883.6.73 2017-01 V03AB02 nalorphine Nalorfin 2.16.840.1.113883.6.73 2017-01 V03AB03 edetates Edetat 2.16.840.1.113883.6.73 2017-01 V03AB04 pralidoxime Pralidoxim 2.16.840.1.113883.6.73 2017-01 V03AB05 prednisolone and promethazine Prednisolon och prometazin 2.16.840.1.113883.6.73 2017-01 V03AB06 thiosulfate Tiosulfat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 154 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03AB08 sodium nitrite Natriumnitrit 2.16.840.1.113883.6.73 2017-01 V03AB09 dimercaprol Dimerkaprol 2.16.840.1.113883.6.73 2017-01 V03AB13 obidoxime Obidoxim 2.16.840.1.113883.6.73 2017-01 V03AB14 protamine Protamin 2.16.840.1.113883.6.73 2017-01 V03AB15 naloxone Naloxon 2.16.840.1.113883.6.73 2017-01 V03AB16 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 V03AB17 methylthioninium chloride Metyltioninklorid 2.16.840.1.113883.6.73 2017-01 V03AB18 potassium permanganate Kaliumpermanganat 2.16.840.1.113883.6.73 2017-01 V03AB19 physostigmine Fysostigmin 2.16.840.1.113883.6.73 2017-01 V03AB20 copper sulfate Kopparsulfat 2.16.840.1.113883.6.73 2017-01 V03AB21 potassium iodide Kaliumjodid 2.16.840.1.113883.6.73 2017-01 V03AB22 amyl nitrite Amylnitrit 2.16.840.1.113883.6.73 2017-01 V03AB23 acetylcysteine Acetylcystein 2.16.840.1.113883.6.73 2017-01 V03AB24 digitalis antitoxin Digitalisantitoxin 2.16.840.1.113883.6.73 2017-01 V03AB25 flumazenil Flumazenil 2.16.840.1.113883.6.73 2017-01 V03AB26 methionine Metionin 2.16.840.1.113883.6.73 2017-01 V03AB27 4-dimethylaminophenol 4-Dimetylaminofenol 2.16.840.1.113883.6.73 2017-01 V03AB29 cholinesterase Kolinesteras 2.16.840.1.113883.6.73 2017-01 V03AB31 prussian blue Järn(III)ferrocyanid 2.16.840.1.113883.6.73 2017-01 V03AB32 glutathione Glutation 2.16.840.1.113883.6.73 2017-01 V03AB33 hydroxocobalamin Hydroxokobalamin 2.16.840.1.113883.6.73 2017-01 V03AB34 fomepizole Fomepizol 2.16.840.1.113883.6.73 2017-01 V03AB35 sugammadex Sugammadex 2.16.840.1.113883.6.73 2017-01 V03AB36 phentolamine Fentolamin 2.16.840.1.113883.6.73 2017-01 V03AB37 idarucizumab Idarucizumab 2.16.840.1.113883.6.73 2017-01 V03AC Iron chelating agents Medel vid järnförgiftning 2.16.840.1.113883.6.73 2017-01 V03AC01 deferoxamine Deferoxamin 2.16.840.1.113883.6.73 2017-01 V03AC02 deferiprone Deferipron 2.16.840.1.113883.6.73 2017-01 V03AC03 deferasirox Deferasirox 2.16.840.1.113883.6.73 2017-01 V03AE Drugs for treatment of hyperkalemia Medel för behandling av and hyperphosphatemia hyperkalemi och hyperfosfatemi 2.16.840.1.113883.6.73 2017-01 V03AE01 polystyrene sulfonate Polystyrensulfonat 2.16.840.1.113883.6.73 2017-01 V03AE02 sevelamer Sevelamer 2.16.840.1.113883.6.73 2017-01 V03AE03 lanthanum carbonate Lantankarbonat 2.16.840.1.113883.6.73 2017-01 V03AE04 calcium acetate and magnesium Kalciumacetat och carbonate magnesiumkarbonat 2.16.840.1.113883.6.73 2017-01 V03AE05 sucroferric oxyhydroxide Sukrojärn(III)oxihydroxid 2.16.840.1.113883.6.73 2017-01 V03AE06 colestilan Kolestilan 2.16.840.1.113883.6.73 2017-01 V03AE07 calcium acetate Kalciumacetat 2.16.840.1.113883.6.73 2017-01 V03AE08 ferric citrate Järn(III)citrat 2.16.840.1.113883.6.73 2017-01 V03AE09 patiromer calcium Patiromerkalcium 2.16.840.1.113883.6.73 2017-01 V03AF Detoxifying agents for antineoplastic Medel mot toxicitet vid treatment cytostatikabehandling 2.16.840.1.113883.6.73 2017-01 V03AF01 mesna Mesna

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 155 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03AF02 dexrazoxane Dexrazoxan 2.16.840.1.113883.6.73 2017-01 V03AF03 calcium folinate Kalciumfolinat 2.16.840.1.113883.6.73 2017-01 V03AF04 calcium levofolinate Kalciumlevofolinat 2.16.840.1.113883.6.73 2017-01 V03AF05 amifostine Amifostin 2.16.840.1.113883.6.73 2017-01 V03AF06 sodium folinate Natriumfolinat 2.16.840.1.113883.6.73 2017-01 V03AF07 rasburicase Rasburikas 2.16.840.1.113883.6.73 2017-01 V03AF08 palifermin Palifermin 2.16.840.1.113883.6.73 2017-01 V03AF09 glucarpidase Glukarpidas 2.16.840.1.113883.6.73 2017-01 V03AF10 sodium levofolinate Natriumlevofolinat 2.16.840.1.113883.6.73 2017-01 V03AG Drugs for treatment of Medel för behandling av hypercalcemia hyperkalcemi 2.16.840.1.113883.6.73 2017-01 V03AG01 sodium cellulose phosphate Natriumcellulosafosfater 2.16.840.1.113883.6.73 2017-01 V03AH Drugs for treatment of hypoglycemia Medel för behandling av hypoglykemi 2.16.840.1.113883.6.73 2017-01 V03AH01 diazoxide Diazoxid 2.16.840.1.113883.6.73 2017-01 V03AK Tissue adhesives Vävnadslim 2.16.840.1.113883.6.73 2017-01 V03AM Drugs for embolisation Medel för embolisering 2.16.840.1.113883.6.73 2017-01 V03AN Medical gases Medicinska gaser 2.16.840.1.113883.6.73 2017-01 V03AN01 oxygen Syre 2.16.840.1.113883.6.73 2017-01 V03AN02 carbon dioxide Koldioxid 2.16.840.1.113883.6.73 2017-01 V03AN03 helium Helium 2.16.840.1.113883.6.73 2017-01 V03AN04 nitrogen Kväve 2.16.840.1.113883.6.73 2017-01 V03AN05 medical air Medicinsk luft 2.16.840.1.113883.6.73 2017-01 V03AX Other therapeutic products Övriga terapeutiska produkter 2.16.840.1.113883.6.73 2017-01 V03AX02 nalfurafine Nalfurafin 2.16.840.1.113883.6.73 2017-01 V03AX03 cobicistat Kobicistat 2.16.840.1.113883.6.73 2017-01 V03AZ Nerve depressants Nervdepressiva 2.16.840.1.113883.6.73 2017-01 V03AZ01 ethanol Etanol 2.16.840.1.113883.6.73 2017-01 V04 DIAGNOSTIC AGENTS Diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V04B URINE TESTS Medel för urintest 2.16.840.1.113883.6.73 2017-01 V04C OTHER DIAGNOSTIC AGENTS Övriga diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V04CA Tests for diabetes Medel för diabetestest 2.16.840.1.113883.6.73 2017-01 V04CA01 tolbutamide Tolbutamid 2.16.840.1.113883.6.73 2017-01 V04CA02 glucose Glukos 2.16.840.1.113883.6.73 2017-01 V04CB Tests for fat absorption Tester för fettabsorption 2.16.840.1.113883.6.73 2017-01 V04CB01 vitamin A concentrates Vitamin A koncentrat 2.16.840.1.113883.6.73 2017-01 V04CC Tests for bile duct patency Medel för tömning av gallblåsan 2.16.840.1.113883.6.73 2017-01 V04CC01 sorbitol Sorbitol 2.16.840.1.113883.6.73 2017-01 V04CC02 magnesium sulfate Magnesiumsulfat 2.16.840.1.113883.6.73 2017-01 V04CC03 sincalide Sinkalid 2.16.840.1.113883.6.73 2017-01 V04CC04 ceruletide Ceruletid 2.16.840.1.113883.6.73 2017-01 V04CD Tests for pituitary function Medel för hypofysfunktionsprov 2.16.840.1.113883.6.73 2017-01 V04CD01 metyrapone Metyrapon 2.16.840.1.113883.6.73 2017-01 V04CD03 sermorelin Sermorelin © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 156 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V04CD04 corticorelin Kortikorelin 2.16.840.1.113883.6.73 2017-01 V04CD05 somatorelin Somatorelin 2.16.840.1.113883.6.73 2017-01 V04CD06 macimorelin Macimorelin 2.16.840.1.113883.6.73 2017-01 V04CE Tests for liver functional capacity Medel för leverfunktionstest 2.16.840.1.113883.6.73 2017-01 V04CE01 galactose Galaktos 2.16.840.1.113883.6.73 2017-01 V04CE02 sulfobromophthalein Sulfobromoftalein 2.16.840.1.113883.6.73 2017-01 V04CE03 methacetin (13C) Metacetin (C-13) 2.16.840.1.113883.6.73 2017-01 V04CF Tuberculosis diagnostics Tuberkulosdiagnostikum 2.16.840.1.113883.6.73 2017-01 V04CF01 tuberculin Tuberkulin 2.16.840.1.113883.6.73 2017-01 V04CG Tests for gastric secretion Ventrikelsekretionstest 2.16.840.1.113883.6.73 2017-01 V04CG01 cation exchange resins Katjonbytarhartser 2.16.840.1.113883.6.73 2017-01 V04CG02 betazole Betazol 2.16.840.1.113883.6.73 2017-01 V04CG03 histamine phosphate Histaminfosfat 2.16.840.1.113883.6.73 2017-01 V04CG04 pentagastrin Pentagastrin 2.16.840.1.113883.6.73 2017-01 V04CG05 methylthioninium chloride Metyltioninklorid 2.16.840.1.113883.6.73 2017-01 V04CG30 caffeine and sodium benzoate Koffein och natriumbensoat 2.16.840.1.113883.6.73 2017-01 V04CH Tests for renal function and ureteral Test för njurfunktion och uretära injuries sjukdomar 2.16.840.1.113883.6.73 2017-01 V04CH01 inulin and other polyfructosans Inulin och andra polyfruktosaner 2.16.840.1.113883.6.73 2017-01 V04CH02 indigo carmine Indigokarmin 2.16.840.1.113883.6.73 2017-01 V04CH03 phenolsulfonphthalein Fenolrött 2.16.840.1.113883.6.73 2017-01 V04CH04 alsactide Alsaktid 2.16.840.1.113883.6.73 2017-01 V04CH30 aminohippuric acid Aminohippursyra 2.16.840.1.113883.6.73 2017-01 V04CJ Tests for thyreoidea function Tyreoideafunktionstest 2.16.840.1.113883.6.73 2017-01 V04CJ01 thyrotropin Tyrotropin 2.16.840.1.113883.6.73 2017-01 V04CJ02 protirelin Protirelin 2.16.840.1.113883.6.73 2017-01 V04CK Tests for pancreatic function Pankreasfunktionstest 2.16.840.1.113883.6.73 2017-01 V04CK01 secretin Sekretin 2.16.840.1.113883.6.73 2017-01 V04CK02 pancreozymin (cholecystokinin) Kolecystokinin 2.16.840.1.113883.6.73 2017-01 V04CK03 bentiromide Bentiromid 2.16.840.1.113883.6.73 2017-01 V04CL Tests for allergic diseases Allergitest 2.16.840.1.113883.6.73 2017-01 V04CM Tests for fertility disturbances Tester för fertilitetsstörningar 2.16.840.1.113883.6.73 2017-01 V04CM01 gonadorelin Gonadorelin 2.16.840.1.113883.6.73 2017-01 V04CX Other diagnostic agents Övriga diagnostiska medel 2.16.840.1.113883.6.73 2017-01 V06 GENERAL NUTRIENTS Näringspreparat 2.16.840.1.113883.6.73 2017-01 V06A DIET FORMULATIONS FOR Dietpreparat för bantning TREATMENT OF OBESITY 2.16.840.1.113883.6.73 2017-01 V06AA Low-energy diets Lågenergidieter 2.16.840.1.113883.6.73 2017-01 V06B PROTEIN SUPPLEMENTS Proteinsupplement 2.16.840.1.113883.6.73 2017-01 V06C INFANT FORMULAS Näringspreparat för barn 2.16.840.1.113883.6.73 2017-01 V06CA Nutrients without phenylalanine Medel vid fenylketonuri 2.16.840.1.113883.6.73 2017-01 V06D OTHER NUTRIENTS Övriga näringspreparat 2.16.840.1.113883.6.73 2017-01 V06DA Carbohydrates/proteins/minerals/vit Kolhydrat-, protein-, mineral- och amins, combinations vitamintillskott, kombinationer

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 157 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V06DB Fat/carbohydrates/proteins/minerals Fett-, kolhydrat-, protein-, mineral /vitamins, combinations och vitamintillskott 2.16.840.1.113883.6.73 2017-01 V06DC Carbohydrates Kolhydrater 2.16.840.1.113883.6.73 2017-01 V06DC01 glucose Glukos 2.16.840.1.113883.6.73 2017-01 V06DC02 fructose Fruktos 2.16.840.1.113883.6.73 2017-01 V06DD Amino acids, incl. combinations with Aminosyror, inkl kombinationer med polypeptides polypeptider 2.16.840.1.113883.6.73 2017-01 V06DE Amino Aminosyror-, kolhydrat-, mineral och acids/carbohydrates/minerals/vitami vitamintillskott, kombinationer ns, combinations 2.16.840.1.113883.6.73 2017-01 V06DF Milk substitutes Mjölksubstitut 2.16.840.1.113883.6.73 2017-01 V06DX Other combinations of nutrients Övriga kombinationer av näringsämnen 2.16.840.1.113883.6.73 2017-01 V07 ALL OTHER NON-THERAPEUTIC Tekniska hjälpmedel PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07A ALL OTHER NON-THERAPEUTIC Tekniska hjälpmedel PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07AA Plasters Plåster 2.16.840.1.113883.6.73 2017-01 V07AB Solvents and diluting agents, incl. Lösningar, spädningsvätskor och irrigating solutions spolvätskor 2.16.840.1.113883.6.73 2017-01 V07AC Blood transfusion, auxiliary products Hjälpmedel vid transfusioner, infusioner m m 2.16.840.1.113883.6.73 2017-01 V07AD Blood tests, auxiliary products Hjälpmedel vid blodprov 2.16.840.1.113883.6.73 2017-01 V07AN Incontinence equipment Inkontinenstillbehör 2.16.840.1.113883.6.73 2017-01 V07AR Sensitivity tests, discs and tablets Känslighetstester, -disker och tabletter 2.16.840.1.113883.6.73 2017-01 V07AS Stomi equipment Stomitillbehör 2.16.840.1.113883.6.73 2017-01 V07AT Cosmetics Kosmetika 2.16.840.1.113883.6.73 2017-01 V07AV Technical disinfectants Tekniska desinfektionsmedel 2.16.840.1.113883.6.73 2017-01 V07AX Washing agents etc. Tvättmedel m.m. 2.16.840.1.113883.6.73 2017-01 V07AY Other non-therapeutic auxiliary Övriga icke terapeutiska hjälpmedel products 2.16.840.1.113883.6.73 2017-01 V07AZ Chemicals and reagents for analysis Kemikalier och reagenser för analyser 2.16.840.1.113883.6.73 2017-01 V08 CONTRAST MEDIA Kontrastmedel 2.16.840.1.113883.6.73 2017-01 V08A X-RAY CONTRAST MEDIA, Joderade röntgenkontrastmedel IODINATED 2.16.840.1.113883.6.73 2017-01 V08AA Watersoluble, nephrotropic, high Vattenlösliga, högosmolära osmolar X-ray contrast media röntgenkontrastmedel med njuraffinitet 2.16.840.1.113883.6.73 2017-01 V08AA01 diatrizoic acid Amidotrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA02 metrizoic acid Metrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA03 iodamide Jodamid 2.16.840.1.113883.6.73 2017-01 V08AA04 iotalamic acid Jotalamsyra 2.16.840.1.113883.6.73 2017-01 V08AA05 ioxitalamic acid Joxitalamsyra 2.16.840.1.113883.6.73 2017-01 V08AA06 ioglicic acid Jogliksyra 2.16.840.1.113883.6.73 2017-01 V08AA07 acetrizoic acid Acetrizoinsyra 2.16.840.1.113883.6.73 2017-01 V08AA08 iocarmic acid Jokarmsyra

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 158 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08AA09 methiodal Metiodal 2.16.840.1.113883.6.73 2017-01 V08AA10 diodone Diodon 2.16.840.1.113883.6.73 2017-01 V08AB Watersoluble, nephrotropic, low Vattenlösliga, lågosmolära osmolar X-ray contrast media röntgenkontrastmedel med njuraffinitet 2.16.840.1.113883.6.73 2017-01 V08AB01 metrizamide Metrizamid 2.16.840.1.113883.6.73 2017-01 V08AB02 iohexol Johexol 2.16.840.1.113883.6.73 2017-01 V08AB03 ioxaglic acid Joxaglinsyra 2.16.840.1.113883.6.73 2017-01 V08AB04 iopamidol Jopamidol 2.16.840.1.113883.6.73 2017-01 V08AB05 iopromide Jopromid 2.16.840.1.113883.6.73 2017-01 V08AB06 iotrolan Jotrolan 2.16.840.1.113883.6.73 2017-01 V08AB07 ioversol Joversol 2.16.840.1.113883.6.73 2017-01 V08AB08 iopentol Jopentol 2.16.840.1.113883.6.73 2017-01 V08AB09 iodixanol Jodixanol 2.16.840.1.113883.6.73 2017-01 V08AB10 iomeprol Jomeprol 2.16.840.1.113883.6.73 2017-01 V08AB11 iobitridol Jobitridol 2.16.840.1.113883.6.73 2017-01 V08AB12 ioxilan Joxilan 2.16.840.1.113883.6.73 2017-01 V08AC Watersoluble, hepatotropic X-ray Vattenlösliga röntgenkontrastmedel contrast media med leveraffinitet 2.16.840.1.113883.6.73 2017-01 V08AC01 iodoxamic acid Jodoxamsyra 2.16.840.1.113883.6.73 2017-01 V08AC02 iotroxic acid Jotroxinsyra 2.16.840.1.113883.6.73 2017-01 V08AC03 ioglycamic acid Joglykamsyra 2.16.840.1.113883.6.73 2017-01 V08AC04 adipiodone Adipiodon 2.16.840.1.113883.6.73 2017-01 V08AC05 iobenzamic acid Jobensamsyra 2.16.840.1.113883.6.73 2017-01 V08AC06 iopanoic acid Jopansyra 2.16.840.1.113883.6.73 2017-01 V08AC07 iocetamic acid Jocetamsyra 2.16.840.1.113883.6.73 2017-01 V08AC08 sodium iopodate Natriumjopodat 2.16.840.1.113883.6.73 2017-01 V08AC09 tyropanoic acid Tyropanoinsyra 2.16.840.1.113883.6.73 2017-01 V08AC10 calcium iopodate Kalciumjopodat 2.16.840.1.113883.6.73 2017-01 V08AD Non-watersoluble X-ray contrast Vattenolösliga media röntgenkontrastmedel 2.16.840.1.113883.6.73 2017-01 V08AD01 ethyl esters of iodised fatty acids Etylestrar av jodiserade fettsyror 2.16.840.1.113883.6.73 2017-01 V08AD02 iopydol Jopydol 2.16.840.1.113883.6.73 2017-01 V08AD03 propyliodone Propyljodon 2.16.840.1.113883.6.73 2017-01 V08AD04 iofendylate Jofendylat 2.16.840.1.113883.6.73 2017-01 V08B X-RAY CONTRAST MEDIA, NON- Röntgenkontrastmedel utan jod IODINATED 2.16.840.1.113883.6.73 2017-01 V08BA Barium sulfate containing X-ray Bariumsulfat contrast media 2.16.840.1.113883.6.73 2017-01 V08BA01 barium sulfate with suspending Bariumsulfat agents 2.16.840.1.113883.6.73 2017-01 V08BA02 barium sulfate without suspending Bariumsulfat agents 2.16.840.1.113883.6.73 2017-01 V08C MAGNETIC RESONANCE Kontrastmedel för magnetisk IMAGING CONTRAST MEDIA resonanstomografi 2.16.840.1.113883.6.73 2017-01 V08CA Paramagnetic contrast media Paramagnetiska kontrastmedel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 159 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08CA01 gadopentetic acid Gadopentetat 2.16.840.1.113883.6.73 2017-01 V08CA02 gadoteric acid Gadoterinsyra 2.16.840.1.113883.6.73 2017-01 V08CA03 gadodiamide Gadodiamid 2.16.840.1.113883.6.73 2017-01 V08CA04 gadoteridol Gadoteridol 2.16.840.1.113883.6.73 2017-01 V08CA05 mangafodipir Mangafodipir 2.16.840.1.113883.6.73 2017-01 V08CA06 gadoversetamide Gadoversetamid 2.16.840.1.113883.6.73 2017-01 V08CA07 ferric ammonium citrate Järn(III)ammoniumcitrat 2.16.840.1.113883.6.73 2017-01 V08CA08 gadobenic acid Gadobenat 2.16.840.1.113883.6.73 2017-01 V08CA09 gadobutrol Gadobutrol 2.16.840.1.113883.6.73 2017-01 V08CA10 gadoxetic acid Gadoxetinsyra 2.16.840.1.113883.6.73 2017-01 V08CA11 gadofosveset Gadofosveset 2.16.840.1.113883.6.73 2017-01 V08CB Superparamagnetic contrast media Superparamagnetiska kontrastmedel 2.16.840.1.113883.6.73 2017-01 V08CB01 ferumoxsil Ferumoxsil 2.16.840.1.113883.6.73 2017-01 V08CB02 ferristene Järnferrit med bärarpartiklar 2.16.840.1.113883.6.73 2017-01 V08CB03 iron oxide, nanoparticles Järnoxid, nanopartiklar 2.16.840.1.113883.6.73 2017-01 V08CX Other magnetic resonance imaging Övriga kontrastmedel för magnetisk contrast media resonanstomografi 2.16.840.1.113883.6.73 2017-01 V08CX01 perflubron Perflubron 2.16.840.1.113883.6.73 2017-01 V08D ULTRASOUND CONTRAST MEDIA Kontrastmedel för ultraljudsundersökningar 2.16.840.1.113883.6.73 2017-01 V08DA Ultrasound contrast media Kontrastmedel för ultraljudsundersökningar 2.16.840.1.113883.6.73 2017-01 V08DA01 microspheres of human albumin Mikrosfärer av humant albumin 2.16.840.1.113883.6.73 2017-01 V08DA02 microparticles of galactose Mikropartiklar av galaktos 2.16.840.1.113883.6.73 2017-01 V08DA03 perflenapent Perflenapent 2.16.840.1.113883.6.73 2017-01 V08DA04 microspheres of phospholipids Mikrosfärer av fosfolipider 2.16.840.1.113883.6.73 2017-01 V08DA05 sulfur hexafluoride Svavelhexafluorid 2.16.840.1.113883.6.73 2017-01 V08DA06 perflubutane polymer microspheres Perflubutanpolymermikrosfärer 2.16.840.1.113883.6.73 2017-01 V09 DIAGNOSTIC Diagnostiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09A CENTRAL NERVOUS SYSTEM Centrala nervsystemet 2.16.840.1.113883.6.73 2017-01 V09AA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09AA01 technetium (99mTc) exametazime Teknetium(Tc-99m)exametazim 2.16.840.1.113883.6.73 2017-01 V09AA02 technetium (99mTc) bicisate Teknetium(Tc- 99m)bicisatdihydroklorid 2.16.840.1.113883.6.73 2017-01 V09AB Iodine (123I) compounds Jod(I-123)föreningar 2.16.840.1.113883.6.73 2017-01 V09AB01 iodine iofetamine (123I) Jodjofetamin(I-123) 2.16.840.1.113883.6.73 2017-01 V09AB02 iodine iolopride (123I) Jodjoloprid(I-123) 2.16.840.1.113883.6.73 2017-01 V09AB03 iodine ioflupane (123I) Jodjoflupan(I-123) 2.16.840.1.113883.6.73 2017-01 V09AX Other central nervous system Övriga diagnostiska radiofarmaka diagnostic radiopharmaceuticals för det centrala nervsystemet 2.16.840.1.113883.6.73 2017-01 V09AX01 indium (111In) pentetic acid Indium(In-111)pentetat 2.16.840.1.113883.6.73 2017-01 V09AX03 iodine (124I) 2beta-carbomethoxy- Jod (I-124) 2beta-karbometoxi- 3beta-(4 iodophenyl)-tropane 3beta-(4 jodofenyl)-tropan 2.16.840.1.113883.6.73 2017-01 V09AX04 flutemetamol (18F) Flutemetamol(F-18) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 160 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09AX05 florbetapir (18F) Florbetapir(F-18) 2.16.840.1.113883.6.73 2017-01 V09AX06 florbetaben (18F) Florbetaben(F-18) 2.16.840.1.113883.6.73 2017-01 V09B SKELETON Skelett 2.16.840.1.113883.6.73 2017-01 V09BA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09BA01 technetium (99mTc) oxidronic acid Teknetium(Tc-99m)oxidronsyra 2.16.840.1.113883.6.73 2017-01 V09BA02 technetium (99mTc) medronic acid Teknetium(Tc-99m)medronat 2.16.840.1.113883.6.73 2017-01 V09BA03 technetium (99mTc) pyrophosphate Teknetium(Tc-99m)pyrofosfat 2.16.840.1.113883.6.73 2017-01 V09BA04 technetium (99mTc) butedronic acid Teknetium(Tc-99m)butedronsyra 2.16.840.1.113883.6.73 2017-01 V09C RENAL SYSTEM Renala systemet 2.16.840.1.113883.6.73 2017-01 V09CA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09CA01 technetium (99mTc) pentetic acid Teknetium(Tc-99m)pentetsyra 2.16.840.1.113883.6.73 2017-01 V09CA02 technetium (99mTc) succimer Teknetium(Tc-99m)succimer 2.16.840.1.113883.6.73 2017-01 V09CA03 technetium (99mTc) mertiatide Teknetium(Tc-99m)mertiatid 2.16.840.1.113883.6.73 2017-01 V09CA04 technetium (99mTc) gluceptate Teknetium(Tc-99m)gluceptat 2.16.840.1.113883.6.73 2017-01 V09CA05 technetium (99mTc) gluconate Teknetium(Tc-99m)glukonat 2.16.840.1.113883.6.73 2017-01 V09CA06 technetium (99mTc) Teknetium(Tc-99m)etylendicystein ethylenedicysteine 2.16.840.1.113883.6.73 2017-01 V09CX Other renal system diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för det renala systemet 2.16.840.1.113883.6.73 2017-01 V09CX01 sodium iodohippurate (123I) Natriumjodhippurat(I-123) 2.16.840.1.113883.6.73 2017-01 V09CX02 sodium iodohippurate (131I) Natriumjodhippurat(I-131) 2.16.840.1.113883.6.73 2017-01 V09CX03 sodium iothalamate (125I) Natriumjotalamat(I-125) 2.16.840.1.113883.6.73 2017-01 V09CX04 chromium (51Cr) edetate Krom(Cr-51)edetat 2.16.840.1.113883.6.73 2017-01 V09D HEPATIC AND RETICULO Hepatiska och retikuloendoteliala ENDOTHELIAL SYSTEM systemet 2.16.840.1.113883.6.73 2017-01 V09DA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09DA01 technetium (99mTc) disofenin Teknetium(Tc-99m)disofenin 2.16.840.1.113883.6.73 2017-01 V09DA02 technetium (99mTc) etifenin Teknetium(Tc-99m)etifenin 2.16.840.1.113883.6.73 2017-01 V09DA03 technetium (99mTc) lidofenin Teknetium(Tc-99m)lidofenin 2.16.840.1.113883.6.73 2017-01 V09DA04 technetium (99mTc) mebrofenin Teknetium(Tc-99m)mebrofenin 2.16.840.1.113883.6.73 2017-01 V09DA05 technetium (99mTc) galtifenin Teknetium(Tc-99m)galtifenin 2.16.840.1.113883.6.73 2017-01 V09DB Technetium (99mTc), particles and Teknetium(Tc-99m), partiklar och colloids kolloider 2.16.840.1.113883.6.73 2017-01 V09DB01 technetium (99mTc) nanocolloid Teknetium(Tc-99m)nanokolloid 2.16.840.1.113883.6.73 2017-01 V09DB02 technetium (99mTc) microcolloid Teknetium(Tc-99m)mikrokolloid 2.16.840.1.113883.6.73 2017-01 V09DB03 technetium (99mTc) Teknetium(Tc-99m)millimikrosfärer millimicrospheres 2.16.840.1.113883.6.73 2017-01 V09DB04 technetium (99mTc) tin colloid Teknetium(Tc-99m)tennkolloid 2.16.840.1.113883.6.73 2017-01 V09DB05 technetium (99mTc) sulfur colloid Teknetium(Tc-99m)svavelkolloid 2.16.840.1.113883.6.73 2017-01 V09DB06 technetium (99mTc) rheniumsulfide Teknetium(Tc- colloid 99m)rheniumsulfidkolloid 2.16.840.1.113883.6.73 2017-01 V09DB07 technetium (99mTc) phytate Teknetium(Tc-99m)fytat 2.16.840.1.113883.6.73 2017-01 V09DX Other hepatic and reticulo Övriga radiofarmaka för diagnostik endothelial system diagnostic av det hepatiska och radiopharmaceuticals retikuloendoteliala systemet 2.16.840.1.113883.6.73 2017-01 V09DX01 selenium (75Se) tauroselcholic acid Selenium(Se-75)tauroselcholsyra © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 161 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09E RESPIRATORY SYSTEM Andningsorganen 2.16.840.1.113883.6.73 2017-01 V09EA Technetium (99mTc), inhalants Teknetium(Tc-99m), inhalationer 2.16.840.1.113883.6.73 2017-01 V09EA01 technetium (99mTc) pentetic acid Teknetium(Tc-99m)pentetsyra 2.16.840.1.113883.6.73 2017-01 V09EA02 technetium (99mTc) technegas Teknetium(Tc-99m)teknegas 2.16.840.1.113883.6.73 2017-01 V09EA03 technetium (99mTc) nanocolloid Teknetium(Tc-99m)nanokolloid 2.16.840.1.113883.6.73 2017-01 V09EB Technetium (99mTc), particles for Teknetium(Tc-99m), partiklar för injection injektion 2.16.840.1.113883.6.73 2017-01 V09EB01 technetium (99mTc) macrosalb Teknetium(Tc-99m)makrosalb 2.16.840.1.113883.6.73 2017-01 V09EB02 technetium (99mTc) microspheres Teknetium(Tc-99m)mikrosfärer 2.16.840.1.113883.6.73 2017-01 V09EX Other respiratory system diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för andningsorganen 2.16.840.1.113883.6.73 2017-01 V09EX01 krypton (81mKr) gas Krypton (Kr-81m) gas 2.16.840.1.113883.6.73 2017-01 V09EX02 xenon (127Xe) gas Xenon(Xe-127)gas 2.16.840.1.113883.6.73 2017-01 V09EX03 xenon (133Xe) gas Xenon(Xe-133)gas 2.16.840.1.113883.6.73 2017-01 V09F THYROID Tyreoidea 2.16.840.1.113883.6.73 2017-01 V09FX Various thyroid diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals för tyreoidea 2.16.840.1.113883.6.73 2017-01 V09FX01 technetium (99mTc) pertechnetate Teknetium(Tc-99m)perteknetat 2.16.840.1.113883.6.73 2017-01 V09FX02 sodium iodide (123I) Natriumjodid(I-123) 2.16.840.1.113883.6.73 2017-01 V09FX03 sodium iodide (131I) Natriumjodid(I-131) 2.16.840.1.113883.6.73 2017-01 V09FX04 sodium iodide (124I) Natriumjodid(I-124) 2.16.840.1.113883.6.73 2017-01 V09G CARDIOVASCULAR SYSTEM Hjärta och kretslopp 2.16.840.1.113883.6.73 2017-01 V09GA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09GA01 technetium (99mTc) sestamibi Teknetium(Tc-99m)sestamibi 2.16.840.1.113883.6.73 2017-01 V09GA02 technetium (99mTc) tetrofosmin Teknetium(Tc-99m)tetrofosmin 2.16.840.1.113883.6.73 2017-01 V09GA03 technetium (99mTc) teboroxime Teknetium(Tc-99m)teboroxim 2.16.840.1.113883.6.73 2017-01 V09GA04 technetium (99mTc) human albumin Teknetium(Tc-99m)albumin, humant 2.16.840.1.113883.6.73 2017-01 V09GA05 technetium (99mTc) furifosmin Teknetium(Tc-99m)furifosmin 2.16.840.1.113883.6.73 2017-01 V09GA06 technetium (99mTc) stannous agent Teknetium(Tc-99m)tennmärkta labelled cells celler 2.16.840.1.113883.6.73 2017-01 V09GA07 technetium (99mTc) apcitide Teknetium(Tc-99m)apcitid 2.16.840.1.113883.6.73 2017-01 V09GB Iodine (125I) compounds Jod(I-125)föreningar 2.16.840.1.113883.6.73 2017-01 V09GB01 fibrinogen (125I) Fibrinogen(I-125) 2.16.840.1.113883.6.73 2017-01 V09GB02 iodine (125I) human albumin Humant jod(I-125)albumin 2.16.840.1.113883.6.73 2017-01 V09GX Other cardiovascular system Övriga diagnostiska radiofarmaka diagnostic radiopharmaceuticals för det kardiovaskulära systemet 2.16.840.1.113883.6.73 2017-01 V09GX01 thallium (201Tl) chloride Tallium(Tl-201)klorid 2.16.840.1.113883.6.73 2017-01 V09GX02 indium (111In) imciromab Indium(In-111)imikromab 2.16.840.1.113883.6.73 2017-01 V09GX03 chromium (51Cr) chromate labelled Natriumkromat(Cr-51) cells 2.16.840.1.113883.6.73 2017-01 V09GX04 rubidium (82Rb) chloride Rubidium(Rb-82)klorid 2.16.840.1.113883.6.73 2017-01 V09H INFLAMMATION AND INFECTION Inflammations- och DETECTION infektionsdetektion 2.16.840.1.113883.6.73 2017-01 V09HA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09HA01 technetium (99mTc) human Teknetium(Tc-99m)immunglobulin, immunoglobulin humant © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 162 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09HA02 technetium (99mTc) exametazime Teknetium(Tc- labelled cells 99m)exametazimmärkta celler 2.16.840.1.113883.6.73 2017-01 V09HA03 technetium (99mTc) antigranulocyte Teknetium(Tc-99m)antigranulocyt antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09HA04 technetium (99mTc) sulesomab Teknetium(Tc-99m)sulesomab 2.16.840.1.113883.6.73 2017-01 V09HB Indium (111In) compounds Indium(In-111)föreningar 2.16.840.1.113883.6.73 2017-01 V09HB01 indium (111In) oxinate labelled cells Indium(In-111)oxin 2.16.840.1.113883.6.73 2017-01 V09HB02 indium (111In) tropolonate labelled Indium(In-111)tropolonatmärkta cells celler 2.16.840.1.113883.6.73 2017-01 V09HX Other diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals for för inflammations- och inflammation and infection detection infektionsdetektion 2.16.840.1.113883.6.73 2017-01 V09HX01 gallium (67Ga) citrate Gallium(Ga-67)citrat 2.16.840.1.113883.6.73 2017-01 V09I TUMOUR DETECTION Tumördetektion 2.16.840.1.113883.6.73 2017-01 V09IA Technetium (99mTc) compounds Teknetium(Tc-99m)föreningar 2.16.840.1.113883.6.73 2017-01 V09IA01 technetium (99mTc) Teknetium(Tc- antiCarcinoEmbryonicAntigen 99m)antiCarcinoEmbryoAntigen antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IA02 technetium (99mTc) antimelanoma Teknetium(Tc-99m)antimelanom antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IA03 technetium (99mTc) pentavalent Teknetium(Tc-99m)pentavalent succimer succimer 2.16.840.1.113883.6.73 2017-01 V09IA04 technetium (99mTc) votumumab Teknetium(Tc-99m)votumumab 2.16.840.1.113883.6.73 2017-01 V09IA05 technetium (99mTc) depreotide Teknetium(Tc-99m)depreotid 2.16.840.1.113883.6.73 2017-01 V09IA06 technetium (99mTc) arcitumomab Teknetium(Tc-99m)arcitumomab 2.16.840.1.113883.6.73 2017-01 V09IA07 technetium (99mTc) hynic- Teknetium(Tc-99m)hynik-oktreotid octreotide 2.16.840.1.113883.6.73 2017-01 V09IA08 technetium (99mTc) etarfolatide Teknetium(Tc-99m)etarfolatid 2.16.840.1.113883.6.73 2017-01 V09IA09 technetium (99mTc) tilmanocept Teknetium(Tc-99m)tilmanocept 2.16.840.1.113883.6.73 2017-01 V09IB Indium (111In) compounds Indium(In-111)föreningar 2.16.840.1.113883.6.73 2017-01 V09IB01 indium (111In) pentetreotide Indium(In-111)pentetreotid 2.16.840.1.113883.6.73 2017-01 V09IB02 indium (111In) satumomab Indium(In-111)satumomabpendetid pendetide 2.16.840.1.113883.6.73 2017-01 V09IB03 indium (111In) Indium(In-111)antiovariumkarcinom antiovariumcarcinoma antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IB04 indium (111In) capromab pendetide Indium(In-111)kapromabpentid 2.16.840.1.113883.6.73 2017-01 V09IX Other diagnostic Övriga diagnostiska radiofarmaka radiopharmaceuticals for tumour för tumördetektion detection 2.16.840.1.113883.6.73 2017-01 V09IX01 iobenguane (123I) Jobenguan(I-123) 2.16.840.1.113883.6.73 2017-01 V09IX02 iobenguane (131I) Jobenguan(I-131) 2.16.840.1.113883.6.73 2017-01 V09IX03 iodine (125I) CC49-monoclonal Jod (I-125) CC49-monoklonal antibody antikropp 2.16.840.1.113883.6.73 2017-01 V09IX04 fludeoxyglucose (18F) Fludeoxiglukos(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX05 fluorodopa (18F) Fluorodopa(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX06 sodium fluoride (18F) Natriumfluorid(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX07 fluoromethylcholine (18F) Fluorokolin(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX08 fluoroethylcholine (18F) Fluoroetylkolin(F-18)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 163 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09IX09 gallium (68Ga) edotreotide Gallium(Ga-68)edotreotid 2.16.840.1.113883.6.73 2017-01 V09IX10 fluoroethyl-L-tyrosine (18F) Fluoroetyl-L-tyrosin(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX11 fluoroestradiol (18F) Fluoroestradiol(F-18) 2.16.840.1.113883.6.73 2017-01 V09IX12 fluciclovine (18F) Fluciklovin(F-18) 2.16.840.1.113883.6.73 2017-01 V09X OTHER DIAGNOSTIC Övriga diagnostiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09XA Iodine (131I) compounds Jod(I-131) föreningar 2.16.840.1.113883.6.73 2017-01 V09XA01 iodine (131I) norcholesterol Jod(I-131)norkolesterol 2.16.840.1.113883.6.73 2017-01 V09XA02 iodocholesterol (131I) Jodokolesterol(I-131) 2.16.840.1.113883.6.73 2017-01 V09XA03 iodine (131I) human albumin Jod(I-131)humanalbumin 2.16.840.1.113883.6.73 2017-01 V09XX Various diagnostic Diverse diagnostiska radiofarmaka radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09XX01 cobalt (57Co) cyanocobalamine Cyanokobalamin(Co-57) 2.16.840.1.113883.6.73 2017-01 V09XX02 cobalt (58Co) cyanocobalamine Cyanokobalamin(Co-58) 2.16.840.1.113883.6.73 2017-01 V09XX03 selenium (75Se) norcholesterol Selen(Se-75)norkolesterol 2.16.840.1.113883.6.73 2017-01 V09XX04 ferric (59Fe) citrate Järn(Fe-59)citrat 2.16.840.1.113883.6.73 2017-01 V10 THERAPEUTIC Terapeutiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10A ANTIINFLAMMATORY AGENTS Antiinflammatoriska medel 2.16.840.1.113883.6.73 2017-01 V10AA Yttrium (90Y) compounds Yttrium(Y-90)föreningar 2.16.840.1.113883.6.73 2017-01 V10AA01 yttrium (90Y) citrate colloid Yttrium(Y-90)citratkolloid 2.16.840.1.113883.6.73 2017-01 V10AA02 yttrium (90Y) ferrihydroxide colloid Yttrium(Y-90)ferrihydroxidkolloid 2.16.840.1.113883.6.73 2017-01 V10AA03 yttrium (90Y) silicate colloid Yttrium(Y-90)silikatkolloid 2.16.840.1.113883.6.73 2017-01 V10AX Other antiinflammatory therapeutic Övriga antiinflammatoriska radiopharmaceuticals terapeutiska radiofarmaka 2.16.840.1.113883.6.73 2017-01 V10AX01 phosphorous (32P) Fosfor(P-32)kromfosfatkolloid chromicphosphate colloid 2.16.840.1.113883.6.73 2017-01 V10AX02 samarium (153Sm) hydroxyapatite Samarium(Sm- colloid 153)hydroxiapatitkolloid 2.16.840.1.113883.6.73 2017-01 V10AX03 dysprosium (165Dy) colloid Dysprosium(Dy-165)kolloid 2.16.840.1.113883.6.73 2017-01 V10AX04 erbium (169Er) citrate colloid Erbium(Er-169)citratkolloid 2.16.840.1.113883.6.73 2017-01 V10AX05 rhenium (186Re) sulfide colloid Rhenium(Re-186)sulfidkolloid 2.16.840.1.113883.6.73 2017-01 V10AX06 gold (198Au) colloidal Guld(Au-198), kolloidalt 2.16.840.1.113883.6.73 2017-01 V10B PAIN PALLIATION (BONE Smärtlindring (ben-sökande ämnen) SEEKING AGENTS) 2.16.840.1.113883.6.73 2017-01 V10BX Various pain palliation Diverse smärtlindrande radiopharmaceuticals radiofarmaka 2.16.840.1.113883.6.73 2017-01 V10BX01 strontium (89Sr) chloride Strontium(Sr-89)klorid 2.16.840.1.113883.6.73 2017-01 V10BX02 samarium (153Sm) lexidronam Samarium(Sm-153)lexidronam 2.16.840.1.113883.6.73 2017-01 V10BX03 rhenium (186Re) etidronic acid Rhenium(Re-186)etidronsyra 2.16.840.1.113883.6.73 2017-01 V10X OTHER THERAPEUTIC Övriga terapeutiska radiofarmaka RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10XA Iodine (131I) compounds Jod(I-131) föreningar 2.16.840.1.113883.6.73 2017-01 V10XA01 sodium iodide (131I) Natriumjodid(I-131) 2.16.840.1.113883.6.73 2017-01 V10XA02 iobenguane (131I) Jobenguan(I-131)

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 164 of 624 Service Provider MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V10XA53 tositumomab/iodine (131I) Tositumomab/jod(I- tositumomab 131)tositumomab 2.16.840.1.113883.6.73 2017-01 V10XX Various therapeutic Diverse terapeutiska radiofarmaka radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V10XX01 sodium phosphate (32P) Natriumfosfat(P-32) 2.16.840.1.113883.6.73 2017-01 V10XX02 ibritumomab tiuxetan (90Y) Ibritumomabtiuxetan(Y-90) 2.16.840.1.113883.6.73 2017-01 V10XX03 radium (223Ra) dichloride Radium(Ra-223)diklorid 2.16.840.1.113883.6.73 2017-01 V20 SURGICAL DRESSINGS Kirurgiska förband

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 165 of 624 Service Provider MTC epSOSAdministrativeGender

epSOSAdministrativeGender

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.34

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.1 913-20091020 F Female Femme kvinna Femme 2.16.840.1.113883.5.1 913-20091020 M Male Male man Homme 2.16.840.1.113883.5.1 913-20091020 UN Undifferentiated Indifférencié odifferentierad Indifférencié

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 166 of 624 Service Provider MTC epSOSAdverseEventType

epSOSAdverseEventType

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.18

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 235719002 Food intolerance Intolérance alimentaire 2.16.840.1.113883.6.96 2016-07 29544009 Intolerance Intolérance 2.16.840.1.113883.6.96 2016-07 414285001 Food allergy Allergie alimentaire 2.16.840.1.113883.6.96 2016-07 416098002 Drug allergy Allergie à un médicament 2.16.840.1.113883.6.96 2016-07 418038007 Propensity to adverse reactions to substance 2.16.840.1.113883.6.96 2016-07 418471000 Propensity to adverse reactions to food 2.16.840.1.113883.6.96 2016-07 419199007 Allergy to substance Allergie à une substance 2.16.840.1.113883.6.96 2016-07 419511003 Propensity to adverse reactions to drug 2.16.840.1.113883.6.96 2016-07 420134006 Propensity to adverse reactions 2.16.840.1.113883.6.96 2016-07 59037007 Drug intolerance Intolérance à un médicament

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 167 of 624 Service Provider MTC epSOSAllergenNoDrugs

epSOSAllergenNoDrugs

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.19

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 102259006 Citrus fruit 2.16.840.1.113883.6.96 2016-07 102261002 Strawberry 2.16.840.1.113883.6.96 2016-07 102262009 Chocolate 2.16.840.1.113883.6.96 2016-07 102263004 Eggs (edible) 2.16.840.1.113883.6.96 2016-07 102264005 Cheese 2.16.840.1.113883.6.96 2016-07 111088007 Latex 2.16.840.1.113883.6.96 2016-07 11526002 Aspartame 2.16.840.1.113883.6.96 2016-07 115589000 Ethanolamine 2.16.840.1.113883.6.96 2016-07 116273005 Dietary substance 2.16.840.1.113883.6.96 2016-07 116549003 Organochlorine pesticide 2.16.840.1.113883.6.96 2016-07 116637007 Fungal antigen 2.16.840.1.113883.6.96 2016-07 11894001 Clostridium botulinum toxin 2.16.840.1.113883.6.96 2016-07 119417004 Organophosphate insecticide 2.16.840.1.113883.6.96 2016-07 12503006 Aluminium 2.16.840.1.113883.6.96 2016-07 12510000 Eucalyptus oil 2.16.840.1.113883.6.96 2016-07 128488006 House dust 2.16.840.1.113883.6.96 2016-07 128489003 Sand 2.16.840.1.113883.6.96 2016-07 13577000 Nut 2.16.840.1.113883.6.96 2016-07 13652007 Silicone 2.16.840.1.113883.6.96 2016-07 14402002 Wood 2.16.840.1.113883.6.96 2016-07 14423008 Adhesive bandage 2.16.840.1.113883.6.96 2016-07 226359003 Fish oil - dietary 2.16.840.1.113883.6.96 2016-07 226491003 Apple juice 2.16.840.1.113883.6.96 2016-07 226760005 Dairy foods 2.16.840.1.113883.6.96 2016-07 226915003 Red meat 2.16.840.1.113883.6.96 2016-07 226934003 Pork 2.16.840.1.113883.6.96 2016-07 227037002 Fish - dietary 2.16.840.1.113883.6.96 2016-07 227144008 Tuna fish 2.16.840.1.113883.6.96 2016-07 227146005 Shellfish - dietary 2.16.840.1.113883.6.96 2016-07 227161006 Octopus - dietary 2.16.840.1.113883.6.96 2016-07 227163009 Squid - dietary 2.16.840.1.113883.6.96 2016-07 227252000 Mushroom - dietary

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 168 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 227313005 Pulse vegetables 2.16.840.1.113883.6.96 2016-07 227344001 Broad bean - dietary 2.16.840.1.113883.6.96 2016-07 227374009 Herbs and spices 2.16.840.1.113883.6.96 2016-07 227388008 Cinnamon 2.16.840.1.113883.6.96 2016-07 227425007 Figs 2.16.840.1.113883.6.96 2016-07 227444000 Raspberries 2.16.840.1.113883.6.96 2016-07 230031005 Lobster - dietary 2.16.840.1.113883.6.96 2016-07 230032003 Oyster - dietary 2.16.840.1.113883.6.96 2016-07 230034002 Nuts and seeds 2.16.840.1.113883.6.96 2016-07 2309006 Gold 2.16.840.1.113883.6.96 2016-07 23182003 Cereal 2.16.840.1.113883.6.96 2016-07 255640000 Biocide 2.16.840.1.113883.6.96 2016-07 255667006 Paraffin 2.16.840.1.113883.6.96 2016-07 256259004 Pollen 2.16.840.1.113883.6.96 2016-07 256260009 Tree and shrub pollen 2.16.840.1.113883.6.96 2016-07 256277009 Grass pollen 2.16.840.1.113883.6.96 2016-07 256292005 Flower and weed pollen 2.16.840.1.113883.6.96 2016-07 256303006 Ragweed pollen 2.16.840.1.113883.6.96 2016-07 256305004 Tree resin 2.16.840.1.113883.6.96 2016-07 256307007 Banana 2.16.840.1.113883.6.96 2016-07 256309005 Peach - dietary 2.16.840.1.113883.6.96 2016-07 256310000 Cherry - dietary 2.16.840.1.113883.6.96 2016-07 256311001 Apple - dietary 2.16.840.1.113883.6.96 2016-07 256319004 Carrot 2.16.840.1.113883.6.96 2016-07 256323007 Onion - dietary 2.16.840.1.113883.6.96 2016-07 256326004 Celery 2.16.840.1.113883.6.96 2016-07 256327008 Tomato - dietary 2.16.840.1.113883.6.96 2016-07 256349002 Peanut - dietary 2.16.840.1.113883.6.96 2016-07 256352005 Walnut - nut 2.16.840.1.113883.6.96 2016-07 256355007 Soya bean 2.16.840.1.113883.6.96 2016-07 256417003 Horse dander 2.16.840.1.113883.6.96 2016-07 256419000 Mouse epithelium 2.16.840.1.113883.6.96 2016-07 256435007 Feathers 2.16.840.1.113883.6.96 2016-07 256440004 Wasp venom 2.16.840.1.113883.6.96 2016-07 256443002 Egg white 2.16.840.1.113883.6.96 2016-07 256504004 Polycarbonate dental material 2.16.840.1.113883.6.96 2016-07 260118006 Wall pellitory pollen 2.16.840.1.113883.6.96 2016-07 260126003 Olive pollen 2.16.840.1.113883.6.96 2016-07 260152009 Cat dander 2.16.840.1.113883.6.96 2016-07 260153004 Cow dander 2.16.840.1.113883.6.96 2016-07 260154005 Dog dander 2.16.840.1.113883.6.96 2016-07 260156007 Mouse urine proteins 2.16.840.1.113883.6.96 2016-07 260167008 Sesame seed © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 169 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 260170007 Potato - dietary 2.16.840.1.113883.6.96 2016-07 260172004 Garlic - dietary 2.16.840.1.113883.6.96 2016-07 260176001 Kiwi fruit 2.16.840.1.113883.6.96 2016-07 260177005 Melon 2.16.840.1.113883.6.96 2016-07 261243003 Brass 2.16.840.1.113883.6.96 2016-07 264287008 Animal dander 2.16.840.1.113883.6.96 2016-07 264295007 Cow's milk protein 2.16.840.1.113883.6.96 2016-07 264337003 Seed 2.16.840.1.113883.6.96 2016-07 276310004 Animal hair 2.16.840.1.113883.6.96 2016-07 278840001 Shrimp product 2.16.840.1.113883.6.96 2016-07 2799001 Methylbenzethonium chloride 2.16.840.1.113883.6.96 2016-07 280939008 Insect venom 2.16.840.1.113883.6.96 2016-07 28230009 Poultry 2.16.840.1.113883.6.96 2016-07 28647000 Meat 2.16.840.1.113883.6.96 2016-07 288328004 Bee venom 2.16.840.1.113883.6.96 2016-07 289122001 Cosmetic material 2.16.840.1.113883.6.96 2016-07 289949002 Cypress pollen 2.16.840.1.113883.6.96 2016-07 303300008 Egg protein 2.16.840.1.113883.6.96 2016-07 303314008 Scorpion venom 2.16.840.1.113883.6.96 2016-07 303315009 Spider venom 2.16.840.1.113883.6.96 2016-07 31006001 Kingdom Plantae 2.16.840.1.113883.6.96 2016-07 311846002 Pyrethroid insecticide 2.16.840.1.113883.6.96 2016-07 311984009 Chemical or external agent 2.16.840.1.113883.6.96 2016-07 33008008 Dust 2.16.840.1.113883.6.96 2016-07 33396006 Nickel 2.16.840.1.113883.6.96 2016-07 37017009 Helminth 2.16.840.1.113883.6.96 2016-07 3829006 Iron 2.16.840.1.113883.6.96 2016-07 386936005 Azelaic acid 2.16.840.1.113883.6.96 2016-07 387293003 Dithranol 2.16.840.1.113883.6.96 2016-07 387398009 Podophyllum resin 2.16.840.1.113883.6.96 2016-07 391737006 Almond oil 2.16.840.1.113883.6.96 2016-07 395922006 Wool alcohols 2.16.840.1.113883.6.96 2016-07 396031000 Dimeticone 2.16.840.1.113883.6.96 2016-07 406466009 House dust allergen 2.16.840.1.113883.6.96 2016-07 406470001 Insect allergen 2.16.840.1.113883.6.96 2016-07 406472009 Animal protein and epidermal allergen 2.16.840.1.113883.6.96 2016-07 406473004 Contact allergen 2.16.840.1.113883.6.96 2016-07 406771001 Sulphite and/or sulphite derivative 2.16.840.1.113883.6.96 2016-07 406774009 Fish derived omega 3 fatty acid 2.16.840.1.113883.6.96 2016-07 410853002 Perfluorochemical 2.16.840.1.113883.6.96 2016-07 412061001 Blueberries 2.16.840.1.113883.6.96 2016-07 412068007 Rye

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 170 of 624 Service Provider MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 412069004 Flavouring agent 2.16.840.1.113883.6.96 2016-07 412071004 Wheat 2.16.840.1.113883.6.96 2016-07 412145001 Hair dye 2.16.840.1.113883.6.96 2016-07 412153009 Rabbit dander 2.16.840.1.113883.6.96 2016-07 412156001 Silk 2.16.840.1.113883.6.96 2016-07 412160003 Suture allergen 2.16.840.1.113883.6.96 2016-07 412161004 Wool 2.16.840.1.113883.6.96 2016-07 412357001 Corn 2.16.840.1.113883.6.96 2016-07 415710007 Terpene 2.16.840.1.113883.6.96 2016-07 418266005 Yellow paraffin 2.16.840.1.113883.6.96 2016-07 418504009 Oats 2.16.840.1.113883.6.96 2016-07 418785009 Perfume 2.16.840.1.113883.6.96 2016-07 418920007 Adhesive agent 2.16.840.1.113883.6.96 2016-07 419420009 Watermelon 2.16.840.1.113883.6.96 2016-07 419604006 Weed pollen 2.16.840.1.113883.6.96 2016-07 419633007 White paraffin 2.16.840.1.113883.6.96 2016-07 41967008 Silver 2.16.840.1.113883.6.96 2016-07 420111002 Contact metal agent 2.16.840.1.113883.6.96 2016-07 42416001 Lanolin 2.16.840.1.113883.6.96 2016-07 430503006 Glutamate 2.16.840.1.113883.6.96 2016-07 43230003 Rubber 2.16.840.1.113883.6.96 2016-07 43735007 Sulphur 2.16.840.1.113883.6.96 2016-07 44027008 Seafood 2.16.840.1.113883.6.96 2016-07 47703008 Lactose 2.16.840.1.113883.6.96 2016-07 51905005 Mustard 2.16.840.1.113883.6.96 2016-07 52454007 Albumin 2.16.840.1.113883.6.96 2016-07 57126000 Glue 2.16.840.1.113883.6.96 2016-07 59351004 Citrate 2.16.840.1.113883.6.96 2016-07 59533004 Food additive 2.16.840.1.113883.6.96 2016-07 59545008 Pesticide 2.16.840.1.113883.6.96 2016-07 61789006 Dye 2.16.840.1.113883.6.96 2016-07 66925006 Copper 2.16.840.1.113883.6.96 2016-07 67324005 Rice 2.16.840.1.113883.6.96 2016-07 72511004 Fruit 2.16.840.1.113883.6.96 2016-07 7791007 Soy protein 2.16.840.1.113883.6.96 2016-07 80237000 Cocoa butter 2.16.840.1.113883.6.96 2016-07 83619009 Polyvinyl alcohol 2.16.840.1.113883.6.96 2016-07 89811004 Gluten 2.16.840.1.113883.6.96 2016-07 89889006 Cotton fibre 2.16.840.1.113883.6.96 2016-07 9021002 Carbaryl 2.16.840.1.113883.6.96 2016-07 91598004 Benzoyl peroxide

TRANSCODINGS © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 171 of 624 Service Provider MTC epSOSAllergenNoDrugs

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 172 of 624 Service Provider MTC epSOSBloodGroup

epSOSBloodGroup

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.20

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 112144000 Blood group A 2.16.840.1.113883.6.96 2016-07 112149005 Blood group B 2.16.840.1.113883.6.96 2016-07 165743006 Blood group AB 2.16.840.1.113883.6.96 2016-07 278147001 Blood group O Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278148006 Blood group O Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278149003 Blood group A Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278150003 Blood group B Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278151004 Blood group AB Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278152006 Blood group A Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278153001 Blood group B Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278154007 Blood group AB Rh(D) negative 2.16.840.1.113883.6.96 2016-07 58460004 Blood group O

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 173 of 624 Service Provider MTC epSOSBloodPressure

epSOSBloodPressure

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.21

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 8462-4 Diastolic blood pressure 2.16.840.1.113883.6.1 2.59 8480-6 Systolic blood pressure

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 174 of 624 Service Provider MTC epSOSCodeProb

epSOSCodeProb

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.23

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.96 2016-07 248536006 Finding of functional performance and activity 2.16.840.1.113883.6.96 2016-07 282291009 Diagnosis interpretation 2.16.840.1.113883.6.96 2016-07 404684003 Clinical finding 2.16.840.1.113883.6.96 2016-07 409586006 Complaint 2.16.840.1.113883.6.96 2016-07 418799008 Finding reported by subject or history provider 2.16.840.1.113883.6.96 2016-07 55607006 Problem 2.16.840.1.113883.6.96 2016-07 64572001 Disease

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 175 of 624 Service Provider MTC epSOSConfidentiality

epSOSConfidentiality

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.31

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.5.25 913-20091020 N normal Normal 2.16.840.1.113883.5.25 913-20091020 R restricted restreint Restreint 2.16.840.1.113883.5.25 913-20091020 V very restricted très restreint Confidentiel

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 176 of 624 Service Provider MTC epSOSCountry

epSOSCountry

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.4

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.0.3166.1 2006-2nd AD ANDORRA 1.0.3166.1 2006-2nd AE UNITED ARAB EMIRATES 1.0.3166.1 2006-2nd AF AFGHANISTAN 1.0.3166.1 2006-2nd AG ANTIGUA AND BARBUDA 1.0.3166.1 2006-2nd AI ANGUILLA 1.0.3166.1 2006-2nd AL ALBANIA 1.0.3166.1 2006-2nd AM ARMENIA 1.0.3166.1 2006-2nd AO ANGOLA 1.0.3166.1 2006-2nd AQ ANTARCTICA 1.0.3166.1 2006-2nd AR ARGENTINA 1.0.3166.1 2006-2nd AS AMERICAN SAMOA 1.0.3166.1 2006-2nd AT AUSTRIA 1.0.3166.1 2006-2nd AU AUSTRALIA 1.0.3166.1 2006-2nd AW ARUBA 1.0.3166.1 2006-2nd AX ÅLAND ISLANDS 1.0.3166.1 2006-2nd AZ AZERBAIJAN 1.0.3166.1 2006-2nd BA BOSNIA AND HERZEGOVINA 1.0.3166.1 2006-2nd BB BARBADOS 1.0.3166.1 2006-2nd BD BANGLADESH 1.0.3166.1 2006-2nd BE BELGIUM 1.0.3166.1 2006-2nd BF BURKINA FASO 1.0.3166.1 2006-2nd BG BULGARIA 1.0.3166.1 2006-2nd BH BAHRAIN 1.0.3166.1 2006-2nd BI BURUNDI 1.0.3166.1 2006-2nd BJ BENIN 1.0.3166.1 2006-2nd BL SAINT BARTHÉLEMY 1.0.3166.1 2006-2nd BM BERMUDA 1.0.3166.1 2006-2nd BN BRUNEI DARUSSALAM 1.0.3166.1 2006-2nd BO BOLIVIA (PLURINATIONAL STATE OF) 1.0.3166.1 2006-2nd BQ BONAIRE, SINT EUSTATIUS AND SABA 1.0.3166.1 2006-2nd BR BRAZIL © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 177 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd BS BAHAMAS 1.0.3166.1 2006-2nd BT BHUTAN 1.0.3166.1 2006-2nd BV BOUVET ISLAND 1.0.3166.1 2006-2nd BW BOTSWANA 1.0.3166.1 2006-2nd BY BELARUS 1.0.3166.1 2006-2nd BZ BELIZE 1.0.3166.1 2006-2nd CA CANADA 1.0.3166.1 2006-2nd CC COCOS (KEELING) ISLANDS 1.0.3166.1 2006-2nd CD CONGO, DEMOCRATIC REPUBLIC OF 1.0.3166.1 2006-2nd CF CENTRAL AFRICAN REPUBLIC 1.0.3166.1 2006-2nd CG CONGO 1.0.3166.1 2006-2nd CH SWITZERLAND 1.0.3166.1 2006-2nd CI COTE D'IVOIRE 1.0.3166.1 2006-2nd CK COOK ISLANDS 1.0.3166.1 2006-2nd CL CHILE 1.0.3166.1 2006-2nd CM CAMEROON 1.0.3166.1 2006-2nd CN CHINA 1.0.3166.1 2006-2nd CO COLOMBIA 1.0.3166.1 2006-2nd CR COSTA RICA 1.0.3166.1 2006-2nd CU CUBA 1.0.3166.1 2006-2nd CV CAPE VERDE 1.0.3166.1 2006-2nd CW CURACAO 1.0.3166.1 2006-2nd CX CHRISTMAS ISLAND 1.0.3166.1 2006-2nd CY CYPRUS 1.0.3166.1 2006-2nd CZ CZECH REPUBLIC 1.0.3166.1 2006-2nd DE GERMANY 1.0.3166.1 2006-2nd DJ DJIBOUTI 1.0.3166.1 2006-2nd DK DENMARK 1.0.3166.1 2006-2nd DM DOMINICA 1.0.3166.1 2006-2nd DO DOMINICAN REPUBLIC 1.0.3166.1 2006-2nd DZ ALGERIA 1.0.3166.1 2006-2nd EC ECUADOR 1.0.3166.1 2006-2nd EE ESTONIA 1.0.3166.1 2006-2nd EG EGYPT 1.0.3166.1 2006-2nd EH WESTERN SAHARA 1.0.3166.1 2006-2nd ER ERITREA 1.0.3166.1 2006-2nd ES SPAIN 1.0.3166.1 2006-2nd ET ETHIOPIA 1.0.3166.1 2006-2nd FI FINLAND 1.0.3166.1 2006-2nd FJ FIJI 1.0.3166.1 2006-2nd FK FALKLAND ISLANDS (MALVINAS) 1.0.3166.1 2006-2nd FM MICRONESIA (FEDERATED STATES OF) © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 178 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd FO FAROE ISLANDS 1.0.3166.1 2006-2nd FR FRANCE 1.0.3166.1 2006-2nd GA GABON 1.0.3166.1 2006-2nd GB UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1.0.3166.1 2006-2nd GD GRENADA 1.0.3166.1 2006-2nd GE GEORGIA 1.0.3166.1 2006-2nd GF FRENCH GUIANA 1.0.3166.1 2006-2nd GG GUERNSEY 1.0.3166.1 2006-2nd GH GHANA 1.0.3166.1 2006-2nd GI GIBRALTAR 1.0.3166.1 2006-2nd GL GREENLAND 1.0.3166.1 2006-2nd GM GAMBIA 1.0.3166.1 2006-2nd GN GUINEA 1.0.3166.1 2006-2nd GP GUADELOUPE 1.0.3166.1 2006-2nd GQ EQUATORIAL GUINEA 1.0.3166.1 2006-2nd GR GREECE 1.0.3166.1 2006-2nd GS SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS 1.0.3166.1 2006-2nd GT GUATEMALA 1.0.3166.1 2006-2nd GU GUAM 1.0.3166.1 2006-2nd GW GUINEA-BISSAU 1.0.3166.1 2006-2nd GY GUYANA 1.0.3166.1 2006-2nd HK HONG KONG 1.0.3166.1 2006-2nd HM HEARD ISLAND AND MCDONALD ISLANDS 1.0.3166.1 2006-2nd HN HONDURAS 1.0.3166.1 2006-2nd HR CROATIA 1.0.3166.1 2006-2nd HT HAITI 1.0.3166.1 2006-2nd HU HUNGARY 1.0.3166.1 2006-2nd ID INDONESIA 1.0.3166.1 2006-2nd IE IRELAND 1.0.3166.1 2006-2nd IL ISRAEL 1.0.3166.1 2006-2nd IM ISLE OF MAN 1.0.3166.1 2006-2nd IN INDIA 1.0.3166.1 2006-2nd IO BRITISH INDIAN OCEAN TERRITORY 1.0.3166.1 2006-2nd IQ IRAQ 1.0.3166.1 2006-2nd IR IRAN (ISLAMIC REPUBLIC OF) 1.0.3166.1 2006-2nd IS ICELAND 1.0.3166.1 2006-2nd IT ITALY 1.0.3166.1 2006-2nd JE JERSEY 1.0.3166.1 2006-2nd JM JAMAICA 1.0.3166.1 2006-2nd JO JORDAN © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 179 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd JP JAPAN 1.0.3166.1 2006-2nd KE KENYA 1.0.3166.1 2006-2nd KG KYRGYZSTAN 1.0.3166.1 2006-2nd KH CAMBODIA 1.0.3166.1 2006-2nd KI KIRIBATI 1.0.3166.1 2006-2nd KM COMOROS 1.0.3166.1 2006-2nd KN SAINT KITTS AND NEVIS 1.0.3166.1 2006-2nd KP KOREA (DEMOCRATIC PEOPLE'S REPUBLIC OF) 1.0.3166.1 2006-2nd KR KOREA, REPUBLIC OF 1.0.3166.1 2006-2nd KW KUWAIT 1.0.3166.1 2006-2nd KY CAYMAN ISLANDS 1.0.3166.1 2006-2nd KZ KAZAKHSTAN 1.0.3166.1 2006-2nd LA LAO PEOPLE'S DEMOCRATIC REPUBLIC 1.0.3166.1 2006-2nd LB LEBANON 1.0.3166.1 2006-2nd LC SAINT LUCIA 1.0.3166.1 2006-2nd LI LIECHTENSTEIN 1.0.3166.1 2006-2nd LK SRI LANKA 1.0.3166.1 2006-2nd LR LIBERIA 1.0.3166.1 2006-2nd LS LESOTHO 1.0.3166.1 2006-2nd LT LITHUANIA 1.0.3166.1 2006-2nd LU LUXEMBOURG 1.0.3166.1 2006-2nd LV LATVIA 1.0.3166.1 2006-2nd LY LIBYA 1.0.3166.1 2006-2nd MA MOROCCO 1.0.3166.1 2006-2nd MC MONACO 1.0.3166.1 2006-2nd MD MOLDOVA, REPUBLIC OF 1.0.3166.1 2006-2nd ME MONTENEGRO 1.0.3166.1 2006-2nd MF SAINT MARTIN (FRENCH PART) 1.0.3166.1 2006-2nd MG MADAGASCAR 1.0.3166.1 2006-2nd MH MARSHALL ISLANDS 1.0.3166.1 2006-2nd MK MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF 1.0.3166.1 2006-2nd ML MALI 1.0.3166.1 2006-2nd MM MYANMAR 1.0.3166.1 2006-2nd MN MONGOLIA 1.0.3166.1 2006-2nd MO MACAO 1.0.3166.1 2006-2nd MP NORTHERN MARIANA ISLANDS 1.0.3166.1 2006-2nd MQ MARTINIQUE 1.0.3166.1 2006-2nd MR MAURITANIA 1.0.3166.1 2006-2nd MS MONTSERRAT 1.0.3166.1 2006-2nd MT MALTA 1.0.3166.1 2006-2nd MU MAURITIUS

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 180 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd MV MALDIVES 1.0.3166.1 2006-2nd MW MALAWI 1.0.3166.1 2006-2nd MX MEXICO 1.0.3166.1 2006-2nd MY MALAYSIA 1.0.3166.1 2006-2nd MZ MOZAMBIQUE 1.0.3166.1 2006-2nd NA NAMIBIA 1.0.3166.1 2006-2nd NC NEW CALEDONIA 1.0.3166.1 2006-2nd NE NIGER 1.0.3166.1 2006-2nd NF NORFOLK ISLAND 1.0.3166.1 2006-2nd NG NIGERIA 1.0.3166.1 2006-2nd NI NICARAGUA 1.0.3166.1 2006-2nd NL NETHERLANDS 1.0.3166.1 2006-2nd NO NORWAY 1.0.3166.1 2006-2nd NP NEPAL 1.0.3166.1 2006-2nd NR NAURU 1.0.3166.1 2006-2nd NU NIUE 1.0.3166.1 2006-2nd NZ NEW ZEALAND 1.0.3166.1 2006-2nd OM OMAN 1.0.3166.1 2006-2nd PA PANAMA 1.0.3166.1 2006-2nd PE PERU 1.0.3166.1 2006-2nd PF FRENCH POLYNESIA 1.0.3166.1 2006-2nd PG PAPUA NEW GUINEA 1.0.3166.1 2006-2nd PH PHILIPPINES 1.0.3166.1 2006-2nd PK PAKISTAN 1.0.3166.1 2006-2nd PL POLAND 1.0.3166.1 2006-2nd PM SAINT PIERRE AND MIQUELON 1.0.3166.1 2006-2nd PN PITCAIRN 1.0.3166.1 2006-2nd PR PUERTO RICO 1.0.3166.1 2006-2nd PS PALESTINE, STATE OF 1.0.3166.1 2006-2nd PT PORTUGAL 1.0.3166.1 2006-2nd PW PALAU 1.0.3166.1 2006-2nd PY PARAGUAY 1.0.3166.1 2006-2nd QA QATAR 1.0.3166.1 2006-2nd RE REUNION 1.0.3166.1 2006-2nd RO ROMANIA 1.0.3166.1 2006-2nd RS SERBIA 1.0.3166.1 2006-2nd RU RUSSIAN FEDERATION 1.0.3166.1 2006-2nd RW RWANDA 1.0.3166.1 2006-2nd SA SAUDI ARABIA 1.0.3166.1 2006-2nd SB SOLOMON ISLANDS 1.0.3166.1 2006-2nd SC SEYCHELLES 1.0.3166.1 2006-2nd SD SUDAN 1.0.3166.1 2006-2nd SE SWEDEN © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 181 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd SG SINGAPORE 1.0.3166.1 2006-2nd SH SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA 1.0.3166.1 2006-2nd SI SLOVENIA 1.0.3166.1 2006-2nd SJ SVALBARD AND JAN MAYEN 1.0.3166.1 2006-2nd SK SLOVAKIA 1.0.3166.1 2006-2nd SL SIERRA LEONE 1.0.3166.1 2006-2nd SM SAN MARINO 1.0.3166.1 2006-2nd SN SENEGAL 1.0.3166.1 2006-2nd SO SOMALIA 1.0.3166.1 2006-2nd SR SURINAME 1.0.3166.1 2006-2nd SS SOUTH SUDAN 1.0.3166.1 2006-2nd ST SAO TOME AND PRINCIPE 1.0.3166.1 2006-2nd SV EL SALVADOR 1.0.3166.1 2006-2nd SX SINT MAARTEN (DUTCH PART) 1.0.3166.1 2006-2nd SY SYRIAN ARAB REPUBLIC 1.0.3166.1 2006-2nd SZ SWAZILAND 1.0.3166.1 2006-2nd TC TURKS AND CAICOS ISLANDS 1.0.3166.1 2006-2nd TD CHAD 1.0.3166.1 2006-2nd TF FRENCH SOUTHERN TERRITORIES 1.0.3166.1 2006-2nd TG TOGO 1.0.3166.1 2006-2nd TH THAILAND 1.0.3166.1 2006-2nd TJ TAJIKISTAN 1.0.3166.1 2006-2nd TK TOKELAU 1.0.3166.1 2006-2nd TL TIMOR-LESTE 1.0.3166.1 2006-2nd TM TURKMENISTAN 1.0.3166.1 2006-2nd TN TUNISIA 1.0.3166.1 2006-2nd TO TONGA 1.0.3166.1 2006-2nd TR TURKEY 1.0.3166.1 2006-2nd TT TRINIDAD AND TOBAGO 1.0.3166.1 2006-2nd TV TUVALU 1.0.3166.1 2006-2nd TW TAIWAN, PROVINCE OF CHINA 1.0.3166.1 2006-2nd TZ TANZANIA, UNITED REPUBLIC OF 1.0.3166.1 2006-2nd UA UKRAINE 1.0.3166.1 2006-2nd UG UGANDA 1.0.3166.1 2006-2nd UM UNITED STATES MINOR OUTLYING ISLANDS 1.0.3166.1 2006-2nd US UNITED STATES OF AMERICA 1.0.3166.1 2006-2nd UY URUGUAY 1.0.3166.1 2006-2nd UZ UZBEKISTAN 1.0.3166.1 2006-2nd VA HOLY SEE 1.0.3166.1 2006-2nd VC SAINT VINCENT AND THE GRENADINES

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 182 of 624 Service Provider MTC epSOSCountry

1.0.3166.1 2006-2nd VE VENEZUELA (BOLIVARIAN REPUBLIC OF) 1.0.3166.1 2006-2nd VG VIRGIN ISLANDS, BRITISH 1.0.3166.1 2006-2nd VI VIRGIN ISLANDS, U.S. 1.0.3166.1 2006-2nd VN VIET NAM 1.0.3166.1 2006-2nd VU VANUATU 1.0.3166.1 2006-2nd WF WALLIS AND FUTUNA 1.0.3166.1 2006-2nd WS SAMOA 1.0.3166.1 2006-2nd YE YEMEN 1.0.3166.1 2006-2nd YT MAYOTTE 1.0.3166.1 2006-2nd ZA SOUTH AFRICA 1.0.3166.1 2006-2nd ZM ZAMBIA 1.0.3166.1 2006-2nd ZW ZIMBABWE

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 183 of 624 Service Provider MTC epSOSDisplayLabel

epSOSDisplayLabel

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.46

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 1 Active Ingredient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 10 Clinical Manifestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 108 Original narrative 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 109 Translated coded 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 11 Closed/Inactive Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 110 Clinical sections 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 111 Prescription and Dispensation details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 112 Code System 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 113 Code 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 114 Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 115 Dispensed Number of packages 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 116 If substitution of brand name is marked as not allowed, pharmacists may still consider dispensing the national equivalent even though the brand name might be slightly different. This is a known situation: the same pharmaceutical company is marketing the same medicinal product in different countries with slightly different names due to marketing reasons. If the pharmacist is certain that this is the case, the systems allows the input of the new brand name. 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 117 Original Document Language 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 118 Diagnostic Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 119 Blood Group 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 12 Contact Information 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 120 Min 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 121 Max 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 122 Administered 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 123 Severity 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 13 Country 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 15 Creation Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 16 Custodian

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 184 of 624 Service Provider MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 17 Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 18 Date To 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 19 Date of Birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 2 Active Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 20 Date of Prescription 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 202 Mark the checkbox if brand name (when allowed) has been substituted or package size has been changed 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 21 Device/Implant 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 22 Dispense 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 23 Dispensed Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 24 Dispensed Product 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 25 Dose Form 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 26 End Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 27 Every 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 28 Facility ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 29 Facility Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 3 Address 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 30 Family Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 31 for 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 32 Frequency of Intakes 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 33 Gender 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 34 Given Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 35 Guardian 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 36 Implant Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 37 Instructions to patient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 38 Is substitution of brand name allowed? 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 39 Last Update 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 4 Advise to the dispenser 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 40 Legal Authenticator 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 41 National Insurance Number 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 42 No 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 43 Number of packages 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 44 Observation Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 45 Onset Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 46 Organisation Identifier 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 47 Organisation Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 48 Other Active Ingredients 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 49 Other Contacts 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 5 Agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 50 Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 51 Patient

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 185 of 624 Service Provider MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 52 Patient IDs 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 53 per unit 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 54 Preferred HCP/Legal organization to contact 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 55 Prefix 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 56 Prescriber 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 58 Prescription ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 6 at 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 62 Procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 63 Procedure Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 64 Profession 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 65 Reaction Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 66 Regional/National Health ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 67 Route of Administration 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 68 See details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 69 Specialty 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 7 Author (HCP) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 70 Strength 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 71 Substitute 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 72 The Active Problem section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 73 The Allergies, adverse reactions, alerts section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 74 The Medical Devices and implants section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 75 The Medication Summary section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 76 The History of Procedures section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 77 unit(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 78 Units per intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 79 Vaccination 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 8 Authoring Device 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 80 Vaccination Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 81 Yes 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 84 Observation Value 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 85 Date From 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.2 9 Brand Name

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 186 of 624 Service Provider MTC epSOSDocumentCode

epSOSDocumentCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.32

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.6.1 2.59 34133-9 Summary of episode note Synthèse des notes épisodiques 2.16.840.1.113883.6.1 2.59 56445-0 Medication summary Document Synthèse médicamenteuse 2.16.840.1.113883.6.1 2.59 57016-8 Privacy policy acknowledgment Accord sur les politiques privées Document 2.16.840.1.113883.6.1 2.59 57833-6 Prescription for medication Prescription 2.16.840.1.113883.6.1 2.59 60591-5 Patient summary Document Volet de synthèse médicale Dossier Patient 2.16.840.1.113883.6.1 2.59 60593-1 Medication dispensed.extended Dispensation médicamenteuse Document

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 187 of 624 Service Provider MTC epSOSDoseForm

epSOSDoseForm

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.2

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 0.4.0.127.0.16.1.1.2.1 2017-04-14 10100500 Concentrate for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10101000 Oral drops, solution Orala droppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10102000 Oral drops, suspension Orala droppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10103000 Oral drops, emulsion Orala droppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10104000 Oral liquid Oral vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10105000 Oral solution Oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10106000 Oral suspension Oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10107000 Oral emulsion Oral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10108000 Oral gel Oral gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10109000 Oral paste Oral pasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10110000 Powder for oral solution Pulver till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10111000 Powder for oral suspension Pulver till oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10112000 Granules for oral solution Granulat till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10113000 Granules for oral suspension Granulat till oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10114000 Powder and solvent for oral solution Pulver och vätska till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115000 Powder and solvent for oral Pulver och vätska till oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115500 Powder and solvent for syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10117000 Syrup Sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10118000 Powder for syrup Pulver till sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10119000 Granules for syrup Granulat till sirap 0.4.0.127.0.16.1.1.2.1 2017-04-14 10120000 Soluble tablet Löslig tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121000 Dispersible tablet Dispergerbar tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121500 Dispersible tablets for dose dispenser 0.4.0.127.0.16.1.1.2.1 2017-04-14 10122000 Herbal tea Örtte 0.4.0.127.0.16.1.1.2.1 2017-04-14 10201000 Oral powder Oralt pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10202000 Instant herbal tea Örtte, lösligt 0.4.0.127.0.16.1.1.2.1 2017-04-14 10203000 Effervescent powder Bruspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10204000 Granules Granulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10205000 Effervescent granules Brusgranulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10206000 Gastro-resistant granules Enterogranulat 0.4.0.127.0.16.1.1.2.1 2017-04-14 10207000 Prolonged-release granules Depotgranulat © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 188 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10208000 Modified-release granules Granulat med modifierad frisättning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10209000 Cachet Oblatkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10210000 Capsule, hard Kapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10211000 Capsule, soft Kapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10212000 Gastro-resistant capsule, hard Enterokapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10213000 Gastro-resistant capsule, soft Enterokapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10214000 Chewable capsule, soft Tuggkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10215000 Prolonged-release capsule, hard Depotkapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10216000 Prolonged-release capsule, soft Depotkapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10217000 Modified-release capsule, hard Kapsel med modifierad frisättning, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10218000 Modified-release capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10219000 Tablet Tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10220000 Coated tablet Dragerad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10221000 Film-coated tablet Filmdragerad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10222000 Effervescent tablet Brustablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10223000 Orodispersible tablet Munsönderfallande tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10224000 Oral lyophilisate Frystorkad tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10225000 Gastro-resistant tablet Enterotablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10226000 Prolonged-release tablet Depottablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10227000 Modified-release tablet Tablett med modifierad frisättning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10228000 Chewable tablet Tuggtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10229000 Medicated chewing-gum Medicinskt tuggummi 0.4.0.127.0.16.1.1.2.1 2017-04-14 10230000 Oral gum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10231000 Pillules Granuler 0.4.0.127.0.16.1.1.2.1 2017-04-14 10236100 Orodispersible film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10301000 Gargle Gurgelvatten 0.4.0.127.0.16.1.1.2.1 2017-04-14 10302000 Concentrate for gargle Koncentrat till gurgelvatten 0.4.0.127.0.16.1.1.2.1 2017-04-14 10303000 Gargle, powder for solution Gurgelvatten, pulver till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10304000 Gargle, tablet for solution Gurgelvatten, tablett till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10305000 Oromucosal solution Munhålelösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10306000 Oromucosal suspension Munhålesuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10307000 Oromucosal drops Munhåledroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308100 Oromucosal spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308200 Oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308300 Oromucosal spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309100 Sublingual spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309200 Sublingual spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309300 Sublingual spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10310000 Mouthwash Munsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10311000 Mouthwash, tablet for solution Munsköljvätska, tablett till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10312000 Gingival solution Tandköttslösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10313000 Oromucosal gel Munhålegel

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 189 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10314000 Oromucosal paste Munhålepasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314005 Oromucosal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314010 Oromucosal cream Munhålekräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314011 Buccal film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10315000 Gingival gel Tandköttsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10316000 Gingival paste Tandköttspasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317000 Oromucosal capsule Munhålekapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317500 Sublingual film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10318000 Sublingual tablet Resoriblett, sublingual 0.4.0.127.0.16.1.1.2.1 2017-04-14 10319000 Muco-adhesive buccal tablet Buckaltablett, häftande 0.4.0.127.0.16.1.1.2.1 2017-04-14 10320000 Buccal tablet Buckaltablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10321000 Lozenge Sugtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10322000 Compressed lozenge Komprimerad sugtablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10323000 Pastille Pastill 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401000 Periodontal powder Periodontalpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401500 Dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10402000 Dental gel Dentalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10403000 Dental stick Dentalstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10405000 Dental powder Dentalpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10406000 Dental solution Dentallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10407000 Dental suspension Dentalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10408000 Dental emulsion Dentalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10409000 Toothpaste Tandkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10410000 Periodontal gel Periodontalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10411000 Periodontal insert 0.4.0.127.0.16.1.1.2.1 2017-04-14 10412000 Powder and solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10413000 Powder for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10414000 Solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10501000 Bath additive Badtillsats 0.4.0.127.0.16.1.1.2.1 2017-04-14 10502000 Cream Kräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10503000 Gel Gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10504000 Ointment Salva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10505000 Cutaneous paste Kutan pasta 0.4.0.127.0.16.1.1.2.1 2017-04-14 10506000 Medicated plaster Medicinskt plåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10507000 Cutaneous foam Kutant skum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10508000 Shampoo Schampo 0.4.0.127.0.16.1.1.2.1 2017-04-14 10509000 Cutaneous spray, solution Kutan spray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10510000 Cutaneous spray, suspension Kutan spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10511000 Cutaneous spray, powder Kutan spray, pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10512000 Cutaneous liquid Kutan vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10513000 Cutaneous solution Kutan lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10514000 Concentrate for cutaneous solution Koncentrat till kutan lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 190 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10514500 Powder for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10515000 Cutaneous suspension Kutan suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10516000 Cutaneous emulsion Kutan emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10517000 Cutaneous powder Puder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10517500 Cutaneous patch Kutant plåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518000 Solution for iontophoresis Lösning för jontofores 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518500 Powder for solution for iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 10519000 Transdermal patch Depotplåster 0.4.0.127.0.16.1.1.2.1 2017-04-14 10520000 Collodion Kollodium 0.4.0.127.0.16.1.1.2.1 2017-04-14 10521000 Medicated nail lacquer Medicinskt nagellack 0.4.0.127.0.16.1.1.2.1 2017-04-14 10522000 Poultice Medicinskt omslag 0.4.0.127.0.16.1.1.2.1 2017-04-14 10523000 Cutaneous stick Kutant stift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10525000 Impregnated dressing Salvkompress 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546250 Transdermal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546400 Transdermal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546500 Transdermal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10547000 Transdermal system 0.4.0.127.0.16.1.1.2.1 2017-04-14 10548000 Solution for skin-prick test Lösning för pricktest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10549000 Solution for skin-scratch test Lösning för risttest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10550000 Plaster for provocation test Plåster för provokationstest 0.4.0.127.0.16.1.1.2.1 2017-04-14 10600500 Concentrate for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 10601000 Eye cream Ögonkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10602000 Eye gel Ögongel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10603000 Eye ointment Ögonsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604000 Eye drops, solution Ögondroppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604500 Eye drops, emulsion Ögondroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10605000 Eye drops, suspension Ögondroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10606000 Eye drops, powder and solvent for Ögondroppar, pulver och vätska till solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10607000 Eye drops, powder and solvent for Ögondroppar, pulver och vätska till suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10608000 Eye drops, solvent for reconstitution Vätska för beredning av ögondroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10609000 Eye drops, prolonged-release Depotögondroppar 0.4.0.127.0.16.1.1.2.1 2017-04-14 10610000 Eye lotion Ögonsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10611000 Eye lotion, solvent for reconstitution Vätska för beredning av ögonsköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10612000 Ophthalmic insert Ögonlamell 0.4.0.127.0.16.1.1.2.1 2017-04-14 10613000 Ophthalmic strip 0.4.0.127.0.16.1.1.2.1 2017-04-14 10701000 Ear cream Öronkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10702000 Ear gel Örongel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10703000 Ear ointment Öronsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10704000 Ear drops, solution Örondroppar, lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 191 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10705000 Ear drops, suspension Örondroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10706000 Ear drops, emulsion Örondroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10707000 Ear drops, powder and solvent for Örondroppar, pulver och vätska till suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10708000 Ear powder Öronpulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10709000 Ear spray, solution Öronspray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10710000 Ear spray, suspension Öronspray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10711000 Ear spray, emulsion Öronspray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10712000 Ear wash, solution Öronsköljvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10713000 Ear wash, emulsion Öronsköljvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10714000 Ear tampon Örontampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 10715000 Ear stick Öronstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10801000 Nasal cream Näskräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10802000 Nasal gel Näsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10803000 Nasal ointment Nässalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10804000 Nasal drops, solution Näsdroppar, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10805000 Nasal drops, suspension Näsdroppar, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10806000 Nasal drops, emulsion Näsdroppar, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10807000 Nasal powder Näspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 10808000 Nasal spray, solution Nässpray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10809000 Nasal spray, suspension Nässpray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10810000 Nasal spray, emulsion Nässpray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10811000 Nasal wash Nässköljvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 10812000 Nasal stick Nässtift 0.4.0.127.0.16.1.1.2.1 2017-04-14 10901000 Vaginal cream Vaginalkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 10902000 Vaginal gel Vaginalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10903000 Vaginal ointment Vaginalsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 10904000 Vaginal foam Vaginalskum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10905000 Vaginal solution Vaginallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10906000 Vaginal suspension Vaginalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10907000 Vaginal emulsion Vaginalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10908000 Tablet for vaginal solution Tablett till vaginallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 10909000 Pessary Vagitorium 0.4.0.127.0.16.1.1.2.1 2017-04-14 10910000 Vaginal capsule, hard Vaginalkapsel, hård 0.4.0.127.0.16.1.1.2.1 2017-04-14 10911000 Vaginal capsule, soft Vaginalkapsel, mjuk 0.4.0.127.0.16.1.1.2.1 2017-04-14 10912000 Vaginal tablet Vaginaltablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10913000 Effervescent vaginal tablet Vaginal brustablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 10914000 Medicated vaginal tampon Vaginaltampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 10915000 Vaginal delivery system Vaginalinlägg 0.4.0.127.0.16.1.1.2.1 2017-04-14 11001000 Rectal cream Rektalkräm 0.4.0.127.0.16.1.1.2.1 2017-04-14 11002000 Rectal gel Rektalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11003000 Rectal ointment Rektalsalva 0.4.0.127.0.16.1.1.2.1 2017-04-14 11004000 Rectal foam Rektalskum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 192 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11005000 Rectal solution Rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11006000 Rectal suspension Rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11007000 Rectal emulsion Rektalemulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11008000 Concentrate for rectal solution Koncentrat till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11009000 Powder for rectal solution Pulver till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010 Oral drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010000 Powder for rectal suspension Pulver till rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11011000 Tablet for rectal solution Tablett till rektallösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11012000 Tablet for rectal suspension Tablett till rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11013000 Suppository Suppositorium 0.4.0.127.0.16.1.1.2.1 2017-04-14 11014000 Rectal capsule Rektalkapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11015000 Rectal tampon Rektaltampong 0.4.0.127.0.16.1.1.2.1 2017-04-14 11101000 Nebuliser solution Lösning för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11102000 Nebuliser suspension Suspension för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11103000 Powder for nebuliser suspension Pulver till suspension för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11104000 Powder for nebuliser solution Pulver till lösning för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11105000 Nebuliser emulsion Emulsion för nebulisator 0.4.0.127.0.16.1.1.2.1 2017-04-14 11106000 Pressurised inhalation, solution Inhalationsspray, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11107000 Pressurised inhalation, suspension Inhalationsspray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11108000 Pressurised inhalation, emulsion Inhalationsspray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11109000 Inhalation powder Inhalationspulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 11110000 Inhalation powder, hard capsule Inhalationspulver, hård kapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11111000 Inhalation powder, pre-dispensed Inhalationspulver, avdelad dos 0.4.0.127.0.16.1.1.2.1 2017-04-14 11112000 Inhalation vapour, powder Inhalationsånga, pulver 0.4.0.127.0.16.1.1.2.1 2017-04-14 11113000 Inhalation vapour, capsule Inhalationsånga, kapsel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11114000 Inhalation vapour, solution Inhalationsånga, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11115000 Inhalation vapour, tablet Inhalationsånga, tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 11116000 Inhalation vapour, ointment Inhalationsånga, salva 0.4.0.127.0.16.1.1.2.1 2017-04-14 11117000 Inhalation vapour, liquid Inhalationsånga, vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11201000 Solution for injection Injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11202000 Suspension for injection Injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11203000 Emulsion for injection Injektionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11204000 Gel for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11205000 Powder for solution for injection Pulver till injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11206000 Powder for suspension for injection Pulver till injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11207000 Powder and solvent for solution for Pulver och vätska till injection injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208000 Powder and solvent for suspension Pulver och vätska till for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208400 Powder for prolonged-release suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208500 Prolonged-release suspension for injection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 193 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11209000 Concentrate for solution for injection Koncentrat till injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11209500 Solution for cardioplegia 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210000 Solution for infusion Infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210500 Solution for infusion in Infusionsvätska, lösning i administration system administreringssats 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211000 Emulsion for infusion Infusionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211500 Powder for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11212000 Powder for solution for infusion Pulver till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11213000 Concentrate for solution for infusion Koncentrat till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11214000 Powder and solvent for solution for Pulver och vätska till infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11216000 Solvent for parenteral use Spädningsvätska för parenteral användning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11301000 Implant Implantat 0.4.0.127.0.16.1.1.2.1 2017-04-14 11302000 Implantation tablet Tablett för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303000 Implantation chain Kedja för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303300 Implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303500 Implantation suspension Suspension för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11304000 Powder and solvent for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 11401000 Solution for peritoneal dialysis Peritonealdialysvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11402000 Solution for haemofiltration Hemofiltrationsvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11403000 Solution for haemodiafiltration Hemodiafiltrationsvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11404000 Solution for haemodialysis Hemodialysvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 11405000 Concentrate for solution for Hemodialyskoncentrat haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502000 Bladder irrigation Spolvätska för urinblåsan 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502500 Intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11503000 Powder for bladder irrigation Pulver till spolvätska för urinblåsan 0.4.0.127.0.16.1.1.2.1 2017-04-14 11504000 Urethral gel Uretralgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11505000 Urethral stick Uretralstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 11601000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11602000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, powder for solution pulver till lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 11603000 Endotracheopulmonary instillation, Instillationsvätska för luftvägarna, suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11604000 Endotracheopulmonary instillation, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11605000 Endotracheopulmonary instillation, powder and solvent for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11701000 Endocervical gel Endocervikalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11702000 Powder and solvent for endocervical Pulver och vätska till gel endocervikalgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11901000 Intrauterine delivery system Intrauterint inlägg 0.4.0.127.0.16.1.1.2.1 2017-04-14 12100 Capsule © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 194 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 12101000 Denture lacquer 0.4.0.127.0.16.1.1.2.1 2017-04-14 12102000 Anticoagulant and preservative solution for blood 0.4.0.127.0.16.1.1.2.1 2017-04-14 12103000 Solution for blood fraction Lösning för modifiering av modification blodfraktion 0.4.0.127.0.16.1.1.2.1 2017-04-14 12104000 Wound stick Sårstift 0.4.0.127.0.16.1.1.2.1 2017-04-14 12105000 Radiopharmaceutical precursor Stamlösning till radioaktiva läkemedel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12106000 Radionuclide generator Radionuklidgenerator 0.4.0.127.0.16.1.1.2.1 2017-04-14 12107000 Kit for radiopharmaceutical Beredningssats för radioaktiva preparation läkemedel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12108000 Gastroenteral solution Gastroenteral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 12110000 Gastroenteral suspension Gastroenteral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111000 Gastroenteral emulsion Gastroenteral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111500 Intraperitoneal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 12112000 Solution for organ preservation Vätska för organförvaring 0.4.0.127.0.16.1.1.2.1 2017-04-14 12113000 Irrigation solution Spolvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 12114000 Stomach irrigation Magspolvätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115000 Sealant Vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115100 Sealant matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115200 Sealant powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 12116000 Powder and solvent for sealant Pulver och vätska till vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 12117000 Impregnated pad Impregnerad kudde 0.4.0.127.0.16.1.1.2.1 2017-04-14 12117500 Impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 12118000 Living tissue equivalent 0.4.0.127.0.16.1.1.2.1 2017-04-14 12119000 Medicated sponge Medicinerad svamp 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120 Gastro-resistant capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120000 Intestinal gel Intestinal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12130000 Medicated thread 0.4.0.127.0.16.1.1.2.1 2017-04-14 12131000 Solution for provocation test Lösning för provokationstest 0.4.0.127.0.16.1.1.2.1 2017-04-14 12150 Prolonged-release capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12301000 Medicinal gas, compressed Medicinsk gas, komprimerad 0.4.0.127.0.16.1.1.2.1 2017-04-14 12302000 Medicinal gas, cryogenic Medicinsk gas, kryogen 0.4.0.127.0.16.1.1.2.1 2017-04-14 12303000 Medicinal gas, liquefied Medicinsk gas, flytande 0.4.0.127.0.16.1.1.2.1 2017-04-14 13001000 Concentrate for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13002000 Concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13003000 Concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13004000 Concentrate for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13005000 Dispersion for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13006000 Ear drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13007000 Effervescent granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13008000 Emulsion for emulsion for injection © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 195 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 13009000 Endotracheopulmonary instillation, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13010000 Eye drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13011000 Eye drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13012000 Gas for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13013000 Gas for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13014000 Gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13015000 Granules for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13016000 Laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13017000 Laryngopharyngeal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13018000 Matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13020000 Nasal drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13021000 Powder for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13022000 Powder for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13023000 Powder for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13024000 Powder for endocervical gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13025000 Powder for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13026000 Powder for gingival gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13027000 Powder for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13028000 Powder for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13029000 Powder for intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13031000 Powder for sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 13032000 Powder for solution for skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13033000 Solution for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13035000 Solvent for... 0.4.0.127.0.16.1.1.2.1 2017-04-14 13036000 Suspension for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13037000 Suspension for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13039000 Suspension for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13040000 Powder for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13041000 Endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13042000 Epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13043000 Implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13044000 Intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13045000 Intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13046000 Coated granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 13047000 Solution for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13048000 Granules for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13049000 Dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13050 Oromucosal liquid

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 196 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 13050000 Gas for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13051000 Solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13052000 Powder for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13053000 Solution for injection in administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 13057000 Powder and solvent for prolonged- release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 13060000 Powder for oral/rectal suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 14050 Dental liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 15090 Cutaneous spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 16040 Eye drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17040 Ear drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17090 Ear spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 17120 Ear wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 18040 Nasal drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 18080 Nasal spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 19050 Vaginal liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 19100 Vaginal capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 20050 Enema 0.4.0.127.0.16.1.1.2.1 2017-04-14 21010 Nebuliser liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 21060 Pressurised inhalation 0.4.0.127.0.16.1.1.2.1 2017-04-14 21140 Inhalation vapour 0.4.0.127.0.16.1.1.2.1 2017-04-14 22010 Injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22030 Powder for concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22050 Powder for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22060 Powder for prolonged-release injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22090 Sterile concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22100 Infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 22120 Powder for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 26010 Endotracheopulmonary instillation 0.4.0.127.0.16.1.1.2.1 2017-04-14 30047500 Pouch 0.4.0.127.0.16.1.1.2.1 2017-04-14 31030 Blood fraction modifier 0.4.0.127.0.16.1.1.2.1 2017-04-14 31080 Gastroenteral liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001000 Chewable/dispersible tablet Tuggtablett/dispergerbar tablett 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001250 Coated granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50002000 Concentrate and solvent for Koncentrat och vätska till koncentrat concentrate for solution for infusion till infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50003000 Concentrate and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50006000 Concentrate and solvent for solution Koncentrat och vätska till for infusion infusionsvätska, lösning

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 197 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50007000 Concentrate and solvent for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50007500 Concentrate and solvent for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50008000 Concentrate and solvent for Koncentrat och vätska till suspension for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009000 Concentrate for cutaneous spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009300 Concentrate for dispersion for Koncentrat till infusionsvätska, infusion dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009500 Concentrate for emulsion for Koncentrat till infusionsvätska, infusion emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009750 Concentrate for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50010000 Concentrate for oral solution Koncentrat till oral lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50011000 Concentrate for oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50013250 Concentrate for solution for peritoneal dialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015200 Cutaneous/nasal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015450 Cutaneous solution/concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015500 Cutaneous spray, emulsion Kutan spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50016000 Cutaneous spray, ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017000 Dental paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017200 Ear drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017500 Dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017550 Ear drops, suspension in single- dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018000 Ear/eye drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018500 Ear/eye drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019000 Ear/eye ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019500 Ear/eye/nasal drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50020200 Ear/nasal drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021000 Emulsion for injection/infusion Injektionsvätska/infusionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021250 Emulsion for injection/infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021500 Emulsion and suspension for Emulsion och suspension till emulsion for injection injektionsvätska, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022000 Endosinusial wash, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022500 Eye drops, prolonged-release solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023000 Eye drops, solution in single-dose Ögondroppar, lösning i container endosbehållare 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023100 Eye drops, suspension in single- dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023300 Eye gel in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023400 Eye ointment in single-dose container

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 198 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50023700 Film-coated tablet and gastro- resistant granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024000 Gargle/mouthwash 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024500 Gargle/nasal wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026000 Gastro-resistant granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026150 Gastro-resistant granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026400 Gel in pressurised container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026500 Granules and solvent for oral Granulat och vätska till oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50027000 Granules and solvent for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029150 Granules for oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029170 Granules for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029200 Granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029500 Granules for vaginal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029550 Granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029700 Herbal tea in bag Örtte i påse 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029750 Implant in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50030000 Inhalation powder, tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50031000 Inhalation vapour, effervescent tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50032000 Inhalation vapour, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033000 Inhalation vapour, impregnated pad 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033100 Inhalation vapour, impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033400 Intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033500 Intravitreal implant in applicator Intravitrealt implantat i applikator 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036000 Modified-release granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036050 Mouthwash, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036200 Nasal drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036500 Nasal/oromucosal solution Näs-/munhålelösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036700 Nasal/oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037100 Nasal spray, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037250 Nasal spray, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037400 Nasal spray, solution/oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037500 Oral drops, granules for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037600 Oral emulsion in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037700 Oral paste in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037750 Oral drops, liquid Orala droppar, vätska 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037800 Oral powder in sachet

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 199 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50037900 Oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038000 Oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038500 Oral solution/concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038600 Oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038650 Oral solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038700 Oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039000 Oromucosal patch 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039300 Oromucosal powder in pouch Munhålepulver i portionspåse 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039500 Oromucosal/laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50040500 Oromucosal/laryngopharyngeal solution/spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041000 Pillules in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041200 Powder and gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041500 Powder and solution for solution for Pulver och lösning till injection injektionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50042000 Powder and solvent for concentrate Pulver och vätska till koncentrat till for solution for infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50043000 Powder for concentrate for solution Pulver till koncentrat till for infusion infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044000 Powder and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044500 Powder and solvent for dispersion Pulver och vätska till for injection injektionsvätska, dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044700 Powder and solvent for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045000 Powder and solvent for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045500 Powder and solvent for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50046000 Powder and solvent for gingival gel Pulver och vätska till tandköttsgel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047000 Powder and solvent for intraocular Pulver och vätska till instillation solution instillationsvätska, lösning för intraokulär användning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047500 Powder and solvent for intravesical Pulver och vätska till intravesikal solution lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047600 Powder and solvent for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047650 Nasal drops, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047700 Powder and solvent for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048000 Powder and solvent for prolonged- Pulver och vätska till release suspension for injection injektionsvätska, depotsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048010 Powder and solvent for prolonged- release suspension for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048050 Powder and solvent for solution for injection in cartridge © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 200 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50048150 Powder and solvent for solution for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048250 Powder and solvent for solution for Pulver och vätska till injection in pre-filled syringe injektionsvätska, lösning i förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048270 Powder and solvent for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048300 Powder and solvent for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048500 Powder and suspension for Pulver och suspension till suspension for injection injektionsvätska, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048600 Powder, dispersion and solvent for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048750 Powder for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049100 Powder for concentrate for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049200 Powder for concentrate for solution for haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049250 Powder for concentrate for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049270 Powder for dental solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049300 Powder for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049500 Powder for implantation suspension Pulver till suspension för implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050000 Powder for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050500 Powder for intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50051000 Powder for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052000 Powder for oral/rectal suspension Pulver till oral / rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052500 Powder for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50053500 Powder for solution for Pulver till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50055350 Powder, solvent and matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056000 Prolonged-release granules for oral Depotgranulat för oral suspension suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056150 Prolonged-release granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056200 Prolonged-release granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056250 Prolonged-release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056500 Radiopharmaceutical precursor, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056600 Solution and suspension for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50057000 Solution for haemodialysis/haemofiltration

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 201 of 624 Service Provider MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50058500 Solution for infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060000 Solution for injection/infusion Injektionsvätska, lösning / infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060100 Solution for injection in cartridge Injektionsvätska, lösning i cylinderampull 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060150 Solution for injection in needle-free injector 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060200 Solution for injection in pre-filled pen Injektionsvätska, lösning i förfylld injektionspenna 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060300 Solution for injection in pre-filled Injektionsvätska, lösning i förfylld syringe spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060500 Solution for injection/infusion in pre- Injektions- / infusionsvätska, lösning filled syringe i förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50061500 Solution for sealant Lösningar till vävnadslim 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062000 Suspension and effervescent Suspension och brusgranulat för granules for oral suspension oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062500 Suspension and solution for spray Suspension och lösning till spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063100 Suspension for injection in cartridge Injektionsvätska, suspension i cylinderampull 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063200 Suspension for injection in pre-filled Injektionsvätska, suspension i pen förfylld injektionspenna 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063300 Suspension for injection in pre-filled Injektionsvätska, suspension i syringe förfylld spruta 0.4.0.127.0.16.1.1.2.1 2017-04-14 50064000 Tablet and solvent for rectal Tablett och vätska till suspension rektalsuspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50065000 Tablet and powder for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50071000 Powder and solvent for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073000 Powder for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073500 Solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50074000 Solvent for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50076000 Solvent for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50077000 Dispersion for injection Injektionsvätska, dispersion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50078000 Gas and solvent for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50079000 Concentrate for solution for Koncentrat till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50080000 Powder and solvent for solution for Pulver och vätska till injektions- injection/infusion /infusionsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50081000 Inhalation solution Inhalationsvätska, lösning 0.4.0.127.0.16.1.1.2.1 2017-04-14 50082000 Oral drops, powder for suspension

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 202 of 624 Service Provider MTC epSOSDoseForm

Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 203 of 624 Service Provider MTC epSOSHealthcareProfessionalRoles

epSOSHealthcareProfessionalRoles

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.1

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 2.16.840.1.113883.2.9.6.2.7 2008 22 Health professionals Professionnels de Santé 2.16.840.1.113883.2.9.6.2.7 2008 221 Medical doctors Docteurs Läkare 2.16.840.1.113883.2.9.6.2.7 2008 2211 Generalist medical practitioners Médecins Généraliste 2.16.840.1.113883.2.9.6.2.7 2008 2212 Specialist medical practitioners Médecin Spécialisé 2.16.840.1.113883.2.9.6.2.7 2008 222 Nursing and midwifery professionals Infirmières et Auxiliaires de Santé 2.16.840.1.113883.2.9.6.2.7 2008 2221 Nursing professionals Infirmières Sjuksköterska 2.16.840.1.113883.2.9.6.2.7 2008 2222 Midwifery professionals Auxiliaires de Santé Barnmorska 2.16.840.1.113883.2.9.6.2.7 2008 223 Traditional and complementary Médecins Traditionnel et medicine professionals Complémentaire 2.16.840.1.113883.2.9.6.2.7 2008 224 Paramedical practitioners Médecins Paramédical 2.16.840.1.113883.2.9.6.2.7 2008 225 Veterinarians Vétérinaires 2.16.840.1.113883.2.9.6.2.7 2008 226 Other health professionals Autres Professionnels de Santé 2.16.840.1.113883.2.9.6.2.7 2008 2261 Dentists Dentiste Tandläkare 2.16.840.1.113883.2.9.6.2.7 2008 2262 Pharmacists Pharmaciens Farmaceut 2.16.840.1.113883.2.9.6.2.7 2008 2263 Environmental and occupational Professionnels Environnement et health and hygiene professionals Hygiène et Santé Public 2.16.840.1.113883.2.9.6.2.7 2008 2264 Physiotherapists Physiothérapeutes 2.16.840.1.113883.2.9.6.2.7 2008 2265 Dieticians and nutritionists Diététiciens et Nutritionnistes 2.16.840.1.113883.2.9.6.2.7 2008 2266 Audiologists and speech therapists Audio-logistes et Orthophonistes 2.16.840.1.113883.2.9.6.2.7 2008 2267 Optometrists and ophthalmic Opticiens opticians 2.16.840.1.113883.2.9.6.2.7 2008 2269 Health professionals not elsewhere classified 2.16.840.1.113883.2.9.6.2.7 2008 32 Health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 321 Medical and pharmaceutical technicians 2.16.840.1.113883.2.9.6.2.7 2008 3211 Medical imaging and therapeutic equipment technicians 2.16.840.1.113883.2.9.6.2.7 2008 3212 Medical and pathology laboratory technicians 2.16.840.1.113883.2.9.6.2.7 2008 3213 Pharmaceutical technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3214 Medical and dental prosthetic technicians 2.16.840.1.113883.2.9.6.2.7 2008 322 Nursing and midwifery associate professionals © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 204 of 624 Service Provider MTC epSOSHealthcareProfessionalRoles

2.16.840.1.113883.2.9.6.2.7 2008 3221 Nursing associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3222 Midwifery associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 323 Traditional and complementary medicine associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 325 Other health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3251 Dental assistants and therapists tandhygienist 2.16.840.1.113883.2.9.6.2.7 2008 3252 Medical records and health information technicians 2.16.840.1.113883.2.9.6.2.7 2008 3253 Community health workers 2.16.840.1.113883.2.9.6.2.7 2008 3254 Dispensing opticians 2.16.840.1.113883.2.9.6.2.7 2008 3255 Physiotherapy technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3256 Medical assistants 2.16.840.1.113883.2.9.6.2.7 2008 3257 Environmental and occupational health inspectors and associates 2.16.840.1.113883.2.9.6.2.7 2008 3258 Ambulance workers Ambulanciers 2.16.840.1.113883.2.9.6.2.7 2008 3259 Health associate professionals not elsewhere classified

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 205 of 624 Service Provider MTC epSOSIllnessesandDisorders

epSOSIllnessesandDisorders

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.5

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) fr-FR sv-SE fr-BE 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00 Cholera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.1 Cholera due to Vibrio cholerae 01, biovar eltor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.9 Cholera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01 Typhoid and paratyphoid fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.0 Typhoid fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.1 Paratyphoid fever A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.2 Paratyphoid fever B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.3 Paratyphoid fever C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.4 Paratyphoid fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02 Other salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.0 Salmonella enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.1 Salmonella sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.2 Localized salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.8 Other specified salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.9 Salmonella infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03 Shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.0 Shigellosis due to Shigella dysenteriae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.1 Shigellosis due to Shigella flexneri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.2 Shigellosis due to Shigella boydii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.3 Shigellosis due to Shigella sonnei 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.8 Other shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.9 Shigellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04 Other bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.0 Enteropathogenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.1 Enterotoxigenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.2 Enteroinvasive Escherichia coli infection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 206 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.3 Enterohaemorrhagic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.4 Other intestinal Escherichia coli infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.5 Campylobacter enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.6 Enteritis due to Yersinia enterocolitica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.7 Enterocolitis due to Clostridium difficile 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.8 Other specified bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.9 Bacterial intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05 Other bacterial foodborne intoxications, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.0 Foodborne staphylococcal intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.1 Botulism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.3 Foodborne Vibrio parahaemolyticus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.4 Foodborne Bacillus cereus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.8 Other specified bacterial foodborne intoxications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.9 Bacterial foodborne intoxication, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06 Amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.0 Acute amoebic dysentery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.1 Chronic intestinal amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.2 Amoebic nondysenteric colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.3 Amoeboma of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.4 Amoebic liver abscessK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.5 Amoebic lung abscessJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.6 Amoebic brain abscessG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.7 Cutaneous amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.8 Amoebic infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.9 Amoebiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07 Other protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.0 Balantidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.1 Giardiasis [lambliasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.2 Cryptosporidiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.3 Isosporiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.8 Other specified protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.9 Protozoal intestinal disease, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 207 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08 Viral and other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.0 Rotaviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.1 Acute gastroenteropathy due to Norwalk agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.2 Adenoviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.3 Other viral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.4 Viral intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.5 Other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09 Other gastroenteritis and colitis of infectious and unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.0 Other and unspecified gastroenteritis and colitis of infectious origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.9 Gastroenteritis and colitis of unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15 Respiratory tuberculosis, bacteriologically and histologically confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.0 Tuberculosis of lung, confirmed by sputum microscopy with or without culture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.1 Tuberculosis of lung, confirmed by culture only 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.2 Tuberculosis of lung, confirmed histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.3 Tuberculosis of lung, confirmed by unspecified means 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.4 Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.5 Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.6 Tuberculous pleurisy, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.7 Primary respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.8 Other respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.9 Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.0 Tuberculosis of lung, bacteriologically and histologically negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.1 Tuberculosis of lung, bacteriological and histological examination not done © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 208 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.3 Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.4 Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.5 Tuberculous pleurisy, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.7 Primary respiratory tuberculosis without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.8 Other respiratory tuberculosis, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.9 Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17 Tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.0 Tuberculous meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.1 Meningeal tuberculomaG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.8 Other tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.9 Tuberculosis of nervous system, unspecifiedG99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18 Tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.0 Tuberculosis of bones and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.1 Tuberculosis of genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.2 Tuberculous peripheral lymphadenopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.3 Tuberculosis of intestines, peritoneum and mesenteric glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.4 Tuberculosis of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.5 Tuberculosis of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.6 Tuberculosis of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.7 Tuberculosis of adrenal glandsE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.8 Tuberculosis of other specified organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19 Miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.0 Acute miliary tuberculosis of a single specified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.1 Acute miliary tuberculosis of multiple sites

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 209 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.2 Acute miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.8 Other miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.9 Miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20 Plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.0 Bubonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.1 Cellulocutaneous plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.2 Pneumonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.3 Plague meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.7 Septicaemic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.8 Other forms of plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.9 Plague, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21 Tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.0 Ulceroglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.1 Oculoglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.2 Pulmonary tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.3 Gastrointestinal tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.7 Generalized tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.8 Other forms of tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.9 Tularaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22 Anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.0 Cutaneous anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.1 Pulmonary anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.2 Gastrointestinal anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.7 Anthrax sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.8 Other forms of anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.9 Anthrax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23 Brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.0 Brucellosis due to Brucella melitensis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.1 Brucellosis due to Brucella abortus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.2 Brucellosis due to Brucella suis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.3 Brucellosis due to Brucella canis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.8 Other brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.9 Brucellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24 Glanders and melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.0 Glanders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.1 Acute and fulminating melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.2 Subacute and chronic melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.3 Other melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.4 Melioidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25 Rat-bite fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.0 Spirillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.1 Streptobacillosis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 210 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.9 Rat-bite fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26 Erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.0 Cutaneous erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.7 Erysipelothrix sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.8 Other forms of erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.9 Erysipeloid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27 Leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.0 Leptospirosis icterohaemorrhagica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.8 Other forms of leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.9 Leptospirosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28 Other zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.0 Pasteurellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.1 Cat-scratch disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.2 Extraintestinal yersiniosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.8 Other specified zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.9 Zoonotic bacterial disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30 Leprosy [Hansen disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.0 Indeterminate leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.1 Tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.2 Borderline tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.3 Borderline leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.4 Borderline lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.5 Lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.8 Other forms of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.9 Leprosy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31 Infection due to other mycobacteria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.0 Pulmonary mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.1 Cutaneous mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.8 Other mycobacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.9 Mycobacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32 Listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.0 Cutaneous listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.1 Listerial meningitis and meningoencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.7 Listerial sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.8 Other forms of listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.9 Listeriosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A33 Tetanus neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A34 Obstetrical tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A35 Other tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36 Diphtheria

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 211 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.0 Pharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.1 Nasopharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.2 Laryngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.3 Cutaneous diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.8 Other diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.9 Diphtheria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37 Whooping cough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.0 Whooping cough due to Bordetella pertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.1 Whooping cough due to Bordetella parapertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.8 Whooping cough due to other Bordetella species 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.9 Whooping cough, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A38 Scarlet fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39 Meningococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.0 Meningococcal meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.1 Waterhouse-Friderichsen syndromeE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.2 Acute meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.3 Chronic meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.4 Meningococcaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.5 Meningococcal heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.8 Other meningococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.9 Meningococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40 Streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.0 Sepsis due to streptococcus, group A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.1 Sepsis due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.2 Sepsis due to streptococcus, group D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.3 Sepsis due to Streptococcus pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.8 Other streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.9 Streptococcal sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41 Other sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.0 Sepsis due to Staphylococcus aureus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.1 Sepsis due to other specified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.2 Sepsis due to unspecified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.3 Sepsis due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.4 Sepsis due to anaerobes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 212 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.5 Sepsis due to other Gram-negative organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.8 Other specified sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.9 Sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42 Actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.0 Pulmonary actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.1 Abdominal actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.2 Cervicofacial actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.7 Actinomycotic sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.8 Other forms of actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.9 Actinomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43 Nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.0 Pulmonary nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.1 Cutaneous nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.8 Other forms of nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.9 Nocardiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44 Bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.0 Systemic bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.1 Cutaneous and mucocutaneous bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.8 Other forms of bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.9 Bartonellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A46 Erysipelas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48 Other bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.0 Gas gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.1 Legionnaires disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.2 Nonpneumonic Legionnaires disease [Pontiac fever] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.3 Toxic shock syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.4 Brazilian purpuric fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.8 Other specified bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49 Bacterial infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.0 Staphylococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.1 Streptococcal and enterococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.2 Haemophilus influenzae infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.3 Mycoplasma infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.8 Other bacterial infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.9 Bacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50 Congenital syphilis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 213 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.0 Early congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.1 Early congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.2 Early congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.3 Late congenital syphilitic oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.4 Late congenital neurosyphilis [juvenile neurosyphilis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.5 Other late congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.6 Late congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.7 Late congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.9 Congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51 Early syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.0 Primary genital syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.1 Primary anal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.2 Primary syphilis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.3 Secondary syphilis of skin and mucous membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.4 Other secondary syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.5 Early syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.9 Early syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52 Late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.0 Cardiovascular syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.1 Symptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.2 Asymptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.3 Neurosyphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.7 Other symptomatic late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.8 Late syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.9 Late syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53 Other and unspecified syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.0 Latent syphilis, unspecified as early or late 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.9 Syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54 Gonococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.1 Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.2 Gonococcal pelviperitonitis and other gonococcal genitourinary infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.3 Gonococcal infection of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.4 Gonococcal infection of musculoskeletal system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 214 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.5 Gonococcal pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.6 Gonococcal infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.8 Other gonococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.9 Gonococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A55 Chlamydial lymphogranuloma (venereum) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56 Other sexually transmitted chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.0 Chlamydial infection of lower genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.1 Chlamydial infection of pelviperitoneum and other genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.2 Chlamydial infection of genitourinary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.3 Chlamydial infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.4 Chlamydial infection of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.8 Sexually transmitted chlamydial infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A57 Chancroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A58 Granuloma inguinale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59 Trichomoniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.0 Urogenital trichomoniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.8 Trichomoniasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.9 Trichomoniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60 Anogenital herpesviral [herpes simplex] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.0 Herpesviral infection of genitalia and urogenital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.1 Herpesviral infection of perianal skin and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.9 Anogenital herpesviral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63 Other predominantly sexually transmitted diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.0 Anogenital (venereal) warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.8 Other specified predominantly sexually transmitted diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A64 Unspecified sexually transmitted disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A65 Nonvenereal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66 Yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.0 Initial lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.1 Multiple papillomata and wet crab yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.2 Other early skin lesions of yaws

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 215 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.3 Hyperkeratosis of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.4 Gummata and ulcers of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.5 Gangosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.6 Bone and joint lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.7 Other manifestations of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.8 Latent yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.9 Yaws, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67 Pinta [carate] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.0 Primary lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.1 Intermediate lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.2 Late lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.3 Mixed lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.9 Pinta, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68 Relapsing fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.0 Louse-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.1 Tick-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.9 Relapsing fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69 Other spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.0 Necrotizing ulcerative stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.1 Other Vincent infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.2 Lyme disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.8 Other specified spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.9 Spirochaetal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A70 Chlamydia psittaci infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71 Trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.0 Initial stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.1 Active stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.9 Trachoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74 Other diseases caused by chlamydiae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.0 Chlamydial conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.8 Other chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.9 Chlamydial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75 Typhus fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.1 Recrudescent typhus [Brill disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.2 Typhus fever due to Rickettsia typhi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.3 Typhus fever due to Rickettsia tsutsugamushi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.9 Typhus fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77 Spotted fever [tick-borne rickettsioses]

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 216 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.0 Spotted fever due to Rickettsia rickettsii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.1 Spotted fever due to Rickettsia conorii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.2 Spotted fever due to Rickettsia sibirica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.3 Spotted fever due to Rickettsia australis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.8 Other spotted fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.9 Spotted fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A78 Q fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79 Other rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.0 Trench fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.1 Rickettsialpox due to Rickettsia akari 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.8 Other specified rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.9 Rickettsiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80 Acute poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.0 Acute paralytic poliomyelitis, vaccine-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.1 Acute paralytic poliomyelitis, wild virus, imported 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.2 Acute paralytic poliomyelitis, wild virus, indigenous 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.3 Acute paralytic poliomyelitis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.4 Acute nonparalytic poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.9 Acute poliomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81 Atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.0 Creutzfeldt-Jakob disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.1 Subacute sclerosing panencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.2 Progressive multifocal leukoencephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.8 Other atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.9 Atypical virus infection of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82 Rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.0 Sylvatic rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.1 Urban rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.9 Rabies, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83 Mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.0 Japanese encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.1 Western equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.2 Eastern equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.3 St Louis encephalitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 217 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.4 Australian encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.5 California encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.6 Rocio virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.8 Other mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.9 Mosquito-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84 Tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.0 Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.1 Central European tick-borne encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.8 Other tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.9 Tick-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85 Other viral encephalitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.0 Enteroviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.1 Adenoviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.2 Arthropod-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.8 Other specified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A86 Unspecified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87 Viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.0 Enteroviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.1 Adenoviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.2 Lymphocytic choriomeningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.8 Other viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.9 Viral meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88 Other viral infections of central nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.0 Enteroviral exanthematous fever [Boston exanthem] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.1 Epidemic vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.8 Other specified viral infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A89 Unspecified viral infection of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92 Other mosquito-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.0 Chikungunya virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.1 O'nyong-nyong fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.2 Venezuelan equine fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.3 West Nile virus infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.4 Rift Valley fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.8 Other specified mosquito-borne viral fevers

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 218 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.9 Mosquito-borne viral fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93 Other arthropod-borne viral fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.0 Oropouche virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.1 Sandfly fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.2 Colorado tick fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.8 Other specified arthropod-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A94 Unspecified arthropod-borne viral fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95 Yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.0 Sylvatic yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.1 Urban yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.9 Yellow fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96 Arenaviral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.0 Junin haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.1 Machupo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.2 Lassa fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.8 Other arenaviral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.9 Arenaviral haemorrhagic fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97 Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.0 Dengue without warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.1 Dengue with warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.2 Severe Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.9 Dengue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98 Other viral haemorrhagic fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.0 Crimean-Congo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.1 Omsk haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.2 Kyasanur Forest disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.3 Marburg virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.4 Ebola virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.5 Haemorrhagic fever with renal syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.8 Other specified viral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A99 Unspecified viral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00 Herpesviral [herpes simplex] infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.0 Eczema herpeticum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.1 Herpesviral vesicular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 219 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.3 Herpesviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.4 Herpesviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.5 Herpesviral ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.7 Disseminated herpesviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.8 Other forms of herpesviral infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.9 Herpesviral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01 Varicella [chickenpox] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.0 Varicella meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.1 Varicella encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.2 Varicella pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.8 Varicella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.9 Varicella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02 Zoster [herpes zoster] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.0 Zoster encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.1 Zoster meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.2 Zoster with other nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.3 Zoster ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.7 Disseminated zoster 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.8 Zoster with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.9 Zoster without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B03 Smallpox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B04 Monkeypox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05 Measles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.0 Measles complicated by encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.1 Measles complicated by meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.2 Measles complicated by pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.3 Measles complicated by otitis mediaH67.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.4 Measles with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.8 Measles with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.9 Measles without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06 Rubella [German measles] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.0 Rubella with neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.8 Rubella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.9 Rubella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B07 Viral warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.0 Other orthopoxvirus infections

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 220 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.1 Molluscum contagiosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.2 Exanthema subitum [sixth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.3 Erythema infectiosum [fifth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.4 Enteroviral vesicular stomatitis with exanthem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.5 Enteroviral vesicular pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.8 Other specified viral infections characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B09 Unspecified viral infection characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15 Acute hepatitis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.0 Hepatitis A with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.9 Hepatitis A without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16 Acute hepatitis B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.2 Acute hepatitis B without delta- agent with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.9 Acute hepatitis B without delta- agent and without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17 Other acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.0 Acute delta-(super)infection of hepatitis B carrier 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.1 Acute hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.2 Acute hepatitis E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.8 Other specified acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.9 Acute viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18 Chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.0 Chronic viral hepatitis B with delta- agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.1 Chronic viral hepatitis B without delta-agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.2 Chronic viral hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.8 Other chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.9 Chronic viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19 Unspecified viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.0 Unspecified viral hepatitis with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.9 Unspecified viral hepatitis without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.0 HIV disease resulting in mycobacterial infection

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 221 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.1 HIV disease resulting in other bacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.2 HIV disease resulting in cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.3 HIV disease resulting in other viral infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.4 HIV disease resulting in candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.5 HIV disease resulting in other mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.6 HIV disease resulting in Pneumocystis jirovecii pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.7 HIV disease resulting in multiple infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.8 HIV disease resulting in other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.9 HIV disease resulting in unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.0 HIV disease resulting in Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.1 HIV disease resulting in Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.2 HIV disease resulting in other types of non-Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.7 HIV disease resulting in multiple malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.8 HIV disease resulting in other malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.9 HIV disease resulting in unspecified malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.0 HIV disease resulting in encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.1 HIV disease resulting in lymphoid interstitial pneumonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.2 HIV disease resulting in wasting syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.7 HIV disease resulting in multiple diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23 Human immunodeficiency virus [HIV] disease resulting in other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.0 Acute HIV infection syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.1 HIV disease resulting in (persistent) generalized lymphadenopathy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 222 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.8 HIV disease resulting in other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B24 Unspecified human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25 Cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.0 Cytomegaloviral pneumonitisJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.1 Cytomegaloviral hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.2 Cytomegaloviral pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.8 Other cytomegaloviral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.9 Cytomegaloviral disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26 Mumps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.0 Mumps orchitisN51.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.1 Mumps meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.2 Mumps encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.3 Mumps pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.8 Mumps with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.9 Mumps without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27 Infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.0 Gammaherpesviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.1 Cytomegaloviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.8 Other infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.9 Infectious mononucleosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30 Viral conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.0 Keratoconjunctivitis due to adenovirusH19.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.1 Conjunctivitis due to adenovirusH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.2 Viral pharyngoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)H13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.8 Other viral conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.9 Viral conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33 Other viral diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.0 Epidemic myalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.1 Ross River disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.2 Viral carditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.3 Retrovirus infections, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]J17.1

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 223 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.8 Other specified viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34 Viral infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.0 Adenovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.1 Enterovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.2 Coronavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.3 Parvovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.4 Papovavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.8 Other viral infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.9 Viral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35 Dermatophytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.0 Tinea barbae and tinea capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.1 Tinea unguium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.2 Tinea manuum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.3 Tinea pedis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.4 Tinea corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.5 Tinea imbricata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.6 Tinea inguinalis [Tinea cruris] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.8 Other dermatophytoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.9 Dermatophytosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36 Other superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.0 Pityriasis versicolor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.1 Tinea nigra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.2 White piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.3 Black piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.8 Other specified superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.9 Superficial mycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37 Candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.0 Candidal stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.1 Pulmonary candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.2 Candidiasis of skin and nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.3 Candidiasis of vulva and vaginaN77.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.4 Candidiasis of other urogenital sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.5 Candidal meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.6 Candidal endocarditisI39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.7 Candidal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.8 Candidiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.9 Candidiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38 Coccidioidomycosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 224 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.0 Acute pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.1 Chronic pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.2 Pulmonary coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.3 Cutaneous coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.4 Coccidioidomycosis meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.7 Disseminated coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.8 Other forms of coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.9 Coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39 Histoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.0 Acute pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.1 Chronic pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.2 Pulmonary histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.3 Disseminated histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.4 Histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.5 Histoplasmosis duboisii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.9 Histoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40 Blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.0 Acute pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.1 Chronic pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.2 Pulmonary blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.3 Cutaneous blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.7 Disseminated blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.8 Other forms of blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.9 Blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41 Paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.0 Pulmonary paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.7 Disseminated paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.8 Other forms of paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.9 Paracoccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42 Sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.0 Pulmonary sporotrichosisJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.1 Lymphocutaneous sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.7 Disseminated sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.8 Other forms of sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.9 Sporotrichosis, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 225 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43 Chromomycosis and phaeomycotic abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.0 Cutaneous chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.1 Phaeomycotic brain abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.2 Subcutaneous phaeomycotic abscess and cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.8 Other forms of chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.9 Chromomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44 Aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.0 Invasive pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.1 Other pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.2 Tonsillar aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.7 Disseminated aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.8 Other forms of aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.9 Aspergillosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45 Cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.0 Pulmonary cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.1 Cerebral cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.2 Cutaneous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.3 Osseous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.7 Disseminated cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.8 Other forms of cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.9 Cryptococcosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46 Zygomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.0 Pulmonary mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.1 Rhinocerebral mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.2 Gastrointestinal mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.3 Cutaneous mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.4 Disseminated mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.5 Mucormycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.8 Other zygomycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.9 Zygomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47 Mycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.0 Eumycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.1 Actinomycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.9 Mycetoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48 Other mycoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.0 Lobomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.1 Rhinosporidiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.2 Allescheriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.3 Geotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.4 Penicillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.7 Opportunistic mycoses

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 226 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.8 Other specified mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B49 Unspecified mycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50 Plasmodium falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.0 Plasmodium falciparum malaria with cerebral complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.8 Other severe and complicated Plasmodium falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.9 Plasmodium falciparum malaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51 Plasmodium vivax malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.0 Plasmodium vivax malaria with rupture of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.8 Plasmodium vivax malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.9 Plasmodium vivax malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52 Plasmodium malariae malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.0 Plasmodium malariae malaria with nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.8 Plasmodium malariae malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.9 Plasmodium malariae malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53 Other parasitologically confirmed malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.0 Plasmodium ovale malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.1 Malaria due to simian plasmodia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.8 Other parasitologically confirmed malaria, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B54 Unspecified malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55 Leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.0 Visceral leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.1 Cutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.2 Mucocutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.9 Leishmaniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56 African trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.0 Gambiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.1 Rhodesiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.9 African trypanosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57 Chagas disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.0 Acute Chagas disease with heart involvementI41.2I98.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.1 Acute Chagas disease without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.2 Chagas disease (chronic) with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.3 Chagas disease (chronic) with digestive system involvement © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 227 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.4 Chagas disease (chronic) with nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.5 Chagas disease (chronic) with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58 Toxoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.0 Toxoplasma oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.1 Toxoplasma hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.2 Toxoplasma meningoencephalitisG05.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.3 Pulmonary toxoplasmosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.8 Toxoplasmosis with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.9 Toxoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B59 PneumocystosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60 Other protozoal diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.0 Babesiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.1 Acanthamoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.2 Naegleriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.8 Other specified protozoal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B64 Unspecified protozoal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65 Schistosomiasis [bilharziasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.1 Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.2 Schistosomiasis due to Schistosoma japonicum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.3 Cercarial dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.8 Other schistosomiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.9 Schistosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66 Other fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.0 Opisthorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.1 Clonorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.2 Dicrocoeliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.3 Fascioliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.4 Paragonimiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.5 Fasciolopsiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.8 Other specified fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.9 Fluke infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67 Echinococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.0 Echinococcus granulosus infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.1 Echinococcus granulosus infection of lung

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 228 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.2 Echinococcus granulosus infection of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.3 Echinococcus granulosus infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.4 Echinococcus granulosus infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.5 Echinococcus multilocularis infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.6 Echinococcus multilocularis infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.7 Echinococcus multilocularis infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.8 Echinococcosis, unspecified, of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.9 Echinococcosis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68 Taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.0 Taenia solium taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.1 Taenia saginata taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.9 Taeniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69 Cysticercosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.0 Cysticercosis of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.1 Cysticercosis of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.8 Cysticercosis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.9 Cysticercosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70 Diphyllobothriasis and sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.0 Diphyllobothriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.1 Sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71 Other cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.0 Hymenolepiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.1 Dipylidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.8 Other specified cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.9 Cestode infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B72 Dracunculiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B73 Onchocerciasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74 Filariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.0 Filariasis due to Wuchereria bancrofti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.1 Filariasis due to Brugia malayi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.2 Filariasis due to Brugia timori 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.3 Loiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.4 Mansonelliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.8 Other filariases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.9 Filariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B75 Trichinellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76 Hookworm diseases

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 229 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.0 Ancylostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.1 Necatoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.8 Other hookworm diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.9 Hookworm disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77 Ascariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.0 Ascariasis with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.8 Ascariasis with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.9 Ascariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78 Strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.0 Intestinal strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.1 Cutaneous strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.7 Disseminated strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.9 Strongyloidiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B79 Trichuriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B80 Enterobiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81 Other intestinal helminthiases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.0 Anisakiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.1 Intestinal capillariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.2 Trichostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.3 Intestinal angiostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.4 Mixed intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.8 Other specified intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82 Unspecified intestinal parasitism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.0 Intestinal helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.9 Intestinal parasitism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83 Other helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.0 Visceral larva migrans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.1 Gnathostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.2 Angiostrongyliasis due to Parastrongylus cantonensis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.3 Syngamiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.4 Internal hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.8 Other specified helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.9 Helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85 Pediculosis and phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.0 Pediculosis due to Pediculus humanus capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.1 Pediculosis due to Pediculus humanus corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.2 Pediculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.3 Phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.4 Mixed pediculosis and phthiriasis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 230 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B86 Scabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87 Myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.0 Cutaneous myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.1 Wound myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.2 Ocular myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.3 Nasopharyngeal myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.4 Aural myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.8 Myiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.9 Myiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88 Other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.0 Other acariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.1 Tungiasis [sandflea infestation] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.2 Other arthropod infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.3 External hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.8 Other specified infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.9 Infestation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B89 Unspecified parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90 Sequelae of tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.0 Sequelae of central nervous system tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.1 Sequelae of genitourinary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.2 Sequelae of tuberculosis of bones and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.8 Sequelae of tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.9 Sequelae of respiratory and unspecified tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B91 Sequelae of poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B92 Sequelae of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94 Sequelae of other and unspecified infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.0 Sequelae of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.1 Sequelae of viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.2 Sequelae of viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.8 Sequelae of other specified infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.9 Sequelae of unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 231 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.2 Streptococcus group D and enterococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.4 Other streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.7 Other staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.5 Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97 Viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.0 Adenovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.1 Enterovirus as the cause of diseases classified to other chapters

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 232 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.2 Coronavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.3 Retrovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.4 Respiratory syncytial virus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.5 Reovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.6 Parvovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.7 Papillomavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.8 Other viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98 Other specified infectious agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B99 Other and unspecified infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00 Malignant neoplasm of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.0 Malignant neoplasm: External upper lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.1 Malignant neoplasm: External lower lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.2 Malignant neoplasm: External lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.3 Malignant neoplasm: Upper lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.4 Malignant neoplasm: Lower lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.5 Malignant neoplasm: Lip, unspecified, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.6 Malignant neoplasm: Commissure of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.8 Malignant neoplasm: Overlapping lesion of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.9 Malignant neoplasm: Lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C01 Malignant neoplasm of base of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02 Malignant neoplasm of other and unspecified parts of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.0 Malignant neoplasm: Dorsal surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.1 Malignant neoplasm: Border of tongue

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 233 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.2 Malignant neoplasm: Ventral surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.3 Malignant neoplasm: Anterior two- thirds of tongue, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.4 Malignant neoplasm: Lingual tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.8 Malignant neoplasm: Overlapping lesion of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.9 Malignant neoplasm: Tongue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03 Malignant neoplasm of gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.0 Malignant neoplasm: Upper gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.1 Malignant neoplasm: Lower gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.9 Malignant neoplasm: Gum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04 Malignant neoplasm of floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.0 Malignant neoplasm: Anterior floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.1 Malignant neoplasm: Lateral floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.8 Malignant neoplasm: Overlapping lesion of floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.9 Malignant neoplasm: Floor of mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05 Malignant neoplasm of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.0 Malignant neoplasm: Hard palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.1 Malignant neoplasm: Soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.2 Malignant neoplasm: Uvula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.8 Malignant neoplasm: Overlapping lesion of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.9 Malignant neoplasm: Palate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06 Malignant neoplasm of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.0 Malignant neoplasm: Cheek mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.1 Malignant neoplasm: Vestibule of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.2 Malignant neoplasm: Retromolar area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.8 Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.9 Malignant neoplasm: Mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C07 Malignant neoplasm of parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08 Malignant neoplasm of other and unspecified major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.0 Malignant neoplasm: Submandibular gland

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 234 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.1 Malignant neoplasm: Sublingual gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.8 Malignant neoplasm: Overlapping lesion of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.9 Malignant neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09 Malignant neoplasm of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.0 Malignant neoplasm: Tonsillar fossa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.1 Malignant neoplasm: Tonsillar pillar (anterior)(posterior) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.8 Malignant neoplasm: Overlapping lesion of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.9 Malignant neoplasm: Tonsil, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10 Malignant neoplasm of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.0 Malignant neoplasm: Vallecula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.1 Malignant neoplasm: Anterior surface of epiglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.2 Malignant neoplasm: Lateral wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.3 Malignant neoplasm: Posterior wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.4 Malignant neoplasm: Branchial cleft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.8 Malignant neoplasm: Overlapping lesion of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.9 Malignant neoplasm: Oropharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11 Malignant neoplasm of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.0 Malignant neoplasm: Superior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.1 Malignant neoplasm: Posterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.2 Malignant neoplasm: Lateral wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.3 Malignant neoplasm: Anterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.8 Malignant neoplasm: Overlapping lesion of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.9 Malignant neoplasm: Nasopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C12 Malignant neoplasm of piriform sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13 Malignant neoplasm of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.0 Malignant neoplasm: Postcricoid region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.1 Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.2 Malignant neoplasm: Posterior wall of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.8 Malignant neoplasm: Overlapping lesion of hypopharynx © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 235 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.9 Malignant neoplasm: Hypopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14 Malignant neoplasm of other and ill- defined sites in the lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.0 Malignant neoplasm: Pharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.2 Malignant neoplasm: Waldeyer ring 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.8 Malignant neoplasm: Overlapping lesion of lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15 Malignant neoplasm of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.0 Malignant neoplasm: Cervical part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.1 Malignant neoplasm: Thoracic part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.2 Malignant neoplasm: Abdominal part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.3 Malignant neoplasm: Upper third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.4 Malignant neoplasm: Middle third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.5 Malignant neoplasm: Lower third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.8 Malignant neoplasm: Overlapping lesion of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.9 Malignant neoplasm: Oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16 Malignant neoplasm of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.0 Malignant neoplasm: Cardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.1 Malignant neoplasm: Fundus of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.2 Malignant neoplasm: Body of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.3 Malignant neoplasm: Pyloric antrum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.4 Malignant neoplasm: Pylorus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.5 Malignant neoplasm: Lesser curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.6 Malignant neoplasm: Greater curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.8 Malignant neoplasm: Overlapping lesion of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.9 Malignant neoplasm: Stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17 Malignant neoplasm of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.0 Malignant neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.1 Malignant neoplasm: Jejunum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.2 Malignant neoplasm: Ileum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.3 Malignant neoplasm: Meckel diverticulum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 236 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.8 Malignant neoplasm: Overlapping lesion of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.9 Malignant neoplasm: Small intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18 Malignant neoplasm of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.0 Malignant neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.1 Malignant neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.2 Malignant neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.3 Malignant neoplasm: Hepatic flexure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.4 Malignant neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.5 Malignant neoplasm: Splenic flexure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.6 Malignant neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.7 Malignant neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.8 Malignant neoplasm: Overlapping lesion of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.9 Malignant neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C19 Malignant neoplasm of rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C20 Malignant neoplasm of rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21 Malignant neoplasm of anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.0 Malignant neoplasm: Anus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.1 Malignant neoplasm: Anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.2 Malignant neoplasm: Cloacogenic zone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.8 Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22 Malignant neoplasm of liver and intrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.0 Malignant neoplasm: Liver cell carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.1 Malignant neoplasm: Intrahepatic bile duct carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.2 Malignant neoplasm: Hepatoblastoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.3 Malignant neoplasm: Angiosarcoma of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.4 Malignant neoplasm: Other sarcomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.7 Malignant neoplasm: Other specified carcinomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.9 Malignant neoplasm: Liver, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C23 Malignant neoplasm of gallbladder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 237 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24 Malignant neoplasm of other and unspecified parts of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.0 Malignant neoplasm: Extrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.1 Malignant neoplasm: Ampulla of Vater 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.8 Malignant neoplasm: Overlapping lesion of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.9 Malignant neoplasm: Biliary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25 Malignant neoplasm of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.0 Malignant neoplasm: Head of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.1 Malignant neoplasm: Body of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.2 Malignant neoplasm: Tail of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.3 Malignant neoplasm: Pancreatic duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.4 Malignant neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.7 Malignant neoplasm: Other parts of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.8 Malignant neoplasm: Overlapping lesion of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.9 Malignant neoplasm: Pancreas, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26 Malignant neoplasm of other and ill- defined digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.0 Malignant neoplasm: Intestinal tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.1 Malignant neoplasm: Spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.8 Malignant neoplasm: Overlapping lesion of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.9 Malignant neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30 Malignant neoplasm of nasal cavity and middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.0 Malignant neoplasm: Nasal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.1 Malignant neoplasm: Middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31 Malignant neoplasm of accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.0 Malignant neoplasm: Maxillary sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.1 Malignant neoplasm: Ethmoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.2 Malignant neoplasm: Frontal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.3 Malignant neoplasm: Sphenoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.8 Malignant neoplasm: Overlapping lesion of accessory sinuses

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 238 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.9 Malignant neoplasm: Accessory sinus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32 Malignant neoplasm of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.0 Malignant neoplasm: Glottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.1 Malignant neoplasm: Supraglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.2 Malignant neoplasm: Subglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.3 Malignant neoplasm: Laryngeal cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.8 Malignant neoplasm: Overlapping lesion of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.9 Malignant neoplasm: Larynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C33 Malignant neoplasm of trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34 Malignant neoplasm of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.0 Malignant neoplasm: Main bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.1 Malignant neoplasm: Upper lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.2 Malignant neoplasm: Middle lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.3 Malignant neoplasm: Lower lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.8 Malignant neoplasm: Overlapping lesion of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.9 Malignant neoplasm: Bronchus or lung, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C37 Malignant neoplasm of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38 Malignant neoplasm of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.0 Malignant neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.1 Malignant neoplasm: Anterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.2 Malignant neoplasm: Posterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.3 Malignant neoplasm: Mediastinum, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.4 Malignant neoplasm: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.8 Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39 Malignant neoplasm of other and ill- defined sites in the respiratory system and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.0 Malignant neoplasm: Upper respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.8 Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.9 Malignant neoplasm: Ill-defined sites within the respiratory system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 239 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40 Malignant neoplasm of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.0 Malignant neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.1 Malignant neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.2 Malignant neoplasm: Long bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.3 Malignant neoplasm: Short bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.9 Malignant neoplasm: Bone and articular cartilage of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.0 Malignant neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.1 Malignant neoplasm: Mandible 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.2 Malignant neoplasm: Vertebral column 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.3 Malignant neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.4 Malignant neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.9 Malignant neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43 Malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.0 Malignant neoplasm: Malignant melanoma of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.1 Malignant neoplasm: Malignant melanoma of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.2 Malignant neoplasm: Malignant melanoma of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.3 Malignant neoplasm: Malignant melanoma of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.4 Malignant neoplasm: Malignant melanoma of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.5 Malignant neoplasm: Malignant melanoma of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.6 Malignant neoplasm: Malignant melanoma of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.7 Malignant neoplasm: Malignant melanoma of lower limb, including hip © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 240 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.8 Malignant neoplasm: Overlapping malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.9 Malignant neoplasm: Malignant melanoma of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44 Other malignant neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.0 Malignant neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.1 Malignant neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.2 Malignant neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.3 Malignant neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.4 Malignant neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.5 Malignant neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.6 Malignant neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.7 Malignant neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.8 Malignant neoplasm: Overlapping lesion of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.9 Malignant neoplasm: Malignant neoplasm of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45 Mesothelioma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.0 Mesothelioma of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.1 Mesothelioma of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.2 Mesothelioma of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.7 Mesothelioma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.9 Mesothelioma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46 Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.0 Kaposi sarcoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.1 Kaposi sarcoma of soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.2 Kaposi sarcoma of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.3 Kaposi sarcoma of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.7 Kaposi sarcoma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.8 Kaposi sarcoma of multiple organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.9 Kaposi sarcoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47 Malignant neoplasm of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.0 Malignant neoplasm: Peripheral nerves of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.1 Malignant neoplasm: Peripheral nerves of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.2 Malignant neoplasm: Peripheral nerves of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.3 Malignant neoplasm: Peripheral nerves of thorax

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 241 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.4 Malignant neoplasm: Peripheral nerves of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.5 Malignant neoplasm: Peripheral nerves of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.6 Malignant neoplasm: Peripheral nerves of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.8 Malignant neoplasm: Overlapping lesion of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.9 Malignant neoplasm: Peripheral nerves and autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48 Malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.0 Malignant neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.1 Malignant neoplasm: Specified parts of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.2 Malignant neoplasm: Peritoneum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.8 Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49 Malignant neoplasm of other connective and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.0 Malignant neoplasm: Connective and soft tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.1 Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.2 Malignant neoplasm: Connective and soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.3 Malignant neoplasm: Connective and soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.4 Malignant neoplasm: Connective and soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.5 Malignant neoplasm: Connective and soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.6 Malignant neoplasm: Connective and soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.8 Malignant neoplasm: Overlapping lesion of connective and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.9 Malignant neoplasm: Connective and soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50 Malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.0 Malignant neoplasm: Nipple and areola 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.1 Malignant neoplasm: Central portion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.2 Malignant neoplasm: Upper-inner quadrant of breast

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 242 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.3 Malignant neoplasm: Lower-inner quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.4 Malignant neoplasm: Upper-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.5 Malignant neoplasm: Lower-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.6 Malignant neoplasm: Axillary tail of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.8 Malignant neoplasm: Overlapping lesion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.9 Malignant neoplasm: Breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51 Malignant neoplasm of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.0 Malignant neoplasm: Labium majus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.1 Malignant neoplasm: Labium minus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.2 Malignant neoplasm: Clitoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.8 Malignant neoplasm: Overlapping lesion of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.9 Malignant neoplasm: Vulva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C52 Malignant neoplasm of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53 Malignant neoplasm of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.0 Malignant neoplasm: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.1 Malignant neoplasm: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.8 Malignant neoplasm: Overlapping lesion of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.9 Malignant neoplasm: Cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54 Malignant neoplasm of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.0 Malignant neoplasm: Isthmus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.1 Malignant neoplasm: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.2 Malignant neoplasm: Myometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.3 Malignant neoplasm: Fundus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.8 Malignant neoplasm: Overlapping lesion of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.9 Malignant neoplasm: Corpus uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C55 Malignant neoplasm of uterus, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C56 Malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57 Malignant neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.0 Malignant neoplasm: Fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.1 Malignant neoplasm: Broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.2 Malignant neoplasm: Round ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.3 Malignant neoplasm: Parametrium

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 243 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.4 Malignant neoplasm: Uterine adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.7 Malignant neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.8 Malignant neoplasm: Overlapping lesion of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.9 Malignant neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C58 Malignant neoplasm of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60 Malignant neoplasm of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.0 Malignant neoplasm: Prepuce 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.1 Malignant neoplasm: Glans penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.2 Malignant neoplasm: Body of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.8 Malignant neoplasm: Overlapping lesion of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.9 Malignant neoplasm: Penis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C61 Malignant neoplasm of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62 Malignant neoplasm of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.0 Malignant neoplasm: Undescended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.1 Malignant neoplasm: Descended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.9 Malignant neoplasm: Testis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63 Malignant neoplasm of other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.0 Malignant neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.1 Malignant neoplasm: Spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.2 Malignant neoplasm: Scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.7 Malignant neoplasm: Other specified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.8 Malignant neoplasm: Overlapping lesion of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.9 Malignant neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C64 Malignant neoplasm of kidney, except renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C65 Malignant neoplasm of renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C66 Malignant neoplasm of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67 Malignant neoplasm of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.0 Malignant neoplasm: Trigone of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.1 Malignant neoplasm: Dome of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.2 Malignant neoplasm: Lateral wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.3 Malignant neoplasm: Anterior wall of bladder © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 244 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.4 Malignant neoplasm: Posterior wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.5 Malignant neoplasm: Bladder neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.6 Malignant neoplasm: Ureteric orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.7 Malignant neoplasm: Urachus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.8 Malignant neoplasm: Overlapping lesion of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.9 Malignant neoplasm: Bladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68 Malignant neoplasm of other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.0 Malignant neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.1 Malignant neoplasm: Paraurethral gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.8 Malignant neoplasm: Overlapping lesion of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.9 Malignant neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69 Malignant neoplasm of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.0 Malignant neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.1 Malignant neoplasm: Cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.2 Malignant neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.3 Malignant neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.4 Malignant neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.5 Malignant neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.6 Malignant neoplasm: Orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.8 Malignant neoplasm: Overlapping lesion of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.9 Malignant neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70 Malignant neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.0 Malignant neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.1 Malignant neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.9 Malignant neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71 Malignant neoplasm of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.0 Malignant neoplasm: Cerebrum, except lobes and ventricles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.1 Malignant neoplasm: Frontal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.2 Malignant neoplasm: Temporal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.3 Malignant neoplasm: Parietal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.4 Malignant neoplasm: Occipital lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.5 Malignant neoplasm: Cerebral ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.6 Malignant neoplasm: Cerebellum © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 245 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.7 Malignant neoplasm: Brain stem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.8 Malignant neoplasm: Overlapping lesion of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.9 Malignant neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.0 Malignant neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.1 Malignant neoplasm: Cauda equina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.2 Malignant neoplasm: Olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.3 Malignant neoplasm: Optic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.4 Malignant neoplasm: Acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.5 Malignant neoplasm: Other and unspecified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.8 Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.9 Malignant neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C73 Malignant neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74 Malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.0 Malignant neoplasm: Cortex of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.1 Malignant neoplasm: Medulla of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.9 Malignant neoplasm: Adrenal gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75 Malignant neoplasm of other endocrine glands and related structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.0 Malignant neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.1 Malignant neoplasm: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.2 Malignant neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.3 Malignant neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.4 Malignant neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.5 Malignant neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.8 Malignant neoplasm: Pluriglandular involvement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.9 Malignant neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76 Malignant neoplasm of other and ill- defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.0 Malignant neoplasm of other and ill- defined sites: Head, face and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 246 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.1 Malignant neoplasm of other and ill- defined sites: Thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.2 Malignant neoplasm of other and ill- defined sites: Abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.3 Malignant neoplasm of other and ill- defined sites: Pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.4 Malignant neoplasm of other and ill- defined sites: Upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.5 Malignant neoplasm of other and ill- defined sites: Lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.7 Malignant neoplasm of other and ill- defined sites: Other ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.8 Malignant neoplasm of other and ill- defined sites: Overlapping lesion of other and ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77 Secondary and unspecified malignant neoplasm of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.0 Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.1 Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.2 Secondary and unspecified malignant neoplasm: Intra- abdominal lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.3 Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.4 Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.5 Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.8 Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.9 Secondary and unspecified malignant neoplasm: Lymph node, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78 Secondary malignant neoplasm of respiratory and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.0 Secondary malignant neoplasm of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.1 Secondary malignant neoplasm of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.2 Secondary malignant neoplasm of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.4 Secondary malignant neoplasm of small intestine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 247 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.5 Secondary malignant neoplasm of large intestine and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.8 Secondary malignant neoplasm of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79 Secondary malignant neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.0 Secondary malignant neoplasm of kidney and renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.2 Secondary malignant neoplasm of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.3 Secondary malignant neoplasm of brain and cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.5 Secondary malignant neoplasm of bone and bone marrow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.6 Secondary malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.7 Secondary malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.8 Secondary malignant neoplasm of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.9 Secondary malignant neoplasm, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80 Malignant neoplasm, without specification of site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.0 Malignant neoplasm, primary site unknown, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.9 Malignant neoplasm, primary site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81 Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.0 Nodular lymphocyte predominant Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.1 Nodular sclerosis classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.2 Mixed cellularity classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.3 Lymphocyte depleted classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.4 Lymphocyte-rich (classical) Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.7 Other classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.9 Hodgkin lymphoma, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 248 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82 Follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.0 Follicular lymphoma grade I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.1 Follicular lymphoma grade II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.2 Follicular lymphoma grade III, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.3 Follicular lymphoma grade IIIa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.4 Follicular lymphoma grade IIIb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.5 Diffuse follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.6 Cutaneous follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.7 Other types of follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.9 Follicular lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83 Non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.0 Small cell B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.1 Mantle cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.3 Diffuse large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.5 Lymphoblastic (diffuse) lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.7 Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.8 Other non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.9 Non-follicular (diffuse) lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84 Mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.0 Mycosis fungoides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.1 Sézary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.4 Peripheral T-cell lymphoma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.5 Other mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.6 Anaplastic large cell lymphoma, ALK-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.7 Anaplastic large cell lymphoma, ALK-negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.8 Cutaneous T-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.9 Mature T/NK-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85 Other and unspecified types of non- Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.1 B-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.2 Mediastinal (thymic) large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.7 Other specified types of non- Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.9 Non-Hodgkin lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86 Other specified types of T/NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.0 Extranodal NK/T-cell lymphoma, nasal type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.1 Hepatosplenic T-cell lymphoma © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 249 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.2 Enteropathy-type (intestinal) T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.3 Subcutaneous panniculitis-like T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.4 Blastic NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.5 Angioimmunoblastic T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.6 Primary cutaneous CD30-positive T- cell proliferations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88 Malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.0 Waldenström macroglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.2 Other heavy chain disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.3 Immunoproliferative small intestinal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.7 Other malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.9 Malignant immunoproliferative disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90 Multiple myeloma and malignant plasma cell neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.0 Multiple myeloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.1 Plasma cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.2 Extramedullary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.3 Solitary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91 Lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.0 Acute lymphoblastic leukaemia [ALL] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.1 Chronic lymphocytic leukaemia of B- cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.3 Prolymphocytic leukaemia of B-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.4 Hairy-cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.6 Prolymphocytic leukaemia of T-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.7 Other lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.8 Mature B-cell leukaemia Burkitt-type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.9 Lymphoid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92 Myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.0 Acute myeloblastic leukaemia [AML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.2 Atypical chronic myeloid leukaemia, BCR/ABL- negative

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 250 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.3 Myeloid sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.4 Acute promyelocytic leukaemia [PML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.5 Acute myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.6 Acute myeloid leukaemia with 11q23-abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.7 Other myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.8 Acute myeloid leukaemia with multilineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.9 Myeloid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93 Monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.0 Acute monoblastic/monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.1 Chronic myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.3 Juvenile myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.7 Other monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.9 Monocytic leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94 Other leukaemias of specified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.0 Acute erythroid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.2 Acute megakaryoblastic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.3 Mast cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.4 Acute panmyelosis with myelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.7 Other specified leukaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95 Leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.0 Acute leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.1 Chronic leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.7 Other leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.9 Leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.2 Malignant mast cell tumour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.4 Sarcoma of dendritic cells (accessory cells) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.6 Unifocal Langerhans-cell histiocytosis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 251 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.8 Histiocytic sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C97 Malignant neoplasms of independent (primary) multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00 Carcinoma in situ of oral cavity, oesophagus and stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.0 Carcinoma in situ: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.1 Carcinoma in situ: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.2 Carcinoma in situ: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01 Carcinoma in situ of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.0 Carcinoma in situ: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.1 Carcinoma in situ: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.2 Carcinoma in situ: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.3 Carcinoma in situ: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.4 Carcinoma in situ: Other and unspecified parts of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.5 Carcinoma in situ: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.7 Carcinoma in situ: Other specified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.9 Carcinoma in situ: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02 Carcinoma in situ of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.0 Carcinoma in situ: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.1 Carcinoma in situ: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.2 Carcinoma in situ: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.3 Carcinoma in situ: Other parts of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.4 Carcinoma in situ: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03 Melanoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.0 Melanoma in situ of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.1 Melanoma in situ of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.2 Melanoma in situ of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.3 Melanoma in situ of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.4 Melanoma in situ of scalp and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 252 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.5 Melanoma in situ of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.6 Melanoma in situ of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.7 Melanoma in situ of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.8 Melanoma in situ of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.9 Melanoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04 Carcinoma in situ of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.0 Carcinoma in situ: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.1 Carcinoma in situ: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.2 Carcinoma in situ: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.3 Carcinoma in situ: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.4 Carcinoma in situ: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.5 Carcinoma in situ: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.6 Carcinoma in situ: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.7 Carcinoma in situ: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.8 Carcinoma in situ: Skin of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.9 Carcinoma in situ: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05 Carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.0 Lobular carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.1 Intraductal carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.7 Other carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.9 Carcinoma in situ of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06 Carcinoma in situ of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.0 Carcinoma in situ: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.1 Carcinoma in situ: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.7 Carcinoma in situ: Other parts of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.9 Carcinoma in situ: Cervix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07 Carcinoma in situ of other and unspecified genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.0 Carcinoma in situ: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.1 Carcinoma in situ: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.2 Carcinoma in situ: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.3 Carcinoma in situ: Other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.4 Carcinoma in situ: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.5 Carcinoma in situ: Prostate

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 253 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.6 Carcinoma in situ: Other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09 Carcinoma in situ of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.0 Carcinoma in situ: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.1 Carcinoma in situ: Other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.2 Carcinoma in situ: Eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.3 Carcinoma in situ: Thyroid and other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.7 Carcinoma in situ of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.9 Carcinoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10 Benign neoplasm of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.0 Benign neoplasm: Lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.1 Benign neoplasm: Tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.2 Benign neoplasm: Floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.3 Benign neoplasm: Other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.4 Benign neoplasm: Tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.5 Benign neoplasm: Other parts of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.6 Benign neoplasm: Nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.7 Benign neoplasm: Hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.9 Benign neoplasm: Pharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11 Benign neoplasm of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.0 Benign neoplasm: Parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.7 Benign neoplasm: Other major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.9 Benign neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12 Benign neoplasm of colon, rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.0 Benign neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.1 Benign neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.2 Benign neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.3 Benign neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.4 Benign neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.5 Benign neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.6 Benign neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.7 Benign neoplasm: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.8 Benign neoplasm: Rectum

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 254 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.9 Benign neoplasm: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13 Benign neoplasm of other and ill- defined parts of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.0 Benign neoplasm: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.1 Benign neoplasm: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.2 Benign neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.3 Benign neoplasm: Other and unspecified parts of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.4 Benign neoplasm: Liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.5 Benign neoplasm: Extrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.6 Benign neoplasm: Pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.7 Benign neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.9 Benign neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14 Benign neoplasm of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.0 Benign neoplasm: Middle ear, nasal cavity and accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.1 Benign neoplasm: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.2 Benign neoplasm: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.3 Benign neoplasm: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.4 Benign neoplasm: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15 Benign neoplasm of other and unspecified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.0 Benign neoplasm: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.1 Benign neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.2 Benign neoplasm: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.7 Benign neoplasm: Other specified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.9 Benign neoplasm: Intrathoracic organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16 Benign neoplasm of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.0 Benign neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.1 Benign neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.2 Benign neoplasm: Long bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.3 Benign neoplasm: Short bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.4 Benign neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.5 Benign neoplasm: Lower jaw bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.6 Benign neoplasm: Vertebral column © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 255 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.7 Benign neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.8 Benign neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.9 Benign neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17 Benign lipomatous neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.4 Benign lipomatous neoplasm of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.5 Benign lipomatous neoplasm of intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.6 Benign lipomatous neoplasm of spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.7 Benign lipomatous neoplasm of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.9 Benign lipomatous neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18 Haemangioma and lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.0 Haemangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.1 Lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19 Benign neoplasm of mesothelial tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.0 Benign neoplasm: Mesothelial tissue of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.1 Benign neoplasm: Mesothelial tissue of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.7 Benign neoplasm: Mesothelial tissue of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.9 Benign neoplasm: Mesothelial tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.0 Benign neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.1 Benign neoplasm: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21 Other benign neoplasms of connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.0 Benign neoplasm: Connective and other soft tissue of head, face and neck

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 256 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.1 Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.2 Benign neoplasm: Connective and other soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.3 Benign neoplasm: Connective and other soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.4 Benign neoplasm: Connective and other soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.5 Benign neoplasm: Connective and other soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.6 Benign neoplasm: Connective and other soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.9 Benign neoplasm: Connective and other soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22 Melanocytic naevi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.0 Melanocytic naevi of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.1 Melanocytic naevi of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.2 Melanocytic naevi of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.3 Melanocytic naevi of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.4 Melanocytic naevi of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.5 Melanocytic naevi of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.6 Melanocytic naevi of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.7 Melanocytic naevi of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.9 Melanocytic naevi, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23 Other benign neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.0 Benign neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.1 Benign neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.2 Benign neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.3 Benign neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.4 Benign neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.5 Benign neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.6 Benign neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.7 Benign neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.9 Benign neoplasm: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D24 Benign neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25 Leiomyoma of uterus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 257 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.0 Submucous leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.1 Intramural leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.2 Subserosal leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.9 Leiomyoma of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26 Other benign neoplasms of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.0 Other benign neoplasm: Cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.1 Other benign neoplasm: Corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.7 Other benign neoplasm: Other parts of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.9 Other benign neoplasm: Uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D27 Benign neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28 Benign neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.0 Benign neoplasm: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.1 Benign neoplasm: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.2 Benign neoplasm: Uterine tubes and ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.7 Benign neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.9 Benign neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29 Benign neoplasm of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.0 Benign neoplasm: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.1 Benign neoplasm: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.2 Benign neoplasm: Testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.3 Benign neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.4 Benign neoplasm: Scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.7 Benign neoplasm: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.9 Benign neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30 Benign neoplasm of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.0 Benign neoplasm: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.1 Benign neoplasm: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.2 Benign neoplasm: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.3 Benign neoplasm: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.4 Benign neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.7 Benign neoplasm: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.9 Benign neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31 Benign neoplasm of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.0 Benign neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.1 Benign neoplasm: Cornea © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 258 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.2 Benign neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.3 Benign neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.4 Benign neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.5 Benign neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.6 Benign neoplasm: Orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.9 Benign neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32 Benign neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.0 Benign neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.1 Benign neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.9 Benign neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33 Benign neoplasm of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.0 Benign neoplasm: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.1 Benign neoplasm: Brain, infratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.2 Benign neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.3 Benign neoplasm: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.4 Benign neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.7 Benign neoplasm: Other specified parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.9 Benign neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D34 Benign neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35 Benign neoplasm of other and unspecified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.0 Benign neoplasm: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.1 Benign neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.2 Benign neoplasm: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.3 Benign neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.4 Benign neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.5 Benign neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.6 Benign neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.7 Benign neoplasm: Other specified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.8 Benign neoplasm: Pluriglandular involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.9 Benign neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36 Benign neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.0 Benign neoplasm: Lymph nodes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 259 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.1 Benign neoplasm: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.7 Benign neoplasm: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.9 Benign neoplasm: Benign neoplasm of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.0 Neoplasm of uncertain or unknown behaviour: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.1 Neoplasm of uncertain or unknown behaviour: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.2 Neoplasm of uncertain or unknown behaviour: Small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.3 Neoplasm of uncertain or unknown behaviour: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.4 Neoplasm of uncertain or unknown behaviour: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.5 Neoplasm of uncertain or unknown behaviour: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.6 Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.7 Neoplasm of uncertain or unknown behaviour: Other digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.9 Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.0 Neoplasm of uncertain or unknown behaviour: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.1 Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.2 Neoplasm of uncertain or unknown behaviour: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.3 Neoplasm of uncertain or unknown behaviour: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.4 Neoplasm of uncertain or unknown behaviour: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.5 Neoplasm of uncertain or unknown behaviour: Other respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.6 Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39 Neoplasm of uncertain or unknown behaviour of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.0 Neoplasm of uncertain or unknown behaviour: Uterus

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 260 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.1 Neoplasm of uncertain or unknown behaviour: Ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.2 Neoplasm of uncertain or unknown behaviour: Placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.7 Neoplasm of uncertain or unknown behaviour: Other female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.9 Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40 Neoplasm of uncertain or unknown behaviour of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.0 Neoplasm of uncertain or unknown behaviour: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.1 Neoplasm of uncertain or unknown behaviour: Testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.7 Neoplasm of uncertain or unknown behaviour: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.9 Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41 Neoplasm of uncertain or unknown behaviour of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.0 Neoplasm of uncertain or unknown behaviour: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.1 Neoplasm of uncertain or unknown behaviour: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.2 Neoplasm of uncertain or unknown behaviour: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.3 Neoplasm of uncertain or unknown behaviour: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.4 Neoplasm of uncertain or unknown behaviour: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.7 Neoplasm of uncertain or unknown behaviour: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.9 Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42 Neoplasm of uncertain or unknown behaviour of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.0 Neoplasm of uncertain or unknown behaviour: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.1 Neoplasm of uncertain or unknown behaviour: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.9 Neoplasm of uncertain or unknown behaviour: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.0 Neoplasm of uncertain or unknown behaviour: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.1 Neoplasm of uncertain or unknown behaviour: Brain, infratentorial © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 261 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.2 Neoplasm of uncertain or unknown behaviour: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.3 Neoplasm of uncertain or unknown behaviour: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.4 Neoplasm of uncertain or unknown behaviour: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.7 Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.9 Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44 Neoplasm of uncertain or unknown behaviour of endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.0 Neoplasm of uncertain or unknown behaviour: Thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.1 Neoplasm of uncertain or unknown behaviour: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.2 Neoplasm of uncertain or unknown behaviour: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.3 Neoplasm of uncertain or unknown behaviour: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.4 Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.5 Neoplasm of uncertain or unknown behaviour: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.6 Neoplasm of uncertain or unknown behaviour: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.7 Neoplasm of uncertain or unknown behaviour: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.8 Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.9 Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D45 Polycythaemia vera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46 Myelodysplastic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.0 Refractory anaemia without ring sideroblasts, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.1 Refractory anaemia with ring sideroblasts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.2 Refractory anaemia with excess of blasts [RAEB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.4 Refractory anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.5 Refractory anaemia with multi- lineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.7 Other myelodysplastic syndromes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 262 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.9 Myelodysplastic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.1 Chronic myeloproliferative disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.2 Monoclonal gammopathy of undetermined significance (MGUS) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.3 Essential (haemorrhagic) thrombocythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.4 Osteomyelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.0 Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.1 Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.2 Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.3 Neoplasm of uncertain or unknown behaviour: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.4 Neoplasm of uncertain or unknown behaviour: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.5 Neoplasm of uncertain or unknown behaviour: Skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.6 Neoplasm of uncertain or unknown behaviour: Breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.7 Neoplasm of uncertain or unknown behaviour: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.9 Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50 Iron deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.0 Iron deficiency anaemia secondary to blood loss (chronic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.1 Sideropenic dysphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.8 Other iron deficiency anaemias

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 263 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.9 Iron deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51 Vitamin B12deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.0 Vitamin B12deficiency anaemia due to intrinsic factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.1 Vitamin B12deficiency anaemia due to selective vitamin B12malabsorption with proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.2 Transcobalamin II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.3 Other dietary vitamin B12deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.8 Other vitamin B12deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.9 Vitamin B12deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52 Folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.0 Dietary folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.1 Drug-induced folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.8 Other folate deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.9 Folate deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53 Other nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.0 Protein deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.1 Other megaloblastic anaemias, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.2 Scorbutic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.8 Other specified nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.9 Nutritional anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55 Anaemia due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.0 Anaemia due to glucose-6- phosphate dehydrogenase [G6PD] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.1 Anaemia due to other disorders of glutathione metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.2 Anaemia due to disorders of glycolytic enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.3 Anaemia due to disorders of nucleotide metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.8 Other anaemias due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.9 Anaemia due to enzyme disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56 Thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.0 Alpha thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.1 Beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.2 Delta-beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.3 Thalassaemia trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.4 Hereditary persistence of fetal haemoglobin [HPFH]

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 264 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.8 Other thalassaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.9 Thalassaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57 Sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.0 Sickle-cell anaemia with crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.1 Sickle-cell anaemia without crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.2 Double heterozygous sickling disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.3 Sickle-cell trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.8 Other sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58 Other hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.0 Hereditary spherocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.1 Hereditary elliptocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.2 Other haemoglobinopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.8 Other specified hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.9 Hereditary haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59 Acquired haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.0 Drug-induced autoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.1 Other autoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.2 Drug-induced nonautoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.3 Haemolytic-uraemic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.4 Other nonautoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava- Micheli] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.6 Haemoglobinuria due to haemolysis from other external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.8 Other acquired haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.9 Acquired haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60 Acquired pure red cell aplasia [erythroblastopenia] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.0 Chronic acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.1 Transient acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.8 Other acquired pure red cell aplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.9 Acquired pure red cell aplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61 Other aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.0 Constitutional aplastic anaemia

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 265 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.1 Drug-induced aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.2 Aplastic anaemia due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.3 Idiopathic aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.8 Other specified aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.9 Aplastic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D62 Acute posthaemorrhagic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63 Anaemia in chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.0 Anaemia in neoplastic diseaseC00- D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.8 Anaemia in other chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64 Other anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.0 Hereditary sideroblastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.1 Secondary sideroblastic anaemia due to disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.2 Secondary sideroblastic anaemia due to drugs and toxins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.3 Other sideroblastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.4 Congenital dyserythropoietic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.8 Other specified anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.9 Anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D65 Disseminated intravascular coagulation [defibrination syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D66 Hereditary factor VIII deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D67 Hereditary factor IX deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68 Other coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.0 Von Willebrand disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.1 Hereditary factor XI deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.2 Hereditary deficiency of other clotting factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.3 Haemorrhagic disorder due to circulating anticoagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.4 Acquired coagulation factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.5 Primary thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.6 Other thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.8 Other specified coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.9 Coagulation defect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69 Purpura and other haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.0 Allergic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.1 Qualitative platelet defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.2 Other nonthrombocytopenic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.3 Idiopathic thrombocytopenic purpura

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 266 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.4 Other primary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.5 Secondary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.6 Thrombocytopenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.8 Other specified haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.9 Haemorrhagic condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D70 Agranulocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D71 Functional disorders of polymorphonuclear neutrophils 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72 Other disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.0 Genetic anomalies of leukocytes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.1 Eosinophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.8 Other specified disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.9 Disorder of white blood cells, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73 Diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.0 Hyposplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.1 Hypersplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.2 Chronic congestive splenomegaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.3 Abscess of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.4 Cyst of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.5 Infarction of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.8 Other diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.9 Disease of spleen, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74 Methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.0 Congenital methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.8 Other methaemoglobinaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.9 Methaemoglobinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75 Other diseases of blood and blood- forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.0 Familial erythrocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.1 Secondary polycythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.8 Other specified diseases of blood and blood-forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.9 Disease of blood and blood-forming organs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76 Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.1 Haemophagocytic lymphohistiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.2 Haemophagocytic syndrome, infection-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.3 Other histiocytosis syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D77 Other disorders of blood and blood- forming organs in diseases classified elsewhere © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 267 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80 Immunodeficiency with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.0 Hereditary hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.1 Nonfamilial hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.2 Selective deficiency of immunoglobulin A [IgA] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.4 Selective deficiency of immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.5 Immunodeficiency with increased immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.6 Antibody deficiency with near- normal immunoglobulins or with hyperimmunoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.7 Transient hypogammaglobulinaemia of infancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.8 Other immunodeficiencies with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.9 Immunodeficiency with predominantly antibody defects, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81 Combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.3 Adenosine deaminase [ADA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.4 Nezelof syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.5 Purine nucleoside phosphorylase [PNP] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.6 Major histocompatibility complex class I deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.7 Major histocompatibility complex class II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.8 Other combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.9 Combined immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82 Immunodeficiency associated with other major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.0 Wiskott-Aldrich syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.1 Di George syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.2 Immunodeficiency with short-limbed stature

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 268 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.4 Hyperimmunoglobulin E [IgE] syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.8 Immunodeficiency associated with other specified major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.9 Immunodeficiency associated with major defect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83 Common variable immunodeficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.8 Other common variable immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.9 Common variable immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84 Other immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.0 Lymphocyte function antigen-1 [LFA-1] defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.1 Defects in the complement system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.8 Other specified immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.9 Immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86 Sarcoidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.0 Sarcoidosis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.1 Sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.3 Sarcoidosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.8 Sarcoidosis of other and combined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.9 Sarcoidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89 Other disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.0 Polyclonal hypergammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.1 Cryoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.2 Hypergammaglobulinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.3 Immune reconstitution syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.9 Disorder involving the immune mechanism, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 269 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00 Congenital iodine-deficiency syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.0 Congenital iodine-deficiency syndrome, neurological type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.1 Congenital iodine-deficiency syndrome, myxoedematous type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.2 Congenital iodine-deficiency syndrome, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.9 Congenital iodine-deficiency syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01 Iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.0 Iodine-deficiency-related diffuse (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.1 Iodine-deficiency-related multinodular (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.2 Iodine-deficiency-related (endemic) goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E02 Subclinical iodine-deficiency hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03 Other hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.0 Congenital hypothyroidism with diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.1 Congenital hypothyroidism without goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.2 Hypothyroidism due to medicaments and other exogenous substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.3 Postinfectious hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.4 Atrophy of thyroid (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.5 Myxoedema coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.8 Other specified hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.9 Hypothyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04 Other nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.0 Nontoxic diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.1 Nontoxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.2 Nontoxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.8 Other specified nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.9 Nontoxic goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05 Thyrotoxicosis [hyperthyroidism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.0 Thyrotoxicosis with diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.1 Thyrotoxicosis with toxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.2 Thyrotoxicosis with toxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.3 Thyrotoxicosis from ectopic thyroid tissue

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 270 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.4 Thyrotoxicosis factitia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.5 Thyroid crisis or storm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.8 Other thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.9 Thyrotoxicosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06 Thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.0 Acute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.1 Subacute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.2 Chronic thyroiditis with transient thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.3 Autoimmune thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.4 Drug-induced thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.5 Other chronic thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.9 Thyroiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07 Other disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.0 Hypersecretion of calcitonin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.1 Dyshormogenetic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.8 Other specified disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.9 Disorder of thyroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10 Type 1 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.0 Type 1 diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.1 Type 1 diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.2 Type 1 diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.3 Type 1 diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.4 Type 1 diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.5 Type 1 diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.6 Type 1 diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.7 Type 1 diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.8 Type 1 diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10.9 Type 1 diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11 Type 2 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.0 Type 2 diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.1 Type 2 diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.2 Type 2 diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.3 Type 2 diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.4 Type 2 diabetes mellitus; With neurological complications

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 271 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.5 Type 2 diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.6 Type 2 diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.7 Type 2 diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.8 Type 2 diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11.9 Type 2 diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12 Malnutrition-related diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.0 Malnutrition-related diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.1 Malnutrition-related diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.2 Malnutrition-related diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.3 Malnutrition-related diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.4 Malnutrition-related diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.5 Malnutrition-related diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.6 Malnutrition-related diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.7 Malnutrition-related diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.8 Malnutrition-related diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12.9 Malnutrition-related diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13 Other specified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.0 Other specified diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.1 Other specified diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.2 Other specified diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.3 Other specified diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.4 Other specified diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.5 Other specified diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.6 Other specified diabetes mellitus; With other specified complications

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 272 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.7 Other specified diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.8 Other specified diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13.9 Other specified diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14 Unspecified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.0 Unspecified diabetes mellitus; With coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.1 Unspecified diabetes mellitus; With ketoacidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.2 Unspecified diabetes mellitus; With renal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.3 Unspecified diabetes mellitus; With ophthalmic complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.4 Unspecified diabetes mellitus; With neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.5 Unspecified diabetes mellitus; With peripheral circulatory complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.6 Unspecified diabetes mellitus; With other specified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.7 Unspecified diabetes mellitus; With multiple complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.8 Unspecified diabetes mellitus; With unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14.9 Unspecified diabetes mellitus; Without complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E15 Nondiabetic hypoglycaemic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16 Other disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.0 Drug-induced hypoglycaemia without coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.1 Other hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.2 Hypoglycaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.3 Increased secretion of glucagon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.4 Abnormal secretion of gastrin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.8 Other specified disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.9 Disorder of pancreatic internal secretion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20 Hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.0 Idiopathic hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.1 Pseudohypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.8 Other hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.9 Hypoparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21 Hyperparathyroidism and other disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.0 Primary hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.1 Secondary hyperparathyroidism, not elsewhere classified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 273 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.2 Other hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.3 Hyperparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.4 Other specified disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.5 Disorder of parathyroid gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22 Hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.0 Acromegaly and pituitary gigantism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.1 Hyperprolactinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.2 Syndrome of inappropriate secretion of antidiuretic hormone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.8 Other hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.9 Hyperfunction of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23 Hypofunction and other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.0 Hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.1 Drug-induced hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.2 Diabetes insipidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.3 Hypothalamic dysfunction, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.6 Other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.7 Disorder of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24 Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.0 Pituitary-dependent Cushing disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.1 Nelson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.2 Drug-induced Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.3 Ectopic ACTH syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.4 Alcohol-induced pseudo-Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.8 Other Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.9 Cushing syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25 Adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.0 Congenital adrenogenital disorders associated with enzyme deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.8 Other adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.9 Adrenogenital disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26 Hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.0 Primary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.1 Secondary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.8 Other hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.9 Hyperaldosteronism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27 Other disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.0 Other adrenocortical overactivity © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 274 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.1 Primary adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.2 Addisonian crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.3 Drug-induced adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.4 Other and unspecified adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.5 Adrenomedullary hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.8 Other specified disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.9 Disorder of adrenal gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28 Ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.0 Ovarian dysfunction: Estrogen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.1 Ovarian dysfunction: Androgen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.2 Polycystic ovarian syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.3 Primary ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.8 Other ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.9 Ovarian dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29 Testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.0 Testicular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.1 Testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.8 Other testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.9 Testicular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30 Disorders of puberty, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.0 Delayed puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.1 Precocious puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.8 Other disorders of puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.9 Disorder of puberty, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31 Polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.0 Autoimmune polyglandular failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.1 Polyglandular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.8 Other polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.9 Polyglandular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32 Diseases of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.0 Persistent hyperplasia of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.1 Abscess of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.8 Other diseases of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.9 Disease of thymus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34 Other endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.0 Carcinoid syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.1 Other hypersecretion of intestinal hormones

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 275 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.2 Ectopic hormone secretion, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.3 Short stature, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.4 Constitutional tall stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.5 Androgen resistance syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.8 Other specified endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.9 Endocrine disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35 Disorders of endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.0 Disorders of thyroid gland in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.1 Disorders of adrenal glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.8 Disorders of other endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E40 Kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E41 Nutritional marasmus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E42 Marasmic kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E43 Unspecified severe protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44 Protein-energy malnutrition of moderate and mild degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.0 Moderate protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.1 Mild protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E45 Retarded development following protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E46 Unspecified protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50 Vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.0 Vitamin A deficiency with conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.1 Vitamin A deficiency with Bitot spot and conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.2 Vitamin A deficiency with corneal xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.3 Vitamin A deficiency with corneal ulceration and xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.4 Vitamin A deficiency with keratomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.5 Vitamin A deficiency with night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.6 Vitamin A deficiency with xerophthalmic scars of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.7 Other ocular manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.8 Other manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.9 Vitamin A deficiency, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 276 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51 Thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.1 Beriberi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.2 Wernicke encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.8 Other manifestations of thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.9 Thiamine deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E52 Niacin deficiency [pellagra] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53 Deficiency of other B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.0 Riboflavin deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.1 Pyridoxine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.8 Deficiency of other specified B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.9 Vitamin B deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E54 Ascorbic acid deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55 Vitamin D deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.0 Rickets, active 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.9 Vitamin D deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56 Other vitamin deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.0 Deficiency of vitamin E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.1 Deficiency of vitamin K 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.8 Deficiency of other vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.9 Vitamin deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E58 Dietary calcium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E59 Dietary selenium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E60 Dietary zinc deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61 Deficiency of other nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.0 Copper deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.1 Iron deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.2 Magnesium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.3 Manganese deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.4 Chromium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.5 Molybdenum deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.6 Vanadium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.7 Deficiency of multiple nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.8 Deficiency of other specified nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.9 Deficiency of nutrient element, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63 Other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.0 Essential fatty acid [EFA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.1 Imbalance of constituents of food intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.8 Other specified nutritional deficiencies © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 277 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.9 Nutritional deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64 Sequelae of malnutrition and other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.0 Sequelae of protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.1 Sequelae of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.2 Sequelae of vitamin C deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.3 Sequelae of rickets 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.8 Sequelae of other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.9 Sequelae of unspecified nutritional deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E65 Localized adiposity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66 Obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.0 Obesity due to excess calories 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.1 Drug-induced obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.2 Extreme obesity with alveolar hypoventilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.8 Other obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.9 Obesity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67 Other hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.0 Hypervitaminosis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.1 Hypercarotenaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.2 Megavitamin-B6syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.3 Hypervitaminosis D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.8 Other specified hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E68 Sequelae of hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70 Disorders of aromatic amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.0 Classical phenylketonuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.1 Other hyperphenylalaninaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.2 Disorders of tyrosine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.3 Albinism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.8 Other disorders of aromatic amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.9 Disorder of aromatic amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71 Disorders of branched-chain amino- acid metabolism and fatty-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.0 Maple-syrup-urine disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.1 Other disorders of branched-chain amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.2 Disorder of branched-chain amino- acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.3 Disorders of fatty-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72 Other disorders of amino-acid metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 278 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.0 Disorders of amino-acid transport 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.1 Disorders of sulfur-bearing amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.2 Disorders of urea cycle metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.3 Disorders of lysine and hydroxylysine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.4 Disorders of ornithine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.5 Disorders of glycine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.8 Other specified disorders of amino- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.9 Disorder of amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73 Lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.0 Congenital lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.1 Secondary lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.8 Other lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.9 Lactose intolerance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74 Other disorders of carbohydrate metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.0 Glycogen storage disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.1 Disorders of fructose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.2 Disorders of galactose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.3 Other disorders of intestinal carbohydrate absorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.4 Disorders of pyruvate metabolism and gluconeogenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.8 Other specified disorders of carbohydrate metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.9 Disorder of carbohydrate metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75 Disorders of sphingolipid metabolism and other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.0 GM2gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.1 Other gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.2 Other sphingolipidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.3 Sphingolipidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.4 Neuronal ceroid lipofuscinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.5 Other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.6 Lipid storage disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76 Disorders of glycosaminoglycan metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.0 Mucopolysaccharidosis, type I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.1 Mucopolysaccharidosis, type II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.2 Other mucopolysaccharidoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.3 Mucopolysaccharidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.8 Other disorders of glucosaminoglycan metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 279 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.9 Disorder of glucosaminoglycan metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77 Disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.0 Defects in post-translational modification of lysosomal enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.1 Defects in glycoprotein degradation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.8 Other disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.9 Disorder of glycoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78 Disorders of lipoprotein metabolism and other lipidaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.0 Pure hypercholesterolaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.1 Pure hyperglyceridaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.2 Mixed hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.3 Hyperchylomicronaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.4 Other hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.5 Hyperlipidaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.6 Lipoprotein deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.8 Other disorders of lipoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.9 Disorder of lipoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79 Disorders of purine and pyrimidine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.1 Lesch-Nyhan syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.8 Other disorders of purine and pyrimidine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.9 Disorder of purine and pyrimidine metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80 Disorders of porphyrin and bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.0 Hereditary erythropoietic porphyria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.1 Porphyria cutanea tarda 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.2 Other porphyria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.3 Defects of catalase and peroxidase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.4 Gilbert syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.5 Crigler-Najjar syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.6 Other disorders of bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.7 Disorder of bilirubin metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83 Disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.0 Disorders of copper metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.1 Disorders of iron metabolism © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 280 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.2 Disorders of zinc metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.3 Disorders of phosphorus metabolism and phosphatases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.4 Disorders of magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.5 Disorders of calcium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.8 Other disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.9 Disorder of mineral metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84 Cystic fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.0 Cystic fibrosis with pulmonary manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.1 Cystic fibrosis with intestinal manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.8 Cystic fibrosis with other manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.9 Cystic fibrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85 Amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.0 Non-neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.1 Neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.2 Heredofamilial amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.3 Secondary systemic amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.4 Organ-limited amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.8 Other amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.9 Amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E86 Volume depletion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87 Other disorders of fluid, electrolyte and acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.0 Hyperosmolality and hypernatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.1 Hypo-osmolality and hyponatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.2 Acidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.3 Alkalosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.4 Mixed disorder of acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.5 Hyperkalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.6 Hypokalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.7 Fluid overload 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88 Other metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.0 Disorders of plasma-protein metabolism, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 281 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.1 Lipodystrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.2 Lipomatosis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.3 Tumour lysis syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.8 Other specified metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.9 Metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.0 Postprocedural hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.1 Postprocedural hypoinsulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.2 Postprocedural hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.3 Postprocedural hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.4 Postprocedural ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.5 Postprocedural testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.6 Postprocedural adrenocortical(- medullary) hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.8 Other postprocedural endocrine and metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.9 Postprocedural endocrine and metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E90 Nutritional and metabolic disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00 Dementia in Alzheimer diseaseG30.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.0 Dementia in Alzheimer disease with early onsetG30.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.1 Dementia in Alzheimer disease with late onsetG30.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.2 Dementia in Alzheimer disease, atypical or mixed typeG30.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.9 Dementia in Alzheimer disease, unspecifiedG30.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01 Vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.0 Vascular dementia of acute onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.1 Multi-infarct dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.2 Subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.3 Mixed cortical and subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.8 Other vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.9 Vascular dementia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02 Dementia in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.0 Dementia in Pick diseaseG31.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.1 Dementia in Creutzfeldt-Jakob diseaseA81.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.2 Dementia in Huntington diseaseG10

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 282 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.3 Dementia in Parkinson diseaseG20 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.4 Dementia in human immunodeficiency virus [HIV] diseaseB22.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.8 Dementia in other specified diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F03 Unspecified dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05 Delirium, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.0 Delirium not superimposed on dementia, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.1 Delirium superimposed on dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.8 Other delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.9 Delirium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06 Other mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.0 Organic hallucinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.1 Organic catatonic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.2 Organic delusional [schizophrenia- like] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.3 Organic mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.4 Organic anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.5 Organic dissociative disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.6 Organic emotionally labile [asthenic] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.7 Mild cognitive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07 Personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.0 Organic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.1 Postencephalitic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.2 Postconcussional syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F09 Unspecified organic or symptomatic mental disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 283 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10 Mental and behavioural disorders due to use of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.0 Mental and behavioural disorders due to use of alcohol; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.1 Mental and behavioural disorders due to use of alcohol; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.2 Mental and behavioural disorders due to use of alcohol; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.3 Mental and behavioural disorders due to use of alcohol; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.4 Mental and behavioural disorders due to use of alcohol; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.5 Mental and behavioural disorders due to use of alcohol; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.6 Mental and behavioural disorders due to use of alcohol; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.7 Mental and behavioural disorders due to use of alcohol; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.8 Mental and behavioural disorders due to use of alcohol; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10.9 Mental and behavioural disorders due to use of alcohol; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11 Mental and behavioural disorders due to use of opioids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.0 Mental and behavioural disorders due to use of opioids; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.1 Mental and behavioural disorders due to use of opioids; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.2 Mental and behavioural disorders due to use of opioids; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.3 Mental and behavioural disorders due to use of opioids; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.4 Mental and behavioural disorders due to use of opioids; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.5 Mental and behavioural disorders due to use of opioids; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.6 Mental and behavioural disorders due to use of opioids; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.7 Mental and behavioural disorders due to use of opioids; Residual and late-onset psychotic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 284 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.8 Mental and behavioural disorders due to use of opioids; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11.9 Mental and behavioural disorders due to use of opioids; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12 Mental and behavioural disorders due to use of cannabinoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.0 Mental and behavioural disorders due to use of cannabinoids; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.1 Mental and behavioural disorders due to use of cannabinoids; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.2 Mental and behavioural disorders due to use of cannabinoids; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.3 Mental and behavioural disorders due to use of cannabinoids; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.4 Mental and behavioural disorders due to use of cannabinoids; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.5 Mental and behavioural disorders due to use of cannabinoids; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.6 Mental and behavioural disorders due to use of cannabinoids; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.7 Mental and behavioural disorders due to use of cannabinoids; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.8 Mental and behavioural disorders due to use of cannabinoids; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12.9 Mental and behavioural disorders due to use of cannabinoids; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13 Mental and behavioural disorders due to use of sedatives or hypnotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.0 Mental and behavioural disorders due to use of sedatives or hypnotics; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.1 Mental and behavioural disorders due to use of sedatives or hypnotics; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.2 Mental and behavioural disorders due to use of sedatives or hypnotics; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.3 Mental and behavioural disorders due to use of sedatives or hypnotics; Withdrawal state

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 285 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.4 Mental and behavioural disorders due to use of sedatives or hypnotics; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.5 Mental and behavioural disorders due to use of sedatives or hypnotics; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.6 Mental and behavioural disorders due to use of sedatives or hypnotics; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.7 Mental and behavioural disorders due to use of sedatives or hypnotics; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.8 Mental and behavioural disorders due to use of sedatives or hypnotics; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13.9 Mental and behavioural disorders due to use of sedatives or hypnotics; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14 Mental and behavioural disorders due to use of cocaine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.0 Mental and behavioural disorders due to use of cocaine; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.1 Mental and behavioural disorders due to use of cocaine; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.2 Mental and behavioural disorders due to use of cocaine; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.3 Mental and behavioural disorders due to use of cocaine; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.4 Mental and behavioural disorders due to use of cocaine; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.5 Mental and behavioural disorders due to use of cocaine; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.6 Mental and behavioural disorders due to use of cocaine; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.7 Mental and behavioural disorders due to use of cocaine; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.8 Mental and behavioural disorders due to use of cocaine; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14.9 Mental and behavioural disorders due to use of cocaine; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15 Mental and behavioural disorders due to use of other stimulants, including caffeine

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 286 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.0 Mental and behavioural disorders due to use of other stimulants, including caffeine; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.1 Mental and behavioural disorders due to use of other stimulants, including caffeine; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.2 Mental and behavioural disorders due to use of other stimulants, including caffeine; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.3 Mental and behavioural disorders due to use of other stimulants, including caffeine; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.4 Mental and behavioural disorders due to use of other stimulants, including caffeine; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.5 Mental and behavioural disorders due to use of other stimulants, including caffeine; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.6 Mental and behavioural disorders due to use of other stimulants, including caffeine; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.7 Mental and behavioural disorders due to use of other stimulants, including caffeine; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.8 Mental and behavioural disorders due to use of other stimulants, including caffeine; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15.9 Mental and behavioural disorders due to use of other stimulants, including caffeine; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16 Mental and behavioural disorders due to use of hallucinogens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.0 Mental and behavioural disorders due to use of hallucinogens; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.1 Mental and behavioural disorders due to use of hallucinogens; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.2 Mental and behavioural disorders due to use of hallucinogens; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.3 Mental and behavioural disorders due to use of hallucinogens; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.4 Mental and behavioural disorders due to use of hallucinogens; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.5 Mental and behavioural disorders due to use of hallucinogens; Psychotic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 287 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.6 Mental and behavioural disorders due to use of hallucinogens; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.7 Mental and behavioural disorders due to use of hallucinogens; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.8 Mental and behavioural disorders due to use of hallucinogens; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16.9 Mental and behavioural disorders due to use of hallucinogens; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17 Mental and behavioural disorders due to use of tobacco 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.0 Mental and behavioural disorders due to use of tobacco; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.1 Mental and behavioural disorders due to use of tobacco; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.2 Mental and behavioural disorders due to use of tobacco; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.3 Mental and behavioural disorders due to use of tobacco; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.4 Mental and behavioural disorders due to use of tobacco; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.5 Mental and behavioural disorders due to use of tobacco; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.6 Mental and behavioural disorders due to use of tobacco; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.7 Mental and behavioural disorders due to use of tobacco; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.8 Mental and behavioural disorders due to use of tobacco; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17.9 Mental and behavioural disorders due to use of tobacco; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18 Mental and behavioural disorders due to use of volatile solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.0 Mental and behavioural disorders due to use of volatile solvents; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.1 Mental and behavioural disorders due to use of volatile solvents; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.2 Mental and behavioural disorders due to use of volatile solvents; Dependence syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 288 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.3 Mental and behavioural disorders due to use of volatile solvents; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.4 Mental and behavioural disorders due to use of volatile solvents; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.5 Mental and behavioural disorders due to use of volatile solvents; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.6 Mental and behavioural disorders due to use of volatile solvents; Amnesic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.7 Mental and behavioural disorders due to use of volatile solvents; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.8 Mental and behavioural disorders due to use of volatile solvents; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18.9 Mental and behavioural disorders due to use of volatile solvents; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.0 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Acute intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.1 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Harmful use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.2 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Dependence syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.3 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Withdrawal state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.4 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Withdrawal state with delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.5 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.6 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Amnesic syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 289 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.7 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Residual and late-onset psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.8 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19.9 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; Unspecified mental and behavioural disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20 Schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.0 Paranoid schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.1 Hebephrenic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.2 Catatonic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.3 Undifferentiated schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.4 Post-schizophrenic depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.5 Residual schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.6 Simple schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.8 Other schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.9 Schizophrenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F21 Schizotypal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22 Persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.0 Delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.8 Other persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.9 Persistent delusional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23 Acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.2 Acute schizophrenia-like psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.3 Other acute predominantly delusional psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.8 Other acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.9 Acute and transient psychotic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F24 Induced delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25 Schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.0 Schizoaffective disorder, manic type

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 290 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.1 Schizoaffective disorder, depressive type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.2 Schizoaffective disorder, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.8 Other schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.9 Schizoaffective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F28 Other nonorganic psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F29 Unspecified nonorganic psychosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30 Manic episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.0 Hypomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.1 Mania without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.2 Mania with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.8 Other manic episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.9 Manic episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31 Bipolar affective disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.0 Bipolar affective disorder, current episode hypomanic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.3 Bipolar affective disorder, current episode mild or moderate depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.6 Bipolar affective disorder, current episode mixed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.7 Bipolar affective disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.8 Other bipolar affective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.9 Bipolar affective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32 Depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.0 Mild depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.1 Moderate depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.2 Severe depressive episode without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.3 Severe depressive episode with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.8 Other depressive episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.9 Depressive episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33 Recurrent depressive disorder © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 291 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.0 Recurrent depressive disorder, current episode mild 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.1 Recurrent depressive disorder, current episode moderate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.4 Recurrent depressive disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.8 Other recurrent depressive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.9 Recurrent depressive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34 Persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.0 Cyclothymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.1 Dysthymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.8 Other persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.9 Persistent mood [affective] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38 Other mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.0 Other single mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.1 Other recurrent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.8 Other specified mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F39 Unspecified mood [affective] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40 Phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.0 Agoraphobia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.1 Social phobias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.2 Specific (isolated) phobias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.8 Other phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.9 Phobic anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41 Other anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.0 Panic disorder [episodic paroxysmal anxiety] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.1 Generalized anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.2 Mixed anxiety and depressive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.3 Other mixed anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.8 Other specified anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.9 Anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42 Obsessive-compulsive disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 292 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.0 Predominantly obsessional thoughts or ruminations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.1 Predominantly compulsive acts [obsessional rituals] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.2 Mixed obsessional thoughts and acts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.8 Other obsessive-compulsive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.9 Obsessive-compulsive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43 Reaction to severe stress, and adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.0 Acute stress reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.1 Post-traumatic stress disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.2 Adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.8 Other reactions to severe stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.9 Reaction to severe stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44 Dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.0 Dissociative amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.1 Dissociative fugue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.2 Dissociative stupor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.3 Trance and possession disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.4 Dissociative motor disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.5 Dissociative convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.6 Dissociative anaesthesia and sensory loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.7 Mixed dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.8 Other dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.9 Dissociative [conversion] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45 Somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.0 Somatization disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.1 Undifferentiated somatoform disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.2 Hypochondriacal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.3 Somatoform autonomic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.4 Persistent somatoform pain disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.8 Other somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.9 Somatoform disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48 Other neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.0 Neurasthenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.1 Depersonalization-derealization syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.8 Other specified neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.9 Neurotic disorder, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 293 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50 Eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.0 Anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.1 Atypical anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.2 Bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.3 Atypical bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.4 Overeating associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.5 Vomiting associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.8 Other eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.9 Eating disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51 Nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.0 Nonorganic insomnia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.1 Nonorganic hypersomnia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.2 Nonorganic disorder of the sleep- wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.3 Sleepwalking [somnambulism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.4 Sleep terrors [night terrors] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.5 Nightmares 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.8 Other nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.9 Nonorganic sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52 Sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.0 Lack or loss of sexual desire 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.1 Sexual aversion and lack of sexual enjoyment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.2 Failure of genital response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.3 Orgasmic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.4 Premature ejaculation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.5 Nonorganic vaginismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.6 Nonorganic dyspareunia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.7 Excessive sexual drive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.8 Other sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 294 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.9 Puerperal mental disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F55 Abuse of non-dependence- producing substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60 Specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.0 Paranoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.1 Schizoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.2 Dissocial personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.3 Emotionally unstable personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.4 Histrionic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.5 Anankastic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.6 Anxious [avoidant] personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.7 Dependent personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.8 Other specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.9 Personality disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F61 Mixed and other personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62 Enduring personality changes, not attributable to brain damage and disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.0 Enduring personality change after catastrophic experience 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.1 Enduring personality change after psychiatric illness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.8 Other enduring personality changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.9 Enduring personality change, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63 Habit and impulse disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.0 Pathological gambling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.1 Pathological fire-setting [pyromania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.2 Pathological stealing [kleptomania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.3 Trichotillomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.8 Other habit and impulse disorders

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 295 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.9 Habit and impulse disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64 Gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.0 Transsexualism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.1 Dual-role transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.2 Gender identity disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.8 Other gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.9 Gender identity disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65 Disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.0 Fetishism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.1 Fetishistic transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.2 Exhibitionism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.3 Voyeurism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.4 Paedophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.5 Sadomasochism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.6 Multiple disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.8 Other disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.9 Disorder of sexual preference, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66 Psychological and behavioural disorders associated with sexual development and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.0 Sexual maturation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.1 Egodystonic sexual orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.2 Sexual relationship disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.8 Other psychosexual development disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.9 Psychosexual development disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68 Other disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.0 Elaboration of physical symptoms for psychological reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.8 Other specified disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F69 Unspecified disorder of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70 Mild mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.0 Mild mental retardation; With the statement of no, or minimal, impairment of behaviour

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 296 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.1 Mild mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.8 Mild mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70.9 Mild mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71 Moderate mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.0 Moderate mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.1 Moderate mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.8 Moderate mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71.9 Moderate mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72 Severe mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.0 Severe mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.1 Severe mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.8 Severe mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72.9 Severe mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73 Profound mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.0 Profound mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.1 Profound mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.8 Profound mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73.9 Profound mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78 Other mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.0 Other mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.1 Other mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.8 Other mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78.9 Other mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79 Unspecified mental retardation © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 297 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.0 Unspecified mental retardation; With the statement of no, or minimal, impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.1 Unspecified mental retardation; Significant impairment of behaviour requiring attention or treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.8 Unspecified mental retardation; Other impairments of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79.9 Unspecified mental retardation; Without mention of impairment of behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80 Specific developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.0 Specific speech articulation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.1 Expressive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.2 Receptive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.3 Acquired aphasia with epilepsy [Landau-Kleffner] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.8 Other developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.9 Developmental disorder of speech and language, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81 Specific developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.0 Specific reading disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.1 Specific spelling disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.2 Specific disorder of arithmetical skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.3 Mixed disorder of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.8 Other developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.9 Developmental disorder of scholastic skills, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F82 Specific developmental disorder of motor function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F83 Mixed specific developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84 Pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.0 Childhood autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.1 Atypical autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.2 Rett syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.3 Other childhood disintegrative disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.4 Overactive disorder associated with mental retardation and stereotyped movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.5 Asperger syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.8 Other pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.9 Pervasive developmental disorder, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 298 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F88 Other disorders of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F89 Unspecified disorder of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90 Hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.0 Disturbance of activity and attention 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.1 Hyperkinetic conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.8 Other hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.9 Hyperkinetic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91 Conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.0 Conduct disorder confined to the family context 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.1 Unsocialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.2 Socialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.3 Oppositional defiant disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.8 Other conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.9 Conduct disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92 Mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.0 Depressive conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.8 Other mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.9 Mixed disorder of conduct and emotions, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93 Emotional disorders with onset specific to childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.0 Separation anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.1 Phobic anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.2 Social anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.3 Sibling rivalry disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.8 Other childhood emotional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.9 Childhood emotional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94 Disorders of social functioning with onset specific to childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.0 Elective mutism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.1 Reactive attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.2 Disinhibited attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.8 Other childhood disorders of social functioning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.9 Childhood disorder of social functioning, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95 Tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.0 Transient tic disorder

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 299 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.1 Chronic motor or vocal tic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.2 Combined vocal and multiple motor tic disorder [de la Tourette] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.8 Other tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.9 Tic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.0 Nonorganic enuresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.1 Nonorganic encopresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.2 Feeding disorder of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.3 Pica of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.4 Stereotyped movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.5 Stuttering [stammering] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.6 Cluttering 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F99 Mental disorder, not otherwise specified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00 Bacterial meningitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.0 Haemophilus meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.1 Pneumococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.2 Streptococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.3 Staphylococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.8 Other bacterial meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.9 Bacterial meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G01 Meningitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02 Meningitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.0 Meningitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.1 Meningitis in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03 Meningitis due to other and unspecified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.0 Nonpyogenic meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.1 Chronic meningitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 300 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.2 Benign recurrent meningitis [Mollaret] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.8 Meningitis due to other specified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.9 Meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04 Encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.0 Acute disseminated encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.1 Tropical spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.8 Other encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06 Intracranial and intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.0 Intracranial abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.1 Intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.2 Extradural and subdural abscess, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G08 Intracranial and intraspinal phlebitis and thrombophlebitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G09 Sequelae of inflammatory diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G10 Huntington disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11 Hereditary ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.0 Congenital nonprogressive ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.1 Early-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.2 Late-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.3 Cerebellar ataxia with defective DNA repair

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 301 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.4 Hereditary spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.8 Other hereditary ataxias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.9 Hereditary ataxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12 Spinal muscular atrophy and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.1 Other inherited spinal muscular atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.2 Motor neuron disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.8 Other spinal muscular atrophies and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.9 Spinal muscular atrophy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.0 Paraneoplastic neuromyopathy and neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.2 Systemic atrophy primarily affecting central nervous system in myxoedemaE00.1E03.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G14 Postpolio syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G20 Parkinson disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21 Secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.0 Malignant neuroleptic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.1 Other drug-induced secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.2 Secondary parkinsonism due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.3 Postencephalitic parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.4 Vascular parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.8 Other secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.9 Secondary parkinsonism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G22 Parkinsonism in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23 Other degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.0 Hallervorden-Spatz disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.1 Progressive supranuclear ophthalmoplegia [Steele- Richardson-Olszewski] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.2 Multiple system atrophy, parkinsonian type [MSA-P] © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 302 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.3 Multiple system atrophy, cerebellar type [MSA-C] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.8 Other specified degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.9 Degenerative disease of basal ganglia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24 Dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.0 Drug-induced dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.1 Idiopathic familial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.2 Idiopathic nonfamilial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.3 Spasmodic torticollis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.4 Idiopathic orofacial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.5 Blepharospasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.8 Other dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.9 Dystonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25 Other extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.0 Essential tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.1 Drug-induced tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.2 Other specified forms of tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.3 Myoclonus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.4 Drug-induced chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.5 Other chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.6 Drug-induced tics and other tics of organic origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.8 Other specified extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.9 Extrapyramidal and movement disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G26 Extrapyramidal and movement disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30 Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.0 Alzheimer disease with early onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.1 Alzheimer disease with late onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.8 Other Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.9 Alzheimer disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31 Other degenerative diseases of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.0 Circumscribed brain atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.1 Senile degeneration of brain, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.2 Degeneration of nervous system due to alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.8 Other specified degenerative diseases of nervous system

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 303 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.9 Degenerative disease of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32 Other degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G35 Multiple sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36 Other acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.0 Neuromyelitis optica [Devic] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.8 Other specified acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.9 Acute disseminated demyelination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37 Other demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.0 Diffuse sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.1 Central demyelination of corpus callosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.2 Central pontine myelinolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.3 Acute transverse myelitis in demyelinating disease of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.4 Subacute necrotizing myelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.5 Concentric sclerosis [Baló] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.8 Other specified demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.9 Demyelinating disease of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40 Epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.0 Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.1 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.2 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.3 Generalized idiopathic epilepsy and epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.4 Other generalized epilepsy and epileptic syndromes

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 304 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.5 Special epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.6 Grand mal seizures, unspecified (with or without petit mal) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.7 Petit mal, unspecified, without grand mal seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.8 Other epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.9 Epilepsy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41 Status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.0 Grand mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.1 Petit mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.2 Complex partial status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.8 Other status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.9 Status epilepticus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43 Migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.0 Migraine without aura [common migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.1 Migraine with aura [classical migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.2 Status migrainosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.3 Complicated migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.8 Other migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.9 Migraine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44 Other headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.0 Cluster headache syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.1 Vascular headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.2 Tension-type headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.3 Chronic post-traumatic headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.4 Drug-induced headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.8 Other specified headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45 Transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.0 Vertebro-basilar artery syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.1 Carotid artery syndrome (hemispheric) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.2 Multiple and bilateral precerebral artery syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.3 Amaurosis fugax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.4 Transient global amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.8 Other transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.9 Transient cerebral ischaemic attack, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46 Vascular syndromes of brain in cerebrovascular diseasesI60-I67

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 305 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.0 Middle cerebral artery syndromeI66.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.1 Anterior cerebral artery syndromeI66.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.2 Posterior cerebral artery syndromeI66.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.3 Brain stem stroke syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.4 Cerebellar stroke syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.5 Pure motor lacunar syndromeI60- I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.6 Pure sensory lacunar syndromeI60- I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.7 Other lacunar syndromesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.8 Other vascular syndromes of brain in cerebrovascular diseasesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47 Sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.0 Disorders of initiating and maintaining sleep [insomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.1 Disorders of excessive somnolence [hypersomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.2 Disorders of the sleep-wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.3 Sleep apnoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.4 Narcolepsy and cataplexy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.8 Other sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.9 Sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50 Disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.0 Trigeminal neuralgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.1 Atypical facial pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.8 Other disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.9 Disorder of trigeminal nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51 Facial nerve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.0 Bell palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.1 Geniculate ganglionitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.2 Melkersson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.3 Clonic hemifacial spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.4 Facial myokymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.8 Other disorders of facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.9 Disorder of facial nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52 Disorders of other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.0 Disorders of olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.1 Disorders of glossopharyngeal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.2 Disorders of vagus nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.3 Disorders of hypoglossal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.7 Disorders of multiple cranial nerves © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 306 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.8 Disorders of other specified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.9 Cranial nerve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53 Cranial nerve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.0 Postzoster neuralgiaB02.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.1 Multiple cranial nerve palsies in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.2 Multiple cranial nerve palsies in sarcoidosisD86.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.3 Multiple cranial nerve palsies in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.8 Other cranial nerve disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54 Nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.0 Brachial plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.1 Lumbosacral plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.2 Cervical root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.3 Thoracic root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.4 Lumbosacral root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.5 Neuralgic amyotrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.6 Phantom limb syndrome with pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.7 Phantom limb syndrome without pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.8 Other nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.9 Nerve root and plexus disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55 Nerve root and plexus compressions in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.0 Nerve root and plexus compressions in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.1 Nerve root and plexus compressions in intervertebral disc disordersM50-M51 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.2 Nerve root and plexus compressions in spondylosisM47.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.3 Nerve root and plexus compressions in other dorsopathiesM45-M46M48.-M53- M54 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.8 Nerve root and plexus compressions in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56 Mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.0 Carpal tunnel syndrome

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 307 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.1 Other lesions of median nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.2 Lesion of ulnar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.3 Lesion of radial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.4 Causalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.8 Other mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.9 Mononeuropathy of upper limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57 Mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.0 Lesion of sciatic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.1 Meralgia paraesthetica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.2 Lesion of femoral nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.3 Lesion of lateral popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.4 Lesion of medial popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.5 Tarsal tunnel syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.6 Lesion of plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.8 Other mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.9 Mononeuropathy of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58 Other mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.0 Intercostal neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.7 Mononeuritis multiplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.8 Other specified mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.9 Mononeuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59 Mononeuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.0 Diabetic mononeuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.8 Other mononeuropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60 Hereditary and idiopathic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.0 Hereditary motor and sensory neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.1 Refsum disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.2 Neuropathy in association with hereditary ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.3 Idiopathic progressive neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.8 Other hereditary and idiopathic neuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.9 Hereditary and idiopathic neuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61 Inflammatory polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.0 Guillain-Barré syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.1 Serum neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.8 Other inflammatory polyneuropathies © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 308 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.9 Inflammatory polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62 Other polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.0 Drug-induced polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.1 Alcoholic polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.2 Polyneuropathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.8 Other specified polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.9 Polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63 Polyneuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.1 Polyneuropathy in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.2 Diabetic polyneuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.3 Polyneuropathy in other endocrine and metabolic diseasesE00- E07E15-E16E20-E34E70-E89 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.4 Polyneuropathy in nutritional deficiencyE40-E64 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.5 Polyneuropathy in systemic connective tissue disordersM30- M35 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.6 Polyneuropathy in other musculoskeletal disordersM00- M25M40-M96 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.8 Polyneuropathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G64 Other disorders of peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70 Myasthenia gravis and other myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.0 Myasthenia gravis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.1 Toxic myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.2 Congenital and developmental myasthenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.8 Other specified myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.9 Myoneural disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71 Primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.0 Muscular dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.1 Myotonic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.2 Congenital myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.3 Mitochondrial myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.8 Other primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.9 Primary disorder of muscle, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 309 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72 Other myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.0 Drug-induced myopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.1 Alcoholic myopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.2 Myopathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.3 Periodic paralysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.4 Inflammatory myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.8 Other specified myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.9 Myopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73 Disorders of myoneural junction and muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.0 Myasthenic syndromes in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.1 Lambert-Eaton syndromeC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.2 Other myasthenic syndromes in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.3 Myasthenic syndromes in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.4 Myopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.5 Myopathy in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.6 Myopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.7 Myopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80 Cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.0 Spastic quadriplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.1 Spastic diplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.2 Spastic hemiplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.3 Dyskinetic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.4 Ataxic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.8 Other cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.9 Cerebral palsy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81 Hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.0 Flaccid hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.1 Spastic hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.9 Hemiplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82 Paraplegia and tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.0 Flaccid paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.1 Spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.2 Paraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.3 Flaccid tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.4 Spastic tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.5 Tetraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83 Other paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.0 Diplegia of upper limbs © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 310 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.1 Monoplegia of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.2 Monoplegia of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.3 Monoplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.4 Cauda equina syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.5 Locked-in syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.8 Other specified paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.9 Paralytic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90 Disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.0 Idiopathic peripheral autonomic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.1 Familial dysautonomia [Riley-Day] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.2 Horner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.4 Autonomic dysreflexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.8 Other disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.9 Disorder of autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91 Hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.0 Communicating hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.1 Obstructive hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.2 Normal-pressure hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.3 Post-traumatic hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.8 Other hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.9 Hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G92 Toxic encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93 Other disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.0 Cerebral cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.1 Anoxic brain damage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.2 Benign intracranial hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.3 Postviral fatigue syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.4 Encephalopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.5 Compression of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.6 Cerebral oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.7 Reye syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.8 Other specified disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.9 Disorder of brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94 Other disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.1 Hydrocephalus in neoplastic diseaseC00-D48

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 311 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.2 Hydrocephalus in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.8 Other specified disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95 Other diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.0 Syringomyelia and syringobulbia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.1 Vascular myelopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.2 Cord compression, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.8 Other specified diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.9 Disease of spinal cord, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96 Other disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.0 Cerebrospinal fluid leak 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.1 Disorders of meninges, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.8 Other specified disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.9 Disorder of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97 Postprocedural disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.0 Cerebrospinal fluid leak from spinal puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.1 Other reaction to spinal and lumbar puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.2 Intracranial hypotension following ventricular shunting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.8 Other postprocedural disorders of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.9 Postprocedural disorder of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G98 Other disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99 Other disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.0 Autonomic neuropathy in endocrine and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.2 Myelopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.8 Other specified disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00 Hordeolum and chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.0 Hordeolum and other deep inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.1 Chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01 Other inflammation of eyelid © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 312 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.0 Blepharitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.1 Noninfectious dermatoses of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.8 Other specified inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.9 Inflammation of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02 Other disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.0 Entropion and trichiasis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.1 Ectropion of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.2 Lagophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.3 Blepharochalasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.4 Ptosis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.5 Other disorders affecting eyelid function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.6 Xanthelasma of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.7 Other degenerative disorders of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.8 Other specified disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.9 Disorder of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03 Disorders of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.0 Parasitic infestation of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.1 Involvement of eyelid in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.8 Involvement of eyelid in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04 Disorders of lacrimal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.0 Dacryoadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.1 Other disorders of lacrimal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.2 Epiphora 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.3 Acute and unspecified inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.4 Chronic inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.5 Stenosis and insufficiency of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.6 Other changes in lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.8 Other disorders of lacrimal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.9 Disorder of lacrimal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05 Disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.0 Acute inflammation of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.1 Chronic inflammatory disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.2 Exophthalmic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.3 Deformity of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.4 Enophthalmos © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 313 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.5 Retained (old) foreign body following penetrating wound of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.8 Other disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.9 Disorder of orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06 Disorders of lacrimal system and orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.0 Disorders of lacrimal system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.1 Parasitic infestation of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.2 Dysthyroid exophthalmosE05.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.3 Other disorders of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10 Conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.0 Mucopurulent conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.1 Acute atopic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.2 Other acute conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.3 Acute conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.4 Chronic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.5 Blepharoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.8 Other conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.9 Conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11 Other disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.0 Pterygium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.1 Conjunctival degenerations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.2 Conjunctival scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.3 Conjunctival haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.4 Other conjunctival vascular disorders and cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.8 Other specified disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.9 Disorder of conjunctiva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13 Disorders of conjunctiva in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.0 Filarial infection of conjunctivaB74.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.2 Conjunctivitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.3 Ocular pemphigoidL12.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.8 Other disorders of conjunctiva in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15 Disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.0 Scleritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.1 Episcleritis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 314 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.8 Other disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.9 Disorder of sclera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16 Keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.0 Corneal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.1 Other superficial keratitis without conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.2 Keratoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.3 Interstitial and deep keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.4 Corneal neovascularization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.8 Other keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.9 Keratitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17 Corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.0 Adherent leukoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.1 Other central corneal opacity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.8 Other corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.9 Corneal scar and opacity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18 Other disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.0 Corneal pigmentations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.1 Bullous keratopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.2 Other corneal oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.3 Changes in corneal membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.4 Corneal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.5 Hereditary corneal dystrophies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.6 Keratoconus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.7 Other corneal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.8 Other specified disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.9 Disorder of cornea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19 Disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.0 Scleritis and episcleritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.1 Herpesviral keratitis and keratoconjunctivitisB00.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.8 Other disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20 Iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.0 Acute and subacute iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.1 Chronic iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.2 Lens-induced iridocyclitis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 315 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.8 Other iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.9 Iridocyclitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21 Other disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.0 Hyphaema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.1 Other vascular disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.2 Degeneration of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.3 Cyst of iris, ciliary body and anterior chamber 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.4 Pupillary membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.5 Other adhesions and disruptions of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.8 Other specified disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.9 Disorder of iris and ciliary body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22 Disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.1 Iridocyclitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25 Senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.0 Senile incipient cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.1 Senile nuclear cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.2 Senile cataract, morgagnian type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.8 Other senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.9 Senile cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26 Other cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.0 Infantile, juvenile and presenile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.1 Traumatic cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.2 Complicated cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.3 Drug-induced cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.4 After-cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.8 Other specified cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.9 Cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27 Other disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.0 Aphakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.1 Dislocation of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.8 Other specified disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.9 Disorder of lens, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 316 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28 Cataract and other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.0 Diabetic cataractE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.1 Cataract in other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.2 Cataract in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.8 Other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30 Chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.0 Focal chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.1 Disseminated chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.2 Posterior cyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.8 Other chorioretinal inflammations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.9 Chorioretinal inflammation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31 Other disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.0 Chorioretinal scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.1 Choroidal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.2 Hereditary choroidal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.3 Choroidal haemorrhage and rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.4 Choroidal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.8 Other specified disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.9 Disorder of choroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32 Chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.8 Other chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33 Retinal detachments and breaks 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.0 Retinal detachment with retinal break 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.1 Retinoschisis and retinal cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.2 Serous retinal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.3 Retinal breaks without detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.4 Traction detachment of retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.5 Other retinal detachments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34 Retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.0 Transient retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.1 Central retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.2 Other retinal artery occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.8 Other retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.9 Retinal vascular occlusion, unspecified © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 317 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35 Other retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.0 Background retinopathy and retinal vascular changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.1 Retinopathy of prematurity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.2 Other proliferative retinopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.3 Degeneration of macula and posterior pole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.4 Peripheral retinal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.5 Hereditary retinal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.6 Retinal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.7 Separation of retinal layers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.8 Other specified retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.9 Retinal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36 Retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.0 Diabetic retinopathyE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.8 Other retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40 Glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.0 Glaucoma suspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.1 Primary open-angle glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.2 Primary angle-closure glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.3 Glaucoma secondary to eye trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.4 Glaucoma secondary to eye inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.5 Glaucoma secondary to other eye disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.6 Glaucoma secondary to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.8 Other glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.9 Glaucoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42 Glaucoma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.0 Glaucoma in endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.8 Glaucoma in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43 Disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.0 Vitreous prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.1 Vitreous haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.2 Crystalline deposits in vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.3 Other vitreous opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.8 Other disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.9 Disorder of vitreous body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44 Disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.0 Purulent endophthalmitis © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 318 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.1 Other endophthalmitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.2 Degenerative myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.3 Other degenerative disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.4 Hypotony of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.5 Degenerated conditions of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.6 Retained (old) intraocular foreign body, magnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.7 Retained (old) intraocular foreign body, nonmagnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.8 Other disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.9 Disorder of globe, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45 Disorders of vitreous body and globe in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.0 Vitreous haemorrhage in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.1 Endophthalmitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H46 Optic neuritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47 Other disorders of optic [2nd] nerve and visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.0 Disorders of optic nerve, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.1 Papilloedema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.2 Optic atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.3 Other disorders of optic disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.4 Disorders of optic chiasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.5 Disorders of other visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.6 Disorders of visual cortex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.7 Disorder of visual pathways, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.0 Optic atrophy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.1 Retrobulbar neuritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49 Paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.0 Third [oculomotor] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.1 Fourth [trochlear] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.2 Sixth [abducent] nerve palsy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 319 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.3 Total (external) ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.4 Progressive external ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.8 Other paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.9 Paralytic strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50 Other strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.0 Convergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.1 Divergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.2 Vertical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.3 Intermittent heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.4 Other and unspecified heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.5 Heterophoria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.6 Mechanical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.8 Other specified strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.9 Strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51 Other disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.0 Palsy of conjugate gaze 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.1 Convergence insufficiency and excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.2 Internuclear ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.8 Other specified disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.9 Disorder of binocular movement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52 Disorders of refraction and accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.0 Hypermetropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.1 Myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.2 Astigmatism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.3 Anisometropia and aniseikonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.4 Presbyopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.5 Disorders of accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.6 Other disorders of refraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.7 Disorder of refraction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53 Visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.0 Amblyopia ex anopsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.1 Subjective visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.2 Diplopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.3 Other disorders of binocular vision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.4 Visual field defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.5 Colour vision deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.6 Night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.8 Other visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.9 Visual disturbance, unspecified

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 320 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54 Visual impairment including blindness (binocular or monocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.0 Blindness, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.1 Severe visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.2 Moderate visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.3 Mild or no visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.4 Blindness, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.5 Severe visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.6 Moderate visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.9 Unspecified visual impairment (binocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H55 Nystagmus and other irregular eye movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57 Other disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.0 Anomalies of pupillary function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.1 Ocular pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.8 Other specified disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.9 Disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58 Other disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.0 Anomalies of pupillary function in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.1 Visual disturbances in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.8 Other specified disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59 Postprocedural disorders of eye and adnexa, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.0 Keratopathy (bullous aphakic) following cataract surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.8 Other postprocedural disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.9 Postprocedural disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60 Otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.0 Abscess of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.1 Cellulitis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.2 Malignant otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.3 Other infective otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.4 Cholesteatoma of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.5 Acute otitis externa, noninfective 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.8 Other otitis externa

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 321 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.9 Otitis externa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61 Other disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.0 Perichondritis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.1 Noninfective disorders of pinna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.2 Impacted cerumen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.3 Acquired stenosis of external ear canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.8 Other specified disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.9 Disorder of external ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62 Disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.0 Otitis externa in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.1 Otitis externa in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.2 Otitis externa in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.4 Otitis externa in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.8 Other disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65 Nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.0 Acute serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.1 Other acute nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.2 Chronic serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.3 Chronic mucoid otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.4 Other chronic nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.9 Nonsuppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66 Suppurative and unspecified otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.0 Acute suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.1 Chronic tubotympanic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.2 Chronic atticoantral suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.3 Other chronic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.4 Suppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.9 Otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67 Otitis media in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.0 Otitis media in bacterial diseases classified elsewhere © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 322 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.1 Otitis media in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.8 Otitis media in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68 Eustachian salpingitis and obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.0 Eustachian salpingitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.1 Obstruction of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69 Other disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.0 Patulous Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.8 Other specified disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.9 Eustachian tube disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70 Mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.0 Acute mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.1 Chronic mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.2 Petrositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.8 Other mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.9 Mastoiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H71 Cholesteatoma of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72 Perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.0 Central perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.1 Attic perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.2 Other marginal perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.8 Other perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.9 Perforation of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73 Other disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.0 Acute myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.1 Chronic myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.8 Other specified disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.9 Disorder of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74 Other disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.0 Tympanosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.1 Adhesive middle ear disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.2 Discontinuity and dislocation of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.3 Other acquired abnormalities of ear ossicles

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 323 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.4 Polyp of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.8 Other specified disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.9 Disorder of middle ear and mastoid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75 Other disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80 Otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.0 Otosclerosis involving oval window, nonobliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.1 Otosclerosis involving oval window, obliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.2 Cochlear otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.8 Other otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.9 Otosclerosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81 Disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.0 Ménière disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.1 Benign paroxysmal vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.2 Vestibular neuronitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.3 Other peripheral vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.4 Vertigo of central origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.8 Other disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.9 Disorder of vestibular function, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H82 Vertiginous syndromes in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83 Other diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.0 Labyrinthitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.1 Labyrinthine fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.2 Labyrinthine dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.3 Noise effects on inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.8 Other specified diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.9 Disease of inner ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90 Conductive and sensorineural hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.0 Conductive hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 324 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.2 Conductive hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.3 Sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.5 Sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.6 Mixed conductive and sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.8 Mixed conductive and sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91 Other hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.0 Ototoxic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.1 Presbycusis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.2 Sudden idiopathic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.3 Deaf mutism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.8 Other specified hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.9 Hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92 Otalgia and effusion of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.0 Otalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.1 Otorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.2 Otorrhagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93 Other disorders of ear, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.0 Degenerative and vascular disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.1 Tinnitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.2 Other abnormal auditory perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.3 Disorders of acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.8 Other specified disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.9 Disorder of ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94 Other disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.8 Other specified disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.0 Recurrent cholesteatoma of postmastoidectomy cavity

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 325 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.1 Other disorders following mastoidectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.8 Other postprocedural disorders of ear and mastoid process 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.9 Postprocedural disorder of ear and mastoid process, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I00 Rheumatic fever without mention of heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01 Rheumatic fever with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.0 Acute rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.1 Acute rheumatic endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.2 Acute rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.8 Other acute rheumatic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.9 Acute rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02 Rheumatic chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.0 Rheumatic chorea with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.9 Rheumatic chorea without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05 Rheumatic mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.0 Mitral stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.1 Rheumatic mitral insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.2 Mitral stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.8 Other mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.9 Mitral valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06 Rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.0 Rheumatic aortic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.1 Rheumatic aortic insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.2 Rheumatic aortic stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.8 Other rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.9 Rheumatic aortic valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07 Rheumatic tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.0 Tricuspid stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.1 Tricuspid insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.2 Tricuspid stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.8 Other tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.9 Tricuspid valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08 Multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.0 Disorders of both mitral and aortic valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.1 Disorders of both mitral and tricuspid valves

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 326 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.2 Disorders of both aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.3 Combined disorders of mitral, aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.8 Other multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.9 Multiple valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09 Other rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.0 Rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.1 Rheumatic diseases of endocardium, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.2 Chronic rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.8 Other specified rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.9 Rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I10 Essential (primary) hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11 Hypertensive heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.0 Hypertensive heart disease with (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.9 Hypertensive heart disease without (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12 Hypertensive renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.0 Hypertensive renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.9 Hypertensive renal disease without renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13 Hypertensive heart and renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.0 Hypertensive heart and renal disease with (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.1 Hypertensive heart and renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.9 Hypertensive heart and renal disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15 Secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.0 Renovascular hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.1 Hypertension secondary to other renal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.2 Hypertension secondary to endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.8 Other secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.9 Secondary hypertension, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20 Angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.0 Unstable angina

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 327 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.1 Angina pectoris with documented spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.8 Other forms of angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.9 Angina pectoris, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21 Acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.0 Acute transmural myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.1 Acute transmural myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.2 Acute transmural myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.3 Acute transmural myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.4 Acute subendocardial myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.9 Acute myocardial infarction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22 Subsequent myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.0 Subsequent myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.1 Subsequent myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.8 Subsequent myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.9 Subsequent myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23 Certain current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.0 Haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.1 Atrial septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.2 Ventricular septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.6 Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.8 Other current complications following acute myocardial infarction

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 328 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24 Other acute ischaemic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.0 Coronary thrombosis not resulting in myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.1 Dressler syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.8 Other forms of acute ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.9 Acute ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25 Chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.0 Atherosclerotic cardiovascular disease, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.1 Atherosclerotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.2 Old myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.3 Aneurysm of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.4 Coronary artery aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.5 Ischaemic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.6 Silent myocardial ischaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.8 Other forms of chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.9 Chronic ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26 Pulmonary embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.0 Pulmonary embolism with mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.9 Pulmonary embolism without mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27 Other pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.0 Primary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.1 Kyphoscoliotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.2 Other secondary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.8 Other specified pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.9 Pulmonary heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28 Other diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.0 Arteriovenous fistula of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.1 Aneurysm of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.8 Other specified diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.9 Disease of pulmonary vessels, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30 Acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.0 Acute nonspecific idiopathic pericarditis

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 329 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.1 Infective pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.8 Other forms of acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.9 Acute pericarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31 Other diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.0 Chronic adhesive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.1 Chronic constrictive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.2 Haemopericardium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.3 Pericardial effusion (noninflammatory) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.8 Other specified diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.9 Disease of pericardium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32 Pericarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.0 Pericarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.8 Pericarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33 Acute and subacute endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.0 Acute and subacute infective endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.9 Acute endocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34 Nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.0 Mitral (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.1 Mitral (valve) prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.2 Nonrheumatic mitral (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.8 Other nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.9 Nonrheumatic mitral valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35 Nonrheumatic aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.0 Aortic (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.1 Aortic (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.2 Aortic (valve) stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.8 Other aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.9 Aortic valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36 Nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.0 Nonrheumatic tricuspid (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.1 Nonrheumatic tricuspid (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency © eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 330 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.8 Other nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.9 Nonrheumatic tricuspid valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37 Pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.0 Pulmonary valve stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.1 Pulmonary valve insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.2 Pulmonary valve stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.8 Other pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.9 Pulmonary valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I38 Endocarditis, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39 Endocarditis and heart valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.0 Mitral valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.1 Aortic valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.2 Tricuspid valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.3 Pulmonary valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.4 Multiple valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40 Acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.0 Infective myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.1 Isolated myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.8 Other acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.9 Acute myocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41 Myocarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.0 Myocarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.1 Myocarditis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.8 Myocarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42 Cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.0 Dilated cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.1 Obstructive hypertrophic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.2 Other hypertrophic cardiomyopathy

© eHealth DSI Terminologist CEF eHDSI v3.0.0-RC1 Tue Apr 30 16:24:21 CEST 2019 Page 331 of 624 Service Provider MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.3 Endomyocardial (eosinophilic) disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.4 Endocardial fibroelastosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.5 Other restrictive cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.6 Alcoholic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.7 Cardiomyopathy due to drugs and other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.8 Other cardiomyopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.9 Cardiomyopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43 Cardiomyopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.1 Cardiomyopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.2 Cardiomyopathy in nutritional diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.8 Cardiomyopathy in other diseases classified elsewh